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ABSTRACT 
The thesis set out to document the process of developing and testing a non-pharmacological 
biopsychosocial intervention programme which included exercise and health education for women with 
musculoskeletal conditions attending a clinic in a poorly resourced area of the Free State Province in 
South Africa.    To inform the development of an appropriate intervention, several sub-studies were 
undertaken.  Systematic reviews on the use of exercise and health education in adults were undertaken, 
one on the impact of these interventions on adults with chronic diseases of lifestyle (diabetes mellitus 
type II, hypertension) and the risk factor obesity, and the other on the impact on adults with 
musculoskeletal conditions.   The selected research tools, which were chosen based on the framework 
of the International Classification of Functioning, Disability and Health (ICF) were subjected to a rigorous 
translation process.  A facility-based descriptive observational cross-sectional study was undertaken to 
determine the prevalence and nature of musculoskeletal conditions amongst women between the ages 
of 40 and 64 years attending a community clinic.  The gathered information was then used to modify 
and adapt existing non-pharmacological programmes and develop an intervention programme tailor 
made for these patients.  Finally, an experimental randomised controlled trial was undertaken to 
determine the effectiveness of usual care against a non-pharmacological intervention utilising a 
workbook for the women identified in the survey.   
A total of 16 studies met the inclusion criteria for the review of non-pharmacological interventions 
which included exercise and education for the Chronic Diseases of Lifestyle listed above. Of the seven 
papers which reported adequate information to calculate effect sizes, four of the better quality studies 
reported a medium or large effect size in either the physical or mental components of HRQOL or both.  
Three articles met the criteria for inclusion in the systematic review of randomised control trials in 
adults living with musculoskeletal conditions reporting on Health-Related Quality of Life, function and 
participation. The methodological quality of the studies was high and all three reported medium to large 
effects on the outcome variables related to pain at the cessation of the intervention. 
The observational epidemiological study of 1 376 respondents revealed that the  ‘typical’ respondent 
spoke Sesotho, was married, owned her own brick home and stayed in a household with about five 
other people. They could read and write and had attended secondary school.  As they were unable to 
find work, they were unemployed.  They did not receive any benefit grants. They were visiting the clinic 
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either to collect medication or to consult with a health professional.  They were obese but did not take 
any harmful substances.  The prevalence of joint pain (musculoskeletal conditions) was 62% and 53% 
had joint pain (musculoskeletal conditions) in conjunction with either hypertension and/or diabetes 
mellitus type II.  People with joint pain (musculoskeletal conditions) were less likely to have diabetes 
mellitus type II, but there was no association between hypertension and joint pain (musculoskeletal 
conditions).  The Body Mass Index (BMI) was significantly higher in those who reported joint pain 
(musculoskeletal conditions). 
Those with joint pain (musculoskeletal conditions) reported a poorer quality of life, both with regard to 
the EQ-5D-3L index score and the more global VAS score.  Those with joint pain (musculoskeletal 
conditions) experienced a mild effect on participation restriction such as family life, work and social life 
and a moderate effect on their financial position.  They had to stop working or alter their employment.  
They experienced fatigue and depression. They did report significantly more difficulty with 
concentration, walking long distances, washing and dressing and interacting with unknown people and 
friends, than did those without joint pain (musculoskeletal conditions). 
The WHODAS-2 yielded counterintuitive results and after a post-hoc analysis indicated poor convergent 
and divergent validity, the data were not included in further analysis. 
Utilising the above information an exercise programme and workbook for the six weeks exercise and 
education intervention was developed.  The six-week intervention programme utilized physical exercise 
in group format, health education, facilitated the development of self-management, problem-solving 
skills, decision-making skills and how to maintain a balanced lifestyle.  The aim of the intervention was 
to explore the effectiveness of a non-pharmacological six-week intervention programme for middle aged 
women presenting with only musculoskeletal conditions or musculoskeletal conditions and at least one 
of the following co-morbidities:  hypertension, obesity or diabetes mellitus type II.   Enrolment was 
lower than anticipated and 20 participants were allocated to the control group, of whom five were not 
available for the six week follow-up.   All 22 participants randomised to the intervention group remained 
in the study.  The main findings of the study were that in general the intervention had little effect on the 
health conditions, physiological measures or BMI of the participants.  However, there was evidence that 
functional improvement took place in items related to mobility (including distance walked), 
pain/discomfort (including a decrease in the number of pain sites and an increase in the percentage of 
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pain relief), anxiety/depression and fatigue (Self-efficacy for managing chronic disease 6-item scale).  
The Index Score, which is calculated from the EQ-5D-3L dimensions and reflects the QALYs (Quality 
Adjusted Life Years) gained, indicated that,  if the intervention group maintained their improved health 
status for a year, they would have gained one third of a healthy life compared to those in the control 
group. The change in overall Self-efficacy score was also significantly higher in the intervention group.   
In addition, the high compliance with attendance, 88%, and the positive responses to the Acceptability 
Questionnaire, indicated that the intervention was well received and appropriate for this group of 
women.  
It is concluded that the positive impact of the intervention programme suggests that the programme 
should continue at the clinic in question, but be offered at a more convenient time for participants who 
work.  The workbook needs to be modified as it was not well received.  The primary research 
recommendation is that, as the sample size was smaller than anticipated and the study may have been 
under-powered, further research should be undertaken before the intervention is rolled out to other 
clinics in the Free State or even nationally.  The outcome measures will need to undergo further 
validation, particularly those based on numerical concepts and the Likert scale. The dosage of exercise 
would also need to be investigated to determine whether an intervention of longer duration (e.g. three 
months), greater dosage (twice a week for a longer period of time) and a better system of monitoring 
the extra-class exercise would result in a decrease in the impairments and an improvement in the health 
conditions of the participants.   A large, multi-centre trial should assist in determining whether the 
results of this small study can be generalised to the larger population. 
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 “A health condition is an umbrella term for disease, disorder, injury or trauma and may also include 
other conditions, such as ageing, stress, congenital anomaly or genetic predisposition.  It may also 
include information about pathogeneses and/or aetiology” (1). 
“Body functions are defined as the physiological functions of body systems, including psychological 
functions.  Body structures are the anatomical parts of the body, such as organs, limbs and their 
components.  Abnormalities of function, as well as abnormalities of structures, are referred to as 
impairments” (1).  
“Impairments are defined as a significant deviation or loss (e.g. deformity) of structures or/and functions 
(e.g. reduced range of motion, muscle weakness, pain and fatigue” (1).  
“Activity is the execution of a task or action by an individual and represent the individual perspective of 
functioning” (1). 
“Participation refers to the involvement of an individual in a life situation and represents the societal 
perspective of functioning” (1). 
“Activity limitation refers to difficulties at an activity level (e.g. limitation in mobility such as walking, 
climbing stairs, grasping or carrying)” (1). 
“Participation restriction is a problem an individual may experience in his/her involvement in life 
situations (e.g. restrictions in community life, recreation and leisure)” (1). 
Life course - “a sequence of socially defined events and roles that the individual enacts over time".   In 
particular, the approach focuses on the connection between individuals and the historical and 
socioeconomic context in which these individuals have lived (2).
1 
1 INTRODUCTION 
1.1 Background 
Musculoskeletal conditions (MSC) are a major cause of disability in both low- and high- income countries 
and consume a large amount of health and social resources (3-5). It is anticipated that the impact of 
MSC will continue to increase and aging populations will require more and more relief from chronic pain 
and disability (6). However, the field of musculoskeletal conditions is hampered by a lack of 
epidemiological data across a range of geography and treatments (6). 
1.1.1 Extent and nature of the problem 
In the United Kingdom MSC are the most common cause of pain and this high prevalence is mirrored 
around the world (3). Collaborative studies by the World Health Organisation (WHO), the International 
League of Association for Rheumatology (ILAR) and the Community Orientated Programme for Control 
of Rheumatic Diseases (COPCORD), conducted worldwide have provided substantial evidence regarding 
the burden of MSC, particularly the impact of joint pain on communities (3).  
Burden of disease information is an important component required for health planning as it can be used 
to identify the health gaps in the population to improve population health status (7). Fifty four percent 
of Disability Adjusted Life Years (DALYs), could be attributed to non-communicable diseases and MSC 
account for 6.8% of the total DALYs. Undoubtedly, the burden is growing.  In the 2004 Global Burden of 
Disease study, MSC accounted for only 2.0% of the burden (8). In addition, females seem to carry a 
larger proportion of the burden with the females carrying 56% of the DALYS attributed to MSC (9).  In 
low to middle income countries (“developing countries”) the burden is considerably higher, i.e. 21,076 
thousand DALYS as compared to 8,723 thousand in high income countries. 
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Musculoskeletal conditions impact negatively on physical health and there is evidence that individuals 
with musculoskeletal conditions are more likely to experience activity limitations, not only in the short 
but also in the long term.  There is a strong association between pain and decreased physical activity 
and ultimately to being overweight (10, 11). The resulting combination may increase the pain associated 
with MSC and can add to the stress of daily life, making even simple tasks difficult and affecting the 
cognitive ability of the individual.  These factors can negatively affect the quality of life of the person 
with MSC (12).  With the increasing longevity of the population, it is likely that the prevalence of 
musculoskeletal pain in the community will continue to rise (3, 6, 13). The prevalence of MSC is higher in 
women (3, 14, 15) and musculoskeletal conditions increase with age (6, 13, 14, 16).   
Chronic diseases of lifestyle (CDL) are a group of diseases that develop over many years, have slow 
progression, are complex and have a poorly understood aetiology (17).  The projected increase of CDL 
between 2010 and 2020 is estimated to be 15% globally (18-20).  Inadequate physical activity has been 
linked to a wide variety of chronic diseases of lifestyle, and moderate intensity activity is viewed as being 
protective (17-20).  
It is reasonable to assume that there might be an interaction between musculoskeletal pain and 
diminished levels of physical activity.  However, the influence of musculoskeletal conditions on physical 
activity,  and therefore indirectly on CDL,  is not well documented,  despite the high prevalence of these 
conditions; and the fact that HRQOL is the most important indicator of the impact the group of diseases 
has on a population (3).  
Obesity, a major risk factor for CDL, is reaching epidemic proportions around the world. There is no 
difference in proportions between obesity and musculoskeletal pain (7). As the prevalence of obesity 
continues to grow, there is likely to be a considerable impact on the musculoskeletal burden globally in 
the foreseeable future  (9).  
It would appear that there is a need to interrogate not only the relationship between MSC, CDL and 
obesity within middle-aged women  living in under-resourced areas in South Africa, but also 
preventative strategies to manage these conditions, especially with the increase in prevalence and the 
negative impact they have on the individual and society at large. 
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1.1.2 Management of co-morbidities and musculoskeletal conditions 
The growing burden of disease due to ageing can be ameliorated to some extent by preventative 
strategies, for example encouraging moderate physical activity and weight loss, (9) eating nutritious 
foods, refraining from using tobacco products and avoiding consumption of alcohol (21).  Moderate 
physical exercise and appropriate nutrition underpin many of the preventative strategies for both 
musculoskeletal conditions and co-morbidities.  The prophylactic effects of physical exercise are well 
described and researched (6) and a large percentage of CDL are attributed to sedentary lifestyles (6). 
Many studies have demonstrated the beneficial effects of exercise interventions which target behaviour. 
Improvement in health-related behaviours and HRQOL was recorded in employees of clothing/textile 
manufacturing companies in South Africa who participated in a six-week intervention programme 
utilising exercises, education, goal setting and pacing (22).  Similarly, a six-week aerobic exercise 
programme in women with fibromyalgia syndrome showed improvement not only in cardiovascular 
fitness but also in flexibility and a decreased number of tender points (23).  
The literature reports that there are a large number of disadvantaged women with co-morbid MSC and 
CDL. Self-management and exercises have been found to have a positive effect on these women and
may also have an impact on their quality of life, self-efficacy and the self-management of their 
conditions. 
Pragmatic trials are gaining greater acceptance and they (24) “are designed to evaluate the effectiveness 
of interventions in real-life routine practice conditions, whereas explanatory trials aim to test whether 
an intervention works under optimal situations. Pragmatic trials produce results that can be generalized 
and applied in routine practice settings (24).”  As it is apparent that, in the clinical situation, relatively 
few women have MSC in isolation, developing and testing an intervention on women who do have co-
morbid conditions, through the use of a pragmatic rather than an explanatory trial may yield 
information which will be of more use within the intended future context of such intervention.  
In addition, there may be shared risk factors for MSC and CDL, such as obesity and lack of exercise, and a 
programme that addresses these risk factors may result in improvement in both health conditions. 
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The focus of this thesis was the management of MSC but as the CDL and risk factors included in the 
study are very commonly co-morbid in this group of women, and exercise has been found to have a 
positive impact on all these conditions, a secondary goal was to determine whether the intervention, 
which was aimed at MSC primarily, would also have a positive influence hypertension, Diabetes Mellitus 
type II and obesity. 
1.1.3 Research questions 
The primary research question was whether a non-pharmacological intervention designed to manage 
MSC in middle-aged women would result in an improvement in pain, functioning and HRQOL.  However, 
as this was a pragmatic trial, it was necessary to address the frequent co-morbidities and risk factor of 
obesity. The research questions thus included the following. What is the evidence base for non-
pharmacological interventions for the management of MSC and hypertension, Diabetes Mellitus Type II 
and obesity? What is the prevalence and impact of MSC within female patients attending clinics who are 
likely to have co-morbid MSC and CDL? Can a holistic approach to the management of women with MSC 
and in some cases, co-morbid CDL, be developed? How should intervention programmes be modified to 
meet the cultural and functional needs of these patients? Would the participants attend and find such a 
programme enjoyable? What would be the impact of such an intervention on pain, functioning and 
HRQOL?  
1.2 Aims and objectives of the thesis 
The ultimate aim of the study was to develop and test a non-pharmacological intervention which 
included exercise and health education for women with MSC attending a clinic in a poorly resourced 
area of the Free State in South Africa. Before this could be achieved, however, several other objectives 
had to be met, and these are set out below.  
 The current practice and impact of such programmes for those with CDL and MSC needed to be
established through systematic reviews.  The objectives of these reviews were to:
o determine what exercises or education  are used for adults with diabetes mellitus type
II, hypertension or obesity and musculoskeletal conditions and to ascertain what the
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impact of exercises or education is on the HRQOL, function and participation of adults 
with diabetes mellitus type II, hypertension or obesity and musculoskeletal conditions. 
 In order to plan or modify an intervention, it was necessary to establish the prevalence and
nature of musculoskeletal conditions within the target population of adult middle-aged women.
The specific objectives of the epidemiological sub-study were, within women between the ages
of 40 – 64 years, attending a community clinic in the Free State, to:
o determine the prevalence of joint pain  (musculoskeletal conditions) as measured by the
COPCORD Phase I and II questionnaire;
o determine the nature of joint pain (musculoskeletal conditions)  as measured by the
COPCORD Phase I and II questionnaire;
o establish the most common clusters/patterns of co-morbidities in women experiencing
joint pain (musculoskeletal conditions) as measured by the COPCORD Phase I and II
questionnaire;
o determine the relationship between diabetes type II, hypertension and musculoskeletal
conditions; and
o determine what demographic risk factors (e.g. smoking, obesity ) are associated with
joint pain (musculoskeletal conditions) in these women as measured by the COPCORD
Phase I and II questionnaire;
 The second aim of the sub-study was to determine the impact of musculoskeletal conditions on
activity limitations and participation restrictions within the target population.  The specific
objectives were, within women between the ages of 40 to 64 years, attending a community
clinic in the Free State, to:
o determine the health-related quality of life as measured by the EQ-5-3L;
o determine the functional impact  of joint pain (musculoskeletal conditions) on middle-
aged women  presenting with joint pain (musculoskeletal conditions) as measured by
the WHODAS 2.0; and
o establish the prevalence of dysfunction and/or participation restrictions of participants
to inform the content of the intervention programme.
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 The next aim was to modify and adapt existing non-pharmacological programmes into a non-
pharmacological intervention programme for the target population, with the programme
designed to educate, empower, maximise functional status and improve the quality of life of the
women.
The objectives of the development of the intervention component were to: 
o modify and adapt existing programmes into an intervention programme based on the
results of the systematic reviews and the needs of the participants identified in the
survey;
o compile and design a visually attractive, understandable and explanatory intervention
programme incorporating education, behavioural changes and exercises for women
attending a community clinic with joint paint (musculoskeletal conditions), diabetes
type II, hypertension and obesity;
o compile the intervention programme according to existing guidelines, but to tailor the
programme to the environment and culture of the participants; and
o include the participants identified in the survey of the study in the decision-making
regarding the appropriate programme with regards to their environment and culture
with the aim of increasing compliance with the programme, and to maximise functional
status and the improvement of quality of life of the participants.
The final aim was to explore the effectiveness of a non-pharmacological six-week intervention 
programme for middle aged women presenting with only musculoskeletal conditions or musculoskeletal 
conditions and co-morbidities. 
 The objectives were to determine:
o whether the intervention would result in  a significant difference between the
intervention and control groups with respect to joint pain,  as measured by the Brief
Pain Inventory (Short Form);  HRQOL in women with only joint pain or joint pain and at
least one of the following co-morbidities:  diabetes type II, hypertension and obesity as
measured by the EQ-5D-3L; the functional impact of joint pain on the individual and co-
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morbidities as measured by the Simmonds battery of functional tests and the six-minute 
walk test; and 
o determine the interrelationship between joint pain  (musculoskeletal conditions) and
co-morbidities of individuals as measured by blood pressure, body mass index, venous
glucose readings and cardiovascular fitness using the three-minutes step test.
The long-term aim of the study was either to make available an appropriate, effective workbook or an 
appropriate, sustainable, community integrated, peer-led exercise and education programme for the 
inclusion in the management of musculoskeletal conditions in middle aged women. The workbook and 
the programme should also take the specific needs of the target group into account, and should be 
feasible, effective and acceptable to the community. 
1.3 Significance and justification of the study 
As this was to be a pragmatic study, it made sense to investigate whether there was an interaction 
between the CDL, obesity and MSC.  
1.3.1 Significance of the study 
The influence of MSC on physical activity, and therefore indirectly on CDL is not well documented and 
the impact of joint disease on the functioning of people with CDL has not been adequately studied, 
despite the widespread prevalence of these conditions. The development of an effective exercise and 
education programme using cognitive behavioural principles targeting MSC as well as CDL through 
lifestyle changes and exercise may not only improve the quality of life of participants but may also 
improve their health conditions and in the long term encourage other community members to change 
their lifestyle and behaviour. 
Due to the epidemiological transition that is rapidly occurring, primary health care systems should be 
developing an approach for the management of CDL, responding effectively to community and 
individual needs.  Physiotherapists should target primary level care to minimise the impact on 
functioning and quality of life of those individuals with MSC who are unable to access therapy.   
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Establishing a quality primary health care service will ensure a comprehensive response to a growing 
health care burden, especially in resource poor settings and may have a potential economic impact (25). 
For the optimal planning of quality primary health, care systems need to address the growing health 
burden of CDL, research studies are needed to determine the risk factors of health problems, as well as 
the distribution of health problems in South Africa (25, 26).  It is therefore hypothesised that an 
intervention programme that targets MSC and which includes exercises, behavioural changes and 
education may result in not only improving function and also reducing the impact of diabetes mellitus 
type II, hypertension and obesity, and in addition may enhance the impact of medical interventions that 
are currently offered. 
The impact of the study will be the formalisation of the role of rehabilitation within the primary health 
care setting. The study will provide a model for introducing and sustaining exercise programmes in the 
community, and will provide evidence for a programme that can empower a group of people who are 
often neglected by the health system. 
1.3.2 Justification for the choice of study sample 
Based on the review of the literature and the local context, the target population chosen for this 
research was middle-aged women (45-60 years of age) residing in under-resourced areas and attending 
a primary health care clinic. The justifications for the choice of these parameters are as follows. 
People living in socially deprived areas are more prone to musculoskeletal symptoms and as a result of 
this have worse functional outcomes (27, 28).  These reports, coupled with the BoD estimation of the 
considerably higher burden due to MSC in low to middle income countries, support the targeting of 
people living in under resourced areas. An obvious setting for the provision of interventions would 
appear to be the primary health care clinics, as these are accessible to those living in the less resourced 
areas of South Africa and service those with fewer resources who are unable to afford private health 
care.  
The targeting of females was done on both epidemiological and pragmatic grounds. Several studies have 
indicated that females are more likely to utilise public health services (29, 30). Copley et al (2013) 
conducted a study on MSC at a health care centre in the Bloemfontein area  and reported that 64% of 
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the attendees were female (31). In addition, there is evidence to suggest that females have a higher 
prevalence of MSC (3, 14, 15) and bear a disproportionately larger burden of disease due to MSC (56% 
of the DALYs due to MSC compared to 46% in males)(9). This appears to be true within local South 
African settings. In a similar setting in Cape Town, Parker and Jelsma (2010) screened 1005 individuals 
attending a primary health care clinic for MSC. Of these, 33% reported MSC not due to trauma or 
previous injury (32).  Of relevance is that more than 80% of the individuals living with MSC were female, 
an even  larger proportion than the 1.6:1  ratio of women to men who live with joint pain reported in a 
previous study (33).  In the Bloemfontein clinic 46% reported MSC, of which 64% were female (31).  
Based on both international and local studies, it therefore seemed reasonable to investigate the 
prevalence and impact of MSC in this particular group of women. In a situation where resources are 
limited, it was suggested that intervention aimed at this group might possibly be more cost effective and 
reach a greater number of the target group. As the intervention was to be culturally appropriate and 
include traditional forms of activity, the decision was made to exclude men as their interests and 
preferred physical activities were likely to be different to the women (34-36). 
The age range was chosen to reflect the evidence that musculoskeletal conditions increase with age (6, 
16, 26, 37).  In the Parker and Jelsma (2010) study, the mean age of those with joint pain was 51.7 years 
(eight years older than those without pain) and in the Copley study, the average age was 53 years.  As 
the inclusion criteria for the intervention study was middle aged women, the upper limit of 64 years was 
chosen. According to the World Health Organization most developed countries have accepted the 
chronological age of 65 years as a definition of 'elderly' or older person (38).  Unfortunately, like many 
westernized concepts, this does not always adapt well to the situation in Africa.  According to the World 
Health Organisation, if a definition in Africa is to be developed, it should be either 50 or 55 years of age, 
but this is somewhat subjective and introduces additional problems of data comparability across nations 
as there is not set age limit for old age in the literature for Africa  (38). The more traditional African 
definitions of an elder,  correlates with the chronological ages of 50 to 65 years, depending on the 
setting, the region and the country.  Adding to the difficulty of formulating an accurate definition, actual 
birth dates are quite often unknown to individuals in Africa, as many individuals do not have an official 
record of their birth date.  In addition, definitions of ageing can differ widely from traditional or 
community definitions.  Therefore the researcher decided to follow the lead of the developed worlds  
and use the chronological age of 65 years as a definition of 'elderly' or older person (38).  In addition, the 
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systematic reviews discussed in Chapters 3 and 4, almost all include participants within this age range, 
although several studies do include older participants. 
The inclusion of co-morbidity information in the current study was based on the two local studies cited 
above which indicated that co-morbidities were very common in women with MSC and that the most 
common were hypertension (59.1%) and diabetes (24.8%) (32).  The Copley study additionally reported 
that the participants reporting MSC had a higher prevalence of hypertension and Type II Diabetes than 
their counterparts.  According to the National Demographic and Health Survey of South Africa 1998 30% 
of women in South Africa were obese and those more affected were  black women (39).  Obesity is very 
common in people living in under-resourced areas in South Africa.  Puoane et al (2005) indicated that  
obesity is a major public health problem among black women living in urban areas in South Africa (40). A 
study conducted by van Zyl et al (2012) found  that 26.2% of women in urban and rural settings in South 
Africa were obese in 2011(41). Twenty three percent of women in KwaZulu-Natal, South Africa enrolled 
in a HIV prevention trial were obese according to a study conducted by Wand et al (2013).  A total of 
5 495 women were enrolled in the programme(42).  As this was to be a pragmatic study, it made sense 
not to exclude participants with joint pain (musculoskeletal conditions) who had these co-morbid 
conditions as the pool of eligible participants was likely to have one or more co-morbidities. 
In summary, primary health clinic based interventions target those living in under-resourced areas in 
South Africa and the majority of the attendees are women. A large proportion of these women have 
MSC, CDL, obesity or a combination of these conditions.  The focus of the present study was on joint 
pain but as co-morbidities including diabetes mellitus type II, hypertension and obesity are so common 
among the populations as described above, the development of the intervention needed to address 
these conditions as well. 
1.4 Research setting for the proposed study 
The study was conducted at a community clinic situated in the Bloemfontein area.   The clinic is also a 
referral centre for primary health care clinics and serves as a centre for the follow-up of down-referrals.  
The clinic is situated in Mangaung in a peri-urban environment serving patients from both formal and 
informal settlements (43).  Most of the patients attending the clinic are black and the services at the 
clinic are free of charge and easily accessible for community members in the area.  The clinic was chosen 
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due to its location in the Bloemfontein area and due to the large patient population, ranging between 
19 000 – 22 000 people utilising the centre/clinic services (31).
1.5 Outline of the thesis 
The thesis consists of the following chapters: 
Chapter 1 briefly outlines the background and motivation for the study, and then presents the aims and 
objectives of the different components. 
The following three chapters report on literature reviews. Chapter 2 presents a narrative review 
providing a conceptual framework for the study, and discusses the literature on CDL, including obesity 
and MD.   The role of exercise is examined with regard to the physiological effects of exercise and its 
impact on different CDL.   Finally the research setting is discussed within the context of the primary 
health care system. Chapters 3 and 4 are systematic reviews on the role of exercise and health 
education in CDL and MSC. 
As the use of validated instruments is essential to ensure internal validity, Chapter 5 describes the 
process of identifying and translating the outcome measures used in the study.   As the majority of the 
participants spoke Sesotho, a rigorous translation process was followed, including cognitive debriefing 
of respondents.   
Chapter 6 describes the epidemiological sub-study which was undertaken to establish the prevalence 
and impact of CDL and MSC.   In Chapter 7, the process of integrating the relevant data gathered in the 
previous studies to develop an intervention is described.   Chapter 8 presents the pragmatic intervention 
sub-study, including the methodology, results and discussion. 
Finally, in Chapter 9, the research questions and aims and objectives of all components are revisited and 
recommendations regarding clinical practice, policy and further research are offered. 
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2 NARRATIVE LITERATURE REVIEW 
2.1 Introduction 
Two aims were addressed during the narrative literature review.  The first was to provide an overview of 
the prevalence of musculoskeletal conditions and common chronic diseases of lifestyle, more specifically 
hypertension, diabetes mellitus and obesity.  The second aim of the narrative review was to describe the 
role of exercise as a primary health care intervention in addressing the International Classification of 
Functioning, Disability and Health Framework (ICF)  constructs of impairment, functional limitation and 
participation restriction (including Health Related Quality of Life) for each of the conditions.   
The International Classification of Functioning, Disability and Health Framework (ICF) will be discussed as 
an introduction to the narrative review as it is an accepted model of the interaction between 
functioning, disability and health.  The ICF is a meaningful way to communicate the functional 
limitations that individuals experience, especially with CDL, and it also structures the patient’s problems 
for rehabilitation purposes.  This chapter, therefore, describes the health conditions and impairments 
which fall under the umbrella term of chronic diseases of lifestyle and discusses the bidirectional 
relationship between functioning (physical activity), impairment and health condition.  The contextual or 
environmental factors and the impact of these on access to health care are also briefly discussed. 
Chronic diseases of lifestyle (CDL),  also known as non-communicable diseases,  are a group of diseases 
that develop over many years due to lack of moderate, regular exercise and the unhealthy diets of 
modern lifestyles  (44) and are increasing substantially in all strata of South African society (45).  These 
diseases include amongst others hypertension and diabetes mellitus type II.  Obesity, a major risk factor 
for CDL,  is reaching epidemic proportions around the world and there seems to be a definite association 
between obesity and musculoskeletal pain (7).  Obesity and CDL also share the same modifiable risk 
factor of decreased physical activity.   
Musculoskeletal conditions(MSC) are one of the main causes of disability in developed and developing 
countries worldwide (3, 9, 46) and the management of both MSC and CDL  consumes a large amount of 
health and social resources and will become increasingly important as aging populations require greater 
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relief from chronic pain and disability (3-5).  As mentioned previously, it would appear that there is a 
need to interrogate the relationship between MSC, CDL and obesity within middle-aged people living in 
under-resourced areas in South Africa. 
 
Therefore, hypertension, diabetes mellitus type II, obesity and musculoskeletal conditions are discussed 
below within the ICF framework, with an emphasis on health condition and impairments.  In addition, 
possible interaction between MSC and CDL, the risk factor obesity, the physiological effects of exercise 
as well as the role of exercise in each of the conditions are addressed.  The environmental factors that 
influence the development and management of CDL, particularly the role of primary health care are also 
included in this chapter. Finally the research setting is described to provide contextual information to 
the study. 
 
The electronic databases Africa-Wide, CINAHL, The Cochrane Library, PEDro, PsychArticles, PsycInfo, 
PubMed (which includes Medline), Scopus (which indexes Embase), Web of Science, Science Direct and 
SportDiscuss were searched.  The only limit to the searches was in the inclusion of English articles.  No 
limits were set regarding dates of articles as important information could have been missed if excluded.  
Cross-referencing and hand-search methods were also utilised.  Suitable academic books were also 
included in the search.  In the case where articles were not available, inter-library loans were utilised 
(national and international) to minimise loss of possible secondary sources of data.  The search terms 
used included “prevalence”, epidemiology” or “incidence” of “diabetes”, diabetes mellitus type II”, 
diabetes mellitus type 2”, “type 2 diabetes mellitus” of “hypertension”, “high blood pressure”  of 
“obesity” of “joint pain”, “chronic joint pain”, “musculoskeletal condition”, “musculoskeletal disorders”. 
 
2.2 International Classification of Functioning, Disability and Health 
Framework (ICF) 
 
The World Health Organisation’s International Statistical Classification of Diseases and Related Health 
Problems (ICD10) has been used worldwide to classify health conditions and to gather epidemiological 
data  for different countries (47), but the ICD10 does not describe the overall the functioning and 
disability attendant on the health conditions.  To address this need the WHO developed a new tool in 
1980 for the classification of the consequences of diseases,  called the International Classification on 
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Impairments, Disabilities and Handicaps (ICIDH) (47).  This was subsequently revised and in 2001 the 
International Classification of Functioning, Disability and Health (ICF) was launched.  The updated 
version was  endorsed by the 54th World Health Assembly in 2001 as the framework for measuring 
health and disability at both population and individual level (48).  The ICF  presented a  new conceptual 
framework for the understanding of health, functioning and disability (49) that can serve as the starting 
point for the understanding of the human experiences of functioning and disability. The framework 
emphasises the non-linear relationship and the interrelatedness of health condition, physical function, 
social function and environment in which the person lives in the determination of the well-being of the 
individual, in that all components may influence, and in turn be influenced by, each of the other 
components (49).   
 
The ICF clarifies the concepts of “health” and “disability”, and acknowledges that each and every 
individual can experience a decline in health and also experience some degree of disability.  The ICF also 
allows for record keeping of the impact of the environment on the individual’s functioning by including 
contextual factors in the classification system (48).  
 
Diagnosis alone does not adequately capture the health outcome of individuals and populations, 
especially related to chronic diseases of lifestyle, and therefore the ICF is becoming more and more 
important in improving the quality of data on morbidity and diseases.  The ICF is not limited to 
addressing Western concepts, but has worldwide cultural acceptability as it follows the principle of a 
universal model that covers the entire lifespan of an individual and is multi-dimensional.  Most 
importantly the ICF addresses human functioning and not merely disability (49, 50).  
 
The ICF framework provides a coherent view of the medical and social model (Figure 1)(51).  The 
medical model views disability as a problem caused directly by trauma, disease or other health 
conditions, and utilises individual medical treatment and management of the disability, while the social 
model views disability as being caused by cultural, environmental and social factors (49).   A third model 
is the biopsychosocial model which is viewed as an important conceptual framework behind the ICF and 
attempts to integrate the medical and social model.   In this model the disability of the individual 
emerges as a result of the consequence of personal, biological and social factors (52).   
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Figure 1: The model of functioning and disability upon which the ICF framework is based  
The contextual component which forms part of the ICF framework represents the living situation of an 
individual and the individual’s complete background.  Within the contextual component the 
environmental factors include the social and physical environment of the individual as well as the 
attitude of  a society in which they function (1).  The factors are seen as external to an individual and can 
either act as a barrier or as a facilitator in the individual’s life.  Personal factors are the background of an 
individual’s life and living situation and include gender, age, race, lifestyle and habits (1).  Risk factors are 
mostly associated with the onset of the health condition, but also interact with the disabling process at 
each stage of the health condition.  Risk factors could include personal factors including lifestyle and  
genetic predisposition as well as environmental factors which may include work and living conditions of 
the individual (1).   As discussed below, the primary health care approach to the management of health 
conditions is an essential aspect of the context or environment of the participants of the study. 
The uniqueness and strength of the ICF lies in the potential to improve clinical practice and health 
services, especially in the field of MSC.  If utilised optimally, it may result in more efficient health 
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management and stimulation of research.  The ultimate goal is to optimize participation not only from 
the individual’s perspective, but also from society’s perspective (1). 
In conclusion, the ICF serves as a framework for understanding the impact of MSC on an individual and 
society (1)and is increasingly being used in clinical practice to formulate patient’s problems effectively 
(1).  The components of the ICF can form the basis for research which leads to better understanding of 
functioning, disability and health and their interaction (1).  The non-linear relationship between the 
components and the recognition that each component can influence any of the other components (e.g. 
functioning in the form of physical activity can influence and be in turn affected by e.g. health condition) 
was central to the conceptualisation of this study (50).  A further influence of the ICF on the study is that 
disability is seen as being aetiologically  neutral and this allows for the common management of 
functional limitations, regardless of the  specific health condition (diabetes mellitus type II or 
hypertension or obesity)(53).     
2.3 Chronic diseases of lifestyle 
The term non-communicable diseases or chronic diseases of lifestyle (CDL)  is commonly used in studies 
investigating burden of diseases and represent a group of diseases that develop over many years due to 
lack of moderate, regular exercise and the unhealthy diets of the modern lifestyles (44) and which 
exclude injuries (54).  
There is controversy in the literature regarding hypertension, diabetes mellitus and obesity which are 
classified as CDL by some authors and as risk factors for chronic diseases of lifestyle by others (44, 55-
58).  For example, obesity, diabetes mellitus type II, hypertension, coronary heart disease, stroke, 
cancer, chronic inflammatory bowel diseases , RA, chronic obstructive pulmonary disease, asthma, 
osteoporosis, eye diseases and dementia or Alzheimer disease have all been labelled as CDL by Boeing et 
al., (2012) during a critical review investigating whether vegetables and fruit are effective in the 
prevention of CDL (59).  Contrary to this Coleman (1998); Beaglehole (2007) and the World Health 
Organisation (2010) do not view obesity as a CDL but as a risk factor for CDL (44, 55-58).  Taking into 
consideration all the evidence any chronic condition excluding an injury could per operational definition 
be classified as a CDL, especially if contributing to the burden of disease and using resources related to 
all the other CDL listed in the literature. 
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Contrary to the widely held view that CDL are confined to those in higher income brackets, there is 
growing evidence that the prevalence of CDL are high in people living in lower income areas (45, 51) and 
the prevalence is  increasing substantially in all strata of South African society (45, 51).  In 2005 43% of 
total deaths in South Africa were attributed to CDL while CDL were responsible for 36 million deaths 
globally in 2008, and 80% of these deaths were in low-income countries (18).  In 2010, 65% of the nearly 
59 million deaths per year occurring in the world  were due to CDL and the projected increase for CDL 
between 2010 and 2020 is estimated to be 15% globally (19, 20, 60, 61).   
In the urban black population in South Africa the most common causes of mortality and morbidity 
associated with CDL are hypertension and DM type II (62).  Data from South Africa indicated in 2000 that 
the burden of CDL, particularly diabetes and cardiovascular diseases, (which includes hypertension and 
stroke), is increasing in the urban Black African population (7).  
CDL usually start in middle age after years of exposure to an unhealthy lifestyle,  resulting in higher risk 
factors such as hypertension, dyslipidemia, diabetes and obesity that act independently and 
synergistically (63). These risk factors are often undiagnosed and inadequately managed in health 
services designed mainly to treat acute conditions.  Chronic conditions are mistakenly considered to 
have a limited impact on burden of disease in Sub-Saharan Africa, mainly because of the high rate of 
infectious diseases (44) (63). 
As the risk factors are similar in most of the CDL, it is becoming increasingly common for many patients 
to present with more than one chronic disease of lifestyle and the prevalence of co-morbidity conditions 
are increasing as the population ages (63).   
In conclusion due to the epidemiological transition that is rapidly taking place, primary health care 
systems should be developing an approach to the management of chronic diseases of lifestyle (25). 
According to Steyn et al.,  (2012) “The pattern of chronic disease is changing as the determinants and 
risk factors for chronic diseases of lifestyle develop in this society in transition” – a process dubbed “the 
epidemiological transition” by Omran 1983 (64).  Socio-economic development and rapid globalisation is 
altering the patterns of chronic diseases of lifestyle in South Africa and this transition is predicted by 
changes in demographics and nutritional needs of communities (44). 
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2.4 Chronic diseases of lifestyle (Prevalence and health conditions) 
 
The literature reviewed, using the search terms as described above, reveal a trend towards an increasing 
prevalence of the CDL of diabetes mellitus type II, hypertension, musculoskeletal conditions and the risk 
factor obesity (Table 1).   Not all of the papers were sourced but those in which the primary objective 
was to report on the prevalence of the condition worldwide and those that reported studies in South 
Africa were included.  A spectrum of dates was included to indicate the increasing prevalence of each 
condition.   
 
Table 1: Information related to prevalence of health conditions 
Health condition Country Information related to prevalence Reference(s) 
 
 
 
 
 
 
 
 
 
Diabetes mellitus  
and diabetes 
mellitus type II 
 
 
 
 
 
 
 
 
 
 
Worldwide Age-specific diabetes prevalence estimated was 
applied to United Nations population estimates 
and projections for the number of adults by King et 
al (1998) and indicated that the prevalence of 
diabetes would rise from 4.0% in 1995 to 5.4% in 
2025.  In high income countries the estimated 
increase will be from 6.0% to 7.6% and in low and 
middle income countries the increase will be from 
3.3% to 4.9%. 
 
(65) 
Worldwide A study conducted by Wild et al (2004) 
extrapolated diabetes prevalence data and 
estimated the prevalence rate of diabetes to be 
2.8% in 2002 and 4.4% in 2030.   
(66) 
Low- and middle-
income countries 
According to the Diabetes Atlas (2006) which is 
viewed as a flagship publication by the 
International Diabetes Federation around 246 
billion people live with diabetes type I and II.  
(67) 
199 countries 
and territories 
Trends were estimated by Danaei et al (2011) from 
health examination surveys and epidemiological 
surveys.  The authors concluded that the diabetes 
prevalence doubled from 1980 – 2008. 
(68) 
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Health condition Country Information related to prevalence Reference(s) 
Worldwide The findings of the estimate study of Danaei et al 
(2011) also indicated that In 2008, 9.8% men and 
9.2% women were living with Diabetes mellitus. 
(68) 
Worldwide According to the National Diabetes Federation In 
2014, 415 million adults were living with diabetes 
and in 2040 an estimated 642 million will be living 
with diabetes. 
(69) 
Yonchon county, 
South Korea 
A population based cross-sectional study with 
random cluster sampling was performed by Park et 
al (1994) on 3804 residents and the prevalence 
rate for diabetes was 7.2%. 
(70) 
Australia A cross-sectional survey was conducted by 
Dunstan et al (2002) on 11 247 participants older 
than 25 years of age in Australia and found that 
the prevalence rate of diabetes was 8.0% in men 
and 6.8% in women. 
(71) 
China A national study was performed from 2007 to 2008 
by Yang et al to determine the prevalence of 
diabetes in China.  A nationally representative 
sample indicated that the prevalence rate for 
diabetes was 9.7%.  The prevalence was 10.6% 
among men and 8.8% among women. 
(72) 
South Korea According to Vital Statistics Korea, diabetes is 
ranked in the top five causes of death (2011). 
(73) 
USA According to the Centre for Disease Control and 
Prevention diabetes is the seventh leading cause of 
death in the USA (2011). 
(74)
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Africa Published prevalence rates for diabetes in different 
populations and projected age distributions were 
used by Amos et al (1997) to estimate that by the 
year 2010 the total number of people with 
diabetes is projected to reach 221 million.  The 
regions with the greatest potential increase are 
Asia and Africa where diabetes rates could rise 2-3 
times those experienced currently. 
(75) 
Cape Town, 
South Africa 
A three-stage proportional, stratified, random 
cluster method was used by Levitt et al (1993) to 
determine the age-adjusted prevalence of diabetes 
in urban settings to be 8% age-adjusted to world 
population figures.   
(76) 
Durban, South 
Africa 
A modified glucose tolerance test was performed 
on 479 urbanised South African black individuals in 
a study conducted by Omar et al (1993).  The 
results of the study indicated that the prevalence 
rate of diabetes was 4.2%, with 5.2% in women 
and 2.3% in males. 
(77) 
South Africa A cross-sectional study in which an oral glucose 
tolerance test was performed was conducted by 
Erasmus et al (2001) on 374 Xhosa speaking factory 
workers.  The results indicated that the age-
adjusted prevalence using a standardised world 
population was 4.5% amongst peri-urban Xhosa 
speaking individuals. 
(78) 
South Africa A multi-centre, observational study was conducted 
by Connor et al (2005) on patients attending 
general practices in South Africa.  The results of 
the study indicated that diabetes was the most 
common risk factor in Asians (24%) but least 
common in whites (8%). 
(79)
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Kwa-Zulu Natal, 
South Africa 
A cross-sectional study conducted by Motala et al 
(2008) on 1 025 subjects using an oral glucose 
tolerance test indicated that the overall age-
adjusted prevalence rate of diabetes was 3.9% 
amongst rural dwellers. 
(80) 
South Africa According to the World Health Organisation the 
age standardised mortality rate for diabetes is the 
25th highest in the world (2007). 
(81)  
South Africa The World Health Organisation (2007) also 
indicated that the age standard mortality rate for 
diabetes is 50 per 100 000 of the population. 
(81)  
Southern Free 
State, South 
Africa 
A study conducted by van Zyl et al (2012) utilising 
interviews conducted by trained researchers found 
that the prevalence of self-reported diabetes 
mellitus was 11.1% in rural and 8.1% in urban.   
(41) 
Hypertension 
High, Low- and 
middle-income 
countries 
Different data from different regions of the world 
were pooled together by Kearney et al (2005) 
during a published literature review.  The 
estimated total number of adults with 
hypertension in 2000 was 972 million, 333 million 
in economically developed countries and 639 
million in economically developing countries.  The 
predicted increase in 2025 is about 60%.  
(82) 
90 Countries Systematic analysis of population-based studies 
from 90 countries from 1995 – 2010 was 
conducted by Mills et al (2016).  In 2010, 31.1% of 
adults in the world had hypertension in high 
income countries and 31.5% in low- and middle 
income countries.   
(83)
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Portugal A population-based cross-sectional survey was 
conducted in 2011–2012 by Polonia et al (2014).  
The overall prevalence of hypertension was 42.2%. 
(84) 
Bogota, Columbia Using data from previous studies, Cano-Gutierrez 
et al (2015) estimated that the prevalence of 
hypertension in 2012 in adults 60 years and older 
was 56.9%. 
(85) 
Henan Province, 
China 
A cross-sectional survey was conducted by Fan et 
al (2014) in 2012 on 18 772 randomly selected 15-
74 year old individuals.  The crude prevalence of 
hypertension was 24.9% and the standard rate was 
26.6%, meaning that 25 million were hypertensive 
in the Henan Province.   
(86) 
South Africa A multi-centre, observational study was conducted 
by Connor et al (2005) on patients attending 
general practices in South Africa.  The prevalence 
of hypertension was 59% in Black African people in 
2001.    
(79)  
South Africa A multi-centre, observational study was conducted 
by Connor et al (2005) on patients attending 
general practices in South Africa indicated that 
hypertension was the most common risk factor in 
all population groups (55%). 
(79)  
South Africa A World Health Organisation comparative risk 
assessment was performed by Norman et al (2007) 
and the results indicated that hypertension caused 
9% of all deaths in South Africa in 2000. 
(51) 
South Africa Data from 59 227 individuals who participated in 
the 2010 household survey was analysed by 
Hasumi et al (2012) which that self-reported 
hypertension for adults 18 years and older was 
10.4%.  The prevalence increased significantly with 
age for both male and females.   
(87)
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Eastern Cape, 
South Africa 
A cross-sectional survey utilising a structured 
interview was conducted by Igumbor et al (2011) 
indicated that the prevalence of self-reported 
hypertension was 24 % in rural villages. 
(26) 
Free State, South 
Africa 
A study conducted by van Zyl et al (2012) utilising 
interviews conducted by trained researchers found 
the prevalence of self-reported hypertension in 
rural areas was 62.6%. 
(41)    
Free State, South 
Africa 
A study conducted by van Zyl et al (2012) utilising 
interviews conducted by trained researchers found 
the prevalence of self-reported hypertension in 
urban areas was 48.3%. 
(41)    
Musculoskeletal 
conditions 
Indonesia During a COPCORD survey conducted by 
Darmawan et al (1992) in urban and rural 
populations in Indonesia it was found that the 
incidence of joint pain was 23.6% in rural areas and 
31.1% in urban areas. 
(88) 
Bighwan village, 
India 
During a COPCORD survey conducted by Chopra et 
al (1996) 4096 adults were interviewed and 746 
(18.2%) indicated that they were living with a 
rheumatic disease.   
(89) 
United States of 
America 
Data were reviewed from available surveys by 
Lawrence et al (1998) which determined that the 
prevalence of arthritis is estimated to rise from 
15% in 1990 to 18.2% for 2020, an increase of 57%. 
(90)  
Grampian region, 
United Kingdom 
During a survey conducted in the Grampian region 
of the UK conducted by Elliot et al (1999) it was 
found that 1817 individuals from 3605 individuals 
(50.4%) indicated self-reported chronic joint pain, 
equivalent to 46.5% of the general population. 
(91) 
During a cross-sectional survey conducted by 
Bergman et al (2001) in a Swedish population it 
(37)
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Sweden was found the prevalence of chronic regional pain 
was 23.9% and chronic widespread pain 11.4% 
among 2425 subjects that responded to the 
survey. 
Kuwait A WHO-ILAR-COPCORD study was conducted by Al-
Awadhi et al (2004) on 2 500 randomly selected 
Kuwaiti households.  The results of the study 
indicated that more than 35% of females and 20% 
of males reported musculoskeletal pain.  
(92) 
England Two cross-sectional surveys were conducted over 
40 years apart.  The results of the studies were 
compared and presented by Harkness et al (2005).  
According to the authors the prevalence of 
musculoskeletal pain has increased between two 
and four fold over the last 50 years. 
(93) 
United Kingdom, According to Brooks, P (2007) in an editorial the 
high prevalence of musculoskeletal pain due to 
musculoskeletal conditions is observed in the 
United Kingdom and mirrored around the world in 
other populations.  
(3) 
Cape Town, 
South Africa 
A cross-sectional study was conducted by Parker et 
al (2010) in clinics in two resource poor 
communities, and 1005 people were screened.  
The prevalence of MSC in this clinic- based survey 
was 36%. 
(32) 
World’s 
population 
According to a report from the World Health 
Organisation and The Bone and Joint Decade 
(2010) it is estimated that 10% of the world’s 
population older than 60 have significant clinical 
problems that can be attributed to osteoarthritis. 
(13)
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Primarily in 
Europe 
According to a report from the World Health 
Organisation and The Bone and Joint Decade 
(2010) the prevalence of MSC is expected to 
increase in the next 10 years. 
(13) 
Worldwide A modelling approach was utilised by Bradshaw et 
al (2000) to provide the first burden of disease 
study for South Africa.  According to the authors 
MSC is reaching epidemic proportions. 
(7) 
Obesity 
Worldwide According to the expert opinion of Brooks (2006) 
the prevalence of obesity continues to grow. 
(9) 
Worldwide According to the World Health Organisation fact 
sheet more than 1.9 million adults were 
overweight in 2014 and more than 600 thousand 
of these individuals were classified as being obese 
according to WHO classification guidelines. 
(94)  
Worldwide According to the World Health Organisation fact 
sheet 13% of adults were obese in 2014. 
(94) 
Spain A cross-sectional study carried out between  
2008 – 2010 by Gutiérrez-Fisac et al (2012), 
indicated that the prevalence of obesity was 
22.9%.   
(95) 
South Africa According to the expert opinion of Walker (1998) 
in a technical report indicated that the proportion 
of obese black women is double that of obese 
white women. 
(96) 
Free State, South 
Africa 
A study conducted by van Zyl et al (2012) utilising 
interviews conducted by trained researchers found 
13.5%  of men and 23.3% of women in 2011 were 
overweight and 8.6% of men and 26.2% of women 
were reported as being obese. 
(41)
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As is evident from Table 1, there is a high prevalence of CDL, MSC, musculoskeletal pain and obesity in 
both developed and developing countries with consistent findings in large population-based studies.  It 
is clear that prevalence rates have increased and the prevalence rates and burden experienced are 
expected to increase due to the prolonged average life expectancy in individuals and the increasing 
number of elderly worldwide (3, 13).  There is an indication that this trend will continue until 2025 and 
will impose a heavy financial burden on nations’ health care systems (65, 97).  This burden would 
include absolute disability-adjusted-life years (DALY’s)(3).  “Disability-adjusted life year (DALY) is defined 
by Murray as a summary measure of population health incorporating time lost due to premature death 
and healthy time lost as a result of non-fatal illness episodes.”  Therefore DALY’s as a health measure are 
the sum of a mortality component referred to as years of life lost (YLL’s) and a morbidity component 
referred to as years lived with a disability (YLD’s)” (32, 98, 99).  It is relevant to explore the South African 
data in more detail with particular reference to the environmental and personal factors which are 
specific to the country. 
In South Africa the burden of CDL, MSC, musculoskeletal pain and obesity will be affected by the rapid 
changes in the health profile of the country, conditions related to poverty, and under-development (7).  
Therefore older South African women who are obese and have lower levels of education (who represent 
a large proportion of the population, due to culture and the previous apartheid regime in South Africa) 
are at particular risk.  Through this literature review, a definite need was identified to obtain estimates 
on the prevalence of CDL, MSC and obesity in this population, accounting for global and geographical 
differences to make these estimates as accurate as possible (13, 32).  It is also imperative to establish 
comprehensive health and economic indicators,  to incorporate an assessment of the quality of life of 
individuals (13) and to inform the provision of the necessary support to the patient (9, 32). 
2.4.1 Diabetes mellitus type II 
Diabetes mellitus  (DM) type II is the most common form of diabetes mellitus, which occurs mostly in 
people 50 years and older (100) and is characterised by high levels of glucose, caused by the inability of 
the pancreas to produce insulin or in some instances the reduced capacity to produce insulin. (101)  DM 
II has reached epidemic proportions globally and is associated with an increased risk not only of cardio-
vascular disease but also pre-mature mortality (69).  DM II often goes undiagnosed and early symptoms 
of the disease may include increased thirst, urination, hunger, tiredness and weight gain (100).  The 
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disease is associated with age, genetics, family history, ethnicity, nutrition and poverty (102).  It is now 
thought that there are different combinations and multiple genes involved in individuals with DM II 
(103-105).  Although diabetes mellitus is more prevalent amongst obese individuals (BMI>30), normal 
weight individuals can also develop the disease (106).   Results from a variety of studies have shown that 
DM type II can be prevented through a healthy lifestyle including maintaining normal body weight, 
maintaining physical activity, eating a healthy diet, refraining from smoking and using alcohol 
moderately (107-111). 
Modern medical care uses a variety of pharmaceutical interventions as well as lifestyle interventions in 
an attempt to control hyper-glycemia and to ensure the adequate delivery of glucose to the body tissue 
to prevent damage.  The direct and indirect effect of hyper-glycemia on the human vascular tree, are the 
major cause for morbidity and mortality in DM II and can be divided into macro-vascular complications 
which include coronary artery disease and stroke, and micro-vascular complications which include 
neuropathies and retinopathies (112). 
2.4.2 Hypertension 
Hypertension or high blood pressure is a condition that affects almost 1 billion people worldwide and is 
a leading cause of morbidity and mortality (113).  This condition is usually asymptomatic until the 
damaging effects such as stroke, myocardial infarction, renal dysfunction and visual problems are 
observed and therefore the disease is sometimes called “the silent killer”.  Arterial blood pressure is 
"normal" when the systolic pressure is 90-119 mmHg and the diastolic pressure is 60-79 mmHg.   When 
the arterial pressure is ≥120/80 mmHg, a diagnosis of hypertension is made.   In 90 to 95% of patients 
presenting with hypertension, the cause is unknown and this is called primary hypertension (113, 114).  
The remaining 5 to 10% of patients live with hypertension that is resultant from secondary renal disease, 
endocrine disorders, or other identifiable causes.  This form of hypertension is called secondary 
hypertension (114).  Regardless of the origin of the hypertension, the increase in the arterial blood 
pressure is caused by either an increase in systemic vascular resistance (SVR), or an increase in cardiac 
output (CO) (113). 
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 If hypertension is left untreated, serious cardiovascular complications and threats to an individual’s 
health can occur, including heart attacks and strokes.  For this very reason hypertension is associated 
with high rates of mortality (115).  Cardiovascular complications are associated with depression 
especially in older individuals, (116)  while hypertension is closely related to obstructive sleep apnea 
(OSA) which affects multiple organs and systems within the individual particularly relevant to 
cardiovascular diseases which are closely related to hypertension (117).  
2.4.3 Musculoskeletal Conditions 
According to the literature (99, 100) musculoskeletal pain is a major problem associated with economic 
loss and disability for the individual [80]. The risk factors for musculoskeletal pain also include decreased 
physical activity which is the same as for the other chronic diseases of lifestyle.  Therefore, 
musculoskeletal conditions could also be operationally defined as chronic diseases of lifestyle (101-105). 
Musculoskeletal conditions (MSC) refer to a broad range of disorders and diseases of the 
musculoskeletal system including rheumatoid arthritis, osteoarthritis, osteoporosis, spinal disorders, 
severe limb trauma, fibromyalgia, gout, sprains and strains (13).  Chronic musculoskeletal conditions are 
therefore defined as chronic pain and or/stiffness for three months or more during the last year and 
more than 15 days of symptoms during the last month (118).  
MSC are one of the major causes of morbidity, with the exception of gout, sprains and strains, (13, 119) 
which limit function globally and impact negatively not only on individuals but also on communities (9, 
120).  In 2002  the magnitude of the impact of MSC was recognised in Australia when they were added 
as the country’s seventh national health priority leading to the establishment of a National Arthritis and 
Musculoskeletal Disease Task Force (121).  After a literature review, no information could be obtained 
regarding the impact of MSC in South Africa.   
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2.4.4 Obesity 
Obesity is a broad public health problem and the term refers to the failure of natural physiological body 
weight control in the light of environmental influences that mostly favour a sedentary lifestyle and high 
energy diets (122). Obesity is defined as a body mass index (BMI) of  more than 30kg/m2 according to 
WHO criteria (123).  In a person with normal body weight, weight is regulated by physiological signals 
that regulate appetite and satiety as well as energy expenditure of the individual.  Obesity is viewed as a 
complex medical condition and is affected by a number of contributing factors including environmental, 
cultural, emotional and psychological factors (124).  
The effects of the excess adipose tissue are exerted via the increased amount of production of 
adipokines and the increased release of free fatty acids.  These products include leptin and adiponectin, 
both hormones; transcription factors and cytokines.  In addition to these factors,  enzymes are also 
produced in adipocytes and these enzymes are involved in the production of cortisol and oestrogen 
(125).  Consequently the distribution of adipose tissue influences metabolism and disease risk (126). 
There are several clinical problems that are associated with obesity and can be categorised into those 
associated with excess adipose tissue and those associated with the metabolic effects due to the 
increased adipose tissue (127).  The diseases associated with increased adipose tissue mass include 
osteoarthritis, sleep apnoea and psychological problems, while diseases associated with the metabolic 
effects are coronary heart disease, diabetes mellitus type II, and hypertension as well as certain types of 
cancer including breast, colorectal and uterine cancer (122, 128-133).  
2.5 Impairments and functioning 
The impairments, activity limitations and participation restrictions of the health conditions diabetes 
mellitus type II, hypertension, musculoskeletal conditions and the risk factor obesity according to the ICF 
are presented below in Table 2.  Supporting evidence for the occurrence of the ICF component is 
provided in brackets. 
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Table 2: Impairments, activity limitations and participation restrictions of CDL, MSC and obesity 
ICF component       Condition Risk factor 
DM II Hypertension MSC Obesity 
Impairments 
Pain (134-136) No evidence (16, 93, 137) (138) (139) 
(114) (140) (141, 142) 
(143) (144)  
No evidence 
Vascular complications (134-136) (115-117) No evidence No evidence 
Health state Including physical and mental 
(134-136) 
No evidence (145) No evidence 
Depression and anxiety (134-136) (116) (146) (147-149) (12, 
150) (151, 152) (144) 
(153) (154) 
(155-157) 
 Pain-related fear No evidence No evidence (12, 150) (140)   No evidence 
Decreased range of motion of joints  No evidence No evidence (147-149) (158) (141, 
142) (143) 
(159-161) 
Muscle weakness No evidence No evidence (147-149) (140) (162) 
(141, 142) (143) (143) 
(163, 164) (159) (165)   
Biomechanical changes Due to peripheral neuropathy 
(166, 167) 
No evidence No evidence (168, 169) (164, 169, 
170) (171) (170) (164, 
169, 172) (173) 
Deformities No evidence No evidence (147-149) (143) No evidence 
Decreased joint stability No evidence No evidence (174-180) No evidence 
Physical fatigue No evidence No evidence (152, 181) (143) (144) No evidence 
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ICF component Condition Risk factor 
DM II Hypertension MSC Obesity 
Risk of falling due to poor balance (166, 167) No evidence No evidence (169, 170) (171) 
Cardiovascular and respiratory changes No evidence No evidence No evidence (182, 183) (184) 
Activity Limitations 
Sleep disturbances No evidence (115-117) (185) (147-149) (152, 186) 
(144) 
(187-189) 
Problems with walking Due to changes in balance and 
posture. (166, 167)  
(190, 191) (147-149) (158) (192, 
193) (194) (31, 195) (31)
(141, 142) (196) (197) 
(159, 173) (161, 198-
200) (171) (201)
Climbing stairs No evidence No evidence (147-149) (158) (192, 
193) (141, 142) (31, 195)
(31) (141, 142) (197)
(171) 
Grooming and getting dressed No evidence (190, 191) (147-149) (31, 195) (31) 
(196) (197)
(171) 
Upper limb function No evidence No evidence (147-149) (158) (192, 
193) (143) (31, 195)
(196) (197)
No evidence 
Executive-type cognitive deficits No evidence (185) (152, 186) (144) (202) (189)  
Psychomotor retardation No evidence (185) (144) (202) (189)   
Daily tasks (203) (190, 191) (195) (141, 142) (204)
(197) 
(171) 
Getting in and out of the car No evidence No evidence (31) No evidence 
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ICF component Condition Risk factor 
DM II Hypertension MSC Obesity 
Participation restrictions 
Social (134-136) (185) (146) (147-149) (139)
(205) (12, 206) (12)
(207, 208) 
Interpersonal No evidence (185) (139) (205) (151, 209,
210) (12, 206) (12)
(207, 208) 
Work No evidence No evidence (147-149) (139) (12, 
206) (12) (202) (211)
(207, 208) 
33 
The impairments listed in Table 2 are not directly related to DM II or hypertension, but are rather due to 
the complications experienced by individuals and in older adults, the combination of common age-
related disorders and complications (203) (115-117).  All the impairments listed for DM II and 
hypertension have a moderate to severe impact on the health state of the individual, activities of daily 
living and they have an impact on the quality of life of the individual (134-136) (190, 191). Therefore, the 
impact is bi-directional as hypertension causes decreased activities, which then worsens hypertension.   
In addition, it is clear that functional limitations are influenced by a range of social, and economic as well 
as behavioural factors.  Using the ICF framework allows for the exploration of the complex relationship 
between environmental factors and hypertension.   Hypertension not only arises as a consequence of 
environmental and genetic factors but mostly from the interaction between these factors.   Further, the 
relationship between socio-economic status and hypertension differs substantially in men and women.  
Men in lower economic status groups have a higher risk of hypertension, while women in lower and 
middle income groups have a significantly higher risk (212).  The association between socio-economic 
status and hypertension varies according to a country’s development and ethnic group (213).  
Modifiable socio-economic determinants associated with hypertension include education levels and 
occupation.   Additional socio-economic determinants include urban or rural dwelling and individual, 
local or national economic conditions although these association are complicated and at times 
contradictory.  Other possible explanations include awareness of hypertension prevention, better access 
and adherence to treatment among higher socio-economic groups and higher work strain among lower 
socio-economic status groups (212).  
The bidirectional relationship between impairments and functional limitations is further demonstrated 
in the reciprocal relationship between depression and disability (214-216).  Depression amplifies 
limitations from other health conditions, and worsens health behaviour including poor adherence to 
medication and physical inactivity (185).   Life events that are perceived as negative, such as strained 
interpersonal relationships, due to the impairments and restriction of social activity may then amplify 
the depression (185).  As is evident from Table 2 depression is an impairment experienced by all 
individuals living with a CDL, MSC or the risk factor obesity.   
Also evident from Table 2, is that there are many impairments related to MSC and obesity.  The most 
prominent impairment is pain. The prevalence of chronic MSC-related pain varies from above 20% in the 
Netherlands, Norway, Poland, Italy, Australia, and across 16 European countries to 11 % of adults in 
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Spain (3, 9, 217, 218).  The range in pain rates is likely to be due to differences in the definition of 
chronic pain and using different time frames for reporting pain during the studies.   
Patients with chronic pain conditions experience widespread negative consequences including 
depressive symptoms, sleep-related problems, significant pain intensity and decreased emotional well-
being (147-149). The impairments and functional limitations experienced depend on the area and the 
joint(s) affected and may include decreased range of motion of a joint, muscle weakness and even 
deformities.  In addition, disability and decreased physical performance in individuals with chronic MSC 
create a huge psychological burden which over time may progress into pain-related fear, anxiety and 
avoidance all of which impact on the quality of life of the individual (12, 150).   
A coping style used by individuals living with MSC is to avoid physical activity, a passive pain-coping style 
which has been found to be associated with higher levels of disability (219, 220).  The coping style can 
be explained using the conceptual framework of the avoidance model.  The avoidance model states that 
an individual tends to avoid physical activity due to a fear of increased pain during the activity or 
anticipation of experiencing pain during the activity (221). This coping style may be effective in the short 
term to reduce pain, but unfortunately has long-term negative consequences which include 
deterioration of the individual’s physical condition, especially muscle weakness, resulting in the joints 
becoming less stable leading to a decrease in the ability to carry a load.  Consequently, the individual 
avoids physical activity more, following a vicious cycle towards further decrease in physical activity and 
resultant disability (140).  The fear-avoidance model of chronic pain demonstrates how an impairment 
(pain) results in disuse, depression and disability and further pain, and it clearly illustrates the inter-
relationships between impairments, function, participation, environmental and personal factors which 
impact on a person’s health. 
Pain is not the only impairment associated with MSC.  Physical fatigue, inflammation and muscle 
weakness must also be considered as they interact with each other and are similarly intertwined causing 
activity limitations and participation restriction.  The usefulness of the ICF model is further highlighted 
when the impact of emotional impairments experienced by individuals including frustration, irritability, 
resentment and tearfulness are explored (152, 186). The impairment has activity and participatory 
impact but likewise the activity limitation further has an impact on the impairment.  The same is true for 
depression which, according to the ICF model, can also be viewed as a personal factor.   
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As is the case with DM II and hypertension, impairments associated with MSC, have negative impacts on 
the quality of life of the individual.  According to Lawrence et al., (1998), an estimated 2.8% of the 
United States  population in 1990 would live with arthritis or have a rheumatic condition as a major 
contributing cause of moderate activity limitations in their daily lives (90, 195). 
The prevalence of activity limitation as a consequence of MSC, adjusted for age, was higher in women 
(3.4%) than in men (2.0%) and higher in Black populations (4.0%) compared to white populations (2.6%) 
(90).  Musculoskeletal conditions, not only affect the body of an individual as recorded by individual 
impairments, but these disorders also affect their self-esteem, self-image, sexual relationships and their 
total emotional well-being (12, 206).  Poor physical health can interfere with an individual’s mental 
health and can contribute in the long run to an individual’s poor physical condition (145).  This once 
again emphasises that an impairment has activity and participatory impact, but likewise the activity 
limitation has a further impact on the impairment.  Therefore,  the ICF provides a framework for the 
multi-professional team to better understand the effect the chronic condition has on the overall well-
being of the individual (12).   
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Figure 2 below is a representation of the ICF of an individual living with MSC.  As can be seen from the 
representation this framework can then be used to develop multimodal interventions which address the 
inter-related components. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Representation of an example of the ICF concept applied to an individual living with MSC 
 
In summary, there are many impairments related to MSC and obesity, as is evident from Table 2. In 
addition impairments associated with obesity which are predominately of a biomechanical nature due 
to the increase of the body mass index (BMI) and the effect it has on the body, will compound these 
(159-161).  It is evident that personal and environmental factors also require consideration as they will 
(Disorder) 
Health Condition: 
Musculoskeletal condition 
Participation: 
Work 
Activity: 
Walking 
Body functions & 
structures: Muscle 
weakness 
Environmental factors: 
Nutrition 
Personal factors: 
Inactivity  
Contextual factors  
(Impairments) (Restrictions) (Limitations) 
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differ depending on the MSC as well as the environment in which the individual functions.  Personal and 
environmental factors are summarised in Table 3 followed by a short discussion. 
2.6 Context – environmental and personal factors 
The environmental and personal factors of the health conditions diabetes mellitus type II, hypertension, 
musculoskeletal conditions and the risk factor obesity according to the ICF are presented below in  
Table 3.  Supporting evidence for the occurrence of the ICF component is provided in brackets. 
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Table 3: Environmental and personal factors of CDL, MSC and obesity 
ICF component Condition Risk factor 
DM II Hypertension MSC Obesity 
Environmental Factors 
Nutrition1 (102) (222, 223) (224) (225) (226) (227)
Marital status No evidence No evidence (228) No evidence 
Personal Factors 
Smoking (203) (185) (229) (230, 231) No evidence 
Obesity (232-234) (222, 223) (235) (174-180) (236) (194, 
237-240) (230, 231)
No evidence 
Inactivity (203) (185) (222, 223) (140) (225) (165) (226) (241)
Alcohol consumption (110, 242, 243) (222, 223) (235) (230, 231) 
Availability of nutritional food (102) (222, 223) (224) (225) (226) (227)
Socio-economic status No evidence (222, 223) (90) (174-180) (244)
(245-248) 
(122, 249, 250) 
Age (102) (235) (90) (174-180) (14, 15,
119, 251) (194, 237-240) 
(90, 120, 251-253) 
No evidence 
Ethnicity (102) (235) (254) (194, 237-240) No evidence 
1 Availability of nutritional food can be viewed both as a personal factor and an environmental factor.  The justification being, that many disadvantaged people in South 
Africa live in an environment where their nutritional status is determined by what is available in their immediate vicinity to utilise as food sources rather than a personal 
lifestyle choice.   
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ICF component       Condition Risk factor 
DM II Hypertension MSC Obesity 
Female sex No evidence (254) (194, 237-240) (90, 120, 251-253) (255) 
(14, 15, 119, 251) (120, 
121, 256) 
 
No evidence 
Family history/genetics (104, 257-259) (235) (143) 
 
No evidence 
 DM II Hypertension MSC Obesity 
Other Previous gestational diabetes 
mellitus (102). 
No evidence Stress (260-263) Meet cultural 
expectations (264) 
(227, 265); low 
education levels (122) 
(250) 
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The last components of the ICF are those of environmental and personal factors which have an impact 
on the individual who is living with CDL, MSC or who has the risk factor of obesity.  As can be seen in 
Table 3 several environmental factors and personal factors are common across the conditions.  As 
previously mentioned, it is clear that functional limitations are influenced by a range of social, economic 
and behavioural factors. However, no specific interactions relating to DM II could be found in the 
literature (266-268).  What is mentioned, is that nutrition, particularly poor nutrition related to poverty, 
plays a role in the development of DM II, yet the interplay is not well understood (102). 
Social, lifestyle and cultural factors are all important determinants of the risk of functional impairments. 
In particular smoking; nutrition or diet; obesity; alcohol consumption and inactivity have been identified 
as contributing to impairment.  However, all of these factors do not necessarily play a role in every 
condition; especially obesity. 
Although older individuals are more prone to most of the conditions, excluding obesity, it is interesting 
to note that individuals living with MSC and perceiving themselves as having MSC were in poor 
agreement.  Many of the participants believing they had a musculoskeletal condition could not be 
classified as having a diagnosis of any of the frequent MSC.  On the other hand, people presenting with 
clear signs and symptoms of one of the MSC were actually never diagnosed (4).  This phenomenon may 
be related to the general population’s beliefs and associations that  many MSC symptoms are part of the 
normal aging process, but may also be related to a poor level of health literacy  amongst the general 
population (4). 
In a South African setting, special mention needs to be made regarding the links between culture and 
obesity.  In sub-Saharan Africa and developing countries, including in certain South African cultures, 
there is no definition for obesity, nor is obesity viewed as a disease (227, 265).   Instead, obesity is seen 
as a sign of success, wealth, good health and happiness.  Among African women, obesity is associated 
with being regarded as healthy and attractive due to cultural beliefs, while being thin is undesirable and 
is seen as a sign of poverty, deprivation, ill health and despair (227, 265); therefore, when designing a 
programme to approach obesity as a health problem, societal and cultural context should be considered 
and not merely personal factors.   
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In addition to the cultural attitude towards obesity, changes in culinary practices and eating habits also 
bear consideration in terms of body weight in South Africa.  The socio-cultural paradigm shift described 
by Renzaho (2004) highlights the fact that consumption of high kilojoule foods, soft drinks, and frying of 
foods in vegetable oil is assumed to be the “foods of white people” (227) and therefore indicative of a 
higher social status to those who are struggling economically (227).  It is evident that many of the health 
problems in South Africa are socially and culturally rooted and compounded by poverty, crime and 
violence.  Efforts to promote healthy lifestyles (including regular, moderate physical activity and a 
sensible diet) will have to extend comprehensively to the very core of society and address different 
cultures (7).  Therefore there is a need to develop an integrated intervention programme for CDL, MSC 
and obesity. This integrated intervention programme should include: exercise to increase physical 
activity levels; and health education to address low levels of health literacy, particularly in relation to 
diet/nutrition in the management of these complex and interrelated conditions.    
2.6.1 Co-morbidity 
As can be seen from Table 4 below, DM type II is commonly morbid with decreased pulmonary function 
and depression, while MSC occurs with obesity and DM type II.  The risk factor obesity is commonly 
associated with co-morbidities including DM type II, hypertension, MSC, dyslipidemia and cardiac 
diseases.  Comparison of studies is difficult due to the age, race, ethnicity and sex utilised in the study as 
well as the methodology followed, as in most instances self-reporting of co-morbidities is utilised.  
Hypertension and diabetes mellitus are commonly intertwined.   
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Table 4: Summary of co-morbidities 
Reference Population Number DM type II Hypertension MSC Obesity Other 
DM type II 
(269) Brazil 318 individuals Primary 
condition 
66.4%2 Not reported Not reported Vascular (53.8%) 
Hypercholesterolemia 
(60.8%) 
Ophthalmic (42.8%) 
Vascular (14.5%) 
Kidney (12.9%) 
(270) Rio de Janeiro, 
Brazil 
105 individuals Primary 
condition 
Not reported Not reported Not reported Anxiety (43.8%) 
Depression (38.1%) 
(271) Netherlands 772 individuals Primary 
condition 
Not reported Not reported Not reported Depression (37%-43%) 
(272) Copenhagen 11 763 individuals Primary 
condition 
Not reported Not reported Not reported Decreased pulmonary 
function 
(273) Framingham, 
Massachusetts 
3 254 individuals Primary 
condition 
Not reported Not reported Not reported 
Decreased pulmonary 
function 
(274) Western 
Australia 
495 individuals Primary 
condition 
Not reported Not reported Not reported Decreased pulmonary 
function 
2 In each instance the percentages under the co-morbidities refer to the percentages of those with the primary condition. 
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Reference Population Number DM type II Hypertension MSC Obesity Other 
(275) United States 15 792 individuals Primary 
condition 
Not reported Not reported Not reported Decreased pulmonary 
function 
(276) Mysore, India 90 individuals Not reported Not reported Not reported Decreased pulmonary 
function 
Hypertension 
(277) Poland 12 525 individuals 21.3% Primary 
condition 
OA (7.9%) 
Degenerative 
disc disease 
(11.9%) 
Not reported Coronary artery disease 
(21.6%) 
Gallstones (0.4%) 
Peptic ulcer (2.1%) 
Mood disorders (1.2%) 
(278) United States of 
America 
No evidence 75% Primary 
condition 
Not reported Not reported Micro- and macro-
vascular co-morbidities 
(279) Florida, United 
States of 
America 
578 malignant cases 
of hypertension 
12.6% Primary 
condition 
Not reported 1.7% Hypercholesterolemia 
(5.1%) 
Lipid disorders (5.1%) 
MSC 
(280) Ontario, Canada 1 803 individuals 33.3% Not reported Primary 
condition 
32.6% Coronary Arterial  
Disease (56%) 
Depression (22.3%) 
(281) Ontario, Canada No evidence 74.0% Not reported Primary 
condition 
50.9% Respiratory diseases 
(54.8%) 
Cardiovascular diseases 
(67.3%) 
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Reference Population Number DM type II Hypertension MSC Obesity Other 
(282) Norwegian No numbers 
provided 
No evidence Not reported Primary 
condition 
No evidence Migraine and non-
migraine headaches 
Obesity 
(283) Kampur, India 2 256 individuals 16.7% urban 
and 7% rural 
17% urban and 
14% rural 
33.6% urban 
and 27% rural 
Primary 
condition 
Gall bladder (7% urban 
and 3% rural) 
(284) San Juan 
Metropolitan 
Area of Puerto 
Rico (2005 to 
2007) 
840 individuals 28.7% Not reported No evidence Primary 
condition 
Dyslipidemia 
Coronary heart disease 
(8.6%) 
(285) Kuwait 2 487 individuals 
(55.5%) 
49% 55% OA (46%) Primary 
condition 
Cardiac diseases (15%) 
(286) Germany 6 790 individuals Condition 
only stated 
Condition only 
stated 
Condition only 
stated 
Primary 
condition 
Only stated no specific 
detail provided 
(287) BMI of ≥25 
Canada’s 
Aboriginal First 
Nation  
483 individuals 35% 48% No evidence Primary 
condition 
Dyslipidemia (38%) 
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Reference Population Number DM type II Hypertension MSC Obesity Other 
(288) United States of 
America 
BMI =30-34.9 
3 637 individuals Not reported Not reported  BMI of 30-
34.9 (9.7%) 
BMI of 35-
39.9 (13.5%) 
Primary 
condition 
Not reported 
(289) Not reported Not reported Not reported Not reported Not reported Primary 
condition 
Coronary heart disease 
Stroke 
Cancer 
Gallstones 
Urinary stress 
incontinence 
Gynaecological 
abnormalities 
Dyslipidemia 
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According to Dreher (2003) as cited by Jakovljević  et al., (2003) co-morbidity is based on the 
interconnections of mind, neurotransmitters, endocrine and immune systems of the body which interact 
and influence each other both in health and in illness.  Various pathways to co-morbidity are identified 
including shared pre-disposition and vulnerability (types of personality and personality traits), shared 
risk factors (stress, unhealthy lifestyles and negative emotions) and shared mechanisms (unsuccessful 
coping mechanisms, failed adjustment to situations, defence mechanisms, exhaustion) (290).  
The high prevalence rates of co-morbidity and multi-morbidity have a significant impact on treatment 
responses and occurrence of adverse events in patients.  Therefore,  the focus on single diseases should 
be reviewed and replaced both academically and clinically with holistic treatment approaches (290). 
2.7 Role of exercise and physical activity 
This section examines the interaction between functioning (specifically exercise) health condition and 
impairments of function.  The ICF model emphasises the non-linear nature of the disability process, in 
which there is an interaction between the components.  The health condition and attendant 
impairments do not only cause activity limitations but in turn are influenced and modified by,   
functioning.  
“Lack of activity destroys the good condition of every human being, while movement and 
methodical physical exercise save it and preserve it.”    Plato as cited by King et al., (2010) (291). 
Physical activity is defined as “any bodily movement produced by the contraction of skeletal muscles, 
which result in energy expenditure that is greater than that at rest” (292).  This actually means that 
exercise is not limited to participating in sport, but includes activity of daily life which is associated with 
home life, and mode of transport as well as leisure activities (292).   
There are several clinically important reasons to recommend exercise for patients with chronic disease. 
The first is that exercise may prevent the physical de-conditioning that patients typically experience; 
secondly exercise may optimise the functioning of the individual when used as adjunctive therapy to 
standard pharmacological treatments; thirdly exercise may reduce secondary cardiovascular risk factors 
and prevent other clinical consequences of the chronic disease and/or treatment.   Lastly, improving 
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physical functioning will optimise quality of life, overall well-being and may possibly improve the overall 
long-term outcomes (291, 293-296).   It is well established in the literature that exercise can improve 
emotional health, depression and self-efficacy, thereby improving chronic disease management (297-
302). 
 
As can be seen in Table 5 exercise has a beneficial impact across conditions.  In addition, physical 
inactivity is one of the personal factors that contributes to activity limitations and participation 
restrictions of individuals living with CDL, MSC and obesity.  
 
Table 5: Effects of exercise on CDL, MSC and obesity 
Condition Effect of exercise Reference(s) 
DM II Improved sensitivity to insulin; possible improvement in blood glucose 
control; reduction in body fat and cardiovascular benefit.  
(303-308) 
Hypertension Decrease in plasma nor-epinephrine levels; increase in the circulating 
vasodilator substances in the body; amelioration of hyperinsulinemia and 
changes in renal function.  
(309-315) 
MSC Diminish the effect of inactivity, and effect of symptoms, but the effect of 
exercise on the disease process itself, has not been determined by 
research.  
(316-324) 
Obesity Improved insulin sensitivity; changes in metabolic rate and lipid profiles, 
reduction in blood pressure, changes in glucose metabolism; improvement 
in the mood of the individual; preservation of lean body mass despite lower 
food intake and loss of abdominal fat deposits. 
(325-331) 
 
In summary, the main goals for exercise aligned with physiological principles are to improve and 
increase the overall functional strength and capacity of an individual;  to increase daily physical activity 
and energy expenditure;  enhance the metabolism of lipids and carbohydrates;  promote the 
normalisation of the cardiovascular function,  and to mediate the effects of limited functional ability 
(332).   
 
Exercise is a treatment which works well within the ICF framework for CDL, MSC and obesity (1, 49, 50).   
If the individual has joint stiffness, then exercise addresses the loss of ROM and muscle weakness, which 
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then improves function and also improves participation.  If it is structured around a goal or utilises 
exercise in  groups (333), exercise also addresses personal factors and can assist people in managing 
their environment (334-337).   Furthermore, exercise teaches people skills of goal setting, pacing and 
activity scheduling, all of which are health literacy skills needed for the management of CDL and MSC 
(338).  
Thus, it makes sense to include exercise in the management of CDL, MSC and obesity, however, it is 
important to note that sequential goals should be developed and integrated into a lifestyle modification 
programme for people with co-morbidities (332).  
2.8 Primary health care within the research setting 
Contextual or environmental factors do not only include the physical environment in the ICF but also 
include access to products, such as pharmaceutical and other health management policies related to the 
provision of services, such as social grants, housing and transport.  This section will deal exclusively with 
the research setting, which was within a primary health care clinic in a resource constrained area of the 
Free State. 
Primary health care (PHC) was described in the 1978 Declaration of Alma-Ata as: 
“essential health care based on practical, scientifically sound and socially acceptable methods 
and technology made universally accessible to individuals and families in the community 
through their full participation and at a cost that the community and country can afford to 
maintain at every stage of their development in the spirit of self-reliance and self-
determination” (339).   
PHC consists of two systems in most low income countries.  The first includes the hospital care system 
and the second the network of PHC clinics that offer basic, preventative services to low-income 
communities in urban and rural areas (340).  PHC should form an integral part of both the country’s 
health systems, which it is the central function and main focus, and also of the overall social and 
economic development of the community.  It is the first level of contact of individuals, family and the 
community with the national health system, bringing health care as close as possible to where people 
live and work, and constitutes the first element of a continuing health care process (339).  PHC is seen in 
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many countries as the best model for delivering basic health care to communities (340) and in many low 
and middle income countries disease burdens are mostly managed by these services.  The services 
rendered encompass preventative, promotive, curative, supportive and rehabilitation services (341). 
PHC forms the foundation of the health care delivery system in South Africa.  With the onset of 
democracy in South Africa, PHC was seen as a model “whose time had come” and it was envisaged that 
a health care model with a people-orientated health care system would address the inequities that were 
created by apartheid (342). Primary care available at public sector clinics throughout South Africa was 
declared as a free share point of health care delivery.
The Pholela Health Centre model was used to develop the PHC in South Africa and the model was 
intended to provide comprehensive preventive and curative services in both urban and rural areas. 
From the onset the Pholela Health Centre was seen as innovative.  It utilised population-based 
investigations to inform the health services provided and included health education and health 
promotion as essential elements of the health delivery system (343).  A pioneering feature was the 
model’s reliance on epidemiological and social information of the local community to inform the 
services provided at the centre.  It was argued that an empirical understanding of the community’s 
health profile based on evidence must be established in order to determine the appropriateness of the 
care at local health services to meet the needs of the specific community (343).  One of the key 
elements of the Pholela model was the emphasis on community participation and empowerment in the 
delivery of health care and community members as well as the involvement of local authorities in the 
planning and decision-making. 
The Community clinic forms part of the different models of primary care provision in South Africa and is 
defined as a facility at and from which a range of PHC services are provided (344).  The clinics are open 
eight hours a day and are primarily run by nurses, although doctors do visit the clinics regularly.  If a 
more specialised level of care is needed, patients are referred to District hospitals by clinic staff for 
further management (344).  The physiotherapy services rendered at the clinics are provided by the 
newly graduated community service physiotherapists.  The clinic renders a service to a monthly 
population ranging between 19 000 – 22 000 (31). 
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It is the personal observation of this researcher that the population of the current study is an 
impoverished, ethnically black community, most of whom rely on social grants and part-time 
employment.  Many of the families are supported by one member and in most instances more than one 
family resides in a single informal or formal home depending on the settlement in which the family lives. 
No literature to substantiate the observation of the researcher could be found.  Most of the informal 
settlements do not have access to running water or electricity.  Due to the increase in the number of 
teenage pregnancies in the community as well as the HIV pandemic, the children in the community are 
often raised by the middle-aged women (31, 345).  According to Copley et al., (2013) 89% of the 
population in the specific area of the clinic were literate and could read and write, while only 20.41% 
had obtained a Grade 12 level of education, which in South Africa is the final year of high school, usually 
attained by 18 years of age (31). 
The transformation of the health system has posed an extreme challenge to the government due to 
health worker shortages, the migration of medical and allied health professionals, imbalances of 
resources, shortages in managerial capacity of health systems and leadership at all levels and the 
complex burden of disease which is still evolving with emerging infectious diseases and non–
communicable diseases (346). Padarath et al., reported in 2004 that an estimated 40% of health 
positions in the public sector were unfilled and the numbers are increasing yearly (347).  In 2010 56% of 
doctor posts in South Africa were unfilled as were 46% of nurses posts (348).  Achieving the 
implementation of district-based health services in South Africa is hampered by the  critical shortage of 
health care professionals and the inability to fill the vacant posts (249, 342).  
The primary health care clinic where the research was conducted serves the formal and informal 
community settlements of Freedom Square, Namibia, Turflaagte, Chris Hani, JB Mafora, Kagisanong, 
Albert Luthuli, SE Jake, Buffer and Rocklands.  Within the community there are several schools and 
police stations that also serve the community and there are also two smaller clinics the Freedom Square 
clinic and the Kagisanong clinic.  During data collection for the current study, the Department of Health 
in the Free State Province had financial difficulties and were on the verge of national takeover.  Essential 
services and medication were not being delivered to patients during this time and one clinic was closed 
due to the rent not being paid by the Department of Health (349, 350). 
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Therefore given the context, the setting, the ICF and the impact exercise and education has on CDL, MSC 
and the risk factor obesity, the treatment approach of the study is relevant.   
2.9 Conclusion 
The narrative review has highlighted the fact that the prevalence of health conditions and impairments 
of CDL (including obesity and MSC) is universally high and is increasing.  Several studies have indicated 
that this is the case in South Africa, and that people living in under-resourced areas are particularly 
vulnerable to these conditions.  The interaction between health conditions and risk factors was 
discussed and it is suggested that, as co-morbidity is very common in older persons, and as disability 
should be regarded as being aetiologically neutral, it makes sense to attempt to address therapeutically 
the impairments and activity limitations most commonly encountered co-morbidly through a common 
intervention. 
A common protective factor amongst the CDL and obesity appears to be exercise (physical activity) as it 
has been found to improve impairments of body functioning at a physiological level.   However, despite 
the high prevalence of CDL,  including hypertension, diabetes mellitus type II and musculoskeletal 
conditions and the harmful influence inactivity has on these conditions,  the functioning of people with 
these chronic diseases of lifestyle had not been adequately studied.  As highlighted by the ICF, 
contextual and personal factors can have a major impact on functioning and, to the knowledge of this 
researcher;   very little if any work has been done in severely under-resourced, rural areas of South 
Africa in terms of developing and testing appropriate interventions.  The next two chapters concentrate 
on the impact of therapeutic programmes designed to improve the health-related quality of life 
(HRQOL), functional limitations and participation restrictions of persons living with CDL and obesity.  
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3 EXERCISE AND HEALTH EDUCATION IN THE MANAGEMENT OF 
CHRONIC DISEASES OF LIFESTYLE:  A SYSTEMATIC REVIEW 
3.1 Introduction 
As demonstrated in Chapter 2 chronic diseases of lifestyle may have a major impact on the functioning 
of individuals that in turn may impact on their Health-Related Quality of Life.  Health-Related Quality of 
Life (HRQOL) is defined as an individual’s well-being and describes the perception of individuals 
regarding their health and functioning across social, physical and psychological domains.  It refers to the 
self-reported standard of health and satisfaction experienced by a person or a community, regardless of 
illness or handicap (351). HRQOL is also related to the morbidity and mortality of an individual (352).  
The aim of this chapter is to present the evidence for the use of exercise and health education in adults 
with chronic diseases of lifestyle (diabetes mellitus type II, hypertension) and obesity and the impact 
thereof on HRQOL.  Although it would have been optimal to only deal with interventions which enrolled 
participants similar to those included in the current study, this was not possible. The search was not 
restricted to middle-age women as there were only three studies that dealt exclusively with women. The 
one study addressed obesity, the one study metabolic syndrome and the third study diabetes mellitus 
type II.  Therefore the search had to be widened to include males and female of all age groups (adults) 
to ensure that the objectives of the review were addressed adequately.    
3.2 Objectives 
The objectives of the review were to address the following questions: 
 What exercises are used for adults with diabetes mellitus type II, hypertension or obesity?
 What education is given to adults with diabetes mellitus type II, hypertension or obesity?
 What is the impact of exercises or education on the HRQOL of adults with diabetes mellitus type
II, hypertension or obesity?
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Information related to impairments of body structure and function, activity limitations and participation 
restrictions was also gathered but not included in this review as these outcomes differed considerably 
depending on the underlying health condition. 
3.3 Methods 
3.3.1 Criteria used for selecting studies for review 
Criteria were identified in three categories to guide the selection of studies for the purpose of the 
systematic review.  The following studies were included: 
 Randomised controlled trials were included, while case-control studies, case reports, letters and
cross-sectional studies were excluded.
 Studies on human adults with diabetes mellitus type II, hypertension or obesity were included.
 Studies reporting on the impact of interventions on health-related quality of life, function and
participation were also included.
3.3.2 Search methods 
The following electronic databases were searched from 2009/01/01 to 2013/12/31.  The list of 
synonyms was developed in conjunction with a librarian the Health Sciences Library, at the University of 
Cape Town.   The MeSH (Medical SubHeadings) database for the official MeSH headings as well as free 
language was used to identify synonyms for the specific search.  The thesaurus (MeSH headings) 
provides suitable synonyms for the search in PubMed.   Searching on the MeSH term automatically 
explodes, in other words includes all its subheadings and narrower terms.  Despite including filters for 
example “human” and “adults” these filters would not filter out every article, possibly still in the 
indexing process, therefore articles still had to manually be filter out. When searching the MeSH 
database for Diabetes Mellitus Type 2, the search was directed to the MeSH heading Diabetes Mellitus 
Type 2 and upon exploring this term, further entry terms were provided to map to the initial heading.  
These terms can be used as synonyms for the systematic review search.  The explanation for Diabetes 
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Mellitus Type 2 in the MeSH search was indicated as:  “A subclass of DIABETES MELLITUS that is not 
INSULIN-responsive or dependent (NIDDM). It was characterized initially by INSULIN RESISTANCE and 
HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. 
Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom 
develop KETOSIS but often exhibit OBESITY.”   No definition or explanation was given for any of the 
other MeSH terms in this search.   
Table 6: Search strategies utilised 
Electronic database Limits to the searches Terms excluded using the 
“NOT” Boolean search term 
Africa-Wide 
CINAHL 
The Cochrane Library 
PEDro 
PsychArticles 
PsycInfo 
PubMed (which includes Medline) 
Scopus (which indexes Embase) 
Web of Science 
Science Direct  
SportDiscuss 
Journal articles  
English 
“human”  
“adult” 
“Diabetes ”/ “Diabetes Mellitus” / 
“Diabetes Mellitus Type 2“ / 
“Diabetes Mellitus Type II” / “Type 2 
Diabetes Mellitus” 
OR “Hypertension 
OR “Obesity” 
AND “Health Education 
OR “Exercise”  
“case-control studies” 
“letters” 
“cross-sectional studies” 
“children” 
“adolescents” 
3.3.3 Data extraction and quality assessment 
All the articles identified were imported into Mendeley® and duplicates removed.  Mendeley® is a free
desktop software reference manager tool (353), manufactured by  Elsevier Publishing, United States of 
America, website https://www.mendeley.com .   The researcher and a research assistant independently 
screened all the abstracts for possible inclusion. The full text of articles identified by either the author, 
or the research assistant as containing relevant information for the systematic review was obtained and 
the quality of the full text articles was then assessed.   
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Table 7: Criteria used for screening of abstracts 
Category Inclusion Criteria Exclusion Criteria 
Population Human adults Only children 
Only adolescents 
Study design Randomised clinical control trial Case reports, case studies 
Interventions Exercise or health education/education 
Outcome Reporting  on the health-related quality of life 
of adults with diabetes mellitus type II or 
hypertension or obesity 
Activity limitation of adults with diabetes 
mellitus type II or hypertension or obesity 
Participation restriction of adults with diabetes 
mellitus type II or hypertension or obesity 
Letters and cross-sectional studies 
According to Woolf (2000), assessment is the utilisation of specific analytic criteria to judge the internal 
and external validity of studies (354).  Controversy exists as to whether external validity should be 
included in the criteria (355-357). The Delphi list, as described by Verhagen et al., (1998), clearly 
indicated that internal validity and external validity as well as statistical considerations should form part 
of the concept of quality (355).  Although there is no exact way of assessing the quality of research trials, 
a checklist, for example a Delphi list, is often used by authors with specified criteria rated and a total 
score calculated to estimate the quality of the trial (355-357).  The total score can then be utilised to 
determine the inclusion and exclusion of studies in a meta-analysis, as a weighting factor in the 
statistical analysis (355, 358).  The Physiotherapy Evidence Database (PEDro) scale was developed by the 
Centre for evidence-based Physiotherapy at the University of Sydney, Australia.  The scale includes the 
Delphi list items, which were developed by means of a Delphi consensus, but includes two additional 
items to finalise the PEDro scale (359).  The PEDro scale Table 8 consists of 11 criteria, of which criterion 
one assesses external validity, criteria two to nine measure internal validity and the final two assess the 
statistical information provided to interpret the results of the study (355, 360).  The PEDro scale also 
contains a complete appendix on the definition and interpretation of each criterion (359). 
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Quality assessment of research articles relies on subjective assessment of content, and blinded quality 
assessment by more than one reviewer significantly reduces bias in systematic reviews (357, 361, 362).  
For this reason the researcher and a research assistant were masked reviewers, independently scoring 
the quality of included research articles (362).  Each criterion was marked as yes when the reviewers 
were satisfied that  the criterion had been met after reading the report and no when an unbiased 
decision could be made that the criterion stipulated was not satisfied.  The page where the information 
was obtained was also noted on the scale.  Scores for each study were then calculated as a percentage.  
Due to the fact that so few studies were eligible for inclusion in the systematic review,  the decision was 
made that all studies would be included rather than calculating the mean score of the studies selected 
and only including those scored greater than or equal to the mean as described by Louw et al., (2007) 
(363). 
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Table 8: PEDro scale 
No Criteria Yes No Where 
1 Eligibility criteria were specified. 
2 Subjects were randomly allocated to groups (in a crossover study, subjects 
were randomly allocated an order in which the treatments were received). 
3 Allocation was concealed. 
4 The groups were similar at baseline regarding the most important prognostic 
indicators. 
5 There was blinding of all subjects. 
6 There was blinding of all therapists who administered the therapy. 
7 There was blinding of all assessors who measured at least one key outcome. 
8 Measures of at least one key outcome were obtained from more than 85% of 
the subjects initially allocated to groups. 
9 All subjects for whom outcome measures were available received the 
treatment or control condition as allocated, or, where this was not the case, 
data for at least one key outcome was analysed by “intention to treat”. 
10 The results of between-group statistical comparisons are reported for at least 
one key outcome. 
11 The study provides both point measures and measures of variability for at 
least one key outcome. 
Total (%) 
Data were extracted from the studies identified and entered into spread sheets to create a summary 
that included the information listed in Table 9. 
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Table 9: Information included in spread sheet for study review 
Author(s) 
Year of publication 
Study design 
Aim or purpose of the study 
Exposure (intervention/education) for both the control group and the intervention/experimental group 
Sample size 
Gender and age of the participants 
Relevant demographic characteristics of the sample 
Criteria for diagnosis/condition identification 
Relevant co-morbidities 
Contextual factors including setting and geography 
Comparison of groups at beginning of study 
Inclusion and exclusion criteria 
Selection of participants 
Allocation to the study 
Concealment of allocation 
Blinding method 
Specific details of the intervention and control group 
Measuring instrument 
Observation period 
Outcome measurement 
Time points when the outcome was measured 
Outcome definition identified for the study 
Interpretation of the measurements 
Effects (95% confidence interval) 
Statistical methods used 
Withdrawals/drop-out to allow and intention-to-treat analysis 
Missing data/participants 
Main findings which included the number for which the outcome was being reported and the authors’ key 
conclusion (364) 
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3.3.4 Meta-analysis 
 
Meta-analysis is described as quantitative pooling of data and results of studies reached by similar study 
designs on a specific issue.  A meta-analysis involves several statistical methods of analysis (354, 358, 
365), and increases the statistical power of individual studies by combining their findings, but 
unfortunately is not able to control for errors that have been built into the original set of data collection 
by the researchers.  By performing a heterogeneity test, it can be demonstrated, how individual study 
results compare to the overall summary estimate.  If significant heterogeneity is demonstrated it can 
indicate that the specific individual study possesses a factor that could have significantly influenced the 
results.  Therefore, it is important to seek an explanation for the significant heterogeneity in order to 
identify any weak links in a study that should have been accounted for by the researchers during the 
interpretation of the results/findings (358, 366, 367). 
 
In order to compare studies through meta-analysis,  the studies should be similar in the following 
aspects:  the studies should have the same hypothesis; the outcome of the studies must be similar; 
participants in the studies should be similar and comparable; the intervention of the studies should be 
similar;  and a minimum standard of scientific quality should be met (362).  Other aspects that should be 
considered are randomisation; blinding; adequate sample size of the study, measures taken to ensure 
quality during collection and management of data as well as statistical analyses (356-358, 365). 
 
All studies for each separate condition were considered for meta-analysis regardless of the quality score 
that was achieved using the PEDro scale.  All the studies looking at hypertension was grouped and 
considered for meta-analysis.  Similarly all the studies looking at diabetes mellitus type II were grouped 
together and considered for meta-analysis as were the studies for obesity.  Therefore,  the all-inclusive 
method was chosen for the selected clinical trials (354, 365). The hypotheses of the studies, the 
intervention the outcome measures;  to the characteristics of the study populations, sample size, and 
availability of the results were compared by two independent reviewers to identify the possible pooling 
of results (362).  The researcher was one reviewer while a Biostatistician at the University of the Free 
State was the second reviewer for the meta-analysis section of the study.   Heterogeneity among the 
study populations, the co-morbidities, quality of studies and the interventions utilised in the studies, did 
not allow for statistical pooling of results and therefore a meta-analysis was not performed.  
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3.4 Procedure 
After the online search of the electronic databases as described in Section 3.3.2, the articles identified 
were imported into Mendeley by the researcher and duplicates were removed. A form developed by the 
researcher was used to determine the inclusion or exclusion of the articles.  Even if QOL or HRQOL 
outcome measures were not mentioned in the abstract, the article was included for screening if quality 
of life outcome measures had been included in the studies as secondary measures and therefore not 
mentioned in the abstract.  All abstracts, as well as the form developed by the researcher for the 
screening process were saved on a memory stick and handed to the research assistant (second 
reviewer).  The second reviewer as well as the researcher was qualified physiotherapist with Master’s 
degrees in the field of Orthopaedic Manipulative Therapy at the University of the Free State, both were 
trained in the process but had not previously conducted a systematic review. 
The researcher and the second reviewer independently screened all the abstracts for possible inclusion.  
Once the screening process had been completed, the lists of possible inclusions were compared and 
finalised during a consensus meeting.  Three articles were included by the second reviewer for reviewing 
but not by the researcher.  These three articles were reviewed again during the consensus meeting and 
excluded as the studies did not report on the impact of interventions on impairment, activity limitation 
and participation restriction (including HRQOL) of participants.  The full text of identified articles was 
then obtained.  A meeting was held between the two reviewers to ensure that the interpretation of the 
PEDro score was done correctly and a trial scoring was done on two articles not included in the review.  
No problems were identified.  Data were extracted from the studies identified and entered into the 
spread sheets. The PEDro scale was completed for each study and the total quality score noted.  A table 
was compiled with the scores of each reviewer as well as the mean quality score of each article (Table 
15).  Not interaction between the two reviewers took place to influence the outcome of the quality 
scores during the process.  Fleiss Kappa scores were calculated to determine overall inter-rater 
agreement between reviewers. 
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3.5 Results 
The online search generated a total of 9 946 initial hits.  A total of 9 533 articles were excluded as the 
title and/or the date of publication did not conform to the systematic review’s objectives.  Eight 
duplicates were removed and a total of 405 abstracts were screened by the researcher and the research 
assistant.  A further 389 articles were excluded as they did not report on the impact of interventions on 
impairment, activity limitation and participation restriction (including HRQOL) of participants.  16 
articles remained and full text copies were obtained (Figure 3).  Following full text review, it was decided 
that all 16 articles would be further assessed using the 11 item PEDro scale.  
Table 10: Number of articles obtained from electronic databases 
Database Number of records identified 
Africa-Wide  459 
CINAHL 345 
Psychinfo 35 
The Cochrane Library 82 
PEDro 12 
Scopus (which indexes EMBASE) 73 
PsychArticles 15 
PubMed (which includes Medline) 2 019 
SportDiscuss 1 331 
Science direct 5 575 
TOTAL 9 946 
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Figure 3: Flow diagram of the selection and review process 
3.5.1 Description of the studies 
A total of 16 studies met the inclusion criteria and were summarised in Table 12 below.  The search was 
not restricted to middle-age women as there would be only three studies to be included in this category. 
One study addressed obesity, the other study metabolic syndrome and the third study diabetes mellitus 
type II.  Therefore the search had to be widened to include males and female of all age groups (adults) 
Initial records 
(n = 9 946)
Records excluded
(n = 9 533)
Duplicates removed
(n = 8)
Abstracts screened by author and 
research assistant      
(n = 405)
Records excluded 
(n = 389)
Full-text articles assessed for eligibility 
(n = 16)
Studies included in review 
(n = 16)
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to ensure that the objectives of the review were addressed adequately. In total 2793 participants were 
included in the studies, of which 1492 (53.4%) were female. Sensitivity analysis comparing the impact on 
males compared to females was not performed for any study, and only one study compared the impact 
across age groups (Table 11). The mean ages of the participants in all studies ranged from 38 to 71, with 
seven reporting a mean age of between 60 and 68 years. Thus most studies included “middle aged” 
participants. 
Table 11: Percentage of female participants in included studies 
Author Percentage of female participants 
in each study 
Sensitivity analysis 
Chaveepojnkamjorn et al., (2009) 
(368) 
77.4% None performed 
Deinzer et al., (2009)(369) 66.2% None performed 
Rimmer et al., (2009)(370) 36.1% None performed 
Moriyama et al., (2009)(371) 51.5% None performed 
Bouchard et al., (2010)(372) 100% None performed 
Dyson et al., (2010)(373) 57% None performed 
D’Eramo-Melkus et al., (2010)(374) 100% None performed 
Oh et al., (2010)(375) 100% None performed 
Young et al., (2010)(376) 61% None performed 
Nicolucci et al., (2012)(377) 41.3% None performed 
Park et al.,  (2011)(378) 67.4% None performed 
Vadstrup et al., (2011)(379) 44.5% None performed 
Williams et al., (2012)(380) 37.5% None performed 
De Vico et al., (2013)(381) 40.3% None performed 
Espeland et al., (2013)(382) 55.5% Only done for age (45-64 years and 
65-76 years)
Sakurai et al., (2013)(383) 76% None performed 
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Table 12: Summary of reviewed articles 
Author (year) Setting Population 
(sample size) 
Mean ± SD or 
range of age in 
years 
Female 
% 
Ethnicity 
(%) 
Number of 
participants in 
each group 
Details of 
intervention 
Relevant 
co-morbidities 
Measurement 
Outcomes 
Chaveepojnkam 
jorn et al., 
(2009)(368) 
Saraburi 
Province 
Thailand 
Patients with 
diabetes 
mellitus type II 
(164) 
48.9 (7.1) 77.4% Taiwanese 
(100%) 
80 (Intervention) 
84  (Control) 
 Active 
learning was 
encouraged. 
(Education) 
Missing Interview:  Quality 
of life using 
WHOQOLBREF-
THAI. 
Deinzer et al., 
(2009)(369) 
Nuremberg 
Germany 
Hypertension 
patients (86) 
60.9±10.1 
(Intervention) 
61.1±9.3 
(Control) 
66.2% Missing 
(German 
study) 
40 (Intervention) 
46 (Control) 
Shared 
decision-
making 
practice to 
empower 
patients. 
(Education) 
Missing Blood pressure 
Hypertension 
Questionnaire;  
Difficult-Doctor–
Patient-
Relationship-
Questionnaire 
(DDPRQ);  
Short Form 36-
Item Health 
Survey for health- 
related quality of 
life (SF-36);  
Autonomy. 
Preference Index 
(API); Combined 
Outcome Measure 
for Risk 
Communication 
and Treatment 
Decision-Making 
Effectiveness 
(COMRADE) 
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Author (year) Setting Population 
(sample size) 
Mean ± SD or 
range of age in 
years 
Female 
% 
Ethnicity 
(%) 
Number of 
participants in 
each group 
Details of 
intervention 
Relevant 
co-morbidities 
Measurement 
Outcomes 
Rimmer et al., 
(2009)(370) 
New York, USA Patients with 
severe obesity 
and mobility 
disability (92) 
38.83 36.1% African 
American 
(87%) 
30 (Higher 
support group) 
31 (Lower 
support group) 
31 (Awareness 
group) 
High and low 
levels of 
support to 
maintain 
physical 
activity. 
(Exercise) 
Hypertension 
Cholesterol 
BMI 
Blood pressure 
Blood tests 
Physical Activity 
and Disability 
Scale (PADS); The 
Barriers to 
Physical Activity 
and Disability 
Survey (B-PADS); 
The International 
Classification of 
Functioning, 
Disability and 
Health (ICF) 
Activity Measure; 
The Quality of 
Well-Being (QWB) 
Scale; CARDIA-2 
for social support 
Moriyama et al., 
(2009)(371) 
Japan Patients with 
diabetes 
mellitus type II 
(50) 
66.4 ±9.2 
(Intervention) 
65.2 ± 8.5 
(Control) 
51.5% Japanese 
(100%) 
50 (Intervention) 
25 (Control) 
Acquisition of 
self-
management 
skills.  
(Education) 
Cholesterol 
Hypertension 
BMI 
Blood tests 
Overall QOL scale 
in the WHO-
QOL26; 
Generalised Self-
efficacy Scale for 
the measurement 
of self-confidence 
and 
accomplishment. 
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Author (year) Setting Population 
(sample size) 
Mean ± SD or 
range of age in 
years 
Female 
% 
Ethnicity 
(%) 
Number of 
participants in 
each group 
Details of 
intervention 
Relevant 
co-morbidities 
Measurement 
Outcomes 
Bouchard et al., 
(2010)(372) 
Canada Obese women 
(48) 
62.4 ±  4.4 100% Missing 12  (Caloric 
restriction group) 
12 (Resistance 
training group) 
12: (Resistance 
training group) 
12: (Caloric 
restriction + 
resistance 
training group) 
12: (Control 
group) 
Supervised 
weight loss 
programme 
with 
nutritional 
group and 
exercise 
group.     
Wide range of 
conditions, from 
CDL to muscular 
dystrophy. 
Functional tests 
BMI 
The Medical 
Outcomes Study 
Short Form-36 
questionnaire for 
health-related 
quality of life (SF-
36); Physical 
Activity Scale for 
the Elderly; 
modified version 
of the Older 
American 
Resources and 
Services 
questionnaire 
Dyson et al., 
(2010)(373) 
Oxfordshire 
United 
Kingdom 
Patients with 
newly 
diagnosed 
diabetes 
mellitus type II 
(42) 
60.8 (9.6) 57% Missing 21 (Intervention) 
21 (Control 
group) 
Video 
education 
with expert 
opinions and 
case studies.  
(Education)      
Hypertension ADKnowl 
questionnaire, 
WHO-5 Well-Being 
questionnaire for 
quality of life; 
Dietary intake was 
measured by a 
validated three-
day food diary 
Pedometer 
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Author (year) Setting Population 
(sample size) 
Mean ± SD or 
range of age in 
years 
Female 
% 
Ethnicity 
(%) 
Number of 
participants in 
each group 
Details of 
intervention 
Relevant 
co-morbidities 
Measurement 
Outcomes 
D’Eramo-Melkus 
et al., (2010)(374) 
Urban 
Southern New 
England (USA) 
Patients with 
diabetes 
mellitus type II 
(109) 
48 ± 10 100% Black  
American 
(100%) 
57 (Intervention) 
52 (Control) 
Culturally 
appropriate 
education and 
coping skills.  
(Education) 
Obesity 
High blood 
pressure 
Cholesterol 
Blood tests 
Blood pressure 
Crown-Crisp Index 
for anxiety; 25-
item Problem 
Areas in Diabetes 
Survey (PAID); 
Diabetes-specific 
social support was 
measured using a 
subscale 
of the Diabetes 
Care Profile (DCP); 
The Diabetes Self-
efficacy Outcomes 
Expectancies 
Questionnaire 
(DSE-Q; )The 
Diabetes 
Knowledge Test; 
The Medical 
Outcomes Study 
for general quality 
of life; Modified 
Health Care 
Climate 
Questionnaire for 
health care 
provider support 
(MHCCQ); The 
Medical Outcomes 
Study (MOS)-SF-36 
for quality of life 
68 
Author (year) Setting Population 
(sample size) 
Mean ± SD or 
range of age in 
years 
Female 
% 
Ethnicity 
(%) 
Number of 
participants in 
each group 
Details of 
intervention 
Relevant 
co-morbidities 
Measurement 
Outcomes 
Oh et al., 
(2010)(375) 
South Korea Patients with 
metabolic 
syndrome (52) 
62.7 years 
 (SD = 9.0;) 
range, 49-90  
100% South 
Korean 
(100%) 
31 (Intervention) 
21 (Control)) 
Comprehensi
ve multi-
component, 
therapeutic 
lifestyle 
modification 
programme 
(Education 
and exercise) 
Hypertension 
Diabetes  
Cardiovascular 
disease  
Gastrointestinal 
disease 
BMI 
Blood tests 
Medical Outcome 
Study Short Form-
36 for health-
related quality of 
life 
Young et al., 
(2010)(376) 
Baltimore, 
MD; Baton 
Rouge, LA; 
Durham, NC; 
Portland, OR, 
USA 
Patients with 
Pre-
hypertension 
or stage 1 
hypertension 
(810) 
50.2±8.9 61% African 
American 
(34%) 
268 Established 
Intervention 
269 
Established + 
DASH 
Intervention 
273 (Control) 
Multi-
component 
lifestyle 
intervention. 
(Education) 
Missing BMI 
The Rand 36-item 
Health Survey for 
health- related 
quality of life; 
Stanford 7-day 
physical activity 
Recall 
Nicolucci et al., 
(2012)(377) 
Italy Patients with 
diabetes 
mellitus type II 
(606) 
Missing 41.3% Missing 303 
(Intervention) 
303 (Control) 
Training 
programme. 
(Exercise) 
Missing Blood tests 
36-Item 
Short Form Health 
Survey for health-
related quality of
life (SF-36) 
Park et al., 
(2011)(378) 
Seoul, South 
Korea 
Patients with 
hypertension 
(40) 
71 67.4% Missing 18 (Intervention) 
20 (Control) 
Patient 
tailored 
elastic band 
exercise and 
group health 
education.  
(Education 
and exercise) 
Missing Medical Outcomes 
Study Short-Form 
36 for health-
related quality of 
life (SF-36) 
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Author (year) Setting Population 
(sample size) 
Mean ± SD or 
range of age in 
years 
Female 
% 
Ethnicity 
(%) 
Number of 
participants in 
each group 
Details of 
intervention 
Relevant 
co-morbidities 
Measurement 
Outcomes 
Vadstrup 
(2011)(379) 
Denmark Patients with  
diabetes 
mellitus type II 
(143) 
58.5 ± 9.0 
(Intervention) 
 58.0 ± 10.3 
(Control) 
44.5% Missing 70 (Intervention) 
73 (Control) 
Group-based 
rehabilitation 
programme 
and individual 
counselling 
programme 
and goal 
setting. 
(Education 
and exercise) 
Albuminuria 
Retinopathy  
Peripheral 
neuropathy 
Cardio-vascular 
event 
The Medical 
Outcome Study 
36-item Short
Form Health 
Survey for health-
related quality of
life (SF-36); The 
Diabetes Symptom 
Checklist – Revised 
(DCS-R) 
Williams et al., 
(2012)(380) 
Brisbane 
Australia 
Patient with 
diabetes 
mellitus type II  
(120) 
57.4 (8.3) 37.5% Missing 60 (Intervention) 
60 (Control) 
Australian 
Telephone-
Linked Care 
(TLC) 
Diabetes 
system.  
(Education) 
Depression Blood tests 
SF-36 version for 
health-related 
quality of life 
Da Vico et al., 
(2013)(381) 
Florence 
Italy 
Patients with 
diabetes 
mellitus type II 
(263) 
61 
[54–68] 
(Intervention) 
72 [65–78] 
(Control) 
40.3% Italian 
(100%) 
150 
(Intervention) 
113 (Control) 
Self-
monitoring 
and 
enhancement 
of patients’ 
motivation to 
change. 
(Education) 
Unstated Blood tests 
Short Form 36 for 
health-related 
quality of life (SF-
36) 
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Author (year) 
 
Setting Population 
(sample size) 
Mean ± SD or 
range of age in 
years 
Female 
% 
Ethnicity 
(%) 
Number of 
participants in 
each group 
Details of 
intervention 
Relevant 
co-morbidities 
Measurement 
Outcomes 
Espeland et al., 
(2013)(382) 
United States 
of America 
Patients with 
diabetes 
mellitus  type 
II (1 053 aged 
65-76 and 
4 092 aged  
45 – 64) 
 
Missing 55.5% African 
American 
(14.6%) 
Asian 
(0.87%) 
Hispanic 
(11.3%) 
Native 
American 
(4.3%) 
Non-
Hispanic 
white 
(66.8%) 
 
 
 
2072 
(Intervention) 
 
2022 (Control) 
Intensive 
Lifestyle 
Intervention.  
(Education 
and exercise)  
Hypertension 
Prior cardio-
vascular 
diseases 
Insulin use 
Depression  
 Interview 
BMI 
Blood pressure 
Blood tests 
The Medical 
Outcomes Study 
36-item Short 
Form Health 
Survey (SF-36) for 
health status 
 
 
 
Sakurai et al., 
(2013)(383) 
Japan Older 
individuals 
with obesity 
(127) 
Group A 
(Exercise, diet, 
hot bathing):  
59.9, SD 8.9 
 
Group B 
(Exercise, 
diet):  61.0, SD 
7.3 
 
Group C (Hot 
bathing): 64.7, 
SD 7.6 
 
Group D 
(Control – 
Health class):  
61.3, SD 6.3 
 
76% Japanese 
(100%) 
17 (Exercise, diet, 
hot bathing 
group) 
 
16 (Exercise, diet 
group) 
 
16 (Hot bathing 
group) 
 
17 (Control – 
Health class) 
Structured 
exercise 
classes, diet 
modification 
and hot 
bathing. 
(Education 
and exercise)  
 
Hypertension 
High cholesterol 
Physical tests 
Medical Outcomes 
Study Short-Form 
for quality of life 
(SF-36); The WHO-
Five Well-being 
Index for health-
related conditions 
(WHO-5) 
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All the studies included were randomised controlled trials including 7 961 participants.  The smallest had 
40 participants and the largest study had 1 053 participants between the ages of 65 and 76 and 4 092 
participants between the ages of 45 and 64, the total number of participants in the study being 5 145 
(378, 382).  Both male and female participants were recruited in trials, except two trials which only 
recruited female participants (372, 375).  The studies were all conducted in high income countries, 
except for two in the middle income countries (384)(according to the World Bank classification) of South 
Korea and Thailand (369, 376, 378) 
As seen in Table 12 the majority of the studies (9) were conducted on patients presenting with diabetes 
mellitus type II (368, 371, 373, 374, 377, 379-382).  Only three studies were conducted on patients living 
with hypertension (369, 376, 378) and three of the studies included in the review were conducted on 
obese individuals (370, 372, 383).  One study was conducted on patients with metabolic syndrome 
which is seen as the precursor of diabetes mellitus type II (375).  The interventions included in the 
studies in the review ranged from education, either individual or in groups, exercise and lifestyle 
interventions.  Please refer to Appendix 1 for a detailed description of the interventions and education 
sessions utilised in the studies.   
As can be seen in Table 13 a total of seven studies utilised self-help groups, shared decision-making, self-
management training, coping skills, rehabilitation and health education as the intervention (368, 369, 
374, 375, 379, 381, 382).  Telephone delivered education was used by Moriyama et al., (2009) and 
Williams et al., (2012) for the intervention group (371, 380).  Moriyama et al., (2009) focused on self-
management skills (371) while the study by Williams et al., (2012) used the Telephone-Linked Care (TLC) 
diabetes mellitus system, an automated interactive telephone system (380).  The content of the 
education and or exercises in the studies varied considerably as did the duration, frequency of the 
sessions and the number of session that took place.  The education sessions varied from 30 minutes 
individual sessions to session lasting six hours.  The exercise session ranged from the longest sessions of 
175 minutes per week to the least of 75 minutes per week.  The most frequent sessions were held once 
a week and the least frequent once per month for five months.  The duration of the studies varied from 
four weeks to 12 months.  A number of different health care professionals carried out the interventions 
and were also responsible for the exercise and education sessions of the interventions.  
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Table 13: Summary of interventions of included studies 
Author Country Population Exercise Education topics Duration of 
intervention 
Intervention delivered 
by 
Chaveepojnkamjorn 
et al., (2009)(368) 
Thailand Patients with 
diabetes 
mellitus type II 
No evidence Education regarding building good 
relationships, knowledge regarding 
diabetes mellitus, dietary control skills, 
physical exercise, self-monitoring of 
symptoms, motivation for self-care.  
Process of active learning (exploring, 
reflecting, sharing and finding personal 
solutions) was encouraged. One session 
per month for five months of two hours 
each. 
16 weeks Unstated 
Deinzer et al., (2009) 
(369) 
Germany Hypertension 
patients 
No evidence Shared decision-making regarding 
treatment.  No specifics were given. Five 
modules. 
12 months Physicians 
Rimmer et al., (2009) 
(370) 
United 
States of 
America 
Patients with 
severe obesity 
and mobility 
disability 
Personalised exercise 
programme or monthly 
exercise group. 
Personalised exercise 
programme included 
aerobic and resistance 
exercises (with a greater 
emphasis on aerobic 
exercise).  Monthly exercise 
group lasting 90 minutes.  
No evidence 12 months Qualified fitness 
professional 
Moriyama et al., 
(2009)(371) 
Japan Patients with 
diabetes 
mellitus type II 
No evidence Self-management skills, goal setting, 
knowledge about the disease and self-
care.  Thirty minutes once every two 
weeks. 
12 months Educator 
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Author Country Population Exercise Education topics Duration of 
intervention 
Intervention delivered 
by 
Bouchard et al., 
(2010)(372) 
Canada Obese women Resistance training as 
exercise with caloric 
restriction in one 
intervention group and the 
other two groups of the 
three arm intervention 
received either the 
resistance training or the 
caloric restriction. Three 
times a week and the 
education sessions one 
hour weekly sessions. 
No evidence 3 months Exercise physiologist 
and registered 
nutritionist. 
Dyson et al., (2010) 
(373) 
United 
Kingdom 
Patients with 
newly 
diagnosed 
diabetes 
mellitus type II 
No evidence Lifestyle management education utilising 
10-15 minute videos.
6 months Practice nurse 
D’Eramo-Melkus et 
al., (2010)(374) 
United 
States of 
America 
Patients with 
diabetes 
mellitus type II 
No evidence A culturally relevant group diabetes 
mellitus self-management training (DSMT), 
coping skills training (CST), diabetes 
mellitus care and cook book.  11 weekly 
consultations with the first six weeks 
session’s duration of two hours while last 
five week sessions were only one hour. 
12 week Group leader;  clinical 
psychologist or 
psychiatric mental 
health nurse 
practitioner 
Oh et al., (2010) 
(375) 
South 
Korea 
Patients with 
metabolic 
syndrome 
A standardised exercise 
programme in a supervised 
group included yoga 
stretching and rhythmic 
aerobic dance (Tae-Bo).   
Monitoring of health, counselling, health 
education, exercise and diet.  Health 
monitoring included blood pressure and 
body weight.  Health education included 
information on metabolic syndrome and 
advice on lifestyle modifications.  
Educational booklet, poster and pamphlet 
were distributed.  Intervention group 
followed a low-calorie and low-
carbohydrate diet. Sixty sessions with 
three sessions per week during the first 
three months thereafter two sessions per 
week for next three months each session 
90 minutes duration. 
6 months Community nurse 
practitioner. 
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Author Country Population Exercise Education topics Duration of 
intervention 
Intervention delivered 
by 
Young et al., (2010) 
(376) 
United 
States of 
America 
 
Patients with 
Pre 
hypertension or 
stage 1 
hypertension 
No evidence Physical activity up to 180 min/week, 
dietary recommendations.  Behavioural 
skills, self-monitoring, social support, and 
goal setting.  Eighteen sessions during first 
six months thereafter 12 sessions in 
remaining 12 months. 
 
18 months Unstated 
Nicolucci et al., 
(2012)(377) 
Italy Patients with 
diabetes 
mellitus type II 
Progressive mixed (aerobic 
and resistance) training for 
150 minutes per week in 
two supervised sessions. 
 
No evidence 12 months Unstated 
Park et al.,  (2011) 
(378) 
South 
Korea 
Patients with 
hypertension 
Elastic band exercise twice a 
week. 
Definition and symptoms of hypertension; 
possible complications; adherence to 
medication; blood pressure monitoring ; 
diet; exercise; stress management; 
emergency care; smoking and alcohol; self-
management strategy and programme 
evaluation. Group health education (once 
a week) and individual counselling (once at 
the fourth week) for 30 minutes. 
 
12 weeks Health education by 
trained nurse and 
exercises supervised by 
exercise therapist.   
Vadstrup et al., 
(2011)(379) 
Denmark Patients with  
diabetes 
mellitus type II 
Programme included 
supervised aerobic and 
resistance exercise.  90 
minute sessions twice a 
week. 
 
Group-programme included: patho-
physiology of diabetes mellitus, self-
monitoring of blood glucose, dietary 
instructions, and importance of physical 
activity, weight loss, medication, co-
morbidities, complications and individual 
counselling as well as goal setting.  Ninety 
minutes group sessions once a week for six 
weeks. 
 
6 months Physiotherapist for the 
exercises sessions and 
a diabetes mellitus 
nurse specialist, 
dietician and a 
podiatrist for the 
education component 
of the intervention. 
Williams et al., 
(2012)(380) 
Australia Patient with 
diabetes 
mellitus type II   
No evidence Self-management of blood glucose testing, 
physical activity, nutrition and adherence 
to medication. Weekly calls lasting 5-20 
minutes, once a week for six weeks. 
 
6 months An automated 
interactive telephone 
intervention and 
coordinator. 
De Vico et al., (2013) 
(381) 
Italy Patients with 
diabetes 
mellitus type II 
No evidence Group education included general 
information about diabetes mellitus, 
complications, nutrition, physical exercise 
4 weeks Physician, dietician and 
nurse. 
75 
Author Country Population Exercise Education topics Duration of 
intervention 
Intervention delivered 
by 
education and self- monitoring of blood 
glucose. Five sessions, 
a week apart; first session six hour 
duration and following sessions two hour 
duration. 
Espeland et al., 
(2013)(382) 
United 
States of 
America 
Patients with 
diabetes 
mellitus  type II 
No evidence Intensive Lifestyle Intervention (ILI) with 
calorie goal and 175 minutes of physical 
activity per week. 
4 years Unstated 
Sakurai et al., (2013) 
(383) 
Japan Older 
individuals with 
obesity 
Three arm intervention:  
exercise, diet, hot bathing 
or exercise and diet or 
artificial hot bathing.  75 
minutes twice a week. 
Dietary modification and nutritional 
guidance classes. Participants discussed 
problems of dietary habits and settled 
issues in a group setting. Nutrition 
guidance classes comprised a total of five 
lessons. 
3 months Training instructor, 
physical therapist and 
nurse. 
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3.5.2 Outcome measures used 
 
The following section will describe the outcome measures utilised in each of the studies included in the 
systematic review.  The studies were once again grouped together, depending on the health conditions 
of the participants.   
 
Table 14: Outcomes measures used in the included studies 
Health 
Condition 
HRQOL Outcome measure Other outcome measures 
Obesity MOS SF-36 (372) 
CARDIA-2 (370) 
SF 36 (381)   
 
BMI (370, 372) 
Ten physical tests (372) 
Isometric leg extension strength (372) 
% fat mass, lean body mass (372) 
Physical activity scale for the Elderly (372) 
Cholesterol (Total cholesterol; HDL-C; LDL-C) (370) 
PADS (370) 
B-PADS (370) 
ICF (370) 
Morphometric assessment (383) 
Timed Up & Go Test; Multiple-Sit-To-Stand Test; Stepping Test (383)  
Blood tests (HbA1c) (381)   
Dietary history (381) 
Hypertension SF 36 (369) 
Rand 36 item Health 
Survey (376) 
BP measurements (369) 
DDPRQ (369) 
API (369) 
COMRADE (369) 
Stanford 7-day physical activity recall questionnaire (376) 
NDS-R 1998 (376) 
24 hour urine collection (376) 
IPAQ  short form (378)   
Self-care behaviour and self-efficacy for exercise (378)   
MOS SF-36 (378)   
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Health 
Condition 
HRQOL Outcome measure Other outcome measures 
DM II WHOQOLBREF-THAI (368) 
ADKnowl questionnaire 
(373) 
WHO-5 Well-Being 
questionnaire (373) 
MOS SF-36 ; (374) 
SF-36 (377, 379-383) 
WHO-QOL26 (371) 
DSC-R (379) 
 BMI  (368, 371, 382) 
Blood test (A1c) (373); (triglyceride concentrations) (371, 373); (HbA1c) 
(371, 377, 380-382) (BUN), creatinine and thyroid function (374) 
Cholesterol (HDL and LDL) (373, 382) 
Three-day food diary (373) 
Pedometer (373) 
Crown-Crisp Index; (374) 
PAID (374) 
DSEQ  (374) 
Diabetes knowledge test (374) 
MHCCQ  (374) 
DSC-R (379) 
BP measurements (371, 382) 
As can be seen from Table 14 the most common outcomes measures used in the studies are the SF-36 
for quality of life and blood tests, BMI and blood pressure measurements as other outcome measures. 
3.5.3 Methodological appraisal of the studies 
The methodological appraisal of the studies consisted of firstly utilising the 11 item PEDro scale for 
critically appraising the studies.  As mentioned previously the heterogeneity among the study 
populations, the co-morbidities, quality of studies and interventions did not allow for statistical pooling 
of results.   
A summary of the quality scores of both reviewers and also the mean score of both reviewers are 
presented in Table 15. With the exception of two studies, all scored above 6 out of 11.   A 6-10 score is 
viewed as a high quality score (385).  In Table 16, the author’s appraisal of the studies according to the 
PEDro scale is presented.     
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Table 15: Summary of the quality scores of individual studies 
Author Reviewer 1 Reviewer 2 Mean Score 
Chaveepojnkamjorn et al., (2009)(368) 8 8  8 
Deinzer et al., 
(2009)(369) 
5 7 6 
Rimmer et al., 
(2009)(370) 
8 7 7.5 
Moriyama et al., 
 (2009)(371) 
6 6 6 
Bouchard et al., 
(2010)(372) 
7 7 7 
Dyson et al., 
(2010)(373) 
7 7 7 
D’Eramo-Melkus et al., 
(2010)(374) 
7 7 7 
Oh et al., 
 (2010)(375) 
7 7 7 
Young et al., 
(2010)(376) 
8 7 7.5 
Nicolucci et al., 
(2012)(377) 
7 6 6.5 
Park et al., 
 (2011)(378) 
7 7 7 
Vadstrup 
 (2011)(379) 
6 5 5.5 
Williams et al., 
(2012)(380) 
6 6 6 
Da Vico et al 
(2013)(381) 
6 6 6 
Espeland et al., 
(2013)(382) 
3 4 3.5 
Sakurai et al., 
(2013)(383) 
7 7 7 
Mean quality score:  6.3 6.5 6.4 
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Table 16: Appraisal of articles using the PEDro scale 
Author (year) 1.Eligibility
criteria * 
2.Random
allocation 
3.Allocation 
concealed 
4. Groups
similar at 
baseline  
5. Blinding
of all 
subjects 
6. Blinding
of 
therapists  
7.Blinding
of 
assessors 
8.Measures 
of at least 
one key 
outcome  
9.“intention 
to “treat” 
10. Results
of between-
group 
statistical 
comparisons 
are reported  
11.Measure 
for at least 
one key 
outcome 
SCORE 
(%) 
Chaveepojnkamjorn 
et al.,(2009)(368) 
1 1 0 1 1 0 0 1 1 1 1 72.7 
Deinzer et al., 
(2009)(369) 
1 1 0 0 0 0 0 1 1 1 1 45.5 
Rimmer et al., 
(2009)(370) 
1 1 0 1 0 0 1 1 1 1 1 72.7 
Moriyama et al., 
(2009)(371) 
1 1 0 0 0 0 0 1 1 1 1 54.5 
Bouchard et al., 
(2010)(372) 
1 1 0 1 0 0 0 1 1 1 1 63.6 
Dyson et al., 
(2010)(373) 
1 1 0 1 0 0 0 1 1 1 1 63.6 
D’Eramo-Melkus et 
al.,  (2010)(374) 
1 1 0 1 0 0 0 1 1 1 1 63.6 
Oh et al., 
(2010)(375) 
1 1 0 1 0 0 0 1 1 1 1 63.6 
Young et al., 
(2010)(376) 
1 1 0 1 0 0 1 1 1 1 1 72.7 
Nicolucci et al., 
(2012)(377) 
1 1 0 0 0 0 0 1 1 1 1 63.6 
Park et al., 
(2011)(378) 
1 1 0 1 0 0 0 1 1 1 1 63.6 
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Author (year) 1.Eligibility
criteria  
2.Random
allocation 
3.Allocation 
concealed 
4. Groups
similar at 
baseline  
5. Blinding
of all 
subjects 
6. Blinding
of 
therapists  
7.Blinding
of 
assessors 
8.Measures 
of at least 
one key 
outcome  
9.“intention 
to “treat” 
10. Results
of between-
group 
statistical 
comparisons 
are reported  
11.Measure 
for at least 
one key 
outcome 
SCORE 
(%) 
Vadstrup 
(2011)(379) 
1 1 0 1 0 0 0 0 1 1 1 54.5 
Williams et al., 
(2012)(380) 
1 1 0 0 0 0 0 1 1 1 1 54.5 
Da Vico et 
al.,(2013)(381) 
1 0 0 1 0 0 0 1 1 1 1 54.5 
Espeland et al., 
(2013)(382) 
1 0 0 0 0 0 0 0 0 1 1 27.3 
Sakurai et al., 
(2013)(383) 
1 1 0 1 0 0 0 1 1 1 1 63.6 
1. Eligibility criteria were specified.
2. Subjects were randomly allocated to groups.
3. Allocation was concealed.
4. Groups similar at baseline regarding most important prognostic indicators.
5. Blinding of all subject.
6. Blinding of all therapists who administered the therapy.
7. Blinding of all assessors who measured at least one key outcome.
8. Measures of at least one key outcome were obtained from more than 85% of subjects initially allocated to groups.
9. All subjects for whom outcome measures were available received the treatment or control condition as allocated or data for at least one key outcome was analysed by
“intention to treat”.
10. Initial result of between-group statistical comparisons is reported for at least one key outcome.
11. Study provides both point measures and measures of variability for at least one key outcome.
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There was moderate agreement in the scores between the two reviewers [kappa (K) =0.44] (386).  In 
addition, in no case was there a difference greater than two between the scores allocated (Table 15). 
The reliability of score allocation was therefore judged to be fair/satisfactory (387) . The mean quality 
score among the trials were calculated as 6.4 out of a possible 11. Quality scores ranged from a 
minimum of 3 (allocated by reviewer 1) and a maximum of 8 (allocated by reviewers 1 and 2).   
3.5.4 Risk of bias 
Areas of bias that will be discussed include the concealment of allocation of participants, blinding of the 
researcher/physician or research assistant and management of incomplete data.  
3.5.4.1 Blinding 
Concealment of allocation of participants was unstated in almost all the studies except three (370, 373, 
376).  Blinding of the researcher/physician/research assistant was also unstated in most of the studies 
except in Rimmer et al., (2009) (research assistants were blinded)(370); Young et al., (2010) (research 
assistant was blinded)(376); Vadstrup (2011) (researcher was blinded)(379) and Nicolucci et al., (2012) 
(participants and researcher were not blinded) (377). 
3.5.4.2 Incomplete outcome data 
As can be seen in Table 17 below loss to follow-up varied within studies, with some studies not suffering 
any loss to follow-up and the most significant lost to follow-up 32.7% in an intervention group.   
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Table 17: Lost to follow-up and time of follow-up  
 
Author Population  
(sample size) 
% loss to follow-up for 
intervention and control 
group 
Time to follow-up 
Chaveepojnkamjorn et 
al., (2009)(368) 
Patients with diabetes 
mellitus type II (164) 
 
Intervention: 6.2% 
Control:  5% 
Intervention: 9% 
Control: 13% 
 
12 weeks 
 
24 weeks 
Deinzer et al.,  
(2009)(369) 
Hypertension patients 
(86) 
Intervention: 2.5% 
Control:  2% 
12 months 
Rimmer et al.,  
(2009)(370) 
Patients with severe 
obesity and mobility 
disability (92) 
 
High support: 10% 
Low support: 9.7% 
Control :  25.8% 
6 months 
Moriyama et al., 
 (2009)(371) 
Patients with diabetes 
mellitus type II (50) 
 
Intervention: 16% 
Control: 8% 
12 months 
Bouchard et al.,  
(2010)(372) 
Obese women (48) No specifics are provided  
regarding separate 
groups:  25% 
12 weeks 
Dyson et al.,  
(2010)(373) 
Patients with newly 
diagnosed diabetes 
mellitus type II (42) 
 
Intervention: 0% 
Control: 14% 
6 months 
D’Eramo-Melkus et al.,  
(2010)(374) 
Patients with diabetes 
mellitus type II (109) 
Intervention: 32.7% 
Control: 26% 
Intervention: 23% 
Control: 35% 
12 months 
 
24 months 
Oh et al., 
 (2010)(375) 
Patients with metabolic 
syndrome (52) 
0% 
0% 
Intervention: 12.9% 
Control: 0% 
3 months 
6 months  
12 months 
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Author Population 
(sample size) 
% loss to follow-up for 
intervention and control 
group 
Time to follow-up 
Young et al., 
(2010)(376) 
Patients with Pre-
hypertension or stage 1 
hypertension (810) 
Established: 13.1% 
DASH + Established:  
12.3% 
Control: 14.3% for 
HRQOL scores 
Established: 10.8% 
DASH + Established:  
9.3% 
Control: 9.9% for HRQOL 
scores 
6 months and 
18 months 
Nicolucci et al., 
(2012(377))  
Patients with diabetes 
mellitus type II (606) 
Intervention: 8.3% 
Control: 14.2% 
12 months 
Park et al., 
 (2011)(378) 
Patients with 
hypertension (40) 
Intervention: 18.2% 
Control: 4.3% 
12 weeks 
Vadstrup 
 (2011)(379) 
Patients with  diabetes 
mellitus type II (143) 
Intervention: 18.5% 
Control: 20.5% 
6 months 
Williams et al., 
(2012)(380) 
Patient with diabetes 
mellitus type II  (120) 
Intervention: 5% 
Control: 8.3% 
6 months 
Da Vico et al., 
(2013)(381) 
Patients with diabetes 
mellitus type II (263) 
Not mentioned 
Not mentioned 
No specifics are provided 
regarding separate 
groups: 12.7% withdrew 
from the education 
group. 
3 months 
6 months 
12 months 
Espeland et al., 
(2013)(382) 
Patients with diabetes 
mellitus  type II (1 053 
aged 65-76 and 4 092 
aged 45 – 64) 
Not stated 4 years 
84 
 
Author Population  
(sample size) 
% loss to follow-up for 
intervention and control 
group 
Time to follow-up 
Sakurai et al.,  
(2013)(383) 
Older individuals with 
obesity (127) 
0% 3 months 
 
The methodology regarding formal statistics including means and standard deviations and the outcome 
measured, in this instance quality of life of participants, might have allowed for pooling of data of the 
following studies:  Deinzer et al., (2009); Bouchard et al., (2010); Young et al., (2010); Nicolucci et al., 
(2012); Vadstrup (2011); Williams et al., (2012); Da Vico et al., (2013) and Sakurai et al., (2013) (369, 372, 
376, 377, 379-381, 383).  However, the heterogeneity among the study populations, the variety of co-
morbidities, quality of studies and interventions did not allow for the statistical pooling of results.  
Therefore, the studies are described in a narrative way for the purpose of the systematic review.   
 
3.5.5 Effect of intervention on quality of life, function or participation of adults 
 
Table 18 below summarises the effect of the interventions on the HRQOL of the participants and the 
effect size is included where possible. The standardized mean-difference effect size (d) is designed for 
contrasting two groups on a continuous dependent variable. The Campbell collaboration web-site 
calculator was used to calculate d (388).  
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Table 18: Summarised effects of interventions on HRQOL for adults with diabetes mellitus type II, hypertension or obesity 
Author* Condition Number of 
participants 
in each group 
HRQOL 
Mean, (SD) at 
conclusion 
Effect size 
(Cohens d) 
95%CIs Effect 
size** 
Study 
Score 
Narrative Comments from text. 
Espeland et al., 
(2013)(382) 
Diabetes 
mellitus type 
II 
1 053 aged 
65-76 years 
and 4 092
aged 
45 – 64
years)
Not reported 27.3 Older participants achieved high mean SF-36 
scores on the domains of general health, 
mental health, social function and vitality than 
younger counterparts, but lower mean scores 
for physical function. The reason postulated is 
that older individuals had more free time to 
dedicate to lifestyle changes and were possibly 
more motivated to engage in those self-
management behaviours which are required to 
make meaningful lifestyle changes. 
Vadstrup 
(2011)(379) 
Diabetes 
mellitus type 
II 
268 
(Established 
Intervention) 
269 
(Established + 
DASH 
Intervention) 
273 (Control) 
Physical: 
Rehabilitation 
group: 83 
(18) 
Individual 
group: 87 
(15) 
Mental: 
Rehabilitation 
group: 80 
(18) 
Individual 
group: 82 
(16) 
Physical 
-9.24
Mental 
-0.12
Physical 
-0.41—0.07
Mental
-0.29-0.05
Large 
negative 
No 
effect 
54.5 The group-based rehabilitation programme did 
not improve the participant’s HRQOL more than 
those in an individual counselling programme.   
Positive finding is that lifestyle intervention is 
an important part of managing a patient with 
diabetes mellitus type II 
Deinzer et al., 
(2009)(369) 
Hypertension 40 
(Intervention) 
46 (Control) 
Not reported 45.5 There were no differences between the two 
groups regarding HRQOL. 
Moriyama et al., 
(2009)(371) 
Diabetes 
mellitus type 
II 
50 
(Intervention) 
25 (Control) 
Intervention: 
3.0 (0.6) 
Control: 2.8 
(0.5) 
0.35 (-0.13-0.84) Small 54.5 Intervention group showed significant 
improvement over time in QOL, and self-
efficacy rating (Friedman’s test). 
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Author* Condition Number of 
participants 
in each group 
HRQOL 
Mean, (SD) at 
conclusion  
Effect size 
(Cohens d) 
95%CIs Effect 
size** 
Study 
Score 
Narrative Comments from text. 
Williams et al., 
(2012)(380) 
Diabetes 
mellitus type 
II 
303 
(Intervention) 
303 (Control) 
Physical: 
Intervention: 
45.6 
Control: 45.2 
Mental: 
Intervention: 
51.7 
Control: 48.7 
   54.5 The authors reported significant changes were 
found in the mental health domain of the 
HRQOL of those who participated in the 
intervention.  The authors further stated that 
the physical domain of the HRQOL did not show 
any improvement during the six month 
intervention period. 
Da Vico et al., 
(2013)(381) 
Diabetes 
mellitus type 
II 
18 
(Intervention) 
20 (Control) 
Physical: 
Intervention: 
-0.28 
Control: -0.30 
Mental: 
Intervention: 
-0.31 
Control: -0.33 
 
   54.5 The authors stated that no variations were 
observed in the quality of life scores either in 
the intervention of the control group, however, 
baseline scores for quality of life were similar to 
norms for the Italian general population, so 
there was no real margin for improvement.  The 
authors stated that, In fact, uncomplicated 
diabetes mellitus is not sufficient to induce a 
marked deterioration of HRQOL. 
Nicolucci et al., 
(2012)(389) 
Diabetes 
mellitus type 
II 
 Missing    63.6 Experimental group:   improved QOL, 
improvements in physical and mental HRQOL 
related to volume supervised exercise training.  
Control group:  worsened QOL. 
Bouchard et al., 
(2010)(372) 
Obesity 12  (Caloric 
restriction 
group) 
12 
(Resistance 
training 
group) 
12: 
(Resistance 
training 
group) 
12: (Caloric 
restriction + 
resistance 
training 
group) 
12: (Control 
group) 
Post-
objective: 
86.2 (12.5)  
 Pre-
objective: 
82.8(16.9) 
0.25 -0.41 – 0.90 Small 63.6 Despite improvement in eight out of ten 
physical-capacity tests, no improvement was 
observed for the SF-36 physical function score. 
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Author* Condition Number of 
participants 
in each group 
HRQOL 
Mean, (SD) at 
conclusion 
Effect size 
(Cohens d) 
95%CIs Effect 
size** 
Study 
Score 
Narrative Comments from text. 
Dyson et al., 
(2010)(373) 
Diabetes 
mellitus type 
II 
21 
(Intervention) 
21 (Control 
group) 
Missing 63.6 No significant changes in general quality of life 
after six months and no significant differences 
between the two groups. 
D’Eramo-Melkus et 
al., (2010)(374) 
Diabetes 
mellitus type 
II 
63.6 Experimental group:   Significantly greater role-
physical and physical function QOL and less 
diabetes-related emotional distress compared 
to control group.   Both groups improved in the 
general health, vitality, and bodily pain QOL 
domains. 
Oh et al., 
(2010)(375) 
Metabolic 
syndrome 
57 
(Intervention) 
52 (Control) 
Physical: 
Intervention: 
66.3 (4.0) 
Control: 56.0 
(5.0) 
Mental:  
Intervention:  
69.7 (3.9) 
Control:  57.2 
(5.7) 
Physical  
2.29 
Mental 2.58 
Physical  
1.80-2.80 
Mental 
2.07-3.09 
Large 
Large 
63.6 Intervention group:  Greater improvement in 
physical function, general health, vitality and 
mental health HRQOL compared to control 
group. 
Park et al., 
(2011)(378) 
Hypertension 31 
(Intervention) 
21 (Control)) 
Physical: 
Intervention: 
85.0(18.1) 
Control: 
77.3(20.9) 
Mental: 
Intervention: 
81.7 (11.9) 
Control: 71.6 
(12.9) 
Physical 
0.40 
Mental 
0.82 
Physical -
0.16-0.96 
Mental 
0.25 – 1.40 
Small 
Large 
63.6 Intervention group:   Increases in scores of 
some of the health-related quality of life 
domains (general health, vitality, social 
functioning and mental health). 
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Author* Condition Number of 
participants 
in each group 
HRQOL 
Mean, (SD) at 
conclusion  
Effect size 
(Cohens d) 
95%CIs Effect 
size** 
Study 
Score 
Narrative Comments from text. 
Sakurai et al., 
(2013)(383) 
Obesity 70 
(Intervention) 
 
73 (Control) 
Physical: 
Intervention 
A:  48.6 (4.9) 
Intervention 
B: 49.6 (6.1) 
Intervention 
C: 51.3 (5.0) 
Control: 47.9 
(6.30 
 
Mental: 
Intervention 
A: 53.8 (6.9) 
Intervention 
B: 50.4 (7.8) 
Intervention 
C: 51.5 (6.9) 
Control: 50.8 
(4.6) 
 
 
 
 
 
 
Physical 
(Intervention 
C – chosen 
as largest 
difference) 
0.60 
 
Mental 
(Intervention 
Control) 
0.12 
Physical 
(Intervention 
C) 
0.26- 0.93 
 
 
 
Mental 
(Intervention 
Control) 
-0.21 – 0.45 
 
Medium 
 
 
 
 
 
 
 
No 
effect 
63.6 All three groups improved in the summary 
scores of the physical and mental domains of 
the SF 36 compared to the control group but 
effect was variable. 
Rimmer et al., 
(2009)(370) 
Obesity 30 (Higher 
support 
group)  
31 (Lower 
support 
group) 
31 
(Awareness 
group) 
 
 
 
 
 
Not reported    72.7  
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Author* Condition Number of 
participants 
in each group 
HRQOL 
Mean, (SD) at 
conclusion 
Effect size 
(Cohens d) 
95%CIs Effect 
size** 
Study 
Score 
Narrative Comments from text. 
Young et al., 
(2010)(371) 
Hypertension 269 
(Established + 
DASH 
Intervention) 
273 (Control) 
Physical: 
Intervention: 
0.2 (0.5) 
Control: 0.8 
(0.5) 
Mental: 
Intervention: 
0.9 (0.6) 
Control: -0.1 
(0.6) 
(Mean 
change ± SE) 
6 month 
results. 
72.7 Both intervention groups had modest 
improvement in the physical dimension of 
HRQOL (vitality) after 18 months.  Participants 
losing at least four kg during the intervention 
either after six months or 18 months during the 
study showed improvement in most of the 
physical health dimensions of HRQOL.  The 
authors concluded that their report is one of 
the first to indicate positive changes in HRQOL 
as a result of a multi-component lifestyle 
intervention.  However, increased physical 
activity did not improve the HRQOL of the 
participants when controlling for dietary 
changes in the study. 
Chaveepojnkamjorn 
et al., (2009)(368) 
Diabetes 
mellitus type 
II 
80 
(Intervention) 
84  (Control) 
Intervention:  
96.2 (5.8) 
Control: 79.2 
(8.8) 
2.28 (1.9-3.00) Large 72.7 Intervention group:  mean QOL scores 
increased significantly over 24 weeks.  Control 
group:  No changes in scores. 
*Ranked according to PEDro score.
**Key:
(388) D value 
Small 0.20 
Medium 0.50 
Large 0.80 
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Despite the lack of information in some studies, it was possible to compare the HRQOL impact across 
most and in several of the better quality studies; a medium or large effect size was reported in either 
the physical or mental components of HRQOL or both. The narrative analysis indicates that except for 
three studies, the interventions improved the HRQOL of the participants.  In most of the studies, mental 
function, vitality and general health improved, but not physical function.  The three studies that did not 
show any improvement in HRQOL are; the study by Deinzer et al., (2009) (hypertension); Dyson et al., 
(2010) (DM II) and da Vico et al., (2013) (DM II).  Despite HRQOL not improving in the Deinzer et al., 
(2009) study the authors concluded that the results of their study indicated that the implementation of 
patient education programmes for patients with hypertension empowers patients to participate in the 
management of their own condition (364). Dyson et al., (2010) utilised a short video intervention to 
deliver lifestyle education and this increased the overall knowledge of the diabetes mellitus type II 
individuals compared to the control group.  The lack of difference between the control and intervention 
group for quality of life may according to the authors be due to the small sample size as a results of the 
problems associated with recruitment issues that were experienced during the study (368).  The study 
conducted by da Vico et al., (2013) indicated that group educational programmes are a powerful tool in 
the management of DM II and according to these authors the lack of effect of the programme on the 
QOL of the individuals could be due to the limited sensitivity of the test, as the baseline scores for QOL 
in the participants in the study were similar to the norms for the Italian population and therefore there 
was no real margin for improvement.  The authors also stated that uncomplicated diabetes mellitus is 
not sufficient to indicate a deterioration in the health-related quality of life of the individuals (376).   
 
The studies reporting on interventions for people with DM II and metabolic syndrome indicated positive 
effects on both the physical functioning and mental functioning domains of health-related quality of life.   
Possible reasons why in certain studies the participants only improved in the mental domain of health- 
related quality of life and not in physical function could be that participants in the study could already 
consider themselves as  being physically capable at baseline and that participants could also have 
adapted their physical environment to their physical capacity and physical limitations.  This by 
implication would mean that they may perceive that they do not have any limitations when they actually 
have some limitations when measured objectively (367).   It is thus imperative to realise that the 
measurement instrument used in research to quantify physical function after an intervention could 
potentially have important implications on the outcome of the study and should be carefully analysed in 
regards to the objectives set out for the specific study (367). 
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3.5.6 Implications for practice 
Even small effect sizes of HRQOL improvement may be seen as having a clinical significance in the long 
term (390-392) and medium to large effect sizes were reported in several of the better quality studies. It 
appears that there is evidence to support the efficacy of lifestyle interventions including exercise 
(aerobic as well as resistance training) as well as health education with regard to improving HRQOL. 
These interventions should be utilized in practice but the emphasis should be on tailoring the program 
according to the needs of the community, to make it culturally acceptable and take into account the 
population for which the program is designed.   Based on the conclusion of several authors self-efficacy, 
goal-setting and joint decision making should be encouraged in practice to ensure the sustainability of a 
lifestyle intervention (393-395) . It appears that exercise and education should be incorporated into 
intervention programmes designed for people with hypertension, diabetes mellitus and obesity. 
3.5.7 Implications for research 
It is generally believed that health-related quality of life improves after modification in the lifestyle of 
individuals, but little is known about whether the programmes used are actually improving the HRQOL 
or QOL of individuals (375). Therefore, studies need to focus on standardising the education and 
exercises used in intervention programmes for individuals with chronic diseases in order to allow for 
comparison of the studies.  It is imperative that all studies conducted on individuals living with DMII, 
hypertension or obesity should include HRQOL or QOL measurement instruments in order to focus on 
the biopsychosocial aspects rather than just on the disease.   In conclusion it appears that exercise and 
education interventions make a difference in the lives of the individuals living with the condition.   
3.6 Conclusion 
The first objective of the systematic review was to determine what exercises are used for adults with 
DM II, hypertension or obesity.  Admittedly, the focus of this thesis is on middle-aged women and the 
majority of the papers in the review included both men and women.  However, it is likely that the 
majority of conclusions may be of relevance to women as they were included in the majority of trials 
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and, formed slightly more than half of the participants. However, in the absence of sensitivity analysis, 
this assumption could not be tested.   Due to the complex nature of the review and the search criteria 
set as exercise and health-education, this limited the studies identified and therefore limited the 
potential of learning about the content of individual parts of the intervention package. 
 
Both traditional and less conventional exercise programmes were utilised. Traditional exercise 
programmes included warming up, cardio-vascular exercises, muscle stretches, and strengthening of 
upper and lower limbs, as well as abdominal muscles and finally cooling down.  Less conventional 
exercise programmes included yoga stretching, Tae-Bo and hot bathing.  Personalised exercise 
programmes were also utilised in the studies, depending on the disease.  
 
The second objective was to determine what education is given to adults with DM II, hypertension or 
obesity.  Most of the health education included information on the specific disease, advice on lifestyle 
modifications such as diet and self-care, and also coping skills training and self-management skills.  
Some of the studies issued participants with an educational booklet, poster or pamphlet.  All of the 
health education sessions were culturally relevant for the participants.   
 
The last objective was to determine the impact of exercise or education on impairment, activity 
limitation and participation restriction (including HRQOL) of adults with DM II, hypertension or obesity.  
Moderate changes were observed in the QOL of adults with hypertension or obesity and most of the 
improvement was noted in the physical health dimensions.   Improvement was noted in the physical as 
well as the mental HRQOL dimensions of adults with DM II.   
 
The findings of this review indicate that a limited number of randomised clinical control trials conducted 
on individuals living with DMII, hypertension or obesity include HRQOL or QOL outcome measures.  In 
view of the ICF framework and the biopsychosocial model, it is imperative not only to include outcome 
measures that assess, the impact of the disease on the structures of the body, but rather to assess the 
impact the disease has on the individual’s life and overall well-being.  It is also evident that it is difficult 
to compare the results of studies due to the heterogeneity of samples,  and to the fact of effect sizes not 
being reported, and the lack of standardisation of intervention programmes (either exercise or health 
education).   
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Moderate changes were observed in the quality of life of adults with hypertension or obesity and most 
of the improvement was noted in the physical health dimensions.   Improvement was noted in the 
physical as well as the mental HRQOL dimensions of adults with diabetes mellitus type II.  
Although the overall effect of the interventions in the studies on impairment, activity limitation and 
participation restriction (including health-related quality of life) at the end point of data collection were 
not significant, it is clear that even small effect sizes of improvement in HRQOL may be seen as having a 
clinical significance in the long term on the individual living with DMII, hypertension and obesity.  
Therefore, multi-component lifestyle modification intervention programmes should be developed which 
include exercise, health education, goal setting and cognitive behavioural principles for individuals living 
with chronic diseases.   
94 
4 EXERCISE AND HEALTH EDUCATION IN THE MANAGEMENT OF 
MUSCULOSKELETAL CONDITIONS: A SYSTEMATIC LITERATURE 
REVIEW 
4.1 Introduction 
The aim of the following section is to present the evidence of the current state of knowledge concerning 
exercise and health education in musculoskeletal conditions (MSC) and the impact thereof  on 
impairment, activity limitation and participation restriction (including HRQOL) of adults.  It is important 
to discuss critically the evidence, as MSC are important contributors to the burden of disability (4, 8, 29, 
90, 396). As with the previous review, it would have been preferable to include interventions which 
exclusively enrolled participants similar to those included in the current study, this was not possible. The 
search was not restricted to middle-age women as there were no studies that dealt exclusively with 
women. Therefore the search had to be widened to include males and female of all age groups (adults) 
to ensure that the objectives of the review were addressed adequately.    
4.2 Objectives 
The objectives were to address the following questions: 
 What exercises are used in the treatment of adults with MSC?
 What education is given to adults with MSC?
 What is the impact of exercises or education on impairment, activity limitation and participation
restriction (including HRQOL) of adults with MSC?
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4.3 Methods 
4.3.1 Criteria used for selecting studies for review 
The criteria were identified in three categories to guide the selection of studies for the purpose of the 
review.  The following studies were included:   
 Randomised controlled trials were included, while case-control studies, case reports, letters and
cross-sectional studies were excluded.
 Work-related musculoskeletal studies as well as workplace interventions were excluded.
 Studies on human adults with MSC were included.
 Studies reporting on the impact of interventions on impairment, activity limitation and
participation restriction (including HRQOL) as well as decrease in joint pain of participants were
included.
4.3.2 Search methods 
The following electronic databases were searched from 2009/01/01 to 2013/12/31.  The same 
procedure as described in section 3.3.2 was used to develop and build the search using specific 
synonyms provided in the MeSH database.   
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Table 19: Search strategies utilised 
Electronic database Limits to the searches Terms excluded using the 
“NOT” Boolean search term 
MEDLINE with full text 
CINAHL with full text 
Academic Search Complete 
SPORTDiscuss with full text 
PEDro 
The Cochrane Library 
Journal articles 
English 
“human” 
“adult” 
OR “midlife” 
AND  “musculoskeletal dis” / 
“musculoskeletal” /  
“chronic joint “pain” / joint pain 
AND “rehab” / “rehabilitation” 
OR “fitness” 
OR “therapeutics” 
OR “physiotherapy” /  “physical 
therap 
OR “exercise” 
AND “health knowledge” 
OR “patient information”  
OR “Health promot” / “health 
promotion” 
OR “health education” 
OR “patient education” 
OR “health literac” / “health literacy” 
AND “self manag” / “self 
management 
“case-control studies” 
“case reports” 
“letters” 
“cross-sectional studies” 
“children” 
“adolescents” 
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4.3.3 Data extraction and quality assessment 
All the articles identified were imported into Mendeley (353) and duplicates removed.  The researcher 
and a research assistant independently screened all the abstracts for possible inclusion. The full text of 
articles identified by either the author, or the research assistant as containing relevant information for 
the systematic review were obtained and the quality of the full text articles was then assessed.   Please 
refer to Chapter 3 (Section 3.3.3) for a description of the quality assessment procedure followed.   
Table 20: Criteria used for screening of abstracts 
Category Inclusion Criteria Exclusion Criteria 
Population Human adults Only children 
Only adolescents 
Study design Randomised control clinical trial Case reports, case studies 
Interventions Exercise or health education/education 
Outcome Reporting  on the health-related quality of life 
of adults with musculoskeletal conditions 
Activity limitation of adults with 
musculoskeletal  
conditions 
Participation restriction of adults with 
musculoskeletal conditions 
Decrease in joint pain 
Letters and cross-sectional studies 
Data were extracted from the studies identified and entered into spread sheets to create a summary 
that included the information listed in Table 9. 
4.3.4 Meta-analysis 
All studies were considered for meta-analysis,  regardless of the quality score that was achieved using 
the PEDro scale, therefore the all-inclusive method was chosen for the selected clinical trials (354, 365). 
The hypotheses of the studies, the intervention and also  the outcome measures; the characteristics of 
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the study populations, sample size, availability of the results were compared by two independent 
reviewers to identify the possible pooling of results (362).  The researcher was one reviewer and a 
Biostatistician at the University of the Free State acted as the second reviewer.   Heterogeneity among 
the study populations which targeted different health conditions, the co-morbidities, quality of studies 
and interventions did not allow for statistical pooling of results and therefore meta-analysis was not 
performed.  
4.4 Procedure 
After the online search of the electronic data bases as described in Section 4.3.2, the articles identified 
were imported into Mendeley by the researcher and duplicates were removed. A form developed by the 
researcher was used to decide on the inclusion or exclusion of the articles.  Even if QOL or HRQOL 
outcome measures were not mentioned in the abstract, the article was included for screening if quality 
of life outcome measures were included in the studies as secondary measures and therefore not 
mentioned in the abstract.  All abstracts, as well as the form developed by the researcher for the 
screening process were saved on a memory stick and handed to the research assistant (second 
reviewer).  The second reviewer was a qualified physiotherapist with a Master’s degree in the field of 
Orthopaedic Manipulative Therapy at the University of the Free State, and has been exposed to the 
process of systematic reviews.   
The researcher and the second reviewer independently screened all the abstracts for possible inclusion.  
Once the screening process had been completed the lists of possible inclusions were compared and 
finalised during a consensus meeting.  The full text of identified articles was then obtained.  A meeting 
was held between the two reviewers to ensure that the interpretation of the PEDro score was done 
correctly and a trial scoring was done on two articles not included in the review.  No problems were 
identified.  Data were extracted from the studies identified and entered into the spread sheets. The 
PEDro scale was completed for each study and the total quality score noted.  A table was compiled with 
the scores of each reviewer as well as the mean quality score of each article (Table 27).  No interaction 
between the two reviewers took place to influence the outcome of the quality scores during the 
process.   
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4.5 Results 
The online search generated a total of 146 initial hits. A total of 98 articles were excluded as the title did 
not conform to the systematic review’s objectives.  Three duplicates were removed and a total of 45 
abstracts were screened by the researcher and the research assistant.   A further 24 articles were 
excluded as they did not report on the impact of interventions on impairment, activity limitation and 
participation restriction (including HRQOL) of participants.  Twenty one articles remained and after the 
full text review by the researcher, another 18 were excluded as they did not report on the impact of 
interventions on impairment, activity limitation and participation restriction (including HRQOL) of 
participants.   
Table 21: Number of articles obtained from electronic database 
Database Number of records identified 
MEDLINE with full text  54 
CINAHL with full text 12 
Academic Search Complete 66 
SPORTDiscuss with full text 10 
Africa-Wide 1 
PEDro 0 
The Cochrane Library 0 
TOTAL 146 
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Figure 4: Flow diagram of the selection and review process
Records identified through 
database searching 
(n = 146)
Records excluded 
(n = 98)
Duplicates removed     
(n = 3)
Abstracts screened by author 
and research assistant
(n = 45)
Records excluded 
(n = 24)
Full-text articles assessed for 
eligibility 
(n = 21)
Studies included 
(n = 3)
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4.5.1 Description of the studies 
 
A total of three studies met the inclusion criteria and were summarised in Table 23 and Table 24 below.  
The search was not restricted to middle-age women as there would be no studies to be included in this 
category. Therefore the search had to be widened to include males and female of all age groups (adults) 
to ensure that the objectives of the review were addressed adequately.   The total number of 
participants was 4946, ranging from 114 participants (397) to 4 414 (398) in a single study. Both male 
and female participants were recruited in the trials and two of the three studies had a large 
preponderance of women but the third, large study, had approximately equal numbers of men and 
women.  In total, 57% were female (397-399). 
 
Table 22: Percentage of female participants in included studies 
 
Author Percentage of female 
participants in each study 
Sensitivity analysis 
Hansson et al., (2010)(399) 85% None performed 
Hurley et al., (2012)(397) 70% Done for cost analysis 
Kamada et al., (2013)(398) 55.3% None performed 
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Table 23: Summary of reviewed studies 
Author (year) Setting Population 
(sample size) 
Age (years) 
(mean ± SD 
or range) 
Female 
(%) 
Ethnicity 
(%) 
Number of 
participants 
in each group 
Education / 
Exercise or 
Both 
Relevant 
co-morbidities 
Measurement 
Instrument 
Hansson et al., 
(2010)(399) 
Malmö 
Sweden 
Osteoarthritis 
(114) 
62 (9.43) 85%  Missing 61 
(Intervention) 
53 (Control) 
Education Missing EQ-5D 
Arthritis Self-efficacy scale 
Balance and functional 
tests 
Grip ability test 
Hurley et al., 
(2012)(397) 
South 
East 
London 
Chronic knee 
pain 
(418) 
67(50-91) 
(Intervention) 
67 (51-89) 
(Control) 
70% Missing 278 (ESCAPE-
knee pain 
group) 
140 (GP 
management 
group) 
Both Diabetes 
mellitus, 
cardiovascular 
or respiratory 
disorders 
WOMAC 
Kamada et al., 
(2013)(398) 
Japan Middle-aged 
and elderly 
 (4414) 
60.6 ± 10.5 
(Intervention) 
61.0 ± 10.6 
(Control) 
55.3% Japanese 9 
communities 
(Intervention) 
3 
communities 
(Control) 
Both Missing Change in engagement in 
regular physical activity  
Visual Analogue Scale for 
pain 
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Three studies met the criteria set for the review.  All three were randomised controlled trials. The total 
number of participants was 4946, ranging from 114 participants (399) to  4 414 (398) in a single study. 
Both male and female participants were recruited in the trials and two of the three studies had a large 
preponderance of women but the third, large study, had approximately equal numbers of men and 
women. In total, 57% were female (397-399).  One study was carried out in the United Kingdom (397, 
400), one in Sweden (399), and one in Japan (398). 
The interventions included in the studies ranged from education, either individual or in groups, and 
exercise.  Please refer to Appendix 2 for a detailed description of the interventions and education 
sessions utilised in the studies.   
Not only did the content of the education and/or exercises vary between studies, but also the duration, 
frequency of the sessions and the number of sessions that took place.  The education sessions varied 
from five group sessions, or three hours for each session (399) to 12 supervised sessions of 15 to 20 
minutes each, twice weekly for six weeks (397) and outreach health education by professionals during 
medical check-ups of individuals as well as during community events including various sports events and 
festivals (398). 
The exercise sessions in the studies ranged from simple individualised exercise regimes (397),  to 
encouraging participants to increase their physical activity to at least 150 minutes per week (398).  The 
frequency of sessions varied from once a week for five weeks (399);  35 to 40 minutes twice weekly for 
12 weeks (397) and at least 150 minutes of physical activity per week (398).  The duration of the studies 
ranged from five weeks of education (399) to one year exercise and education programme (398).  
The interventions during the studies were carried out by different health care professionals and included 
physiotherapists (397) or occupational therapists (399) and also encouragement and support from 
various health care professions (398). 
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Table 24: Summary of interventions of included studies 
Author Country Population Nature of 
intervention 
Exercise Education topics 
 
Duration of 
intervention 
Intervention 
delivered by 
Hansson et 
al., 
(2010)(399) 
Sweden OA Patient education 
programme for OA 
with focus on self-
efficacy.   
Exercise and physical activity for 
the lower limbs including home-
training exercises.  
Practical exercises for the hands.    
 
Education included human anatomy, 
physiology of pain and coping with 
pain, OA, medication, diet and current 
research in field. Participants were 
advised to use heat and cold when 
needed.  Brainstorming session to 
determine what patients found difficult 
to do.  Demonstration of orthopaedic 
aids for the lower limbs. Ergonomic 
advice.  Hand advice including using 
paraffin wax.    
 
5 weeks Physiotherapists, 
occupational 
therapists and 
dieticians. 
Hurley et al., 
(2012)(397) 
England Chronic 
knee pain 
Exercise-based 
rehabilitation 
programme 
integrating 
exercise, education 
and self-
management,  
Integrating exercises to 
encourage regular physical 
activity. 
Education and self-management 
strategies to change inappropriate 
health belief and alter behaviour. 
 
 
 
6 weeks Physiotherapist 
Kamada et 
al., 
(2013)(398) 
Japan Middle-
aged and 
elderly 
 
A community wide 
programme to 
promote exercise 
Walking was encouraged as 
aerobic exercise for all the 
groups.  The stretching exercises 
for the two groups were stretches 
for the back muscles, the 
adductor muscles, gluteus 
maximus, the knee extensors and 
flexors, while the strengthening 
exercises included strengthening 
of the trunk flexors, knee flexors 
and extensors. 
 12 months Medical 
professionals 
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A detailed description of the interventions was critically appraised by the researcher during the 
development of the six-week intervention programme as well as the workbook that was adapted from 
previous studies and summarised in table format. (Appendix 2) 
4.5.2 Outcome measures used 
As is evident from the outcome measures summarised in Table 25 various outcomes were explored with 
no consistency between studies.   
Table 25: Outcome measures used in the included studies 
Health Condition HRQOL Outcome measure Other outcome measures 
MSC  EQ-5D (399) 
Western Ontario and McMaster 
Universities Osteoarthritis Index 
(WOMAC) (397) 
Arthritis Self-efficacy Scale (399) 
Lower limb functional tests (399) 
Grip Ability Test  (GAT) (399) 
Participating in physical activity  
(398) 
Standing One Leg Eyes Open 
(SOLEO) and Standing One Leg Eyes 
Closed (SOLEC) balance tests (399) 
Hospital Anxiety and Depression 
Scale (HADS) (397) 
Body Mass Index (BMI) (398) 
Perceived health (398) 
Physical activity levels (398) 
objective functional performance 
measured by the aggregated time 
of four  common activities of daily 
living (AFPT) (397) 
Exercise-related health beliefs and 
self-efficacy questionnaire 
(ExBeliefs) (397) 
McMaster Toronto Arthritis 
Questionnaire (MACTAR) (397) 
Muscle strength (397) 
Voluntary muscle activation (397) 
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4.5.3 Methodological appraisal of the studies 
The methodological appraisal of the studies consisted of firstly utilising the 11 item PEDro scale for 
critically appraising the studies.  As mentioned previously, the heterogeneity among the study 
populations, the co-morbidities, quality of studies and interventions did not allow for statistical pooling 
of results.   
A summary of the quality scores of both reviewers as well as the mean score of both reviewers is 
presented in Table 26.  None of these papers have been scored previously by PEDro but using the same 
scoring system, all the articles achieved a score or 7 or more.  As previously stated a 6-10 score is viewed 
as a high quality score.(385).   In Table 27 the author’s appraisal of the studies according to the PEDro 
scale is presented.    
Table 26: Summary of the quality scores of individual studies 
Author Reviewer 1 Reviewer 2 Mean Score 
Hansson et al.,  
(2010)(399)  
8 8 8 
Hurley et al.,  
(2012) (397) 
9 8 8.5 
Kamada et al.,  
(2013)(398)  
8 7 7.5 
Mean quality score:  8.3 7.6 7.8 
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Table 27: Appraisal of articles using the PEDro scale 
Author (year) 1.Eligibility 
criteria * 
2.Random 
allocation 
3.Allocation 
concealed 
4. Groups 
similar at 
baseline  
5.Blinding 
of all 
subjects 
6. Blinding 
of 
therapists  
7. Blinding 
of 
assessors 
8.Measures 
of at least 
one key 
outcome  
9.“intention 
to “treat” 
 
10. Result of 
between-
group 
statistical 
comparisons 
are reported  
11.Measure 
for at least 
one key 
outcome 
SCORE 
(%) 
Hansson et al., 
(2010)(399) 
1 1 0 1 0 0 1 1 1 1 1 73% 
Hurley et al.,  
(2012)(397) 
1 1 1 1 0 0 1 1 1 1 1 82% 
Kamada et al., 
(2013)(398) 
1 1 0 1 0 0 1 1 1 1 1 73% 
1. Eligibility criteria were specified. 
2. Subjects were randomly allocated to groups. 
3. Allocation was concealed. 
4. Groups similar at baseline regarding most important prognostic indicators. 
5. Blinding of all subject. 
6. Blinding of all therapists who administered the therapy. 
7. Blinding of all assessors who measured at least one key outcome. 
8. Measures of at least one key outcome were obtained from more than 85% of subjects initially allocated to groups. 
9. All subjects for whom outcome measures were available received the treatment or control condition as allocated or data for at least one key outcome was analysed by  
    “intention to treat”. 
10. Initial results of between-group statistical comparisons are reported for at least one key outcome. 
11. Study provides both point measures and measures of variability for at least one key outcome.
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4.5.4 Risk of bias 
Areas of bias that will be discussed include concealment of allocation of participants, blinding of the 
researcher/physician or research assistant and management of incomplete data.  
4.5.4.1 Blinding 
In terms of blinding, consideration was given to participant blinding and researcher blinding. 
Concealment was unstated in two studies.  Blinding of the researcher was clearly stated in the study 
conducted by Hansson et al., (2010)(399) and the assessors were blinded to the allocation of the 
participants in the study conducted by Hurley et al., (2012)(397).  The researchers were also blinded in 
the study conducted by Kamada et al., (2013) as the staff members who were responsible for the 
allocation of the clusters were not involved in the execution of the research study (398). 
4.5.4.2 Incomplete outcome data 
Loss to follow-up was variable within the studies, with some studies suffering larger numbers of loss-to 
follow up than others.  The least lost to follow-up was in the study of Hansson et al., (2010) with 12.3%. 
Table 28 below summarises the lost to follow-up of all the studies.  The loss to follow-up was calculated 
for the entire study and not for individual groups.    
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Table 28: Lost to follow-up and time of follow-up 
Author Population 
(sample size) 
% loss to follow-up Time to follow-up 
Hansson et al., 
(2010)(399) 
Osteoarthritis 
(114) 
Intervention: 16.4% 
Control: 7.5% 
6 months 
Hurley et al., (2010)(397) 
Patients with chronic 
knee pain  
(418) 
ESCAPE knee group: 15% 
Control: 9% 
ESCAPE knee group: 18% 
Control: 19% 
ESCAPE knee group: 25% 
Control: 29% 
ESCAPE knee group: 32% 
Control: 33% 
6 weeks 
6 months 
18 months 
30 months 
Kamada et al., 
(2013)(398) 
Middle-aged and elderly 
individuals 
 (4 414) 
Aerobic activity group: 
18.9% 
Flexibility and muscle 
strengthening group: 
22.4% 
Aerobic, flexibility and 
muscle strengthening 
group: 19.3% 
Control: 21.7% 
12 months 
4.5.5 Effect of intervention on quality of life, function or participation of adults 
Hansson et al., (2010) showed that there was a statistically significant difference between the two 
groups in the five domains of the EQ-5D-3L, with the intervention group having a higher number of 
participants indicating that they had no problems after six months of the intervention in all the 
dimensions of the EQ-5D-3L (mobility, self-care, usual activities, pain/discomfort and 
anxiety/depression).  The VAS score of the EQ-5D-3L also improved significantly more in the intervention 
group than in the control group (399). 
The WOMAC function score, as well as all other secondary outcomes, showed large improvements 
immediately after the intervention, in the participants who completed the ESCAPE- knee pain 
programme in comparison to the usual care group in the study by Hurley et al., (2012).  Unfortunately,  
at all subsequent follow-up assessments there were no differences between the ESCAPE-knee pain 
group and the usual care group, except for improvement in the ESCAPE-knee pain participants’ exercise 
110 
 
health beliefs and self-efficacy and physiological measures of sensori-motor muscle function which 
showed no  improvement during any stage of the study.   
 
 
The results of the study conducted by Kamada et al., (2013) revealed that the programme did not 
improve physical activity levels of middle-aged participants, but significant differences were observed in 
awareness and knowledge between the two groups in the short term (398).   Please refer to Table 29 
and Table 30 for a summary of all the effects of the interventions. 
 
The large number of  drop-outs in the Hansson et al., (2010) study did not have an impact on the results 
of the study as intention-to-treat analysis was utilised (399). Hansson et al., (2010) observed an 
improvement in the EQ-5D-3L domains, but not in the physical tests included in the study.  The reason 
for this could be that the study only included education and no exercise under supervision which is the 
only way to change behaviour (399, 401). 
 
The community wide campaign study of Kamada et al., (2013) with its robust design and community 
wide coverage revealed that the programme did not increase the physical activity levels of middle-aged 
individuals, but did improve their knowledge and awareness regarding increased physical activity levels.  
There were also no significant changes between pain outcomes of the control and the intervention 
group.  The results found were short-term changes and it might be that changes in behaviour towards 
increased physical activity is rather a long-term change which was not observed and,  as previously 
mentioned,  individuals have to be supervised to see improvement in exercise and not just encouraged 
to exercise (398, 401, 402). 
 
In summary the review of the studies reveals shortcomings in the research that affected the outcome of 
the studies. There appears to be definite merit in the education programme utilised by Hansson et al., 
(2010) to be effective in increasing the HRQOL of individuals with MSC as well as the ESCAPE-knee pain 
programme of Hurley et al., (2012) that improved the physical function of the participants with chronic 
knee pain in the short term.   
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Table 29: Effect of interventions for adults with musculoskeletal conditions summarised 
Author 
(year) 
Outcome 
measure 
Mean 
Intervention 
(SD) 
Mean Control 
(SD) 
d 95% CI Effect size Narrative 
Hansson et 
al., 
(2010)(399) 
EQ-5D, 
other tests 
of function 
Not reported Changes in score were reported. 
Statistical improvement only shown 
in the EQ-5D VAS and the standing 
one leg eyes closed test  
Hurley et al., 
(2012)(397) 
Baseline: 
ESCAPE knee 
pain group 
n = 278 
GP group: 
n = 140 
6 weeks: 
ESCAPE knee 
pain group 
n = 237 
GP group: 
n = 128 
6 months: 
ESCAPE knee 
pain group 
n = 229 
WOMAC 
(Baseline) 
27.1 ± 6.7 27.2 ± 7.0 -0.015 (-0.2178, 0.1884) No effect 
ESCAPE-knee pain, produced 
considerable improvements in 
physical function that declined over 
time, but were still evident 30 
months after completing the 
programme, and was more cost 
effective than usual care. 
WOMAC 
pain 
7.5 ± 1.7 7.7 ± 1.7 -0.118 (-0.3209, 0.0856) No effect 
WOMAC 
(6 weeks) 
20.0 ±5.9 25.9 ± 6.3 -0.976 (-1.2027, -0.75) Large 
WOMAC 
pain 
5.2 ± 1.7 7.1 ± 1.8 -1.0947 (-1.3239, -0.8655) Large 
WOMAC 
(6 months) 
21.7 ± 6.7 23.4 ± 7.5 -0.39 (-0.6172, -0.1628) Small 
WOMAC 
pain 
5.7 ± 1.9 6.5 ± 2.1 -0.4065 (-0.6338, -0.1791) Medium 
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GP group:  
n = 113 
18 months: 
ESCAPE knee 
pain group  
n = 209 
 
WOMAC 
(18 months) 
 
 
21.9 ± 7.5 24.3 ± 6.6 -0.3323 (-0.5721, -0.0926) Small 
WOMAC 
pain 
5.7 ± 2.0 6.4 ± 2.1 -0.3444 (-0.5842, -0.1045) Small 
-0.1878 (-0.4357, 0.06) No effect 
GP group:  
n = 100 
30 months: 
ESCAPE knee 
pain group  
n = 189 
GP group: 
 n = 94 
 
WOMAC 
(30 months) 
 
 
22.3 ± 8.7 23.8 ± 6.3 Not reported Large 
WOMAC 
pain 
5.9 ± 2.6 6.4 ± 2.0 Not reported Large 
Kamada et 
al., 
(2013)(398) 
 
Effect size 
reported 
 Group A 
(Aerobic 
activity) 
Group FM 
(Flexibility and 
muscle 
strengthening) 
Group AFM: (Aerobic 
+Flexibility + muscle 
strengthening) 
  
 
 
 
Intervention group:  Although the 
effect sizes ranged from Medium to 
Large in most case, no significant 
improvement in physical function, 
decrease in regular physical activity, 
increased awareness and knowledge 
in short term was found. 
Control:  Decrease in regular physical 
activity; no other changes.   
Changes in 
physical 
activity 
Effect size :  
1.02 
Effect size:  0.94 Effect size:  0.97 Large 
VAS pain 
score low 
back pain* 
Effect size:  
0.66 
Effect size:  1.53 Effect size: 0.54 Medium to 
large 
VAS pain 
score knee 
pain* 
Effect size:  
0.49 
Effect size:  0.81 Effect size:  −0.15 No effect to 
large effect 
Low back 
pain at 
follow up 
Effect size:  
0.92 
Effect size:  0.91 Effect size:  1.04 Large 
Knee pain 
at follow up 
Effect size:  
1.20 
Effect size:  
1.23 
Effect size: 1.00  Large 
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4.5.5.1 Implications for practice 
All of the studies were of high quality and the results, although not statistically significant in most cases, 
did indicate some positive effects of the interventions. Due to the limited number of articles that were 
included in the review it is difficult to determine the clinical significance or implications for practise 
utilizing exercise in musculoskeletal conditions.  Although the evidence supporting lifestyle interventions 
including exercise is limited it seems to still be useful to include exercise (aerobic as well as on 
strengthening exercises) as well as health education in practice. However, the programs should be 
tailored according to the needs of the community and take into account the population for which the 
program is developed,  in this instance middle-aged women between the ages of 40 – 64 years.  It is 
clear that self-efficacy, goal-setting and community involvement should be encouraged in practice to 
ensure the sustainability of any intervention program. 
4.5.5.2 Implications for research 
Due to the lack of evidence regarding the effect of education and/or exercise on MSC, it is imperative 
that further research be conducted to determine the clinical significance of exercise on musculoskeletal 
conditions with special emphasis on determining the effect the intervention or education has 
impairment, activity limitation and participation restriction (including HRQOL) of individuals living with 
musculoskeletal conditions.  There is also a need to conduct similar studies on elderly populations.  It is 
also clear that the population and the needs of the community should be taken into account when 
developing interventions studies to make the intervention programme culturally acceptable and 
appropriate. 
4.6 Conclusion 
The objectives of this review were firstly, to identify what exercises and education are used for adults 
with musculoskeletal conditions.  Due to the complex nature of the review and the search criteria set as 
exercise and health-education, this limited the studies identified and therefore limited the potential of 
learning about the content of individual parts of the intervention package.  Two of the studies provided 
information regarding the exercise programmes followed while one study did not specify the exercises 
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included in the programmes.  Different models of education were provided in all three studies 
depending on the study population.  The last aim of the systematic review was to determine what the 
impact of exercises or education was on impairment, activity limitation and participation restriction 
(including HRQOL) of adults with musculoskeletal conditions.  One study on patients with OA indicated 
that there was an improvement in HRQOL and self-perceived health while another study indicated that 
there was an immediate improvement in function after the programme but that the effect declined over 
time.  The community wide campaign study did increase knowledge and awareness regarding increase 
physical activity in middle-aged and elderly individuals in the community.   
A limitation of the review is that the participants were not restricted to women, and the focus of this 
thesis is on middle-aged women. However, it is likely that the majority of conclusions may be of 
relevance to women as they were included in the majority of trials and, formed slightly more than half 
of the participants. However, in the absence of sensitivity analysis, this assumption could not be tested. 
The information obtained from the two systematic reviews was utilised in conjunction with the 
prevalence, nature and impact of musculoskeletal conditions discussed in Chapter 6 as well as existing 
intervention programmes as discussed in Chapter 7 to modify and adapt an exercise programme and 
workbook for the intervention component of the study.   
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5 INSTRUMENTATION 
5.1 Introduction 
Associated with the exponential increase in health sciences research, the number of measurement 
instruments available has increased dramatically and the choice of whether to choose a measurement 
instrument or a questionnaire to be used in research has become a major challenge to researchers.   
Measurement tools in rehabilitation are generally aimed at recording functioning and disability which 
includes impairment of body structures and function, activity limitations and participation restrictions, 
according to the principles of the ICF as discussed in Chapter 2.  The measurements may further include 
environmental and personal factors that may affect the functioning and disability of the individual or the 
group.  All of these need to be taken into consideration when selecting a measurement tool.   
A description of the measurement instruments chosen for the specific research study will follow in this 
chapter as well as an explanation of the translation project which was a collaborative initiative between 
the Department of Linguistics and Language Practices and the researcher at the University of the Free 
State. 
5.2 Measurement instruments 
There are many instruments that could be used to measure the different constructs covered by the ICF 
domains. The choice of instrumentation was therefore challenging.  After an extensive review of the 
literature, several candidate instruments were identified and these are listed in Appendix 3.  The final 
list of instruments chosen for the current studies is given in Table 30. A detailed discussion on the 
included instruments follows the list. The criteria for choosing the instruments to be included in the 
study were: 
 Availability – the measurement instrument had to be available to the researcher within the
research context. The researcher had limited funds and was not in a position to purchase
expensive measurement tools.
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 Feasibility – the tests needed to be done within the environment of the research, i.e. within the
clinic and within the community centre which was used for the intervention study.  As the
survey required testing of large numbers of people, the instruments chosen needed to be short
and easy to apply.
 Complexity of language used was a big consideration. Bantu is a major branch of the Niger-
Congo language family spoken by most populations in Africa. Bantu languages are spoken
throughout central and Southern Africa and have a common root (403).  English is an extremely
rich language and the Global Language Monitor estimates that there are over one million English
words (404). Although no reference could be found regarding the number of words in Sesotho, a
Bantu language, the researcher and supervisors had had considerable experience in translating
instruments into local South African languages. Other Bantu languages, Shona, isiXhosa (405,
406) and Zulu, for example, were unable to support the nuances and range of meanings of the
English words in many cases. It was not always possible to find semantically and culturally 
equivalent words. Thus a primary consideration in the choice of self-report instruments was the 
relative simplicity of the language used to formulate the questions and the ease with which it 
was anticipated that comparable Sesotho words could be found. 
 A further consideration, linked to the above, was whether the instrument had already been
translated into another Bantu language and validated and used within a similar context to that
of the current research. This would give the researcher confidence that the instrument could be
translated into a Bantu language and that it had performed well when used with respondents
from similar backgrounds. In addition, the data gathered from this study would be more readily
compared to other South African studies.
 The psychometric properties, i.e. validity, reliability and responsiveness, had to be satisfactory
and preferably tested within the South African context.
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Table 30:  List of examples of standardised instruments to measure the different components of the ICF 
Component Function Instrument 
Health component  Self-designed questionnaire based on self-report. 
COPCORD 
Impairment Blood pressure 
maintenance 
Electronic table-model sphygmomanometer. 
Cardiovascular fitness 
 
Kasch Pulse Recovery (407-409) 
6-minute walk test (410, 411) 
Random serum glucose 
levels 
Check classic blood glucose monitoring unit. 
Maintenance of body 
weight: Weight 
Calibrated electronic digital scale accurate to 
0.05kg. 
Maintenance of Body 
height: Height 
Stadiometer accurate to the nearest 0.1 cm. 
Pain Brief Pain Inventory (412-414) 
Simmonds battery of functional tests (415-417) 
WHODAS 2.0 – components 
Participation HRQOL EQ-5D-3L (406, 418-421) 
Pedometer (422) (423-425) 
Personal factors Demographic Self-designed questionnaire 
Self-efficacy Self-efficacy for managing chronic disease 6-item 
scale (426) (413, 427, 428) 
WHODAS 2.0 – component.  
Environmental and 
contextual factors 
 WHODAS 2.0 – components 
Self-designed questionnaire 
 
5.2.1 Health condition and impairment of body function 
The choice of instrumentation to monitor changes in the health condition and impairment of body 
function was made based on availability and ease of administration.  In all cases standard measurement 
practices were used. 
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5.2.1.1 Blood Pressure 
An electronic table-model sphygmomanometer (Clever Chek TD-3250 – 2 in 1 blood pressure monitoring 
system) was used to measure blood pressure. It was manufactured by TaiDoc Technology Corporation, 
New Taipei City, Taiwan. 
5.2.1.2 Blood glucose monitoring unit 
The Gluco Check classic blood glucose monitoring unit TD 4255 was used to determine blood glucose 
levels. It is manufactured by TaiDoc Technology Corporation, New Taipei City, Taiwan. The Gluco Check 
classic blood glucose monitor uses new technology which means fewer steps is needed during the 
testing process and there is no risk of false readings due to the  “no coding needed” technology which 
ensures correct coding and therefore more accurate results.  Gluc Check system has a top-loading strip 
port with strip ejection capability, ensuring optimal safety for health-care providers.  The strip eject 
function eliminates any blood contamination dangers associated with manually releasing a strip, offering 
the safest disposal possible.  The system stores 450 readings with time and date which ensures more 
effective management of patients’ blood glucose readings.   
5.2.1.3 Weight measurement 
The measurement of body weight was done through the use of Electronic Safeway digital scale accurate 
to 0.05 kg.  Manufactured by Pure Pleasure (code:  TF –SA 10155) of the Stingray Group, Cape Town, 
South Africa. The electronic digital scale is accurate to 0.05 kg. 
5.2.1.4 Height 
Height was measured by the Seca Leceister 214 portable stadiometer which is manufactured by Seca, 
Hamburg, Germany. 
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5.2.1.5 COPCORD epidemiological survey 
In the 1980s WHO (The World Health Organisation) and ILAR (International League of Associations for 
Rheumatology) started the COPCORD (Community Orientated Programme for Control of Rheumatic 
Diseases) low cost and low infrastructure, locally based community programme.  The aim of the 
programme was to record pain and disability, related to MSC in specific populations rather than focusing 
on diseases and syndromes (429). 
WHO/ILAR/COPCORD studies conducted worldwide have provided substantial evidence regarding the 
burden of MSC, particularly the impact of joint pain on communities,  and have been the drivers behind 
the development of the Bone and Joint Decade (3). Burden of disease information is an important 
component of health information required for health planning as it can be used to identify health gaps 
in the population that need to be addressed in order to improve the health status of a population (7).
The standardised COPCORD questionnaire Phase I and II was therefore selected for the epidemiological 
study, to identify the joint pain and disability related to MSC in the specific population, but 
supplementary questions were added according to previously conducted studies in South Africa to 
address those aims of the present study that were not covered by the standard COPCORD questionnaire 
(32, 41, 430, 431). (Appendix 4)   
The COPCORD questionnaire has been used in studies in South Africa to determine the prevalence of 
joint pain and the present study was based upon the same methodology as the previously conducted 
studies in both Cape Town and Bloemfontein (31, 32). 
This measure was thus chosen as it had been found to be valid and reliable and robust in similar settings 
both internationally (432-435)  and within the South African context (31, 32).  
5.2.1.6 Cardiovascular fitness tests 
The Kasch Pulse Recovery test and the six-minute walk test will be utilised during the study to determine 
the cardiovascular fitness of participants (408, 410, 411, 436).  Both the tests are used widely in clinical 
settings.  The Kasch Pulse Recovery test is scored as the number of heart beats per minute over a period 
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of one-minute, taken after five seconds after cessation of a three-minute step test.  A lower heart rate 
indicates better cardiovascular fitness (409).  The six-minute walk test is used to measure the maximum 
distance that a participant can walk in six minutes and is used clinically in determining function in 
patients with cardiovascular or pulmonary diseases.  The six-minute walk test is a useful instrument 
because of its similarity to the normal activities of daily living.   The minimal clinically important 
difference for the six minute walk test in patients living with chronic obstructive pulmonary disease is an 
increase of 54 metres (437).  The test, according to Cahalin et al., (1996) and Faggiano et al., (1997) is a 
better measure of exercise endurance than maximal exercise capacity. Studies have shown good 
construct validity and test-retest reliability for the test (438, 439).  As discussed previously in Chapter 2,  
one of the impairments experienced by individuals living with musculoskeletal conditions, hypertension, 
diabetes mellitus type II and obesity is fatigue and consequently including the Kasch pulse recovery test 
and six-minute walk test would address the impact fatigue has on the function of individuals living with 
chronic diseases of lifestyle.   
This measure was chosen as it was easy to administer within the constraints of the testing environment 
and required no specialised equipment. 
5.2.1.7 Brief Pain Inventory (Short form) 
There are numerous reliable and valid measurement instruments available to measure pain.  The Brief 
Pain Inventory (BPI) is a self-administered questionnaire which was initially developed for use in the 
cancer patient population,  but has since been validated for use in non-cancer pain and is now widely 
used in other chronic conditions in which pain plays an important role in the clinical presentation (413, 
440). The BPI is available in a short and long format , with the short form primarily designed for research 
purposes,  while the longer form enquires about the patient’s illness history (440).  
The short form contains three important elements which are not included specifically in other pain 
measurement instruments available.  The first element takes the form of generalised questions which 
clarify to the participant that it is normal to experience some form of pain on a regular basis, but the aim 
of the questions is to determine whether the participant has experienced more pain than that he/she 
would normally expect.  The second element is the assessment of the impact the pain has on various 
functional levels and the last element is to explore the effectiveness of medication through the Pain 
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Management Index (413, 441, 442).  The severity of pain is measured by asking the participant to rate 
their “worst pain”, “least pain”, “average pain” and “pain right now” on a numeric scale from 0 – 10 
during the previous 24 hours.  “No pain” scored as 0 and “pain as bad as you can imagine” scored as 10.   
The four pain severity scores are then averaged to give a pain severity scale of the participant(s).The BPI 
short form also asks participants for information regarding treatments or medication they are receiving 
for pain and in the previous 24 hours how much relief these treatments have given them.  The 
treatment relief is recorded on a numeric scale from 0% to 100%, with 0% being “no relief” and 100% 
being “complete relief”.   The last section of the BPI consists of seven questions exploring how pain 
during the previous 24 hours interfered with activities of daily life and quality of life.  The seven 
questions address “general activity”, “mood”, “walking ability”, “normal work” which includes both work 
outside the home and housework, “relations with other people”, “sleep” and “enjoyment of life”.  The 
scale used is a 10-point scale with 0 indicating “no interference at all” to 10 “completely interferes”.  
These seven scores are averaged to generate a pain interference score (443).    The decrease in pain on a 
scale from 0 – 10 should be at least 2 points for minimal clinically important difference (444) . 
The BPI has been translated and validated for use in several populations, including patients living with 
cancer, (441, 445-451)  patients with non-malignant, chronic pain (414) and patients with painful 
diabetic peripheral neuropathy (452).   The BPI demonstrates reliability as well as content and construct 
validity when used as a self-administered or interviewer administered instrument in North India, Taiwan, 
Germany, China, South Korea, Norway, Vietnam, Philippines, Mexico, France, the Dominican Republic 
and in South Africa in patients living with cancer (414, 440, 445-451).  Although a Sesotho version of the 
BPI short form is available,  no literature could be found to indicate that the translated Sesotho version 
had been validated.  Due to the short BPI’s value in exploring the presence and areas of pain, severity, 
treatment and functional impact of pain on individuals the measurement tool was selected for inclusion 
in the intervention phase as an outcome measure.   The inclusion of the BPI also addressed the 
impairment of pain as discussed in Chapter 2 which in turn affects the functional limitations experienced 
 by individuals living with MSC.  (Appendix 8) 
 
The BPI was chosen in preference to the Glasgow pain scale [362] and McGill pain questionnaires [363, 
364] as both of these use very rich and descriptive language to describe the experience of pain.  
Translation would be unlikely to yield the same nuanced terms to discriminate between pain 
experiences. In addition, the BPI had been translated into isiXhosa and used successfully to monitor pain 
in women living with HIV (453) and had been previously been translated into Sesotho (454). 
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5.2.2 Activity limitations and Participation Restrictions 
5.2.2.1 WHODAS 2.0 
The World Health Organisation Disability Assessment Schedule 2.0 (WHODAS 2.0) is an instrument 
developed by the World Health Organisation (WHO).   The WHODAS 2.0 is a generic instrument that was 
developed in order to assess activity limitations and restriction on participation experienced by an 
individual; and disability from a biopsychosocial approach.  The WHODAS 2.0 is linked to the concepts of 
the ICF;   it covers six domains of functioning including: mobility (moving around); self-care (hygiene and 
dressing); cognition (communication and understanding); getting along (interaction with other people); 
participation (taking part in community activities);   and life activities (work, school, and domestic 
responsibilities) and has a recall period of 30 days.  Each item is scored according to five levels - none, 
mild, moderate, severe and extreme/cannot do (455). (Appendix 5a)  
The instrument has been validated and shows reliability in a wide range of settings and in different 
conditions (456-460).   The WHODAS 2.0 displays good psychometric properties in rehabilitation and 
clinical samples, therefore confirming its suitability to measuring disability based on the ICF framework 
in the present study (460, 461).  
The internal consistency and test-retest reliability of the WHODAS 2.0 are high in mental disorders 
(Europe, Australia, Americas, Middle East, Nigeria, Asia and New Zealand)(457, 458, 462, 463); early 
inflammatory arthritis (Canada)(456, 459); and ankylosing spondylitis (Netherlands)(460) as well as in 
older people with mental disorders in seven low and middle income countries (464), suggesting that the 
instrument can be used both in the assessment of individuals as well as to establish differences between 
groups.  In comparison with other disability measures available,  the WHODAS 2.0 has been validated 
not only in a wide range of patient populations (mental, arthritis, chronic back, neck and headaches, 
diabetes mellitus, heart disease and respiratory diseases),  but also across different countries and 
languages (the Americas, Europe, the Middle East, Africa, South Africa, Asia and New Zealand)(463, 465).  
During the evaluation of responsiveness to change,  the WHODAS 2.0 performed well across diverse 
chronic conditions and it performed equal to and sometimes even better than the SF-36 sub-scales 
(462).  
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The WHODAS 2.0 was chosen as a measurement instrument because it met many of the criteria listed 
above.  It was available and compact so would not take too long to administer. The most important 
consideration, however, was that it had been translated and validated into both Afrikaans and isiXhosa 
(a Bantu language)(466). It had been found to perform particularly well in an under-resourced area of 
Cape Town.  Similarly it had been used to describe the functional profile of people living with HIV in 
Rwanda after being translated into Kinyarwanda, another Bantu language. (467). In addition, the 
WHODAS 2.0 was specifically developed to capture information related to functional limitations and 
participation restrictions, as conceptualised by the ICF. 
 The WHODAS 2.0 was translated by the researcher into Sesotho as part of the translation process of the 
study as no Sesotho version was available.   
5.2.2.2 EQ-5D-3L 
There are numerous Health-Related Quality of Life measurement instruments available,  but one of the 
most commonly used instruments is the EQ-5D-3L (418). The EQ-5D-3L is a single index, generic 
measurement instrument devised to measure health of an individual developed by the EuroQol Group 
(419).  The EQ-5D-3L is therefore an important tool to be used to unpack the health-related quality of 
life of an individual by using five domains of function:  mobility, self-care, usual activities (which includes 
study, work, housework, family or leisure, pain or discomfort) and lastly depression or anxiety.  The 
participants then had to indicate whether they perceive no problems, moderate problems or extreme 
problems.  The instrument also includes a vertical visual analogue scale (VAS) on which participants rate 
their own perceived health state on a scale from 0 – 100 where the end points are labelled “worst 
imaginable health state” and “best imaginable health state”(468).  The EQ-5D-3L instrument has been 
validated in a wide range of settings, including in South Africa and Zimbabwe (406, 420) and in patients 
with different conditions, such as cancer and arthritis (469).  Another major advantage of the instrument 
is that there is a Sesotho version of the instrument available from the EuroQol Research Foundation 
which has undergone the rigorous translation processes required by the Foundation.  (Appendix 6)  
Finally, the instrument yields disability weights or value sets which can be used to calculate Quality 
adjusted life years. This allows the researcher to use preference based measures to calculate a 
numerical value for each health state (470).  
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Although the SF36 (471) was a strong contender for incorporation, the EQ-5D was chosen as it met more 
of the criteria mentioned above.  It is very brief and easy to administer. The language used is less 
idiomatic and simpler to translate.  It had been translated into Sesotho by the EuroQol Foundation 
which requires rigorous adherence to a forward/backward translation process, followed by cognitive 
debriefing (472). Translated versions had already been validated in isiXhosa and Shona, two Bantu 
languages (406, 420).  The availability of the value sets would also make it possible to calculate the 
number of QALYs that might be gained through the intervention.  
5.2.2.3 Simmonds battery of functional tests 
Impairments of pain and decreased movement or movement dysfunction are the most common signs 
and symptoms experienced as a result of a musculoskeletal disorder or other health problems.  
Movement dysfunction may be caused by pain, can be a co-morbid problem or may be a consequence 
of pain.  Pain and movement are both multi-dimensional and complex and not as simple as generally 
believed.  Cognitive, emotional and social factors play a major role in the complexity of pain or 
movement and therefore the limitations of a biomedical and biomechanical model as an explanation of 
pain and movement dysfunction have led to the biopsychosocial model of health and disability that is 
widely used (415).  It was clear that the new model of management requires a new assessment 
approach that focuses on assessment and management at a functional level rather than an impairment 
level.  The assessment at a functional level would require functional tests that assessed the ability of an 
individual to perform a series of movements (a specific task) rather than just a single movement of a 
single joint in a single plane.  To achieve this assessment,  Simmonds et al., (1998) developed a 
standardised, simple to perform battery of physical tests to be used in a variety of conditions (417).  The 
tests can be used to quantify the impact of the specific conditions on the individual.  The battery of tests 
has been tested on patients with back pain, and also on cancer patients and patients with HIV/AIDS 
(415-417). 
The battery of tests have a strong test-retest as well as intra and inter-rater reliability and according to 
Novy et al., (2002),  shows strong concurrent, construct, predictive and discriminative validity in adult 
patients with low back pain in an urban area in Texas, USA (473).  The validity of the Simmonds battery 
of functional tests has been tested in musculoskeletal diseases as well as systemic diseases with 
optimum management predicted (415, 473).  
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Many individuals living with MSC as well as other systemic diseases often have an impairment of either 
central or physical fatigue.  Although the mechanism of this has not been established,  it is possible that 
the decrease of movement and performance in the individual might be contributors to the physical 
fatigue, but it is also possible that this might not be a consequence of the disorder, but rather an 
expression of the disorder in terms of motor function (474). 
Two major constructs that underpin physical performance are speed and endurance and, therefore, 
individuals living with pain and certain illnesses such as cancer may move more slowly than matched 
cohorts across a variety of performance tests (415, 473, 474).   They may move slower when they are 
actually attempting to move “as fast as they can” and move more slowly than their normal counterparts 
when they perform tasks such as walking and sit-to-stand (474). 
The Simmonds battery of functional tests was included as a measurement instrument to determine the 
the physical performance of participants.  The performance battery consists of a series of nine tasks 
(415, 474).  There are several version of the battery of functional tests (415-417, 474).  Refer to Table 31 
for a description of the nine tasks included for this specific study and based upon the studies for 
individuals living with cancer (415) and patients living with HIV/AIDS (416).  The individual tests which 
make up the battery have been separately validated for use in patients with OA (475)   and were 
appropriate for use in our sample. The coin test was not included as part of the current study as it did 
not relate to lower limb balance or function. The coin test requires participants to sit at a table, while 
they are timed to pick up four coins (a quarter, a dime, a nickel, and a penny) and place them in a cup. 
Participants are required to pick up each coin individually. The pen pick up test was also not included in 
the present study.  The test requires patients to stand and a pen is placed on the floor directly in front of 
their feet. They are timed as they bend down and pick up the pen as fast as they can (416).  This test was 
also not included in the study conducted by Saw (2015) to determine the effects of a six-weeks  
physiotherapist-led exercise and education intervention in patients with osteoarthritis , awaiting an 
arthroplasty in South Africa (475).  The six minute walk test was used as proposed by Simmonds (415) 
instead of the 5 minute walk test as previously proposed by Simmonds (417) due to literature 
supporting the psychometric properties of the 6 minute walk test (476-479). 
The Simmonds test battery had been used previously within a South African population of women living 
in an under-resourced area and had performed well (447). The test battery does not require expensive 
equipment and could be performed in the space available to the researcher and participants. A further 
advantage is that the test yields numerical data which could be analysed using parametric tests.  
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Personal communication with Maureen Simmonds indicated that 15 metres is equivalent to 50 feet and 
is recommended for countries working in the metric system including South Africa.   
Table 31: Description of the Simmonds battery of functional tests 
Name of test Description of test Recorded as: 
15 metres walking at preferred 
speed 
Walk 7.5 metres turn around and 
walk back to the starting position at 
preferred walking speed.  
Seconds 
15 metres walking at fastest speed  Walk 7.5 metres turn around and 
walk back to the start as fast as you 
can. 
Seconds 
Unloaded forward reach Stand adjacent to a wall on which a 
tape measure is positioned 
horizontally at shoulder height.  
Reach forward as far as you can. 
Centimetres 
Timed, repeated sit-to-stand Sit in a standard chair, stand up and 
then sit back down. Repeat after a 
brief rest. 
Seconds 
Sock test Sit in a standard chair. Put on one 
loose-fitting sock. 
Seconds 
Loaded forward reach Stand adjacent to a wall on which a 
tape measure is positioned 
horizontally at shoulder height.  
Hold a weighted 4.46 kg bar with 
both hands close to your body and 
at shoulder height.  Reach forward 
as far as you can with the bar in a 
horizontal position, maintaining 
hands at shoulder height. 
Centimetres 
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Name of test Description of test Recorded as: 
Timed, repeated reach-up Stand facing a wall and reach up as 
high as you can with both hands.  A 
mark is placed on the wall at the 
reached distance.  You must reach 
up and return your hands to your 
side three times as fast as you can. 
Seconds 
Distance walked in six minutes Walk as far and as fast as you can 
for six minutes.  You are allowed to 
rest if necessary during the six 
minutes. 
Metres 
Timed belt tie Sit in a standard chair and wrap a 
standard wrap bandage 
(approximately 1 metre) around 
your waist and tie it in front of you. 
Seconds 
5.2.2.4  International Physical Activity Questionnaire 
Due to the modern lifestyle, physical inactivity of individuals has now become a global health concern 
contributing to an increase in chronic diseases of lifestyle as discussed in Chapter 2.  Standardised 
approaches to measure physical activity are limited and the comparison of international data is difficult 
(480, 481). 
The International Physical Activity Questionnaire (IPAQ) was developed in Geneva in 1998 to provide a 
measurement tool to obtain internationally comparable data on health-related physical activity.  The 
validity and reliability of the questionnaire has been shown to have acceptable measurement properties 
for use in many settings, different languages, and these questionnaires are suitable for national 
population-based prevalence studies determining the level of physical activity of individuals in a specific 
population (335, 442, 482).  These populations included those of Guatemalan, Australia, Brazil, United 
Kingdom, Canada, Finland, United States of America, Japan and South Africa.  Most of the samples were 
middle-aged individuals in large cities, but rural populations with generally lower education levels were 
included in the South African and Guatemala samples (335, 442, 482). The questionnaire is suitable for 
use in young and middle-aged adults from 15 to 69 years of age (482). The age scope is well within the 
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bounds of the population of women being studies in the present study which has been identified as 
women between the ages of 40 to 64 years of age.   
The short form of the questionnaire comprises four generic items.  The questions are related to the 
physical activity of the participants in the previous seven days (335). Participants are specifically asked 
to consider all activities that they engage in at work, as part of their house and garden work, to think 
about how they get from place to place and also what they do during their spare time for recreation, 
exercise or sport.    The first set of questions enquires about vigorous physical activities that the 
participant engages in and the term vigorous physical activity is referred to as “activities that take hard 
physical effort and make you breathe much harder than normal”.  Participants are asked to think about 
the activities that they did for at least 10 minutes at a time.  The next set of questions enquires about 
moderate physical activities.  Moderate physical activities refer to “activities that take moderate 
physical effort and make you breathe somewhat harder than normal”.   It is specifically mentioned that 
moderate physical activities should not include walking activities, but that participants should think 
about activities like carrying light loads, cycling at a regular pace or playing doubles tennis.   The third set 
of questions requires participants to think about the time they spend walking.  This includes walking at 
work, at home, walking to travel from place to place and any other walking that they do for recreation, 
sport, exercise or leisure.  The last set of questions is about the time the participants spent sitting on 
weekdays.  This includes time spent at work, at home, while doing work and during leisure time.  This 
may include time spent sitting at a desk, visiting friends, reading and sitting or lying down to watch 
television.  In each instance participants are required to indicate how many days during the previous 
seven days they have engaged in the specific activities and also how many hours per day or minutes per 
day they spent on the activity during one of those days in the seven days.  (Appendix 9) 
The IPAQ was translated by the researcher into Sesotho as part of the translation process of the study as 
no Sesotho version was available.   
The IPAQ was chosen as it had been used previously in a South African study to estimate the burden of 
disease attributable to inactivity in South Africa. It was reported to have been validated in both rural and 
urban South Africans. It had been used in the 2003 nationally representative set of data on inactivity in 
South Africa (483). 
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5.2.2.5 Pedometers 
Pedometers are used to provide information on ambulatory activities (422) and are used in research to 
validate the physical activity levels of individuals (484) or to encourage individuals to increase their 
physical  activity levels (423-425).  One of the advantages of pedometers is that they provide an 
objective, accurate and low-cost measure of  walking activities (422).  The validity of questionnaires is 
often limited due to the  individuals inability to give information accurately especially regarding 
moderate-intensity activities (422) and therefore pedometers are used to give an objective measure of 
these activities.  The pedometers (model E01758, manufactured in China on behalf of Unilever by 
Supremia international Plc, Jubilee House, Merion Avenue, Stanmore, Middlesex, UK) used would be 
individualised for each participant according to the manufacturer’s guidelines.  This procedure includes 
entering the weight of the participant as well as the stride length of the participant – distance measured 
heel to toe as the participant walks.  The stride length is set in centimetres.   
5.2.3 Personal and Contextual Factors 
5.2.3.1 Demographic information 
Questions specifically related to demographic and environmental factors were included, as according to 
the ICF personal and environmental factors influence the impairments, activity limitations as well as 
participation restrictions of the individual living with the chronic disease (48-50). Demographic 
information included dealt with specifics regarding the age of the individual, ethnicity, home language,  
marital status,  literacy, highest education level,  type of dwelling and how many people were living with 
them.  Further information would include their employment status and, if employed, their current job.  
If not employed, it would refer to the reason why they were not employed and whether they received 
social grants and if so what grant(s) did they receive.   
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5.2.3.2 Self-efficacy for Managing Chronic Disease Six-item scale 
Self-efficacy refers to an individual’s confidence about being  able to perform a specific behaviour or to 
overcome a barrier to that specific behaviour (485, 486).  It has been determined in various studies that 
self-efficacy plays an important role in the management of a chronic disease and it has been found that 
there is a definite correlation between self-efficacy and pain in MSC such as low back pain, rheumatoid 
arthritis and fibromyalgia,  as well as other chronic diseases including diabetes mellitus (23, 335, 426, 
440, 487-490).   
Various studies have also reported that individuals with the same amount of pain, but with different 
levels of self-efficacy, have different levels of disability.  The higher the self-efficacy levels, the lower the 
reported disability (488, 491-493).  This is clearly indicated in a study conducted by Oliver and Cronan 
(2005) that reported that women with fibromyalgia with high levels of self-efficacy showed a decrease in 
their symptoms and an increase in their physical activity compared to their counterparts with lower 
levels of self-efficacy (23). 
The present study explored  the effectiveness of a non-pharmacological six weeks intervention 
programme, including exercise and educational sessions utilizing a workbook, for middle-aged women 
presenting with musculoskeletal conditions and either/or hypertension, diabetes mellitus type II and/or 
obesity.   Therefore,  the inclusion of a self-efficacy questionnaire was deemed appropriate based on the 
association between self-efficacy and musculoskeletal pain (491) and on self-efficacy and self-
management in chronic diseases (426, 494, 495). 
The measurement tool selected for the study was the Self-efficacy for Managing Chronic Disease six-
item scale (SE-6)(426).  The scale was specifically developed in the United States of America on arthritis 
patients to test the efficacy of chronic disease education programmes (427, 496). The scale was derived 
from the more comprehensive and burdensome Chronic Disease Self-efficacy Scales which consist of 
three sections.  The sections include:  the self-management behaviour section with 11 questions; the 
general self-efficacy section with five questions;  and the self-efficacy section with 17 questions (497).  
The shorter version of the measurement tool includes the dimensions of symptom control, emotional 
functioning of the individual, the role of function in the individual and communication with the 
physician.  Participants have to indicate on a numeric scale from 0 – 10 how confident they are about 
performing certain activities relating to their chronic disease.  Zero indicates that they are “not at all 
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confident” and 10 indicate that they are “totally confident”.  The scale has been found to be valid and 
reliable for measuring self-efficacy in chronic conditions in several countries including:  chronic 
conditions in France, China, England, Canada, Mexico and Australia (497-499); spinal cord injuries in 
Hong Kong (500); DM II in the USA (501); cancer patients in the UK (502); hypertension in United States 
of America (503), and China and South Korea (504) as well as in primary care patients in the United 
States of America (505). The chronic disease self-efficacy scale has been validated in German, English, 
Spanish, Afrikaans, isiXhosa and Zulu, but has not been translated or validated into Sesotho (475, 506-
509).  The instrument was translated into Sesotho as part of the collaborative translation project of the 
study. (Appendix 7)   
This instrument was chosen as it had previously been translated successfully into a Bantu language 
(isiXhosa) and used in intervention studies aimed at reducing pain through improving self-efficacy and 
exercise (475). It is also brief and does not take long to administer. 
5.2.3.3 Acceptability questionnaire 
An acceptability questionnaire designed by the researcher using the available literature was included to 
determine the attitude of the participants in the intervention group towards the programme (334, 338).  
Five simple questions were formulated asking the participants what they liked most, liked least about 
the programme, what they would change or add to the programme and whether they liked the self-
management booklet that had been developed and modified by the researcher from the available 
literature, and from the results of the epidemiological study as well as from existing programmes (364). 
(Appendix 10)  Although no validity testing was done on the questionnaire, this method of evaluating 
acceptability of interventions has been used in previous research including people living with HIV, 
chronic low back pain and promoting physical activity (364, 510, 511). 
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5.3 Translation of measurement instruments 
5.3.1 Introduction 
As discussed, most questionnaires have been validated in English and within a very different cultural 
context to that of the current study.  Translation of all standardised self-report questionnaires was 
therefore required. The translation process not only poses challenges due to differences in language, 
but also because of the cultural acceptability and validity of the translated questionnaire.  The 
translation of the questionnaires from an English source text to a Sesotho text requires that three types 
of equivalence should be achieved between the source language text and the target language text:  
semantic, normative and conceptual equivalence (512, 513). Semantic equivalence refers to the extent 
that each item has the same meaning in the language or idiom of each culture.  Normative equivalence 
refers to the capacity of the translated instrument to address successfully the difference between 
cultures and that the intended message is the same.  Thirdly, conceptual equivalence addresses the 
degree to which a given concept is present in both the source and target text.  Other requirements 
include that  the content of each of the items in the questionnaire should be culturally relevant (content 
equivalence); the method of data collection should be equivalent in each culture (technical 
equivalence);  that the interpretation of the instrument remains the same when being compared with 
the norm for each of the cultures (criterion equivalence);  and lastly that the same theoretical construct 
is tested in each culture (513).   
The main challenge of the project was the lack of terminology in Sesotho for formulating the questions 
and the cultural differences between English and Sesotho, as the target audience were mostly Sesotho 
speaking women. 
5.3.2 Translation process 
A multistep translation methodology has been developed although variations in the details of the steps 
are followed by researchers (514).  In one variation, the proposed steps of the translation methodology 
include translating the questionnaire from the source language into the target language and this process 
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is called forward translation. The translation should be done by two independent professional 
translators with a third independent translator reconciling the two translated documents and resolving 
any discrepancies before proposing the final translation to be used for the second step in the translation 
process (515).  The second step in the process is when the resulting target language version of the 
questionnaire is translated back into the source language, the so called back-translation.  The back 
translation is seen as the quality-control step of the translation process.  The process consists of the 
reconciled versions of the questionnaire being blindly translated back into the source text by two 
translators who have never seen the questionnaire before,  either in the source language or the target 
language (515).  These two back translations are then again compared by an independent moderator, 
after which a final translation is provided.   In the translation process, it is essential to utilise different 
translators for the different roles (e.g. forward translation, back translation) for the sake of quality 
control. The moderator is the last person in the process who produces a synthesis. The moderator 
should not have been involved earlier in the process and should be an experienced language 
practitioner.    In a second variation, the source text is translated by one professional translator, i.e. 
forward translation. This translation is then back translated into the source text by a second translator. 
A moderator then compares the back translations with the forward translation, pointing out and 
documenting discrepancies and suggesting a final translation.  The first version needs more people 
during that translation process and the second variation fewer people (514, 515).  
 
Therefore the methodological approached followed during the translation collaboration project of this 
study was mainly the first variation , but with the exclusion of a third independent translator, reconciling 
the two forward translated documents and resolving any discrepancies, before proposing a final 
translation to be used for the back translation process.  The high cost involved in the translation process 
as well as the limited independent professional translators prepared to assist with the project, required 
the project manager to make adaptations to the process in order to ensure completion of the project 
within the set time frames of the study.   
According to Breugelmans (2009),  a common misconception is that once the back translation has been 
completed, the translation product is considered to have been validated (516). Cultural adaptation of a 
questionnaire, however, requires collaboration between professional translators of both the source text 
language and the target text language, and the researcher who developed the questionnaire as well as 
the population in which the questionnaire is to be used during the research study.  This is done through 
testing of the questionnaire amongst patients who represent the target population of the study and the 
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process entails cognitive debriefing of the respondents on completion of the questionnaire (516). 
Cognitive debriefing is used to determine evidence of equivalence during the translation of 
questionnaires, linguistic validation of questionnaires and cultural adaption of the measurement 
instruments (517). 
5.3.3 Translation collaboration project3 
Four of the instruments selected for use in the present study had not been translated into Sesotho; 
these were the epidemiological survey questionnaire developed by the researcher;  WHODAS 2.0 12 
item self-administered questionnaire;  Self-efficacy for Managing Chronic Disease six-item scale (SE-6),  
and International Physical Activity Questionnaire (IPAQ).  Please refer to Appendix 11- 15 for the 
detailed summary of the translated and moderated texts.  It was agreed with the collaborators from the 
Department of Linguistics and Language Practices that the translation should be standard language, with 
a register of language for general purposes, as the educational levels of the population had not been 
determined beforehand.    It was emphasised in the plan that the translators should be sensitive to 
complicated ways of asking questions, technical terminology and culturally sensitive questions, and the 
layout of the translated questionnaires should be exactly the same as that of the original English source 
text to ensure comparability of the end products.   Qualified translators were appointed based on their 
experience and expertise (Appendix 16).  All the translators spoke Sesotho as their mother tongue, but 
regarded themselves as fully bilingual, having done translations in English as well as Sesotho.  The 
moderator translator was a male freelance translator and was accredited.   
It is recommended by several authors that the back translations should be performed by English first 
language speakers, but due to the translators being either free-lance or professional translators,  it was 
deemed adequate that the back translators were fully bilingual and bicultural (405, 513, 518).  This 
approach was judged to be effective in the translation of the EQ-5D-3L quality of life instrument (405).  
The process followed is illustrated in Figure 5 below. 
3 A concept paper describing the questionnaires and translation in the knowledge economy is in preparation. 
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Figure 5: Flow diagram of methodology of proposed translation process 
The two back translations utilised different translators than the forward translations and the 
moderation was performed once again by a different translator from the previous two translations.  The 
moderator would be responsible for comparing the two back translations, with annotations and then 
Source language (English
Forward translation x 2 
Translator 1 and 2
Target language (Sesotho)
Back translation x 2 Translator 
3 and 4
Source language (English)
Moderation 
Moderator
Final translation document 
(Sesotho)
Cognitive debriefing
Pilot study
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compiling a final translation.  In this, translation project both moderators were accredited4 in the 
language combination of English and Sesotho.    A cognitive debriefing interview for the four translated 
questionnaires was conducted among five female participants whose native language was Sesotho.  The 
interview was facilitated by a qualified physiotherapist who was fluent in both Sesotho and English.  The 
interview was recorded by the researcher and the qualified physiotherapist assisted the researcher in 
the interpretation of the findings afterwards.    Prior to the cognitive debriefing session, all the members 
of the cognitive debriefing session, including the facilitator, gave written consent for participation after 
they had been informed regarding the process and what was to be expected of them.  The participants 
also specifically gave permission for the session to be audio taped.  The results of the cognitive 
debriefing exercises are presented in Appendix 17.   The last stage of the translation process was the 
observation of the pilot study conducted by the fieldworkers which involved the testing of the translated 
questionnaires combined with observations by the project managers and the researcher, as well as an 
informal focus-group discussion between the fieldworkers and the project managers to address any 
problems which might arise with the translated questionnaire.   
 
5.3.4 Results 
 
Unfortunately, despite the rigour of the planning process, the developed protocol could not be followed 
exactly due to a Sesotho forward translation that turned out to be inadequate and of poor quality.  The 
methodology for the actual translation process that took place during the translation project is 
illustrated in Figure 6 below.   
 
 
 
 
                                                          
4 Accreditation of a moderator is done by the South African Translators institute and the institute accredits the 
person as a professional translator in a specific given language combination.  The accreditation is internationally 
recognised by the International Translation Federation.  Accreditation, is however, not required to practise as a 
translator due to the industry not having a statutory body.   
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Figure 6: Flow diagram of actual methodology of translation process 
The inadequate forward translation could not be redone because the back translator only reported the 
inadequacy of the translation late in the process, while the implementation date of the survey was 
confirmed with all stake holders.  To resolve the situation in the best possible way, the moderator of the 
Sesotho project was asked by the project manager to produce an annotated translation using the one 
forward translation. The moderator then compared the one forward translation with the two back 
Source language (English
Forward translation - good quality
Translator 1 
Forward translation - inadequate
Translator 2
Annotated translation by 
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Target language (Sesotho)
Back translation x 2 
Translator 3 and 4
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Final translation document 
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138 
translations and from this comparison, suggested a final translation, motivated by detailed annotations. 
These versions were then tested during the cognitive debriefing and pilot study. 
A total of five participants (three with joint pain and two healthy individuals) completed the 
epidemiological survey, WHODAS 2.0 (12 item self-administered) questionnaire, IPAQ and SE-6.  The 
questionnaires were initially given to participants to complete by themselves (self-administered) but the 
literacy level of some of the respondents was low, and after it came apparent that the participants were 
struggling with the questionnaires, the rest of the questionnaires were completed with the interviewer.  
Therefore, after the cognitive debriefing, it was agreed that utilising fieldworkers for completion of the 
questionnaires would be the best strategy. The fieldworkers were trained to minimize confusion with 
certain terms, phrases and concepts that were identified during the cognitive debriefing.   Participants 
were all female with a mean age of 50.8 years.  Participants were predominantly in the lower 
educational categories, with one participant having a higher education level than the other participants.  
The median time to complete the epidemiological survey was 17 minutes and to complete the WHODAS 
2.0 seven minutes.  The detailed description of the results is presented in Appendix 18.  During the 
cognitive debriefing changes were only made to the COPCORD epidemiological survey. 
The demographic details of the respondents are provided in Table 32. 
Table 32:  Demographic information epidemiological survey questionnaire 
Age of each participant Gender Profession 
R1: 46 Female Supervisor for cleaning service 
R2:  52 Female General worker 
R3:  42 Female Unemployed 
R4:  54 Female Cleaning lady 
R5:  60 Female Retired 
Mean age:  50.8 years 
Median age:  52 years 
There were few issues that arose out of the cognitive debriefing and these are presented in Appendix 
19. No changes were made to any concepts in the translated version of the WHODAS 2.0 (12 item self-
administered) questionnaire, the Self-efficacy for Managing Chronic Disease six-item scale (SE-6) and the 
International Physical Activity Questionnaire (IPAQ).  According to the IPAQ website, it is recommended 
that no changes be made to the order or wording of the questions as this would affect the psychometric 
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properties of the instrument (482).   Minor changes were made to wording and grammatical errors were 
corrected in the questionnaires.    
No problems were identified during the observation of questionnaire administration and both the 
fieldworkers and the participants seemed comfortable with the process.  This debriefing session of the 
fieldworkers did, however, serve to clarify some matters. These particular questions are discussed in the 
following paragraph.  An informal focus-group discussion between the fieldworkers and the project 
managers did not identify deficiencies in the translation and no changes were suggested by the 
fieldworkers.  The fieldworkers did mention that older participants did not feel comfortable answering 
questions regarding difficulties experienced during their sexual activities, and the researcher made it 
clear to the fieldworkers that participants had the right to refuse to answer questions that made them 
uncomfortable and that this would be noted as missing data. (Appendix 20) 
5.4 Conclusion 
In this chapter a description of the measurement instruments chosen for the specific research study was 
given.  In addition, the chapter presented details of the translation project, a new collaborative initiative 
between two academic departments, in an attempt to solve the methodological problems that could 
possibly occur during translation were provided.   
The strength of the translation approach lay in the collaborative efforts between the Department of 
Linguistics and Language Practices at the University of the Free State and the Allied Health Professions, 
exploring new methods in an attempt to solve methodological problems that could occur during 
translation of questionnaires.  During this process, professional as well as free-lance translators were 
used and the translation project was managed by a project manager, an accredited moderator for 
translations in South Africa.  Despite using professional translators, the limitations of the translation 
process included a poor standard of translations, and in one instance the poor quality of the translation 
changed the intended plan of the project. Inaccurate translations, difficult wording, advanced and 
unfamiliar vocabulary choices and complex sentences and words were challenges that faced the 
translators.   
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Another limitation is the possible lack of generalisable use of the translations for more rural 
respondents.   All the translators regarded themselves as fully bilingual in Sesotho and English, because 
their first language was Sesotho and they were working in an urban environment.  The questionnaires 
were tested on Sesotho women living in a peri-urban community of Bloemfontein which meant that the 
Sesotho spoken by the women was a mix of IsiXhosa and Setswana due to the urbanisation that is taking 
place in South Africa.   Although some women were IsiXhosa and Setswana speaking, they could all 
fluently speak and understand Sesotho due to urbanisation in the population being investigated in this 
study.  However, the translated questionnaire might not be readily understood in a pure rural Sesotho 
environment or by unilingual Sesotho speaking individuals.  Should the research study be duplicated in 
another population using the translated questionnaires, piloting would be advisable.   
Despite these limitations, the researcher had confidence that the translation process resulted in 
versions that were culturally and linguistically equivalent to the source versions, and data collection was 
then initiated. 
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6 PREVALENCE, NATURE AND IMPACT OF MUSCULOSKELETAL 
CONDITIONS 
 
6.1 Introduction 
 
This study investigated the nature and prevalence of MSC in women between the ages of 40 and 64 
years who attended a community clinic in the Free State for management of chronic diseases of life style 
(CDL) and/or musculoskeletal conditions (MSC).  The outcome was to inform the development of the 
workbook and the intervention. In addition, the relationships between joint pain (musculoskeletal 
conditions) and other co-morbid conditions were examined.  The research questions therefore included: 
How many of the clinic attendees eligible for inclusion experienced joint pain (musculoskeletal 
conditions)?   What was the nature of their pain? Did the MSC occur co-morbidly with CD?   If so, what 
clusters of co-morbidities were present which included MSC?  Was substance use and obesity associated 
with joint pain?  In those that did have joint pain (MSC), a further question was to establish whether the 
joint pain had a negative impact on their activities and participation. 
 
The terminology “joint pain” (musculoskeletal conditions) was used during the formulation of the 
COPCORD questionnaire utilised for the survey.  Therefore for the purpose of the epidemiological survey 
this terminology will be used when discussing the COPCORD questionnaire.   The more generic 
terminology “joint pain” will be used in any other circumstances during the study.   
 
6.1.1 Aims and objectives 
 
The specific objectives of the epidemiological study were to examine joint pain (as defined by the 
COPCORD Phase I and II questionnaire), within women between the ages of 40 and 64 years, attending a 
community clinic in the Free State, in order to: 
 
 determine the prevalence of joint pain;  
 determine the nature of the joint pain; 
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 establish the most common clusters/patterns of co-morbidities in women experiencing joint
pain;
 determine any co-morbid relationships between diabetes mellitus type II, hypertension and
joint pain (musculoskeletal conditions); and
 to determine whether substance use and obesity were associated with joint pain in these
women.
The second aim of the study was to determine the impact of joint pain on activity limitations and 
participation restrictions within the target population. The specific objectives were: 
 to determine if those with joint pain (musculoskeletal conditions) had a lower quality of life as
measured by the EQ-5D-3L compared to those without;
 to compare the functional limitations of those with joint pain (musculoskeletal conditions) to
those without as measured by the WHODAS 2.0; and
 to establish the nature of dysfunction and/or participation restrictions in those participants with
joint pain (musculoskeletal conditions).
6.2 Methods 
6.2.1 Research design 
The research design was a facility-based survey using a descriptive observational cross-sectional design. 
6.2.2 Study population 
The population consisted of all women between the ages of 40 and 64 years attending the community 
clinic in the Bloemfontein area, for CDL health-related issues.   
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6.2.3 Study sample 
A sample of convenience was utilised in that all women between the ages of 40 and 64 years, who 
attended the community clinic, on the days of data collection, were included in the sampling frame. 
There was no randomisation or probability sampling and all women, within the age group, who agreed 
to participate, were included. This age group was recruited as joint pain and CDL increase with age and 
are more common in women (14).   It was of interest to determine the prevalence of joint pain and co-
morbidity within this targeted group as the Primary Health Care system needs to be able to provide their 
existing patients with appropriate and adequate care.  Knowledge of the numbers of women who fit into 
this category would assist the Primary Health Care clinics with planning and aid in designing the 
intervention planned in the second phase.  The planned intervention (Chapter 8) was intentionally 
aimed at those who perceived their health condition as being poor enough to warrant attendance at the 
clinic and who were living with the health conditions of interest. 
6.2.3.1 Participation criteria 
All women between the ages of 40 and 64 years, attending a community clinic, for personal health-
related issues were included in the survey.  The women had to give informed consent.  As the 
questionnaires were only available in two of the three main languages spoken in the Free State 
Province, the women were required to understand English or Sesotho in order to participate in the 
study.  The language proficiency of the participants was determined by asking the participants if they 
would be able to answer the questions asked by the researcher or the fieldworkers in any of the two 
languages.  Women with neurological conditions such as adult cerebral palsy or stroke were excluded as 
they might have experienced joint pain due to abnormal biomechanics arising from contractures, 
increased spasticity or deformities.  Women who had cognitive impairment, which might prevent 
understanding of the informed consent procedure and the questions asked, were also excluded.   
Blinding was not applicable as all attendees at the clinic on the day of data collection fitting the criteria 
described were included and no intervention was performed. 
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6.2.3.2 Sample size 
The sample size was calculated in Epi-info TM 7 based on the prevalence estimates from a similar study in 
a primary health care clinic (PHCC) in Cape Town (32).  It was expected that the population attending the 
PHCC would be 11 000 and that there would be only one clinic or cluster. The design effect was 
therefore set at one (519).  The expected frequency of joint pain (musculoskeletal conditions) was 
entered as 10%, with a confidence limit of 1.5%.  This implied that, if the true prevalence was 10%, the 
prevalence would range from 8.5-11.5% and that the researcher could be 95% sure that this was the 
true prevalence.  One thousand three hundred and fifty three participants would be required, of which it 
was anticipated that approximately 135 would present with MSC.   
6.3 Instrumentation 
Chapter 5 described the translation and semantic validation of the instruments used in this part of the 
study. They included: 
 a self-designed questionnaire to gather demographic and medical information;  (Appendix 4)
 the COPCORD questionnaire to screen for joint pain;  (Appendix 4)
 the EQ-5D-3L to monitor Health-Related Quality of Life (HRQOL) (Appendix 6) and
 functional ability was measured by the WHODAS 2.0. (Appendix 5a)
In addition, the following measurements were taken:  body weight and height of participants, blood 
pressure measurements and random serum glucose levels using the finger prick tests. 
 Body weight was determined by the fieldworkers on a calibrated electronic Safeway digital scale
accurate to 0.05kg.  The body weight was determined without shoes and excess clothing.  The
height of each participant was recorded to the nearest 0.1 cm using an adapted stadiometer,
which consisted of a metal measuring tape, placed securely against a flat wall and a flat
headboard at a right angle to the wall.   Participants were instructed to stand with their backs,
buttocks and heels as close to the wall as possible.  The measurement was taken without shoes
(123). All the measurements were taken in a separate room to protect the privacy of the patient
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(520).  The information obtained was documented on the data form, disclosed to the patient, 
but kept strictly confidential.   
 Blood pressure was measured after a five-minute rest in the sitting position according to WHO
guidelines.  Two readings after three-minute intervals were obtained using an electronic table-
model sphygmomanometer (Clever Chek TD-3250 – 2 in 1 blood pressure monitoring system).
In each instance, the second reading of the participants was used as the baseline measurement
(521).  Blood pressure was classified as low:  systolic blood pressure <120mmHg diastolic blood
pressure < 80mmHg;  normal :  systolic blood pressure 120 – 129mmHg diastolic blood pressure
80 – 90mmHg; high normal/pre-hypertension:  systolic blood pressure 130 – 139mmHg diastolic
blood pressure 80 – 90-mmHg;  stage I hypertension:  systolic blood pressure  140 – 159mmHg
diastolic blood pressure 90 – 99mmHg;  stage 2 hypertension:  systolic blood pressure  160-
179mmHg diastolic blood pressure 100 – 109mmHg and stage 3 hypertension:  systolic blood
pressure  ≥ 180 diastolic blood pressure  ≥ 110mmHg (522).
 Random serum glucose levels were determined by the finger prick test performed by the trained
fieldworkers.  For safety purposes, Medlance extra plus 21 G sterile, needle lancets with a 2.4
mm penetration depth was used.  All the lancets are protected by a safety cap to ensure first
time use and after usage; the lancet retracts as a safety feature of the Medlance products.  All
the used lancets were discarded into a red sharps container at the community clinic in
accordance with the facility’s guidelines and national regulations.   The Gluco Check classic
blood glucose monitoring unit TD 4255, and glucose test strips were used for the test.
Fieldworkers were instructed to wear sterile latex gloves at all times during the testing of the
random serum glucose levels of the participants.  The first drop of blood from the fingertip of
participants was discarded in accordance with the manufacturer’s recommendations as the first
drop usually contains tissue fluid and serum, which may influence the test results.   Plasma
glucose levels range (mmol/L) before meals should be between 3.9 – 7.2 mmol/L and,  two
hours after meals,  less than 10 mmol/L (523).  As the survey was conducted  mostly in the
mornings and women travelled early to reach the clinic in time, most of the glucose levels were
taken before meals, but not all of them . Unfortunately the researcher could not standardise the
time of assessment of glucose levels.    Therefore a non-fasting blood glucose level of more than
7.8mmol/L, were used as cut-off point for the classified as having diabetes mellitus type II.   A
TaiDoc Glucose Control Solution test was performed with each testing device to ensure that the
device was reading the test strips correctly.
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6.4 Fieldworkers 
 
Five trained health care workers were recruited and appointed by the researcher to conduct the survey 
at a community clinic.  The health care workers had recently completed their training, but still needed 
practical time in the field before receiving their training certificates.  Their practical hours involved 
working under supervision in different clinical settings as decided upon by their training institution.  The 
hours spent at the community clinic would count for their clinical hours and therefore the health care 
workers were recruited as fieldworkers for the purpose of the survey.  Before commencement of the 
pilot study, the recruited health care workers were tested by their instructor in determining the body 
weight and height of participants and in the use of the blood pressure monitor and serum blood glucose 
testing device.  After ensuring that they were all proficient in performing the necessary tests, the 
researcher explained the aim and objectives of the questionnaires and how to administer them.  It was 
emphasised that informed consent and voluntary participation were both essential.  Clear instructions 
were given regarding the time and dates for the survey as well as the procedure to be followed. 
 
6.5 Pilot study 
 
In the proposal, it was calculated that a pilot study needed to be conducted on 40 participants at the 
community clinic and if the sample did not yield at least four people (10%) with MSC, it would have to 
be extended until this number was reached. The pilot study was to inform the final sample size and 
determine whether the estimated number was grossly over- or underestimated.  The pilot study was 
conducted  between the 9th  and  10th of  June 2014, using the same procedure as planned for the full 
study and assessed the feasibility in terms of patient commitment, time to fill in questionnaires and to 
establish whether changes needed to be made.  The pilot study was conducted on 53 participants who 
consented to participation.  Unfortunately, one participant had to be excluded due to age.  Of the 52 
participants, 19 (36%) indicated that they had experienced joint pain in the last seven days.  The sample 
size therefore did not change. 
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6.6 Changes made after the pilot study 
Data collection was initially slow as the fieldworkers were unfamiliar with the setting at the community 
clinic and the women attending the community clinic were reluctant to participate in the study.  A 
decision was made by the fieldworkers in consultation with the researcher to wear their caregivers’ 
uniforms with name tags so that the women at the clinic would become familiar with the study.  This 
strategy increased the response rate within the first week and, the more familiar the women became 
with the fieldworkers; the more they were willing to participate in the survey.  The participants were not 
confident enough to complete the questionnaires by themselves in the presence of a fieldworker. 
Therefore, after the first day in the field, the decision was made that the questionnaires would be 
completed through structured interview where the fieldworkers read out the question to the participant 
and ticked their answer in the appropriate box as indicated.  No other changes were made after 
completion of the pilot study.  It was acknowledged that a structured interview might result in 
participant bias and the provision of socially more acceptable answers. In addition, the order and 
method of interview might influence the results.  The researcher attempted to minimise these risks by 
ensuring that the fieldworkers were trained in a standardised method of administering the 
questionnaires. The project manager of the translation process observed and audio-taped a structured 
interview of each fieldworker with no prior warning.  The project leader indicated to the researcher that 
the interviews were conducted as planned and that no discrepancies were noted.    
6.7 Testing procedure 
Ethical approval was obtained from the Human Research Ethics Committee, of the Faculty of Health 
Sciences, at the University of Cape Town (HREC reference number:  605/2013 (Appendix 21) and the 
Ethics Committee of the Faculty of Health Sciences, at the University of the Free State (ECUFS number:  
185/2013) (Appendix 22).  Approval was also obtained from the head of the Department of Health in the 
Free State and the head of the community clinic before commencement of the pilot study and execution 
of the study (Appendices 22 and 23).  A copy of the permission letter for the execution of the survey at 
the community clinic was given to the sister in charge of the clinic well in advance.  Permission was 
obtained from the sister in charge at the clinic and she was given an information leaflet regarding the 
survey and a calendar indicating the days on which the survey was to be conducted at the clinic.  The 
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clinic is open on weekdays between 08:00 – 16:00.  Most of the visits to the clinics take place during the 
mornings.  Data was collected during the period from 11 June 2014 to 19 August 2014. 
On the day of data collection, the fieldworkers approached women in the waiting room/reception area 
of the community clinic awaiting either treatment or the dispensing of their chronic medication for CDL.  
The age of the women as well as the presence of CDL was established by the fieldworkers, to ascertain 
their eligibility in the survey before explaining the aim of the research and obtaining informed consent.  
Participants were made aware that their participation in the study was voluntary, that non-participation 
would not affect their scheduled visit or services at the community clinic and they would not forfeit their 
place in the queue (Appendix 25).  
Those women who consented to participate were taken to a screened-off area at the community clinic 
after ensuring that their place in the queue would not be forfeited.  An information leaflet was then 
handed to the participant in her preferred language – English or Sesotho.   An informed consent form 
complying with the elements as required by the Ethics Committees was read by or read to the 
participants and signed before completing the questionnaire (Appendix 26).  If a participant was 
unwilling or unable to sign her name, she would have been asked to provide a fingerprint in the 
presence of a witness or the sister/nurse on duty at the clinic, who then signed the consent form as a 
witness.  However, in no instance during the survey was this required.  
The completion of the questionnaires was done in the format of a structured interview, as mentioned 
above.  The questionnaires were made available in an English A5 bounded booklet or a Sesotho A5 
bounded booklet.   The first section of the booklet was the COPCORD Phase I questionnaire.  The body 
weight and height of participants, blood pressure measurements and random serum glucose levels using 
the finger prick tests were then determined by the fieldworkers as described under measurements 
instruments/outcomes (Sections 5.2.1 and 6.3) and were entered on the first page of the Phase I 
document.  If a participant indicated that they were living with joint pain (musculoskeletal conditions) 
during Phase I of the questionnaire they then went on to complete Phase II of the questionnaire in the 
booklet.  If they indicated that they did not live with joint pain (musculoskeletal conditions) the 
fieldworkers proceeded by completing the WHODAS 2.0 questionnaire, followed by the EQ-5D-3L 
questionnaire which was the last questionnaire to be completed in the booklet.   Once the fieldworker 
ensured that all the applicable questionnaires in the booklet were completed during the structured 
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interview, the booklet was placed in a sealed box provided by the researcher.  Most of the participants 
preferred the fieldworkers to speak Sesotho to them and only a handful of participants preferred 
English. 
Women who were presenting at the community clinic for the first time, and who had given informed 
consent and completed the questionnaire, but who did not have knowledge regarding their health 
status, were asked by the fieldworkers to return to the fieldworker after the consultation at the clinic to 
complete the data as required.  Unfortunately, in some instances this did not happen and consequently 
some questionnaires had incomplete medical data.   
In order to avoid duplicate responses from study participants, their identity numbers were checked by 
the researcher before data entry.  No duplicate questionnaires were found by the researcher.  
6.8 Statistical analysis 
The overall score of the WHODAS 2.0 was calculated as per the manual (455, 524). (Appendix 5b) 
The EQ-5D-5D-3L Index or utility score was calculated using the York Tariff (470). 
Descriptive statistics, namely frequencies and percentages, were calculated for categorical data.  Non-
parametric tests were used for ordinal data. As the sample size was large, the central limits theorem 
applied (525) and parametric statistics, such as the t-test were used to compare numeric data, provided 
that the distributions were not grossly abnormal (Shapiro Wilk p<.001). 
Analytical statistics, namely the Chi-Square test or Fisher’s Exact test were used to compare proportions 
in different groups. The Mann Whitney U test was used to compare median values in different groups.  A 
significance level () of 0.05 was used throughout the study. 
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6.9 Results 
6.9.1 Description of sample 
Altogether 1774 women were approached of whom 398 women declined consent, but did report 
whether or not they had joint pain.  The reasons for declining to participate included that they did not 
want to answer questions that they did not have time, or no reasons were given.  Of those who gave 
consent, two were excluded as they were too old.  A total of 1376 participants were thus enrolled.  
Figure 7 shows a flow diagram of participation throughout the survey.
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Figure 7: Flow diagram of participation
152 
6.9.2 Demographic information of survey participants 
The age distribution was not normal (W = 0.956 and p < 0.001) (Figure 8).  The median age of the 
participants was 52y (inter-quartile range (IQR): 46-58y, and range of 40-64y).  The mean age of the 
participants was 52y (SD 7.2). 
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Figure 8: Distribution of the age of the participants 
The participants’ demographic and dwelling details are given in Table 33 below. The home language of 
approximately two thirds of the participants was Sesotho, with Isixhosa (18%) and Setswana (13%) being 
the next most common home languages. Less than half of the participants were married (46%), followed 
by those who had never married (36%).   
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Almost 75% of the participants owned their own home, with the rest living with family or friends. Over 
80% lived in brick houses. The median number of residents per household was five people (IQR: 4-6 
people). 
Table 33: Demographic and living conditions of the participants 
Variable Categories Frequency (n) Percentage of total 
Language* 
Sesotho 935 67.95% 
Isixhosa 246 17.87% 
Setswana 176 12.79% 
English 11 0.8% 
Afrikaans 2 0.15% 
Zulu 4 0.29% 
Missing 
2 
0.15% 
Race 
African 1371 99.64% 
Coloured 3 0.22% 
White 1 0.07% 
Missing 
1 
0.07% 
Marital Status 
Married 638 46.37% 
Never married 494 35.89% 
Widowed 171 12.43% 
Separated/divorced 71 5.16% 
Missing 
2 
0.15% 
House ownership 
Own 1024 74.42% 
Friend/family 340 24.71% 
Other 7 0.51% 
Missing 
5 
0.36% 
Type of dwelling 
Brick 1145 83.21% 
Informal 225 16.35% 
Missing 6 0.44% 
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Variable Categories Frequency (n) Percentage of total 
Number of residents per household 
1 59 4.29% 
2 22 1.59% 
3 202 14.68% 
4 388 28.20% 
5 296 21.51% 
6 406 29.51% 
Missing 3 0.22% 
*This question was only based on their home language and not the number of languages spoken.
(n=1376) 
Details of the level of education and employment status of the participants are given in Table 34. About 
15% of the participants were either illiterate or could only read in their home language. The majority of 
participants (90%) had some education, which included primary, secondary or tertiary education.  Only 
14% of the participants had full-time employment, while 49% were currently unemployed.  Sixty three 
per cent indicated the reason for unemployment as not being able to find a job, followed by health 
problems (31%).  Twenty five per cent of the participants received a grant.   
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Table 34: Level of education and employment status of the participants 
Variable Categories Frequency 
(n) 
Percentage 
Literacy 
Unable to read/write 164 11.92% 
Read only 38 2.76% 
Read/write 1171 85.10% 
Missing 
 
3 0.22% 
Education 
None 138 10.03% 
Primary 496 36.05% 
Secondary 692 50.29% 
Tertiary 49 3.56% 
Missing 1 0.07% 
Current employment status 
Unemployed 675 49.06% 
Pensioner 245 17.81% 
Housewife 150 10.90% 
*Worker - Full time 112 8.14% 
*White collar - Full time 82 5.95% 
Worker - Part time 81 5.89% 
White collar - Part time 21 1.53% 
Missing 
 
10 0.72% 
Reason for unemployment (n = 675 unemployed) 
Cannot find work 425 62.96% 
Health problems 209 30.96% 
Family care 22 3.26% 
Disabled 6 0.89% 
Husband prevents 4 0.59% 
Missing 
 
9 1.34% 
Receive grant benefits 
No 1025 74.49% 
Yes 349 25.36% 
Missing 
 
2 0.15% 
Type of grant benefits (n = 349 receiving grants) 
Disability 123 35.24% 
Pension 202 57.88% 
Disability and pension 17 4.87% 
Not known 7 2.01% 
(n=1376) 
* White-collar work is performed in an office, cubicle, or other administrative setting, while a worker’s job requires 
manual labour or service-orientated work. 
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6.9.3  Health-related information  
 
6.9.3.1 Reason for clinic visit 
 
The most frequently reported reasons for visits to the clinic were to collect medication (53%) and for a 
doctor’s consultation (45%). (Table 35) 
 
Table 35: Reasons for participants visiting the clinic 
 Reason Frequency (n) Percentage* 
Collect medication 729 53% 
Doctor consultation 619 45% 
Consultation with nurse and medication collection 234 17% 
Attending on behalf of others 41 3% 
Nurse consultation 41 3% 
Consultation for joint pain  28 2% 
Consult dentist  28 2% 
Consult physiotherapist 14 1% 
Work or training at clinic 0 0% 
Unknown 14 1% 
*Note that some participants attended for more than one reason. (n=1376) 
 
6.9.3.2 Health conditions of participants 
 
Information was obtained regarding the participants’ health over the previous three months.  
Participants were asked to indicate all applicable co-morbidities at the beginning of the questionnaire 
and later to indicate whether they had been diagnosed with a specific health condition and, in a 
separate question, they were asked to indicate  the health condition (s) they suffered from in the last 
three months (Questions Q7, Q25 and Q27, respectively in Appendix 4).   Diagnosed implied that the 
nature of the health condition was determined by examination of the symptoms presented by the 
patient, while self-reported related to the experience or feeling of the specific health condition (526). 
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Hypertension was the most commonly self-reported health condition (62%), followed by joint pain (23%) 
and diabetes mellitus (12%).  The majority of the participants (64%) were also diagnosed with 
hypertension, 25% with joint pain and 13% with diabetes mellitus.  One percent of the participants 
indicated that they had high cholesterol.   It is interesting to note that 45% of the respondent reported 
living with depression. 
Table 36: Health conditions reported by the participants 
Health condition Medically diagnosed health condition self-reported 
Frequency n* (%) 
Hypertension 873 (64%) 
Diabetes mellitus 179 (13%) 
Heart condition (cardio-vascular) Not reported 
Infection Not reported 
Stomach condition Not reported 
Cancer Not reported 
Paralysis Not reported 
Obesity 6 (0.4%) 
Injury Not reported 
Genitourinary tract infection Not reported 
Joint pain 341 (25%) 
Cholesterol 7 (0.5%) 
Depression Not reported 
Stroke 47 (3.4%) 
Respiratory Not reported 
*Note that some participants had more than one condition. Not reported implied that no-one was aware of having
this condition.
(n=1376)
As can be seen from Table 37, the median value for the haemoglucose was 5.5 mmol/l as determined by 
the fieldworkers, but 20% of the participants had a non-fasting blood glucose level of more than 
7.8mmol/L, which meant that they were classified as having diabetes mellitus type II.   The participants 
were classified as having diabetes mellitus type after testing by the fieldworkers, using the method as 
described in the instrumentation (section 6.3).  
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Table 37: Health variables of the participants as determined by the researcher and fieldworkers 
Variable n Median Inter-quartile range 
Haemoglucose (mmol/l) 1370 5.5 4.6 – 7.2 
Systolic BP (mmHg) 1371 147 132 – 159 
Diastolic BP (mmHg) 1371 91 84 - 99 
Table 38: Diagnosed DM II versus DM II as determined by the fieldworkers 
DM II Clinic DM II 
Positive 
Frequency (n) 
Clinic DM II 
Positive 
Percentage 
Clinic DM II 
Negative 
Frequency (n) 
Clinic DM II 
Negative 
Percentage 
Row Percentage 
Test Positive 130 9.5% 143 10.5% 273 20% 
Test 
Negative 
50 3.7% 1045 76.4% 1095 80% 
All Groups 180 13.2% 1188 86.8% 1368 100% 
As can be seen in Table 38 above, 9.5% of the participants tested positive on the days of data collection 
and had been previously managed, 10.5% of the total tested positive for diabetes mellitus type II on the 
days of data collection and had not been previously diagnosed by the clinic staff.   A further 3.7% had 
been diagnosed previously by the clinic staff, but were not positive on testing by the fieldworkers on the 
day of data collection. The total number with diabetes mellitus type II was 323 (273+50), which 
represented 24% of the total sample.   
The majority of the participants (66%) were classified as being hypertensive after testing by the 
fieldworkers, using the method as described in the instrumentation (section 6.3).   It was unclear how 
many participants were taking anti-hypertensive medication due to missing data (Table 39)(527).   
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Table 39: Prevalence of hypertension as determined by objective measurement 
Classification* Frequency Percentage 
Normal 458 33% 
Stage I 501 37% 
Stage II 232 17% 
Stage III 180 13% 
Total 1371 100% 
*Normal: Systolic blood pressure 120-139mmHg Diastolic blood pressure 80-90mmHg 
Stage I hypertension:  Systolic blood pressure 140-159 mmHg Diastolic blood pressure 90-99mmHg 
Stage 2 hypertension: Systolic blood pressure 160-179 mmHg   Diastolic blood pressure 100-109mmHg 
Stage 3 hypertension: Systolic blood pressure ≥ 180mmHg   Diastolic blood pressure ≥110mmHg 
 
(n=1371)  
From Table 40, it can be seen that 918 (66.8%) blood pressure measurements as determined by the 
fieldworkers were classified as being hypertensive, compared to 875 (63.6%) diagnosed by the health 
staff.   Of the total, 18%, who had not been identified by the clinic staff were diagnosed by the 
researcher.  Conversely, 15% had been diagnosed by the clinic staff and were not identified by the 
researcher’s screening.  Approximately one half were diagnosed by both the researcher and clinic staff 
as having hypertension.   The total number with controlled or uncontrolled hypertension was thus 1 125 
(918+207), or about 80% of the respondents.  
 
Table 40: Diagnosed hypertension versus hypertension as determined by the researcher  
 
BP 
classification 
Diagnosis 
Positive 
Frequency (n) 
Diagnosis 
Positive 
Percentage 
Diagnosis 
Negative 
Frequency (n) 
Diagnosis 
Negative 
Percentage 
Row % 
Test Positive 668 48.6% 250 18.2% 918 66.8% 
Test Negative 207 15.1% 250 18.2% 457 33.2% 
All Groups 875 63.6% 500 36.4% 1375 100% 
%= % of total respondents (n=1375) 
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6.9.4 Prevalence of joint pain (musculoskeletal conditions) 
Participants were asked whether they experienced pain, aching, swelling, stiffness (tightness) in or 
around their joints or back which was not related to an injury/accident in two separate questions.  In 
Sesotho the word stiffness has a sexual connection and that is why the wording (tightness was included) 
to provide a clearer description.   The first question enquired regarding the above mentioned symptoms 
during the time frame of the last three months and the second question during the last seven days.  The 
three months was viewed as long term and the seven days as short term.  These were the denominators 
from which the prevalence of joint pain (musculoskeletal conditions) was calculated.  The prevalence of 
joint pain (musculoskeletal conditions), experienced in either the short or long term (within the previous 
three months) was 62.1% (CIs 59.5-64.6%). (Table 42) Only 25% of participants had been diagnosed with 
joint pathology by the clinic staff.   Those with joint pain (musculoskeletal conditions) were twice as 
likely to consent to participation (Table 41).   
Table 41: Prevalence of joint pain (musculoskeletal conditions) in consenters and non-consenters 
Joint pain 
(musculoskeletal 
conditions) 
No joint pain 
(musculoskeletal 
conditions) or unsure 
Total 
Consent 854 (62.1% RT, 82.7% CT) 522 (38.0% RT, 70.5% CT) 1376 (77.6% CT) 
No consent 179 (45.0% RT, 17.3% CT) 219 (55.0% RT, 29.5% CT) 398 (22.4 CT) 
All approached 1033 (58.3% RT) 741 (41.8% RT) 1774 
RT=Row total, CT = Column total 
Chi square = 37.07, p<0.001 Odds ratio = 2.00 (95% CI: 1.60 - 2.51) 
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Table 42: Prevalence of joint pain over short and long term 
Period experiencing 
joint pain 
Count Total number of 
participants 
Percentage with 
joint pain  
95% Confidence 
Intervals 
Long-term joint pain 
(3 months)  
808 1376 58.7% 56.1-61.3 
Short-term joint pain 
(7 days)  
787 1376 57.2% 54.6-60.0 
Long- or short-term 
joint pain  
854 1376 62.1% 59.5-64.6 
Non-consenters with 
joint pain  
179 398 45.0% 40.2-50.0 
All those approached 1033 1774 58.2% 55.9-60.5 
(n=1376) 
* The terminology for short-term or long-term joint pain is standardised according to COPCORD terminology and has been 
validated.  Short-term joint pain refers to joint pain experienced during the last seven days and long-term joint pain to joint
pain experienced during the last three months.
As can be seen in Table 42 and Figure 9, the combined seven day/three month joint pain, had the 
highest prevalence but that the CIs overlapped with the other groups. The prevalence was much lower 
in the non-consenting joint pain group, but as the numbers of participants in the non-consenting joint 
pain group were relatively small, their inclusion in the prevalence rate of all those individuals 
approached, did not result in a prevalence rate in which the CIs overlapped with the combined long- or 
short-term joint pain prevalence (Number 5 in the forest plot).  
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Key: Study number 
5= All those approached 
1033/1774 
4=Non-consenters joint 
pain  
179/398 
3=short-term or long-
term joint pain  
787/1376 
2=short-term joint pain 
787/1376 
1 = long-term joint pain 
(3 months)  
808/1376 
Figure 9: Forest plot of prevalence rates and 95% CI’s of joint pain 
The mean age of those with joint pain was 52.6y (SD=6.8) which was significantly higher than those 
without joint pain (50.3y, SD 7.43; t separate variances =5.73, p<.001). 
6.9.5 Prevalence of co-morbidity 
In each case the denominator used was the combined positive on testing and positive on clinic 
diagnosis.  In summary, the total number of participants with joint pain was 854; with hypertension was 
1125; and 323 with diabetes mellitus type II, below indicates the interaction between these conditions. 
Study 
number
% 
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Note that the rounded up percentage refers to the total number of respondents (n=1348) 6.4% had none of the 
above health conditions. Missing responses = 28 
Figure 10: Interaction between the prevalence of joint pain, hypertension and diabetes mellitus type II 
Over two thirds (67%) reported two or more health conditions. The greatest co-morbidity was between 
hypertension and joint pain, with 53% reporting both.  No difference in proportions was found between 
DM II and joint pain (Chi-Square=.864, p=.352), while the difference between joint pain and 
hypertension approached significance (Chi-square=3.0, p=.085). 
Joint Pain (MSC)
8.7%
DM II 
1.1%
Hypertension 21.4%
 39.8%  1.7% 
 8.7% 
 12.7% 
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6.9.6 Risk factors 
The risk factors for chronic diseases that were examined, included BMI and substance use/abuse. 
The BMI values were not normally distributed (K-S d = 0.90471, p < 0.001), with a mean of 32.5 (SD=8.8, 
range =15.8-94.1) 
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Figure 11: Histogram of BMI of participants 
The median BMI was 31.6 (range 15.8-94.1) (Table 43) and 81% of the participants in the study were 
classified as being overweight or obese (Table 44).  The body weight and height of the participants were 
determined by the fieldworkers as discussed in the instrumentation (section 6.3) while the researcher 
calculated the BMI values.   
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Table 43: Weight, height and BMI of participants 
Variable n Median Inter-quartile range Range Mean 
Standard 
Deviation 
Weight (kg) 1372 80.0 65.0 – 92.7 35.0 – 190.0 80 19.9 
Height (cm) 1370 158 154 – 163 101.0 – 
180.0 
158 8.2 
BMI (kg/m2) 1370 31.6 26.8 – 37.0 15.8 – 94.1 33 8.8 
(n=1372) 
Table 44: Prevalence of obesity 
Classification* Frequency (n) % 
Underweight 23 2% 
Normal 228 17% 
Overweight 294 21% 
Obese 825 60% 
*Underweight: BMI < 18.5; Normal weight: BMI 18.5-24.9; Overweight:  BMI 25-30; Obese:  BMI > 30 –
(n=1370)
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Histograms of the BMI of those with and without joint pain
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Joint pain n=850, without n=500, 26 missing responses 
Figure 12: Histograms of BMI of those with and without joint pain in the last three months 
 
The difference between the BMI of those with and without joint pain was 1.1 which was significantly 
higher (p = 0.023) when tested with separate variances.   The mean BMI for those with joint pain was 
32.9 and for those without joint pain 31.8.  The standard deviation for those with joint pain was 9.15 
and those without joint pain 8.10. The T value*t. was 2.28.   
 
The substance use listed by participants indicated that 86% of participants never smoked, 80% never 
used snuff and 80% never used alcohol. (Table 45) 
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Table 45: Participants’ history of substance use 
Smoking 
(n = 1369) 
Snuff 
(n = 1359) 
Alcohol 
(n = 1366) 
Currently 11% 17% 17% 
Formerly 3% 3% 3% 
Never 85% 80% 80% 
(n=1369) 
There was no difference in proportions found between snuff and alcohol use and having joint pain, with 
fewer respondents with joint pain having never used snuff or alcohol (p=0.001 and p<.001 respectively. 
(Table 46) 
Table 46: Participants without and with joint pain and substance use 
Without joint pain 
n (%) 
Joint pain 
n (%) 
p-value
Never smoked 438 (83.9%) 720 (84.3%) 
p=0.418 
(Chi-square = 1.744 
Currently smoking 51 (9.8%) 99 (11.6%) 
Formerly smoked 13 (2.5%) 30 (3.5%) 
Missing data 20 (3.8%) 5 (0.6%) 
Never used snuff 412 (78.8%) 655 (76.6%) p=0.001 
    (Chi-square =14.729 Currently using snuff 61 (11.5%) 164 (19.2%) 
Formerly used snuff 25 (5.0%) 24 (2.9%) 
Missing data 24 (4.7%) 11 (1.3%) 
Never used alcohol 430 (82.3%) 648 (75.9%) P<.001 
(Chi-square =  19.896) Currently using alcohol 57 (10.9%) 176 (20.6%) 
Formerly used alcohol 12 (2.4%) 25 (2.9%) 
Missing data 23 (4.4) 5 (0.6) 
n = 522 no joint pain n = 854 joint pain  
168 
6.9.7 Impact of joint pain (musculoskeletal conditions) on quality of life 
The quality of life of the participants was assessed using the EQ-5D-3L measurement instrument that 
consists of five dimensions, namely:  mobility (M), self-care (SC), usual activities (UA) (work, study, 
housework and family), pain or discomfort (PD) and anxiety or depression (AD).   Almost half of the 
participants in both groups experienced some problems with pain or discomfort and anxiety or 
depression, while a minority of participants experienced severe problems with anxiety or depression 
and pain or discomfort.   
* JP=Joint Pain Joint Pain N=850, without Joint pain N=498 (some missing responses in some domains).
Figure 13: Dimension for the quality of life experienced by participants without or with joint pain (musculoskeletal 
conditions) 
Those with joint pain (musculoskeletal conditions) reported significantly more problems (p<0.001) in all 
domains apart from self-care (p=0.176) than those without joint pain (musculoskeletal conditions).   
No JP JP No JP JP No JP JP No JP JP No JP JP
Mobility Self-care Usual Activities Pain/Discomfort Anxiety/Depression
Severe problem 0 1 0 1 1 4 3 98 12 168
Some problem 4 64 6 18 11 81 190 445 179 301
No problem 493 785 492 831 486 765 305 307 307 381
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Figure 14: Visual analogue scale of EQ-5D-3L compared between the two groups 
The EQ-5D-3L index score was calculated using the York tariff based on the domain scores, and this and 
the VAS, were significantly different between the two groups, with those reporting joint pain 
(musculoskeletal conditions) having a worse quality of life. Those with joint pain (musculoskeletal 
conditions) had a utility value of 0.13 of a year less than those without (t=-14.1; p<0.001) and their 
perceived health was 8% less (t=-11.1; p<0.001) (Table 47). 
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Table 47: Comparison of the EQ-5D VAS and Index scores between those with joint pain (musculoskeletal conditions) and 
those without. 
Joint Pain 
(MSC) 
Mean 
Std Dev. No Joint Pain 
(MSC) 
Mean 
Std Dev t 
tested with 
separate 
variances. 
df p 
2-sided
Joint 
Pain 
(MSC) 
N 
No Joint 
Pain 
(MSC) 
Mean 
Index 0.70 0.23 0.83 0.11 -14.1 1320 <.001 853 500 
VAS 64.48 17.45 74.65 15.37 -11.1 1146 <.001 850 497 
6.9.8 Comparison of Functioning in those with and without joint pain (musculoskeletal 
conditions) 
6.9.8.1 The WHODAS 2.0 
Participants’ level of functioning was measured using the WHODAS 2.0 instrument consisting of 12 items 
representing possible limitations in functioning. Each item is scored according to five levels - none, mild, 
moderate, severe and extreme/cannot do as seen below.  
Participants experienced mild problems with washing, getting dressed, managing unknown people and 
doing household activities. The functional limitation with the highest proportion of participants 
experiencing no problems was community activities (approximately 40% for both groups). The largest 
overall proportion was those with moderate or severe problems with emotions (54% in those without 
joint pain (musculoskeletal conditions).  
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Table 48: Level of functioning of participants without or with joint pain (musculoskeletal conditions) 
 Item  Group None Mild Moderate Severe Extreme 
Frequency 
(n) 
% Frequency 
(n) 
% Frequency 
(n) 
% Frequency 
(n) 
% Frequency 
(n) 
% Total 
Standing long Without joint pain (MSC) 76 15.3% 200 40.2% 189 38.0% 18 3.6% 14 2.8% 497 
With joint pain (MSC) 215 25.3% 418 49.1% 149 17.5% 52 6.1% 17 2.0% 851 
Household Without joint pain (MSC) 55 11.1% 239 48.1% 184 37.0% 17 3.4% 2 0.4% 497 
With joint pain (MSC) 60 7.1% 578 67.9% 166 19.5% 45 5.3% 2 0.2% 851 
New task Without joint pain (MSC) 56 11.3% 213 42.9% 195 39.2% 19 3.8% 14 2.8% 497 
With joint pain (MSC) 122 14.3% 434 51.0% 245 28.8% 45 5.3% 5 0.6% 851 
Community 
activities 
Without joint pain (MSC) 187 37.6% 94 18.9% 145 29.2% 25 5.0% 46 9.3% 497 
With joint pain (MSC) 400 47.0% 240 28.2% 145 17.0% 50 5.9% 16 1.9% 851 
Emotion Without joint pain (MSC) 58 11.7% 98 19.7% 270 54.3% 64 12.9% 7 1.4% 497 
With joint pain (MSC) 225 26.4% 155 18.2% 320 37.6% 107 12.6% 44 5.2% 851 
Concentration Without joint pain (MSC) 56 11.2% 215 43.2% 212 42.6% 14 2.8% 1 0.2% 498 
With joint pain (MSC) 106 12.5% 480 56.5% 193 22.7% 65 7.6% 6 0.7% 850 
Walking long 
distances 
Without joint pain (MSC) 155 31.1% 113 22.7% 201 40.4% 15 3.0% 14 2.8% 498 
With joint pain (MSC) 247 29.0% 374 43.9% 168 19.7% 45 5.3% 17 2.0% 851 
Washing Without joint pain (MSC) 44 8.8% 236 47.4% 203 40.8% 15 3.0% 0 0.0% 498 
With joint pain(MSC) 45 5.3% 596 70.0% 153 18.0% 51 6.0% 6 0.7% 851 
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 Item  Group None Mild Moderate Severe Extreme 
Frequency 
(n) 
% Frequency 
(n) 
% Frequency 
(n) 
% Frequency 
(n) 
% Frequency 
(n) 
% Total 
Dressing Without joint pain (MSC) 46 9.2% 224 45.0% 212 42.6% 15 3.0% 1 0.2% 498 
With joint pain (MSC) 45 5.3% 596 70.0% 158 18.6% 51 6.0% 1 0.1% 851 
Dealing with 
unknown 
people 
Without joint pain (MSC) 47 9.4% 218 43.8% 187 37.6% 17 3.4% 29 5.8% 498 
With joint pain (MSC) 66 7.8% 558 65.6% 166 19.5% 51 6.0% 10 1.2% 851 
Friends Without joint pain (MSC) 48 9.6% 223 44.8% 177 35.5% 25 5.0% 25 5.0% 498 
With joint pain (MSC) 169 19.9% 434 51.0% 189 22.2% 51 6.0% 8 0.9% 851 
Work Without joint pain (MSC) 77 15.6% 147 29.7% 250 50.5% 21 4.2% 0 0.0% 495 
With joint pain (MSC) 180 21.2% 373 43.8% 235 27.6% 57 6.7% 6 0.7% 851 
(n=1364) 
Joint pain (MSC) n=851, without joint pain (MSC) n=498 (24 missing from total); (3 missing from total), Shaded blocks indicate modal responses.
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The median value for the summed WHODAS  score for those without joint pain (musculoskeletal 
conditions) (n=498) is 13.0 and IQR 11.0 – 20.0 and for those with joint pain (n=851) the median value is 
13 and the IQR 10.0 –  24.0   When comparing the summed WHODAS 2.0 scores, it became apparent 
that the results were counterintuitive, in that those without joint pain (musculoskeletal conditions) 
reported significantly poorer functioning than those with joint pain (musculoskeletal conditions)  (Adj Z= 
-5.51, p<0.001) (Figure 15), thus casting doubt on the discriminate validity of the WHODAS 2.0.   
 
WHODAS 2 Total compared between the two groups
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Figure 15: Comparison of WHODAS 2.0 scores between those with and those without joint pain (musculoskeletal 
conditions) 
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Table 49: Comparative summed WHODAS 2.0 scores 
Valid N Median Minimum Maximum 
Joint pain (musculoskeletal conditions) 854 23.5 12 54 
No Joint pain (musculoskeletal conditions) 502 26.4 12 51 
In addition, there was a significant, although very low, positive correlation between the EQ-5D-3L Index 
score and the WHODAS 2.0, (r = 0.069, p = 0.010). As a higher Index score indicates better health and a 
higher WHODAS 2.0 score should indicate poorer functioning, the WHODAS 2.0 did not demonstrate 
concurrent validity. The data entering process was revisited and it appeared as if the results had all been 
entered correctly. 
The possibility was explored that the respondents were unable to differentiate between “mild “ and 
“moderate” problems and between “severe” and “extreme” problems and we collapsed the items into a 
three-point instead of a five-point scale. The “collapsed” scoring system did not perform better.  Those 
who had had a stroke still scored lower (better functioning), (Adj Z=-3.34, p<o.001), as did those who 
reported joint pain (musculoskeletal conditions) (Adj Z= -3.64, p<0.001).  The concurrent validity was 
also not improved as evidenced by a lack of correlation between the EQ-5D-3L Index score and the 
WHODAS 2.0 (r=0.040, p=0.136). 
It was concluded that the WHODAS 2.0 demonstrated no evidence of validity in this population and the 
results were not subjected to further statistical analysis.   
6.9.9 Characteristics of those with three months of joint pain (musculoskeletal conditions) 
In this section the nature of the joint pain of the respondents who had experienced joint pain within the 
previous three months will be discussed.  
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6.9.9.1 Medical management 
This section refers to the second section of the questionnaire where questions were specifically posed to 
participants who indicated that they live with joint pain (musculoskeletal conditions).  It is interesting to 
note that there is a discrepancy regarding those who indicated in the first section of the questionnaire 
that they had been diagnosed with joint pain (musculoskeletal conditions) and those who completed the 
second section of the questionnaire.  The reason for this discrepancy is not clear. 
Of the 854 respondents experiencing pain or stiffness, 299 (35%) reported that a formal diagnosis of 
joint disease had been made and 177 (21%) indicated that they had been diagnosed or have been told 
by someone that they have arthritis or another joint disease like rheumatism.   None of the participants 
indicated that they were specifically diagnosed with OA.  Of the 299 participants formally diagnosed 
with some type of joint disease, the diagnosis was primarily made at a clinic (86%) with 48% having been 
diagnosed by a doctor. 
More than half (53%) of the 854 participants indicated that they used medication to relieve their joint 
pain of which 56% used over the counter medication and 40% used prescribed medication.  Ointment 
was used by 5% of participants as an alternative method to relieve their pain.  
6.9.9.2 Nature of joint pain 
The majority of the 854 participants (63%) had been experiencing joint pain for over a year and the pain 
of 18% of participants had started three months ago. The same proportion of participants experienced 
severe joint pain during the previous seven days as during the last three months, while more 
participants (29%) had experienced very severe joint pain during the previous seven days than during 
the previous three months (22%). (Figure 16) 
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Figure 16: Joint pain intensity of participants reporting pain over the short and long term 
 (n=859) 
Short- and long-term joint pain will now be generalised for the purpose of the study as simply joint pain.  
Eight hundred and fifty four participants reported recurrent joint pain and 43% reported that the joint 
pain had lasted a few days while 30% indicated that their recurring joint pain had lasted more than three 
months. The most intense joint pain was felt after activities (31%), followed by after resting or sleeping 
(29%).  More than two thirds had experienced joint tightness/stiffness in the morning during the last 
year (71%) and in 50% of the cases that reported tightness/stiffness, the stiffness lasted more than 30 
minutes.   The majority of participants experiencing tightness/stiffness (53%) indicated that the 
tightness/stiffness had gone away after exercise or during movement of the joint. 
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Table 50: Time of day of the activity when joint pain of participants is most intense 
Category Valid N Percent 
After activity 266 31% 
All the time 168 20% 
Mornings 146 17% 
Resting / Sleeping 250 29% 
Walking a distance 2 0.2% 
When cold 5 0.6% 
Missing 22 3% 
(n= 859) 
 
6.9.10 Results summary 
 
Based on the information above, the ‘typical’ respondent in the survey spoke Sesotho, was married, 
owned their own brick home and lived in a household with about five other people.  They could read 
and write and had attended secondary school.   As they were unable to find work, they were 
unemployed.  They did not receive any benefit grants.  They were visiting the clinic either to collect 
medication or to consult with a health professional.   They had hypertension of various stages and 
almost half reported some or severe anxiety/depression and some or severe pain and discomfort.  They 
were obese, but were not using any harmful substances.  
 
The prevalence of joint pain was 62%, and 53% had joint pain in conjunction with either hypertension 
and/or diabetes mellitus type II.  There was a weak association between hypertension and joint pain. 
Those who had joint pain (musculoskeletal conditions) had a BMI which was significantly higher than 
those without any joint pain. 
 
Those with joint pain (musculoskeletal conditions) reported a poorer quality of life, both with regard to 
the EQ-5D-3L index score and the more global VAS score. The dimensions affected include mobility, 
usual activities, pain/discomfort and anxiety/depression. 
 
For those who reported joint pain (musculoskeletal conditions), the joint pain had typically been present 
for over a year and was most intense after activity or after sleeping or resting.  They had experienced 
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joint pain within the previous three months at severe to very severe levels and experienced joint 
stiffness in the mornings that diminished with activity.  They used over the counter medications to 
manage their joint pain. The WHODAS 2 demonstrated a lack of construct validity and was not analysed 
in depth. 
6.10 Discussion 
This discussion will draw on the above summary and will explore whether the sample was 
representative of the target population by comparing it to the demographics of the population. The 
health conditions will be discussed, with particular reference to the interaction of co-morbidities.  The 
prevalence of joint pain (musculoskeletal conditions) will be compared to that in the published literature 
and the nature and effect of joint pain (musculoskeletal conditions) on function and HRQOL will be 
discussed.   Finally, the implications of the findings for the development of a context specific 
intervention will be presented. 
6.10.1 Demographic and living conditions of participants 
The sample of respondents was likely to be representative of the target population, with three quarters 
of those approached agreeing to take part.  The final sample was 1376 and thus the target sample size 
of 1353 was achieved.   The language of two thirds of the participants was Sesotho which is to be 
expected as the languages most spoken in the Free State are Sesotho (64.2%), Afrikaans (12.7%) and 
Isixhosa (7.5%) [560].   Similar to the respondents in the 2015 Mangaung statistics of the area and 2011 
census, the majority of the participants were married and almost three quarters of the participants 
owned their own homes while the rest lived with either family or friends (528, 529). More than 80% of 
the participants indicated that they stayed in brick houses which included Reconstruction and 
Development Programme (RDP) houses (a government initiative for impoverished communities) [561]. 
The median number of residents per household was five and the number varied between 4-6 people. In 
terms of race, only three respondents did not fall within the ethnically Black population (26, 371). The 
majority of the participants (90%) had some level of education, which included primary, secondary or 
tertiary education.  These findings are similar to the findings of Copley et al., in 2013 who found that 
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89% of the population were literate and could read and write while only 20.41% had obtained Grade 12 
level of education.   According to Woolard (2002) about 15% of adults in South Africa are illiterate [562] 
despite government policies stipulating that education is compulsory for every South African child 
between the ages of 7 and 15 years.  The study of Copley et al., included both male and female 
participants over the age of 18 years attending a community clinic [326] and reported that 14% of the 
participants had full time employment while nearly half of the participants (49%) were unemployed.  
The results of the study are similar to the results of the present study.  The unemployment rate in 2014 
in South Africa is stated to be 25.5% at the time of the epidemiological survey, with the unemployment 
rate for women being slightly higher compared to that of their male counterparts [565]. The official 
unemployment rate of people in the Free State was given as 34.7% during this time [565]. 
Unfortunately, the percentage of unemployment stated did not distinguish between male and female 
unemployment and therefore, it is difficult to compare the unemployment rate of the participants with 
that of the rest of the Free State province. A likely explanation for the study participants’ low income 
and high unemployment rate could be that services at the community clinic are free of charge and 
specifically cater for the low-income population, although more affluent patients also utilise services at 
the community clinic [26]. 
The situation reported in 1995 by Ardington and Lund (1995) appears to be the same, with the pension 
system in South Africa reaching rural areas, effectively targeting women in the community and keeping a 
number of households in South Africa out of poverty [561].  This was borne out by this study where 25% 
of all participants indicated that they received a grant or state pension.  In South Africa people can apply 
for pension above the age of 60 for women and above the age of 65 for men [566].   As mentioned 
previously the median number of participants per household of the survey was five individuals, which 
would substantiate the statement made by Posel et al., (2006) regarding living arrangements of 
pensioners in South Africa especially in three-generation African households in rural areas.    
It would thus appear that the sample was representative of the target population.  With regards to 
socio-economic situation, the respondents were generally financially stressed but not destitute, with 
most receiving grants and living in permanent shared accommodation.  Fewer than half were currently 
married.  These findings imply that if the intervention were to be tailored to meet the needs of this 
group, it could be applied with confidence to other women attending the clinic with similar problems.  In 
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addition, individuals with lower educational levels are less likely to have access to health education and 
more often act in ways that would harm their health, as they find it difficult to cover their basic every 
day needs they are unlikely to benefit from medical interventions (530) (531, 532). In contrast, this 
group of women did have access to income and permanent housing and would be more likely to actively 
engage in improving their health.   
6.10.2 Health conditions and risk factors 
The majority of the participants visited the clinic to collect medication (53%) or for a doctor’s 
consultation (45%).  The reasons for the visits by participants would therefore be in line with the 
purpose of the community clinic as described by Prinsloo et al., (2011) as being a “centre for follow-up 
of down-referrals of stabilised secondary patients” (43).  Approximately 64% of the participants were 
diagnosed with hypertension, but there was a discrepancy of 3% between the frequency of 
hypertension as detected by the fieldworkers and the frequency of those reporting being diagnosed 
with hypertension. This discrepancy needs to be researched in the future; it is not clear if it was due to 
participants awaiting a first time diagnosis of hypertension (e.g. first clinic visit), or if the hypertension 
had not been diagnosed on previous clinic visits.  About 13% were aware of being diabetic and had been 
diagnosed as such. This was slightly more than the 10.5% who tested positive with a non-fasting blood 
glucose level of more than 7.8 mmol/L, which is indicative of diabetes mellitus type II, and had not been 
diagnosed previously.  The discrepancy in percentages could be attributed to the fact that the 
fieldworkers were taking blood glucose levels as participants were approached by the fieldworkers 
whilst waiting at the clinic for services and the time frames of the measurements could differ from the 
standardised testing procedures of the clinic.  To be noted is that the fieldworkers were not able to 
diagnose conditions and that the participants received standard care at the clinic.   
Although 60% of participants were classified as obese, very few participants indicated that they had 
been diagnosed with or that they were living with obesity. This high prevalence of obesity was not 
unexpected, in the light of the published literature.   In June 2007 the prevalence of obesity in women 
attending the same community clinic, was reported to be  44.1%, but the mean age of the obese group 
was 30.6 years which is lower than the mean age of survey group of the present study (43).  According 
to Health 24, South Africa has the highest rates of overweight and obesity in sub-Saharan Africa and  
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also ranks high on the world list of regions in the world for overweight and obese women (533).  
According to the same article nearly 30% of people worldwide are overweight or obese and 69.3% of 
South African women fall into this category, which is almost double the global average.  An ObeCity 
Index was created by Discovery Vitality (a private medical scheme in South Africa) along with experts in 
the field of obesity to determine how healthy South Africans were.  Discovery collected information 
about the health status and health habits of their members.  The ObeCity Index revealed that 
Bloemfontein as a community has the least healthy weight status, has the lowest scores for fruit and 
vegetable intake and the highest consumption of salty foods and sugary drinks.  Bloemfontein also 
ranked as the second lowest city for physical activity.  The ObeCity Index ranking is scored on the 
relative weight status of members as well as associated risk factors.  Bloemfontein was ranked lowest in 
three categories, weight status of members, food and beverage choices and finally psychological well-
being and is ranked third in physical activity, rating the city first in the overall ObeCity Index and 
therefore making the city the unhealthiest city in South Africa (534, 535).   
Of concern was the fact that no participant identified herself as obese.  Cultural beliefs and perceptions 
in the black community may contribute to the obesity epidemic in South Africa.  The conclusions of 
Puoane et al., (2005) that being overweight is associated with happiness, respect, health, wealth and 
being treated well, while being thin is stigmatised in black communities due to the belief that many thin 
people are HIV-positive (40, 43), may well apply to this population.  
The implication for the design of the intervention is that a strong educational component should be 
included relating to the dangers and causes of obesity.  It is evident from the literature that obese and 
overweight individuals appear to be in a chronic low grade inflammatory state which contributes to 
chronic pain, while the increased load on the joints and the spine due to the individual’s weight is the 
most discussed link between obesity and pain in the literature.  Altered body mechanics and postures 
often observed in obese individuals may also be involved in the link between obesity and pain (536).   
The BMI of those with joint pain (musculoskeletal conditions) was higher than those without joint pain 
(musculoskeletal conditions) and an exercise programme targeting weight loss would also need to be 
included. In addition, as exercise and physical activity are considered important management strategies 
in the primary and secondary prevention of chronic diseases including diabetes mellitus type II, 
hypertension and obesity, this would be an important component.  Appropriate exercises would include 
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30 to 45 minutes of cardio-vascular exercises of moderate intensity, performed at least three to five 
days per week.  The exercise programme could also include weight resistance modalities (294, 537, 538). 
6.10.3 Prevalence of joint pain (musculoskeletal conditions) and co-morbidities 
The prevalence of joint pain (musculoskeletal conditions) in non-consenters was 45% in the study, while 
the prevalence of consenters was 62.1%.  Taking into consideration both the consenters, and the non-
consenters the prevalence of joint pain (musculoskeletal conditions) for all women in the target 
population was 58.2% (Table 41).   Therefore, the prevalence of joint pain (musculoskeletal conditions) 
in this sample was high, with nearly two out of three participants reporting pain. This is more than 
double that of the general population as reported in other studies. For example, the rates of joint pain 
range from 20-25% of the adult population in European Countries and Australia and 11 % of adults in 
Spain (3, 9, 217, 218).  However these rates are not comparable as this population (middle-aged women 
attending community clinics) was purposively chosen because it was expected that they would exhibit a 
high prevalence of joint pain which was indeed the case.  
The rate was also higher than in other South African studies, which indicated that 30-36% of women 
attending Primary Health Care Clinics had musculoskeletal conditions (30%) (539) or joint pain 
(36%)(32).  In 2013 a study was conducted at a community clinic in Cape Town to determine the 
prevalence and impact of musculoskeletal conditions amongst people attending a community clinic.  The 
prevalence was found to be 45.82% (31).  A major difference between the present survey and the two 
studies undertaken in South Africa was that the population of the present study was only female, whilst 
the other two studies included both sexes.  The ages of the participants also differed in that in the 
present study, the ages ranged from 40 to 64 years and the other two studies included all attendees to 
the health centres above the ages of 18.  As previously mentioned, the current study specifically 
targeted those who were predicted to have a high prevalence of joint pain (musculoskeletal conditions), 
which is higher in women and increases with age (6, 14, 540, 541).  The high reported prevalence in this 
sample supported the development of an intervention programme specifically targeted at older women.  
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It was postulated in the Introduction to this thesis that there might be a relationship between CDL, 
obesity and joint pain and a lack of physical activity.  However, a statistical association between CDL and 
joint pain was not established and CDL were not associated with joint pain.  Nevertheless, the BMI of 
those with joint pain was higher than that of those without joint pain.  
As previously mentioned in Chapter 2, musculoskeletal pain in diabetes mellitus type II patients may be 
caused by various factors and only suggestions can be made regarding the underlying aetiology.  The 
exact patho-physiology of these musculoskeletal conditions remains unanswered; however, advanced 
glycation end products that accumulate in the joints and connective tissue, micro-vascular abnormalities 
with damage to blood vessels and nerves, neuropathy or vasculopathy may have a synergistic effect on 
the increased incidence of musculoskeletal conditions in individuals living with diabetes mellitus type II 
(542-544). 
It was surprising that no association was found between diabetes mellitus and joint pain.  In a large scale 
population-based cross-sectional study in Norway, multivariate analysis indicated that chronic 
widespread musculoskeletal conditions were 1.6 times more likely to be found among subjects younger 
than 60 years of age with diabetes mellitus than those individuals without it.  The authors raised the 
question whether diabetes mellitus type II in some way worsened musculoskeletal conditions or the 
other way around (251).  Similarly, Molsted (2012) reported that  individuals with diabetes mellitus type 
II had a significantly higher prevalence and increased risk of developing rheumatic disorders and 
experiencing musculoskeletal pain compared to a matched sample (age and gender) of the general 
population in the same geographical region in a Danish population (256, 545).   
As previously mentioned in Chapter 2 one of the factors associated with musculoskeletal pain is obesity,  
and reduction in weight has been demonstrated to reduce the functional limitations related to OA of the 
knee by not only reducing the pain of the individual,  but also improving mobility (6).  The prevalence of 
chronic musculoskeletal conditions increases with Body Mass Index (BMI) with a peak among those 
individuals with a BMI of more than 30kg/m2 (251, 256).  In the present study 60% of the participants 
had a BMI of more than 30kg/m2, had joint pain (musculoskeletal conditions) and their BMI was 
significantly higher, which supports the published findings.  
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The majority of respondents with joint pain (musculoskeletal conditions) reported co-morbidities, with 
over half having joint pain (musculoskeletal conditions) and/or hypertension and diabetes mellitus type 
II. It thus emerged that, whereas there was no evidence of a causative link between the conditions, it
would make sense to include aspects of the management of obesity, hypertension and diabetes mellitus 
type II in the intervention programme. 
6.10.4 Impact of joint pain (musculoskeletal conditions) on quality of life 
The quality of life of the participants,  as assessed using the EQ-5D-3L measurement instrument,  
indicated that the majority of participants without and with joint pain (musculoskeletal conditions) 
experienced no problems in mobility, self-care and usual activities, whereas problems in the 
pain/discomfort and anxiety/depression domains were far more frequent. This distribution of findings is 
commonly reported, with the prevalence of problems in the pain/discomfort and anxiety/depression 
domains being higher than in the community-based surveys in Zimbabwe (546), the United Kingdom 
(547) and Latin America (548), all of which reported few problems in the functional domains and a
higher prevalence of moderate to severe problems in the other two.  It is evident that many of the 
health problems in South Africa are socially and culturally rooted and compounded by poverty, crime 
and violence, especially for people in the lower income brackets.  South Africa has a relatively high 12-
month prevalence of anxiety and mood disorders when compared to several other high- and middle-
income countries (549, 550). Therefore, it is not surprising that the anxiety/depression domain is higher.  
It is well recognised that anxiety/depression and pain/discomfort are interrelated and as mentioned 
previously, the anxiety/depression of South Africans are worse, then it is also not surprising that 
pain/discomfort is higher.  Therefore, the interrelationship between anxiety/depression and 
pain/discomfort should be acknowledged in treatments rather than just treating one or the other.  The 
approach in the management of individuals should consequently be according to the bio-psychosocial 
ICF model as discussed in Chapter 2 (551).   
Pain on that day (as stipulated by the EQ-5D-3L questionnaire) was reported in nearly three quarters of 
the participants.  Weir et al., (1996) looked into gender differences in psycho-social adjustment to 
chronic pain and found no differences between males and females in a heterogeneous sample, but they 
found that the predictors for psycho-social adjustment varied between the sexes.  The female 
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participants adjusted to chronic pain primarily through cognitive factors such as the meaning they 
attributed to the pain they experienced, while social support was the strongest predictor of adjustment 
in the male participants (552). Thus the educational component of the intervention as well as goal-
setting and self-efficacy were deemed to be important in the intervention to ensure that the 
participants understood the pain they experienced as well as the management of the pain.    
The high number of those reporting some or severe anxiety/depression corroborates the high 
prevalence of self-reported depression which was not clinically diagnosed.  It would appear that, 
although the proportion with severe or extreme problems was significantly greater in those with joint 
pain (musculoskeletal conditions), many of those attending the clinics are in need of support to manage 
their anxiety and depression.  In 2008 Kagee found in the Western Cape, South Africa,  that 45.9% of 
individuals living with hypertension and diabetes mellitus experienced clinically significant symptoms of 
depression (553) which substantiates the findings of the present study.  It is interesting to note that 
results of a study by Herman et al., (2009) indicated that the lifetime prevalence for all mental disorders 
in the Free State was 37.5% and for anxiety 21.5% (549).  In 2012 Peltzer et al.,  found that 19.4% of 
women attending an urban outpatient department in a Limpopo, hospital in South Africa experienced 
psychological distress which was associated with chronic disease, poor self-rated health status and pain 
(554).  A research study conducted by Novy et al., (1996) on a heterogeneous chronic pain population 
found that there were no sex differences between the total depression scores of participants, but that 
certain depressive symptoms were more common amongst females, especially fatigue and body image 
distortion (555). In addition, one in five respondents with joint pain (musculoskeletal conditions) 
reported feeling severe anxiety/depression, and a comprehensive intervention programme for this 
group should address this aspect of HRQOL. The EQ-5D-3L Index did discriminate between those with 
and those without joint pain (musculoskeletal conditions) and the Index emerged as a good candidate 
outcome measure for the intervention study. 
The median of the measure of global health, the VAS score for those without joint pain (musculoskeletal 
conditions) was 80 and those with joint pain (musculoskeletal conditions) 60 out of a possible 100.  
Those without joint pain (musculoskeletal conditions)are similar to the mean score on the Visual 
Analogue Scale (VAS) reported in a community-based  Zimbabwean sample (mean 79.8),  a United 
Kingdom sample (mean 82.5) (546) and a Cape Town sample of Isixhosa speaking respondents (80).  
Those with joint pain (musculoskeletal conditions) had a mean score of 64.5. This is not surprising as this 
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was a facility based sample, similar to those receiving treatment for HIV in a Cape Town study which 
recorded a mean VAS of 62 prior to the initiation of anti-retroviral therapy,  and 70 after four weeks on 
treatment (556). The participants of this study perceived their health to be worse than that of other 
groups, and it seems as if CDL resulted in a decrease and the presence of joint pain (musculoskeletal 
conditions) further decreased the perceived HRQOL. 
The results of the EQ-5D-3L indicated that an effective intervention programme is needed to address the 
impact of joint pain (musculoskeletal conditions) on performance of day-to-day activities, pain 
perception and on mood. 
6.10.5 Impact of joint pain (musculoskeletal conditions) on functioning 
The WHODAS 2.0 has previously displayed good clinimetric properties, thereby supporting the use of the 
questionnaire as an international instrument for measuring disability based on the ICT model (458, 461). 
Participants experienced mild problems with washing, getting dressed, managing unknown people and 
doing household activities. The functional limitation with the highest proportion of participants 
experiencing extreme problems was community activities, while moderate or severe problems were 
emotions being affected.  The discriminate validity of the questionnaire was found to be poor in the 
present study and the above results cannot be accepted with confidence. 
However, there was some agreement between the questionnaires, in that emotion emerged as the 
domain with the highest number of problems, similar to the EQ-5D-3L domain of anxiety/depression.  In 
contrast, the usual activities domain of the EQ-5D-3L indicated that those with joint pain 
(musculoskeletal conditions) had the most problems, whereas the WHODAS 2 responses showed that 
those without joint pain (musculoskeletal conditions) had more problems.  
It is difficult to explain why this instrument does not seem to be a valid instrument to describe the 
activity limitations and participation restrictions with this study. It had performed well in similar studies 
in South Africa, when the isiXhosa version had been utilised It was subjected to a rigorous translation 
process, as described in Chapter 5 by the Linguistic Department of the University of the Free State and 
had performed well in other community-based surveys in South Africa (466).  The translation was 
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rechecked to ensure that no inversion of levels had inadvertently taken place. Data entry was 
rechecked. Collapsing of the different levels (e.g. mild with moderate and severe with extreme or other 
combinations) did not improve the performance. The counterintuitive results are therefore surprising 
and further research should be undertaken to identify whether the translation was inadequate 
(although done rigorously),  or the choice of the five Likert scale responses was too demanding for older 
rural women with relatively low levels of education.  According to Dowse (2016),  it is troublesome that 
health-literacy in developing countries is under-researched despite the likelihood of inadequate health 
literacy being prevalent in South Africa (557).   It is well known to researchers that low literacy and 
culturally diverse populations struggle with response formats that require more than just a concrete 
“yes” or “no” answer, such as the Likert scale, which is unfamiliar and poorly understood by these 
populations.  The concept of choosing a number on a scale proves to be too abstract and choices are 
often made randomly (557, 558).  
6.10.6 Nature of joint pain 
A common symptom of osteoarthritis is morning stiffness lasting for less than 30 minutes for knee OA 
and less than 60 minutes for hip OA (559) and difficulty with moving when experienced in the lower 
limbs (560).  Specific features of OA include pain during movement, pain during the night when sleeping, 
or constant pain, stiffness and a limited range of movement as well as impairment in everyday activities 
(561).  Although no medical tests or X-rays were taken, nearly two thirds of the participants 
demonstrated symptoms consistent with a diagnosis of OA or at least early degeneration if not the 
stabilisation phase of OA.  During the initial phases of OA there is pain due to a chronic inflammatory 
responses in the synovium,  and during the last phase of OA,  the stabilisation phase, the individual 
complains of pain as well as stiffness as the compensatory bone overgrowth that occurs attempts to 
stabilise the joint (562).   
The study conducted in Cape Town by Parker et al., (2010) in a sample of middle-aged women attending 
a primary health care clinic, reported that those respondents reporting joint pain experienced pain and 
stiffness (80%) most commonly after awakening or a long period of rest. Most of the participants (85%) 
indicated that they experienced improvement of their symptoms with movement or exercise.  The 
stiffness reported by the participants (51%) in the Parker et al., study lasted for more than 30 minutes, 
very similar to the 50% in the present survey (32).  Similarly, Copley et al.,  (2013) reported 84% of their 
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participants experienced stiffness in their joints in the morning, which lasted for more than 30 minutes 
(31).  When analysing the findings of the present survey and the findings of Parker et al., (2010) and 
Copley et al., (2013) it seems that the differences in the findings could be attributed to the different 
populations of the studies and more specifically whether males were included.  In a longitudinal study 
reporting pain from middle to old age by Brattberg et al., (1997) the researchers found that women 
reported musculoskeletal pain in more locations and more often than males (563). The statement of 
Brattberg et al., (1997) is supported by various epidemiological surveys and research which 
demonstrated that females report more pain-related symptoms that males in the general population 
and could therefore not be attributed to the greater tendency among females to seek medical attention 
for pain (564-569).   
After reviewing the available literature it thus appears that females have an increased risk of 
experiencing pain-related symptoms and that women may also differ in their response and adjustment 
to pain.  In both clinical and experimental pain, several mechanisms have been proposed to explain the 
possible sex differences of experiencing pain, and as characterised as biological versus psychosocial 
mechanisms (570-574).  It is, however, essential to take note of the artificial nature of the distinction 
due to the fact that the classification of biological and psychosocial mechanisms, are based on the level 
of analysis of the studies and not the actual mechanisms.  A commonly cited “psychosocial” mechanism 
in pain perception is that the female role in society permits a female to acknowledge pain, while society 
discourages the expression of pain in males.  Despite the appeal of this explanation, there is little 
evidence to support this statement, and the evidence found was primarily in the context of 
experimental rather than clinical pain (570-573).  
At a biological level of analysis, environmental and biological factors that influence perceptual and 
behavioural responses associated with female roles also influence nociceptive processing of pain.  These 
factors could include ovarian hormones, endogenous pain regulatory systems and expectancies, all of 
which have been established as altering the neurophysiology of pain.  It is therefore important when 
considering the possible mechanisms underlying male-female differences in pain responses that 
psychosocial and biological explanations may refer to the same underlying processes, as mentioned 
earlier (570-574).  It is also possible that cognitive-affective factors such as pain coping strategies of the 
individual, and emotional distress experienced at the time as well as pain-related expectancies may 
contribute to the sex differences in pain.  These psychological factors have been noted in both 
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experimental as well as clinical pain (570-574).  An example of psychological factors that play a role in 
pain perception is depression and anxiety. Both have been found to be more prevalent amongst females 
and depression is associated with increased pain and other physical symptoms (565, 575, 576).    
In addition to affective variables, cognitive factors including coping and self-efficacy may also be 
determinants of differences in pain perception by males and females.  Catastrophising has been 
associated with females and is a predictor of poorer adjustment to clinical pain, whereas higher levels  
of self-efficacy to decrease or control pain have been associated with better adjustment to chronic pain 
in females,  but not in males (570, 571, 577-579).  
Only 35% of the participants in the survey experiencing either pain or stiffness had been medically 
diagnosed with some type of joint disease and only 21% had been specifically diagnosed with arthritis. 
When the participants were asked what diagnosis was given to them, they used the colloquial term for 
arthritis and joint pain, “rumatiki”. None of the participants were diagnosed with RA.  In the study done 
by Parker et al., (2010), only 15% of the participants had previously been diagnosed and the majority 
(60%) were diagnosed with joint pathology on examination by a physiotherapist.  The common diagnosis 
was arthritis with a rate of 76% (32).  In the Copley et al., study (2013) 46% of the participants were 
diagnosed with arthritis (31).  It is clear that joint pathology was prevalent in the current study sample 
and that in the majority of cases it had not been diagnosed or treated by the medical personnel at the 
clinic which was expected, but this should be addressed as soon as possible as this has an impact on the 
quality of life of individuals living with MSC.  
More than half (53%) of the participants indicated that they used medication to relieve their joint pain 
(musculoskeletal conditions).  The medication mentioned by the patients most frequently was panado-
co tablets.  Each tablet contains paracetamol 500 mg, codeine phosphate 8 mg and 0.1% m/m 
potassium sorbate as preservative and is sugar free.  In some instance the doctor prescribed anti-
inflammatory medicine and specifically Brufen. No participants indicated that they were ever told by a 
doctor or sister/nurse to follow an exercise program, nor did anyone indicate that they received any 
type of treatment other than medication, for pain.  Therefore the aim of the intervention should be to 
relieve the joint pain (musculoskeletal conditions) experienced by participants and improve their quality 
of life. In the long run an intervention also has the potential to reduce the financial burden placed on 
individuals to buy over the counter medication in an attempt to relieve their joint pain. 
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6.10.7 Strengths and limitations of the study 
 
The STROBE statement checklist (580) of items that should be addressed during observational studies 
will be discussed to validate the reporting of the epidemiological study.  
 
Table 51: Checklist of items discussed and included in the present study 
Included in the present study 
A facility-based survey using a descriptive observational cross-sectional design was identified as being the most 
appropriate design for the study. 
Scientific background and rationale for the study are presented. 
Aims and objectives for the study are specified. 
Setting, location, relevant dates including the period of recruitment and data collection are discussed. 
Eligibility criteria, source and methods of selection of participants are discussed. 
Possible variables and confounders are discussed. 
Details of the methods of measurement are discussed in detail. 
Calculation of the study size is discussed. 
Statistical methods used, methods used to examine subgroups and interactions and missing data are described 
in detail. 
The results of the study regarding reasons for non-participation as well as a flow diagram of participation are 
provided. 
Detailed descriptive data is provided regarding the characteristics of the study participants as well as the 
number of participants with missing data. 
Outcome data and main results of the study are provided.   
A comprehensive discussion is presented including the summary of the key results, the limitations of the study, 
and the overall interpretation of the results.   
 
It was surprising that many of the more common conditions that were to be expected in this specific 
population were not stated when asked whether they suffered from heart conditions etc during the last 
three months.    The main reason why participants visited the primary health care clinic was to either 
collect medication or consult with a doctor for health related reasons, as this is a general clinic.  The 
more specialised clinics are run from the National District Hospital and the Tertiary Hospital in the 
vicinity, and patient attendance at these clinics rather than the local clinic might account for the lack of 
reporting of these conditions.    
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The results of the study are generalisable regarding the prevalence of joint pain (musculoskeletal 
conditions) in middle-aged women attending a community clinic. However, these rates are not 
comparable to the general population because middle-aged women attending community clinics were 
purposively chosen as it was expected that they would exhibit a high prevalence of joint pain 
(musculoskeletal conditions), which was indeed the case.  When comparing the results of the 
epidemiological survey with those of the intervention study regarding demographic information as well 
as health-related information it is clear that the groups were similar.  Sources of funding and role of the 
funders are mentioned under acknowledgements.  The full STROBE statement checklist is attached as 
Appendix 27. 
The use of structured interviews might have resulted in respondent bias and this is acknowledged as a 
weakness of the study. It was hoped that rigorous training and monitoring of the research assistants 
would minimise this affect. 
The disappointing performance of the WHODAS 2, limited the information gathered with regard to 
functional restrictions. However, the EQ-5D-3L did give some guidance as to the areas in which 
participants experienced the greatest number of problems. 
The lack of information relating to the levels of physical activity is acknowledged as a weakness in the 
study.  However, those with joint pain (musculoskeletal conditions) did report more problems with 
mobility and about 30% of the entire sample reported moderate to severe difficulty in walking long 
distances on the WHODAS 2. So it would appear that physical activity is generally curtailed (although not 
necessarily only in the group with joint pain (musculoskeletal conditions) and it would have been useful 
to have an objective measure of the extent of this. 
6.10.8 Conclusion 
The results of the epidemiological survey were used in conjunction with the results of the systematic 
reviews to develop the six-week intervention programme and to modify and adapt existing workbooks.  
The ‘typical’ participant in the survey spoke Sesotho, was married, owned their own brick home and 
lived in a household with about five other people. Therefore,  the workbook was developed in English 
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and translated into Sesotho to make it more user friendly for the participants as the workbook 
contained sections on self-efficacy and goal setting that the participants in the intervention phase of the 
study had to complete during the six-week intervention programme.  It was also decided by the 
researcher to train and educate a fourth year Sesotho speaking physiotherapy student as a research 
assistant  to facilitate the educational session during the intervention and to assist with the explanations 
during the exercise sessions if deemed necessary. 
The ages ranged from 40 to 64 years with the median age of 52 years of the present study’s population.  
During the development of the exercise component of the intervention programme, the 
appropriateness of the exercises for the age range of the participants was considered to ensure the 
safety of the participants during participation without compromising the effectiveness of the exercises.  
Participants could read and write and had some education which included primary, secondary or tertiary 
education.  Therefore it was decided to compile the workbook on the level of Grade 4 (a scholar in their 
fourth year of primary school at approximately 10 years of age) to ensure that participants would be 
able to understand the health-related information in the workbook and that they would be able to 
complete the goal setting tasks set out in the workbook to increase self-efficacy.  According to the Flesch 
Kincaid grade level of readability in Microsoft Word, the readability of the workbook was a Grade 2.5.   
Most of the participants were unable to find work and they did not receive any benefit grants.  They 
were visiting the clinic either to collect medication or to consult with a health professional. They had 
hypertension in various stages; some also had diabetes mellitus type II, and were depressed.  They 
regarded their general health as being fair to poor. They were obese but did not take any harmful 
substances.   Most of the respondents were unsure of what medication they were taking.  The majority 
of the respondents mentioned having joint pain either short or long term and in conjunction with the 
joint pain (musculoskeletal condition) they either had hypertension and/or diabetes mellitus type II.  The 
respondents with joint pain (musculoskeletal conditions) were less likely to have diabetes mellitus type 
II, but there was no association between hypertension and joint pain (musculoskeletal conditions). 
Those who had joint pain (musculoskeletal conditions) had a BMI which was significantly higher than 
those without joint pain (musculoskeletal conditions).  
The exercises included in the intervention were selected after taking into consideration the 
appropriateness of the exercises for individuals with hypertension, diabetes mellitus type II, joint pain 
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(musculoskeletal conditions) and being obese.  The safety of the exercises was also considered by the 
researcher for the target population before including the exercises in the programme.  The workbook 
was designed in accordance with the health conditions of the survey participants and therefore had to 
include education regarding hypertension, diabetes mellitus type II, being overweight and joint pain 
(musculoskeletal conditions).  
To exclude participants with an increased risk attached to participating in exercise during the 
intervention phase (as a number of  participants had Stage II and Stage III hypertension),  it was decided 
that all participants would be screened and a physical examination performed by a qualified medical 
practitioner with a special interest in Community Health before enrolment in the intervention 
programme.  A trained ER 24 paramedic was also approached by the researcher to be present during 
each intervention sessions for any medical emergencies as the targeted group could be deemed to be a 
high risk group.   
Those with joint pain (musculoskeletal conditions) reported a poorer quality of life, both with regard to 
the EQ-5D-3L index score and the more global VAS score. The dimensions affected included mobility, 
usual activities, pain/discomfort and anxiety/depression. With regard to the functional impact of the 
joint pain (musculoskeletal conditions), those with joint pain (musculoskeletal conditions) experienced a 
mild effect on participation such as family life, work and social life and a moderate effect on their 
financial position. They had had to stop working or alter their employment due to their joint pain 
(musculoskeletal conditions). They experienced fatigue and depression. They reported significantly more 
difficulty with concentration, walking long distances, washing and dressing and interacting with 
unknown people and friends than those without joint pain (musculoskeletal conditions).  If possible,  
functional activities for strengthening and cardio-vascular exercise would be considered by the 
researcher for inclusion in the exercise component of the intervention to address the functional impact 
the joint pain (musculoskeletal conditions) has had on the participants’ qualify of life.  
It is accordingly clear from the results of the epidemiological sub-study and the epidemiological 
transition that is rapidly taking place in South Africa that primary health care systems should be 
developing an approach for the effective management and identification of CDL and MSC and should 
respond effectively to specific needs of communities and individuals alike.  There is a definite need for 
improvement in services at the community health care clinics in the area, specifically to be able to 
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screen and identify accurately chronic health conditions within middle-aged women attending the 
clinics.  Based on the above results there are many disadvantaged middle-aged women in the 
community with MSC and CDL and it is time for physiotherapists to participate actively in the 
development of appropriate methods of intervening at community level.  Specifically, physiotherapists 
in primary health care clinics can address the negative impact of MSC and CDL on functioning and 
quality of life of individuals living with the disease.  It is imperative that research should be conducted 
on individuals living with MSC and CDL in the community for the optimal planning of quality primary 
health care systems that need to address the growing health burden of CDL, especially to determine the 
risk factors of health problems, as well as the distribution of health problems in South Africa.   
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7 MODIFYING AND ADAPTING EXISTING PROGRAMMES INTO AN 
INTERVENTION PROGRAMME 
7.1 Introduction 
Based on the information reported in the literature which consistently reported that middle-aged 
women are the most likely to experience joint pain (musculoskeletal conditions) and that many 
experience functional limitations, an intervention was developed for this specific population.  The aim of 
the intervention was to attempt to enhance self-management and increase physical activity for 
individuals living with joint pain (MSC), but to be mindful of common co-morbidities more specifically 
hypertension, diabetes mellitus type II and obesity.  The programme was designed to educate, 
empower, maximise functional status and improve the quality of life of the women.   
The purpose of this chapter is to describe the intervention programme that was developed and to justify 
and discuss the choices made regarding the structure, frequency and duration of the intervention, the 
length of the programme and also the content of each educational session.    
7.2 Description of the intervention 
The six-week intervention programme was developed utilising physical exercise in group format, health 
education, facilitating the development of self-management, problem-solving skills, decision-making 
skills and maintaining a balanced lifestyle utilising a workbook that was adapted and modified from 
previous workbooks successfully used in studies conducted in South Africa and elsewhere (see 7.2.6).  
The workbook and health education were developed taking into account adult learning principles.  
Dietary information as well as practical considerations and safety aspects were also considered during 
development.  The justification for including each aspect of the intervention will be discussed in the 
following sections.   
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7.2.1 Specific population 
The intervention was targeted at middle-aged women, aged 40 to 64 years with joint pain 
(musculoskeletal conditions) and co-morbidities. This population was targeted as the survey indicated 
the majority of women with joint pain (musculoskeletal conditions) in the survey were in this group and 
had at least one co-morbid condition, either hypertension, DM II or were obese.  In addition, this group 
was chosen as they reported a worse HRQOL and more functional problems in the Anxiety/Depression 
and Pain/Discomfort domains.  Finally, they regarded their general health as fair to poor.   
7.2.2 Length of time of the intervention 
Based on the published literature, the planned intervention was to be six weeks long.  The literature 
included intervention programmes conducted in clothing/textile manufacturing companies in South 
Africa (22), on women with fibromyalgia syndrome (23);  on patients with knee pain (397); women living 
with HIV/AIDS and experiencing pain in South Africa (364); women living with DM II (581, 582); 
individuals living with hypertension (583-585),  and on chronic disease self-management programmes  
as well as chronic pain self-management programmes (338, 490, 491, 586-588). In the programmes 
reviewed, a time period of six weeks was used as this is regarded as the minimum time required to 
effect a change in behaviour while also being a period of time which is not regarded as excessively long 
by patients (589). In this time period,  improvement was also demonstrated in the following aspects: 
health-related behaviours, self-efficacy, health-related quality of life and health status of individuals;  
large improvements in physical function;  improvement not only in cardiovascular fitness but also 
flexibility;  reduced pain severity and pain interference; better short- and long term glycaemic outcomes, 
(583) and decreases in blood pressure (583, 585).
7.2.3 Frequency and duration of the intervention 
The frequency of once a week and the duration of two hour sessions (one hour education and one hour 
supervised exercises) were also based on the above literature (22, 23, 364, 583-585, 590-593).  
According to ACSM’s guidelines, exercise training sessions should be approximately 60 minutes, but 
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could start with a shorter duration and then be increased by five to 10 minutes per session every one to 
two weeks over the first four to six weeks (594) to achieve health benefits including cardio-vascular 
fitness.   
 
7.2.4 Type of intervention 
 
The planned intervention was to be delivered in group format.   The group approach has many   
advantages including learning from each other, sharing of goals and group members supporting each  
other, through interaction and feedback. The learning experience is enhanced in a safe and non- 
threatening environment  which is enhanced through sharing experiences and challenges (333, 595).  
 
It is generally recommended that a group size should be limited to a maximum of 12 people to ensure 
that a relationship between the group leader/physiotherapist and the participants can be established 
and to facilitate discussion during the educational sessions (428, 595).  Due to the sample size 
calculation it was anticipated that the group would consist of more than 12 participants which would 
make  it challenging to manage the interaction between the group members and the research assistant 
presenting the programme. Increasing the number of sessions was not feasible given the limited 
availability of the venue. It was therefore decided that  two more research assistants in addition to the 
researcher would be on hand to assist with the facilitation of the exercises as well as the educational 
session if deemed necessary.   
 
7.2.5 Importance of adult learning 
 
An important factor that was considered during the adaptation and development of the workbook and 
the intervention was adult learning.   An adult learner is seen as a learner who carries “adult 
responsibilities” which are translated through their family, community and financial commitments and 
who brings complex life experiences to the learning environment (596). 
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In adult learning there are specific basic principles that need to be followed in order to achieve the 
desired goals in this study of achieving increased self-efficacy regarding chronic conditions of lifestyle.  
According to Knowles, Holton, and Swanson (1998) as cited by Fidishun (2005),  adult learning should be 
autonomous and self-directed (597).  In the standard pedagogical model the students may simply learn 
what they are told, but adult learners need to know the reason why they are learning something and 
how the knowledge would benefit them (597).  
This principle of self-directed adult learning would be achieved in the intervention programme by 
actively involving the participant in the learning process. The research assistant would serve as 
facilitator in order to obtain the participants’ perspectives on the specific topics covered in the 
workbook and to guide the participants in gaining their own knowledge rather than supplying them with 
facts.  Adult learners are viewed as goal-orientated and relevancy oriented.  The goal setting sheets 
included in the workbook would also ensure that this goal would be achieved by the end of the six 
weeks and the research assistant would ask participants regarding their goal setting during follow-up 
educational sessions.  Therefore, the aim of the researcher was to ensure that the education sessions 
and the workbook were organised in specific topics/chapters with specific goals.  The goals and 
objectives would be made clear early in the education session to ensure that the goal-orientated 
component of adult learning was addressed as well as the relevance.   
Adults become ready to learn when they experience a need to learn something in order to cope better 
with real-life tasks or problems (598).  Therefore, one of the most important aspects of adult learning is 
that of practicality.  All educational sessions of the intervention would aim to address aspects that would 
be useful to the participants in their daily lives.  Respect is also seen as one of the key aspects of adult 
learning and, in order to achieve the objective, a female research assistant fluent in Sesotho was 
selected to be trained to present and facilitate the educational sessions of the intervention programme.  
The student would be familiar with the culture of the participants, due to her upbringing and own 
culture,  and could therefore show the necessary respect for the wealth of life experience that the 
participants brought to the sessions; an essential part of adult learning (599).  
Motivation is also seen as a key aspect of adult learning (599) and therefore it was made clear to all the 
research assistants  involved in the intervention not only to motivate and encourage participants as a 
group,  but also to motivate and assist individuals if deemed necessary.  It was also planned by the 
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researcher that participants would receive something to drink and a healthy snack between the exercise 
and education session which would also serve as motivation as the participants would experience being 
cared for.   
Three other critical elements of learning that would be addressed during the educational sessions and 
the workbook were reinforcement, retention and transference.    Reinforcement forms an integral part 
of the learning process,  and according to the literature,  it is the facilitator’s responsibility to encourage 
the correct mode of behaviour and performance in the adult learner (599).  Thus participants in both the 
intervention and control group would be “rewarded” with a T-shirt with the logo “Exercise is Medicine”, 
indicating their commitment and dedication to the research study, to ensure positive reinforcement.  
Participants also needed to retain the information they received during the educational sessions.  The 
amount of retention is directly affected by the degree of original learning.  Simply stated this means that 
if the participant did not learn the material well in the beginning,  she will not retain the information in 
the long run (599).  It was decided that the research assistant would pose specific questions to the 
participants during the follow-up sessions to reinforce the previous week’s information and to ensure 
some retention of information by the participants (599). It was made clear to the student that this 
should be done in a non-threatening manner so as not to discourage further participation. 
The last aspect that needed to be addressed was transference.  Positive transference would mean that   
the participants would use the information and behavioural changes taught in their daily lives. This 
would be achieved by giving participants time before the next educational session to reflect upon their 
exercise diary and their goal setting.   According to Lieb (1991) transference would only occur with 
association, similarity, degree of original learning and critical attributing elements (599).  
In summary, the modern concept of competence does not only consist of relevant knowledge and skills, 
but also of a range of personal qualities of the individual and the ability to perform both flexibility and 
adequately in known and unknown situations (600).  Learning includes two different processes:  the first 
being the external interaction between the participant and her cultural, social and environmental setting 
and the internal psychological process of acquisition of knew knowledge and elaboration of previous 
knowledge.  The second process is that all learning includes three dimensions, a cognitive dimension of 
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knowledge and skills, the emotional dimension of feelings and motivation and lastly,  the social 
dimension of communication and cooperation (600).    
 
7.2.6 Workbook 
 
A workbook titled “Balanced lifestyle” (Appendix 28) was adapted and modified from a workbook titled 
“Positive Living”5 developed by Dr R ParkerPhD, based on chronic pain educational material and also on 
“Living with Osteoarthritis: patient workbook “6 developed by Dr Romy Parker, Melissa Saw and Tina 
Kruger-Jenkins (601) which was found to be appropriate in a similar age group of participants living with 
a chronic disease; and on the findings of the survey.  Both the workbooks aimed to facilitate the 
development of self-management, problem solving skills, decision-making skills and finding and utilising 
resources to assist with managing the chronic disease (586).  Both the workbooks included sections on 
goal setting, problem solving tasks and included an exercise diary to facilitate skills acquisition by the 
participants (586).  In the adapted and developed workbook “Balanced lifestyle”, educational topics 
were more specific to the population identified in the survey, which included middle-aged women living 
with hypertension, diabetes mellitus type II, obesity and joint pain (musculoskeletal conditions) (Table 
52Table 52).  The focus on joint pain (musculoskeletal conditions) was mainstreamed throughout the 
programme and was included in the first session. However it was addressed during week 1 as the self-
management of musculoskeletal conditions. The intention was to provide a holistic approach to the 
management of the co-morbid conditions listed, and therefore the chronic diseases were also included 
in the workbook. 
 
 
 
 
 
 
                                                          
5 http://open.uct.ac.za/handle/11427/1004 
6 http://open.uct.ac.za/handle/11427/12697 
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Table 52: Topics of the “Balanced Lifestyle” workbook 
Topic for the Week Content
Week 1: Self-management  What is high blood pressure
(hypertension)
 What is diabetes mellitus type II (sugar)
 Being overweight
 Musculoskeletal conditions (joint pain)
 Self-management
Week 2: Exercise  Exercises
 Types of exercises
 Steps to success with exercise
 An exercise routine
Week 3: Managing common symptoms of  
musculoskeletal conditions.  
 Symptom management
 Action charts for common symptoms
o Pain
o Stiffness
o Swelling
o Difficulty doing activities
o Pacing and activity
o Tiredness
Week 4: Stress Management  What is stress?
 Managing stress
 Sleep
 Communication with your health carer
Week 5: Eating Well  Balanced nutrition
 Portion sizes
 Losing weight
Week 6: Continuing as a successful self-manager  Action planning for the future
 Reflection on changes
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7.2.7 Health education 
The topics of the workbook as indicated in Table 52 were covered in the weekly education sessions. The 
health education information was written at the level of Grade 4 (a scholar in their fourth year of 
primary school at approximately 10 years of age) as 36% of participants in the survey had attended 
primary school and 50% secondary school.  This was done to ensure that the health education 
information would be understood by all the participants of the survey.   
The need for dietary information was emphasised after the results of the epidemiological survey 
indicated that 81% of the participants were classified as being overweight or obese.  The BMI of those 
individuals with joint pain (musculoskeletal conditions) was 1.1 times higher than those without joint 
pain (musculoskeletal conditions), but both groups were still classified as being obese.  It was therefore 
clear that dietary information should focus not only on weight loss, but also on healthy food options and 
portion sizes according to food-based dietary guidelines specifically for South African populations.  The 
“Eating Well” chapter was compiled in collaboration with the Department of Dietetics and Human 
Nutrition at the University of the Free State.  The dietician compiled the chapter according to the 
specific guidelines suitable for women living with hypertension, DM II and obesity, utilising the revised 
food-based dietary guidelines for South Africa (602).  Specific cultural foods were also included in the 
workbook to ensure that the foods listed were culturally acceptable to the participants.   
The health education information in the workbook was compiled in English as the source language and 
then translated into Sesotho as the target language to ensure better understanding of the information.  
The option would be given to each participant to indicate her language preference when given the 
workbooks with the health education information.   As previously mentioned, a research assistant who 
was fluent in both Sesotho and English was identified and trained by the researcher as a research 
assistant to lead the intervention programme.  Due to the student’s training as a physiotherapist, she 
would also have the necessary theoretical training to be able to convey the health education material of 
the intervention to the participants.   
The researcher also explored the readability of the workbook to ensure that the information would 
reach the target audience.  According to Calderon et al., (2006) readability is the semantic and syntactic 
characteristics of the written word.  Readability can be determined by using readability formulas which 
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provide and can indicate the skills needed to decipher and understand the written text. (603)  Although 
readability formulas are regarded as an objective measure of language complexity, the formulas at the 
same time have faced criticism among researchers as they are only based on two variables, the first one 
being word length and the second one sentence length, which may not be clear predictors of language 
difficulty,  especially in adult populations.  (604) 
The Flesch Reading Ease formula is used to determine the reading difficulty of written material for 
adults and has been incorporated into the Microsoft Word software.  Rather than utilising the Flesch 
Reading Grade level,  the Flesch Reading Ease scores range from 0 – 100, with the lower scored 
indicating more difficult reading material (605).  The Flesch Reading Ease Score for the workbook was 
calculated as 76.3, which according to the range of scores is not too difficult to read.  The most 
important consideration for the present study is that the workbook was translated into Sesotho and 
therefore the Flesch Reading Ease formula which only calculates the reading difficulty in English is only 
an indicator and not a predictor of the difficulty level of the reading material of this study.   
7.2.8 Self-efficacy and self-management 
Self-efficacy is a construct derived from the social cognitive theory, a theory involving a triadic reciprocal 
causation model in which behaviour, understanding and the environment all influence each other in a 
dynamic fashion (606).  The social cognitive theory includes motivational and self-regulatory 
mechanisms, which is more comprehensive than social learning and/or the behavioural approach to 
human action on which the theory is built.  More importantly social cognitive learning is viewed as the 
acquisition of knowledge through cognitive processes of information with the “social” part 
acknowledging the environmental origin of human thoughts and action; whereas the “cognitive” section 
recognizes the contribution and influence of the cognitive processes to human motivation and action.  
The social cognitive theory explains the nature of the bidirectional reciprocal influences through five 
basic human capabilities including symbolizing, forethought, vicarious learning, self-regulation and self-
reflection.  According to the social cognitive theory almost all forms of learning can occur vicariously by 
observing the behaviour of others and the consequences of their behaviour.  This is especially true in 
group format interventions.  The acquisition of knowledge vicariously is critical for both the learning (in 
this instance the participant) and human performance (607).   
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Self-efficacy derives from four sources:  performance accomplishment, vicarious experience, verbal 
persuasion and physiological state.  Performance accomplishment is the most important source of 
efficacy information as this is based on personal mastery experience.  Vicarious experience is obtained 
through observation of others successful or unsuccessful performances  and may account for a major 
part of learning throughout life, especially during adult learning (608).  Vicarious experience  is therefore 
an important part of the acquisition and change of human behaviour, but the nature of the cognitive 
processes involved in vicarious learning however remains obscure (609).  Verbal persuasion is frequently 
used in health education, while it is less powerful than performance accomplishment and vicarious 
experience.  Physiological states, particularly anxiety may influence the individual correctly or not that 
she is able to perform or maintain a given action or change (608).  
Self-efficacy is an individual’s belief in their ability to succeed in different situations (485) and people 
with high levels of self-efficacy believe themselves able to cope with their illness both in managing its 
treatment and in coping with symptoms. Interventions focussing on changing self-efficacy beliefs have 
been reported to improve disease outcome by up to 30%, decrease number of symptoms, improve 
symptom management and reduce cost of medical management in patients with arthritis and other 
chronic conditions (334, 610, 611). 
Bandura (1977) proposed a link between a person’s beliefs about her ability to perform a given 
behaviour or task and her subsequent performance of that behaviour (334). The researcher also stated 
that efficacy expectations determine how much effort people will use and for how long they will persist 
in the face of obstacles and tend to avoid certain experiences. The researcher also stated that efficacy 
expectations determine how much effort people will use and for how long they will persist in the face of 
obstacles and tend to avoid certain experiences (612).  Self-efficacy is a dynamic construct with the 
efficacy judgement changing over time as new information and experiences are acquired by the 
individual (606).  In the clinical context, a patient’s self-efficacy expectancies could be enhanced if the 
individual is more likely to engage in activities previously avoided due to fear (440). 
Self-efficacy of individuals is of essence especially in studies utilizing group format interventions, not 
because of respect for individualism, but because a strong sense of self-efficacy is vital for success 
regardless whether it is achieved individually or by group members putting their personal capabilities to 
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best use.  A committed and loyal group creates an environment where the individual feels obligated to 
do their part as the group pursuits their aim.  In the group the members are respected for their personal 
contributions to group accomplishments (613).  Self-efficacy is therefore an important motivational 
construct which influences an individual’s choices, goals, efforts, emotional reactions, coping and 
persisting at a task.  Self-efficacy changes as a result of learning, experience and feedback and is 
therefore an important motivational construct which influences an individual’s choices, goals, efforts, 
emotional reactions, coping and persisting at a task (606).  Multiple factors affect self-efficacy and it may 
be that simply meeting in a supportive group environment results in the changes observed in health 
education programmes rather than the content or method of delivery of the course itself.  A change in 
self-efficacy beliefs is associated with in an increase in self-management ability (334).   
Individuals living with a chronic disease have to make day-to-day decisions about to self-manage their 
diseases and their lives and lifestyle habits can have a major impact on the quality of their life.(614).  
Approaches to self-management vary, but the majority of self- management interventions are usually 
led by a health care professional where the participants are affected by the same condition and the 
intervention is delivered in a group setting (426, 494, 615). 
One of the key aspects of self-management is empowering the patient in choosing meaningful and 
realistic goals,  and the process is designed to facilitate self-directed behavioural change (616).  Paulo 
Freire’s work accurately describes empowerment as both a process and an outcome (616).  The process 
is when the purpose of the intervention and education is aimed at increasing the patient’s ability to 
think critically and act autonomously.  The outcome is when the patient experiences an enhanced sense 
of self-efficacy as a result of the process.  The fundamental principles of empowerment include the fact 
that the patient has to be involved and provide almost all of his/her own chronic condition care; the 
patient’s self-management decisions during their daily life have the greatest impact on his/her health 
and well-being; the patient has to remain in control of the self-management of his/her condition at all 
times and the health care professionals are responsible for ensuring that the patient has an adequate 
understanding of the chronic condition to be able to make informed self-management decisions (616).   
To achieve this goal, the workbook and health education topics were specifically designed to ensure that 
the participants would be knowledgeable regarding their respective health conditions.   
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In the absence of any effective medical cure for chronic diseases of lifestyle, the emphasis on improving 
the quality of life and functional capacity of the individuals, utilising disease self-management has to 
become the focus (491).   Randomised controlled trials have been conducted to determine the 
effectiveness of self-management programmes on, among others: individuals diagnosed with arthritis 
(337); self-management of a chronic disease in a “real-world” setting following the principles of Lorig et 
al., (2001) (334, 426);  on individuals with knee OA (617),  and on individuals with chronic HIV infection 
(338).  The results showed significant improvement in health behaviours, self-efficacy and health status. 
The results of the epidemiological survey indicated that the prevalence of joint pain (musculoskeletal 
conditions) for all women in the target population was 58.2%. The goal of the intervention programme 
was to improve physical functioning of the participants, increase their general well-being and reduce 
their pain. Barlow et al., (1998) used a social cognitive theory approach which encouraged participants 
to utilise and incorporate their education lessons learned each week to manage their disease (618, 619).  
The social cognitive theory approach incorporates problem solving, goal setting and cognitive 
techniques to encourage self-efficacy and in the long-term facilitate change of behaviour of the 
individual (618, 619). Fear of pain is often a bigger limiting factor than the experience of pain itself and, 
once the participants felt confident enough to be able to perform the exercises without pain and also 
control their pain, they become more confident that their condition was manageable leading to the 
individual becoming more active and improve their physical functioning.   Taking into account the 
literature regarding social cognitive theory, an action chart on how to deal with pain was included in the 
workbook and discussed during the education session to lessen the threat of pain.   
To summarise, empowerment should be viewed as a philosophy, an overall approach and not just as a 
strategy in managing chronic diseases (616).  Health education programmes should be a priority for the 
management of CDL both in urban and rural communities, and more especially in musculoskeletal 
conditions.  It is well established that patients who have access to accurate information regarding their 
health problems and are knowledgeable regarding their self-care, are more likely to take an active role 
in disease management and to adhere to treatment recommendations (12). 
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7.2.9 Exercise 
It is stated in the literature that all CDL and obesity share the same modifiable risk factor of inactivity 
(19, 20, 61).  Exercise can improve physical variables including emotional health, depression, mood 
disturbances and self-efficacy (297-302).  Although few studies have investigated the mood state of 
individuals at multiple time points after exercise, it is well known that the exercise-enhanced mood 
generally lasts for three to four hours (620) (621).  Other benefits of exercise stated are enhanced 
mental performance, concentration (402, 621-626), and better quality of sleep (627). Studies have also 
indicated that exercise can reduce perceived feelings of anger, time pressure and time urgency in daily 
life (623).  Therefore,  involvement in regular exercise may or may not increase the number of years 
lived, but may most certainly enhance the quality of years lived by an individual (628).   
The results of the systematic reviews revealed that both traditional and less conventional exercise 
programmes were utilised. Traditional exercise programmes included warming up, cardio-vascular 
exercises, muscle stretches, strengthening of upper and lower limbs and abdominal muscles and finally 
cooling down.  Less conventional exercise programmes included yoga stretching, Tae-Bo and hot 
bathing.  Based on the literature and the target population, the exercise component of the intervention 
included aerobic exercise, strengthening exercises and also muscle stretches. 
The exercise programme was developed using the American College of Sports Medicine Guidelines and 
included aerobic exercises, strengthening exercises and stretching exercises (629-632), as well as the 
novel programme developed by Parker.  Specific exercises were also chosen by the researcher taking the 
need for safety in an older population and limited availablity of equipment into account. Please refer to 
Appendix 29for a full description of the exercise programme utilised in the study.  Due to the mean age 
of the participants (52 years) and the fact that most of the participants were living with more than one 
health condition, it was decided that the duration of the supervised exercise programme would be 
started at 45 minutes during the first week and increased every week until 60 minutes of exercise was 
achieved during the third week and thus would be maintained for the six weeks (594, 633).  The last 15 
minutes would include physical games for the enjoyment of the participants (634).  It would be 
emphasised by the research assistant that participants should perform the aerobic exercises according 
to the Borg Scale level of  “somewhat hard” to ensure that participants were exerting themselves at the 
correct level of intensity.  (Appendix 30) The level of exertion “somewhat hard” has been found to 
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reflect an effort of 60% of maximum heart rate (265, 635). Appropriate illustrations were selected to be 
able to illustrate to participants what was meant by “somewhat hard”.      
The cultural acceptability of the exercises was also considered,  and  specific adaptations were made 
depending on what was culturally acceptable to participants during the pilot study.   The participants in 
the pilot study indicated during the first session that they enjoyed dancing activities and ball activities.  
The researcher gave each of them the opportunity during the first session to have a turn to show the 
type of dance that they enjoyed the most – this would then serve as aerobic exercises during the 
following sessions.  Some of the cultural dances, however,  entailed moving on their knees.  As most of 
the participants were older women, these were not included in the routine because the floor of the 
community hall was hard and many participants had knee pain.  Therefore,  a safer form of dancing was 
included.  Line dancing was introduced to the participants and after the first session they enjoyed the 
aerobic sessions and especially the music that accompanied these sessions.  As part of cooling down at 
the end of the exercise sessions,  cultural and traditional dances were encouraged.  The participants fully 
engaged in the sessions by singing traditional songs while performing the dances.   
As the participants indicated that they enjoyed activities that involved balls, the researcher and the 
research assistants included activities utilising different sizes balls. (Appendix 29) 
In addition the workbook  included examples of exercises for the participants to use at home, as well as 
exercise planning forms and weekly exercise diaries to encourage participants to exercise independently 
and ultimately increase their activity levels.  The chapter in the workbook on exercise included 
information on how to exercise safely,  and information on when to stop exercises due to  illness or joint 
pain.   
7.2.10 Relaxation 
Relaxation training was included in both the workbooks from which the “Balanced Lifestyle” workbook 
was adapted, and was thus incorporated into the intervention.  Relaxation is one of the commonly used 
approaches in the treatment of chronic pain and has been found to be effective for decreasing chronic 
headaches in patients (636-638). There were 12 participants who indicated that they experienced 
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headaches on the Brief Pain Inventory body chart.  Although relaxation may be regarded as a simple 
task, the skill of relaxation is one that needs to be practised in order to master the technique (636).  
Hence, relaxation training was included in the workbook chapter on stress management and practised in 
a facilitated manner in the groups. 
 
7.2.11 Practical considerations and finalisation 
 
The intervention was based on information gained from several sources but input from possible 
participants in the programme would have been particularly useful and this is acknowledged as a 
weakness of the development process. More engagement with the community might have led to further 
enrichment of the process and unfortunately the researcher had no public involvement in the 
development of the intervention. On the other hand, the intervention was piloted on participants who 
would have met the inclusion criteria of the study and their comments were solicited and resulted in 
modification of the programme.  The pilot study and subsequent changes made did ensure that the 
unique local perspective towards certain activities in the intervention did inform the intervention (See 
8.2.6 Changes made after pilot study).     
 
Several factors had to be considered and challenges overcome before the start of the intervention 
programme.  The first was to ensure the availability of the community hall for the intervention 
programme as the hall was the only suitable venue in the area that could be used for the purpose of the 
study.  The challenge was to ensure that the venue was unlocked on the specific dates given to the 
participants. As the person in charge of the venue was only fluent in Sesotho, the researcher requested 
a staff member of the University of the Free State who is fluent in Sesotho to contact the person in 
charge telephonically a day in advance of the intervention dates to confirm that the venue would be 
unlocked.   
 
The second challenge was to find a suitable person to facilitate the exercise classes as well as the 
educational session of the intervention programme.  Fortunately, a fourth year physiotherapy student 
who was fluent in both Sesotho and English was identified by the researcher and trained as a research 
assistant.  The student had a better understanding of the cultural norms, due to her upbringing in a 
small Sesotho community and the theoretical training empowered her to be able to convey the 
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information in the workbook.  No additional training was needed for the student(s) regarding the 
execution of the exercises in group format as all physiotherapy students are assessed during their third 
year as part of their clinical exposure in Community Service Learning on how to compile and present 
exercise and educational classes in group format for various health conditions, ages and cultures.  The 
researcher, however, had the responsibility of ensuring that the research assistant was familiar with the 
content of the topic as well as the exercises for the specific week.  This researcher and three other 
research assistants would also be present during each session to ensure that exercises were performed 
correctly by participants.   
Participants in the intervention group would receive a telephonic reminder or text message before each 
intervention date as encouragement to adhere to the programme.  The reminders were in accordance 
with the “green prescription” intervention in New Zealand where participants received at least three 
telephone calls during the study to encourage and support them  in ensuring that they adhered  to the 
physical activity required during the study (639). 
The final stage of development of the intervention included piloting of the planned intervention. A pilot 
study was conducted as it was necessary to ensure that the intervention would be culturally appropriate 
and feasible as planned. Once this had been done (described in 8.2.5) the intervention programme was 
adapted and finalised and the randomised trial was initiated. 
7.2.12 Adverse events 
Participants in the intervention study were screened and physically examined by a qualified medical 
practitioner to exclude any risk factors for participating in the study.  A trained paramedic was present 
during baseline measurements, each exercise session once a week for the duration of the study as well 
as endpoint data collection, to ensure that the best possible care was available for the participants in 
case of an emergency.  In the event of an incident taking place, the participant would receive immediate 
post-injury care by the researcher or paramedic on hand and referred to the sister in charge at the clinic 
immediately, or referred for management to the National District Hospital in Bloemfontein.  All adverse 
events would be declared in written format to the sister in charge at the clinic and kept on record at the 
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clinic, National District Hospital and on file by the researcher.  All health-related incidents of participants 
during the intervention would be recorded on the weekly intervention programme for transparency. 
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8 IMPACT OF A NON-PHARMACOLOGY INTERVENTION PROGRAMME: A 
PRAGMATIC, RANDOMISED CONTROL TRIAL. 
 
8.1 Introduction 
 
As discussed in Chapter 2 and supported by the findings of the sub-study on the prevalence and impact 
of musculoskeletal conditions in Chapter 6, it was apparent that chronic diseases of lifestyle, obesity and 
musculoskeletal pain resulted in a large burden of functional limitations in women attending this 
particular primary health care clinic  in Bloemfontein.  An intervention programme was designed 
specifically to meet the needs of this group of women.  This programme was informed by the narrative 
and systematic literature reviews, as well as their demographic and functional characteristics. 
 
It was hoped that such a targeted intervention programme would not only improve the quality of life of 
participants, but would also improve their health conditions and in the long term encourage other 
community members to change their lifestyle and behaviour. 
 
It was hypothesised that a non-pharmacological intervention programme that targeted musculoskeletal 
conditions, and which included exercises, behavioural changes and education, would bring about 
functional improvement and also reduces the impact of diabetes mellitus type II, hypertension and 
obesity. In addition, as many of the intended recipients of such a programme would have co-
morbidities, it was important to include participants in the study who were representative of the clinic 
population. 
 
8.1.1 Aims and objectives 
 
The aim of the sub-study was thus to explore the effectiveness of a non-pharmacological six weeks 
intervention programme for middle aged women presenting with joint pain (musculoskeletal 
conditions). 
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The objectives of the intervention component were to determine whether the six week intervention as 
described in Chapter 7, would result in a significant difference, when compared to the standard of care 
in the following parameters: 
 
 joint pain as measured by the Brief Pain Inventory (Short Form (this was the primary outcome 
measure); 
 health-related quality of life in women with joint pain (musculoskeletal conditions), as measured 
by the EQ-5D-3L; and 
 physical function as measured by the Simmonds battery of functional tests and the six-minute 
walk test. 
Further objectives were to explore the relationship between: 
  joint pain (musculoskeletal conditions) and co-morbidities of individuals as measured by blood 
pressure, body mass index, venous glucose readings and cardiovascular fitness using the three-
minute step test. 
 
Finally we wished to establish the extent to which the intervention programme became integrated 
into the community and the sustainability of the intervention programme after six weeks.   
 
8.2 Methods 
 
8.2.1 Research design 
 
A pragmatic (640), experimental randomised controlled design was adopted to determine the 
effectiveness of usual care against a non-pharmacological intervention programme utilising a workbook 
modified and adapted from existing programmes, for the women identified in the survey.  The trial was 
pragmatic in that it intended to test the impact of the intervention within “a real world” context. The 
pragmatic explanatory continuum indicator summary (PRECIS) tool was developed to reflect the 
continuum from explanatory to pragmatic trials and one of the characteristics of pragmatic trials is that 
eligibility criteria are less rigid. In some cases, there may not even be inclusion and exclusion  
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criteria (24). The implications for this study are that, as many of the target population have both MSC 
and CDL (and or obesity), a programme designed for this context should include participants with co-
morbidities. 
 
8.2.2 Participants 
 
The sampling frame included all women attending the community clinic between the ages of 40 and 64 
years who tested positive on screening for joint pain during the survey described in Chapter 6 and who 
had indicated their willingness to participate in Phase III of the study. Co-morbidities, such as diabetes 
mellitus type II, hypertension and obesity during Phase I (described in Chapter 6) were not exclusion 
criteria.  As it was necessary to contact participants during the course of the study, participants needed 
to be contactable telephonically.  
 
8.2.2.1 Participation criteria 
 
All women attending the community clinic between the ages of 40 and 64 years who met the following 
criteria were eligible for inclusion: 
 Reporting pain, aching, swelling, stiffness (tightness) in or around joints or back which is not 
related to an injury / accident within the last three months (which included the last seven days) 
(Questions 29 a and 29 b in the survey questionnaire). 
 a minimum education level of Grade 4 (typically that of a scholar in their fourth year of primary 
school at approximately 10 years of age) to be able to complete and understand the workbook;  
 able to understand English and /or Sesotho;  
 willing to commit to the intervention for two hours, once a week, for six weeks; and  
 access to a telephone to allow telephonic communication.  
 
Certain CDL and risk factors such as obesity, hypertension and/or diabetes mellitus Type 2, were not 
exclusion criteria and subjects with these co-morbidities were thus enrolled.  
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Exclusion criteria included: 
 other self-reported CDL including cancer, cardio-vascular diseases (coronary heart disease),
stroke, depression and chronic respiratory diseases ;
 an increased risk for participating in exercise,  the latter was determined by screening of
participants and a physical examination performed by a qualified medical practitioner with a
special interest in Community Health;  and
 neurological disorders or being confined to a wheelchair.
8.2.2.2 Screening, randomisation, blinding 
Stratification is commonly used when a researcher wishes a randomly selected sample to be 
representative of the population on some important characteristic of interest (641). This characteristic 
might have a confounding effect on the outcome of an intervention and, in the current study; obesity 
was identified as a variable which might well confound the outcome.  The literature review revealed 
that obesity was commonly co-morbid in hypertension, diabetes mellitus type 2 and, most relevant to 
this study, joint pain (musculoskeletal conditions) (Table 4). In addition, 81% of the survey sample was 
classified as being obese or overweight. As the sample size would be relatively small, the researcher was 
concerned that, despite randomisation, there may have been a preponderance of participants with 
obesity in one or other of the groups. To prevent this, participants meeting the above criteria were 
stratified according to three BMI levels (normal weight, overweight and obese) by the researcher and 
randomisation was done for each group separately. The 187 individuals identified in the survey who had 
indicated their willingness and commitment to take part in the intervention part of the study, were 
randomly contacted.  Eligible women enrolled into the study were then randomly selected by using the 
Microsoft Excel random function to divide the participants into a usual care group (control group) and 
an intervention group.  The randomisation was performed by the researcher.   
8.2.2.3 Sample size 
The researcher invited 187 women to participate.  Ten women were included in the pilot study to 
determine the feasibility and acceptability of the intervention study and the rest of the willing women 
were then included for the implementation of the intervention. 
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The sample size was based on the pain severity score, as this was the primary outcome measure. Pain 
was chosen as joint pain (MSC) was the criterion for inclusion in the study. In addition, previous studies 
using the six weeks exercise and education intervention programme have also demonstrated a 
reduction in pain and improvements in quality of life, and this data was available to utilise for the 
calculation (364)(Table 53).  Therefore reducing pain was a primary target of the intervention.  
 
Table 53: Sample size calculation 
 
Value 
Anticipated mean score at six weeks of control group 5.30 
Anticipated mean score at six weeks of intervention group 3.80 
Standard deviation 2.00 
Significance level 0.05 
Critical Value of t 2.00 
Power Goal 0.80 
Actual Power for Required N 0.80 
Required N (per group) 29 
Statistica Sample Size calculation 
 
A minimum sample of 29 participants in each group was required to achieve an 80% power goal using 
the expected parameters.  
 
8.2.3 Instrumentation 
 
It was anticipated that an effective intervention would lead to changes in lifestyle which would impact 
on the activity limitations and participation restrictions associated with musculoskeletal conditions as 
well as on accompanying chronic diseases.  Blinding was applicable to the research assistants who were 
taking the baseline assessments, venous blood glucose and blood pressure of the participant.  
Measurements were taken at baseline and at six weeks. 
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8.2.3.1 Impairments (including pain) 
 
Random serum glucose levels were determined by a finger prick test.  Random serum glucose levels 
were determined by a research assistant using the method as described in section 6.3.   A level of ≥ 
5.6mmol/L was defined as metabolic syndrome (41)  and a venous plasma glucose concentration of 
greater than 11,1mmol/l, would classify the participant as being diabetic (41, 591, 642). 
 
Blood pressure of participants was determined by a research assistant after a five minute rest in the 
sitting position, according to WHO guidelines using the method as described in section 6.3. 
 
The impact of cardiovascular fitness on function was measured using the Kasch Pulse Recovery test 
which is widely used in clinical settings, and the six-minute walk test (408, 438, 439).  The Kasch Pulse 
Recovery test is scored as the number of heart beats per minute over a period of one minute, the pulse 
rate taken after five seconds after cessation of a three-minute step test.  A lower heart rate indicates 
better cardiovascular fitness (409).   
 
Body weight  of participants were determined by a research assistant using a calibrated electronic digital 
scale (Pure Pleasure code:  TF –SA 10155) accurate to 0.05kg and the height of each participant was 
recorded by the same research assistant to the nearest 0.1 cm using a Seca Leceister 214 portable 
stadiometer.  The measurements for body weight and height were determined using the procedure as 
described in section 6.3. 
 
The Brief Pain Inventory (Short Form) contains three important elements which are not included 
specifically in other pain measurement instruments available.  The first element is generalised questions 
which clarify to the participant that it is normal to experience some form of pain on a regular basis, but 
the aim of the questions is to determine whether the participant has experienced more pain than 
he/she would normally expect.  The second element is the assessment of the impact pain has on various 
functional levels and the last element is to explore the effectiveness of medication through the Pain 
Management Index.  The Brief Pain Inventory (Short Form) is a self-administered questionnaire which 
was initially used in research with the focus on cancer patients, but since it has been validated for use in 
non-cancerous pain (413). The Brief Pain Inventory has been translated into numerous languages 
including Sesotho.  
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8.2.3.2 Functional limitations 
 
The International Physical Activity Questionnaire (IPAQ) was used to monitor the physical activity of the 
participants.  The short form of the questionnaire comprises four generic items.  The questions are 
related to the physical activity of the participants in the last seven days.   Reliability and validity have 
been tested in 12 countries (442, 480).  Pedometer readings were also taken in the intervention group 
to determine whether the physical activity levels of participants increased.  The control group (usual 
care group) did not receive pedometers as the psychological effect of wearing a pedometer on the 
activity levels of participants has been well described in the literature (423). 
 
The six-minute walk test is used to measure the maximum distance that a participant can walk in six 
minutes and is used clinically in determining function in patients with cardiovascular or pulmonary 
diseases.  The six-minute walk test is a useful instrument because of its similarity to normal activities of 
daily living. The test according to Steffen (2002) is a better measure of exercise endurance than maximal 
exercise capacity (409).  Studies have shown good construct validity and good test-retest reliability for 
the test (436, 438, 439). 
 
An exercise/activity diary was included in the generic wellness workbook provided for each participant 
in the intervention group to determine her compliance to the programme and to determine her level of 
activity from baseline measurement to the completion of the study. 
 
The Simmonds battery of functional tests was performed to determine the functional impact the joint 
pain (musculoskeletal conditions) had on the participants.  The performance battery consists of a series 
of nine tasks.  Please refer to Table 31 in Chapter 5 for a detailed description of the Simmonds battery of 
functional tests.  The coin test and the pen-pick up test were not included as participants were fully 
functional and the aim of these items of the test was to determine their arm and lower limb functioning 
(416).  The validity of the Simmonds battery of functional tests has been established in musculoskeletal 
diseases as well as systemic diseases with optimum management predicted (415-417). 
 
The measurements were taken at baseline and again six weeks after completion of the intervention 
study. 
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8.2.3.3 Personal Factors 
Standardised questionnaires were used to determine the health-related quality of life of the participants 
using the EQ-5D-3L and the Brief Pain Inventory (Short form) to determine the impact of pain (See 
Chapter 5 for the description of the translation of these instruments).  The WHODAS 2.0 did not perform 
well during the epidemiological survey and did not display concurrent or divergent validity.  It was thus 
not used as an outcome measure in the intervention component of the study.   
The Self-efficacy for Managing Chronic Disease six-item scale in Sesotho was used to determine the 
efficacy of the education programme (Chapter 5).  The scale has previously been found to be valid and 
reliable for measuring self-efficacy in chronic conditions,  especially in arthritis (488, 490).  
An acceptability questionnaire was designed by the researcher using the available literature to 
determine the attitude of the participants in the intervention group towards the programme (334, 338). 
Five simple questions were formulated asking the participants what they liked most, and/or least about 
the programme, what they would change or add to the programme and whether they liked the self-
management booklet that was developed and modified by the researcher.  
8.2.3.4 Intervention 
The intervention described in Chapter 7 took place for two hours, once a week for six weeks, from 8 
April 2016 to 13 May 2016. Six weeks was chosen as, in addition to the evidence for this duration given 
in 7.2.2, this was to be a pragmatic trial and it was thought unlikely that participants would be prepared 
to attend for much longer than this if the intervention were to be rolled out as part of routine care.   The 
intervention took place during the morning only on a weekday as this was the only time that the 
community hall was available for the study.  
8.2.4 Research setting 
The research setting is described in some detail as, consistent with the ICF framework; environmental 
factors can have a large impact on functioning and disability, both physical and emotional. The 
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community hall where the research was conducted serves ten formal and informal community 
settlements.  Next to the hall is a Secondary school as well as a number of informal spaza community 
shops run from railway metal containers.    The community hall is currently in disrepair.  There are 
broken windows and the entrance door is secured with chains as the hinges have been removed. The 
grounds of the hall are surrounded by barbed wire and the garden has not been cared for in years, with 
plant overgrowth, and the one side has become a rubbish heap for the community.  The surrounding 
little shops built in a half circle around the hall on the same plot are not being used and have been 
vandalised.  The inside of the hall had to be cleaned by the research team before commencement of the 
study due to infestations of rodents and doves.  The researchers transported chairs and tables to the 
venue each time the sessions took place and were also responsible for preparing the facilities for use by 
the participants.   
8.2.5 Pilot study 
The pilot study was conducted at the community hall as this was the only venue available close to the 
clinic for the intervention phase of the study.  Twenty participants were contacted telephonically from 
the master list of the survey to invite them to take part in the pilot study.  Ten participants indicated 
their willingness to participant. Nine of these attended the baseline measurement session and were 
screened and physically examined by a qualified medical practitioner to exclude any risk factors.  The 
screening took place at the community clinic in a treatment cubicle to ensure the privacy of participants. 
All nine participants were declared fit to take part in the three week intervention programme.   
The pilot study took place from 18 February to 4 March 2015.  Baseline measurements were obtained 
for nine participants, but one participant withdrew after the first week due to work commitments.  The 
pilot study was completed on eight participants to determine the feasibility and acceptability of the 
workbook and the intervention programme.  The exact same testing procedures were followed as 
described for the actual intervention.  The results of the pilot study were not included in the results of 
the main study as the pilot study was only conducted for three weeks and not six weeks as planned for 
the intervention. 
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8.2.6 Changes made after pilot study 
After completion of the pilot study the following changes were made to ensure accuracy of 
measurement during the intervention study.  Participants found it challenging to complete the 
questionnaires on their own and this resulted in incomplete questionnaires. Upon reflection it was 
decided that fieldworkers would be trained by the researcher to assist with completion of the 
questionnaires.  Four fieldworkers previously used during the epidemiological survey who were  fluent 
in English and Sesotho were trained regarding completion and understanding of the questionnaires to 
assist in the main study.  Each fieldworker would be assigned to the same participants at baseline and 
again after six weeks to ensure consistency regarding the structured interview.   
8.2.6.1 Self-efficacy six-item scale (SE-6) 
No changes were made to any concepts in the translated version of the self-efficacy six-item scale 
questionnaire.  Minor changes were made to wording, and grammatical errors were corrected in the 
questionnaire.  Unfortunately the time to complete the individual questionnaires was not established 
during the session.   
8.2.6.2 International Physical Activity questionnaires (IPAQ) 
No changes were made to any concepts in the translated version of the International Physical Activity 
questionnaire.  Minor changes were made to wording, and grammatical errors were corrected in the 
questionnaire.  Participants did, however, find it difficult to distinguish between the hours and minutes 
per day that they took part in both vigorous, mild physical activities and sitting activities.  The activities 
were well understood, but they struggled to differentiate between the time frames.  No changes were 
made as the integrity of the standardised questionnaire would then have changed.  Therefore, the 
decision was made that the fieldworkers would clarify the concepts for the participants during the 
completion of the questionnaires.     
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8.2.6.3 Acceptability questionnaires 
No changes were made to the acceptability questionnaire – participants were clear about the concept of 
informing the researcher what they liked or disliked about the workbook and the intervention 
programme.  It was not necessary to determine the time for completion of the questionnaire as the 
questions posed were open-ended questions and were intended to be completed after taking part in the 
intervention and after working through the workbook.   
The physical outcome measures of the study were performed by research assistants trained by the 
researcher to perform the tests, while the fieldworkers assisted participants with the completion of the 
questionnaires.  Blinding was applicable to the research assistants who took the baseline measurements 
of the Simmonds functional tests, venous blood glucose and blood pressure of the participants, as well 
as the fieldworkers who assisted with the completion of the questionnaires.  During the pilot study 
participants could move to testing stations randomly to save time, as some assessments/outcomes took 
longer to complete than others.    Upon reflection it was decided by the researcher that assessment 
stations should be numbered and participants should be instructed to follow the exact sequencing to 
ensure the validity of the battery of tests.  If the sequencing was not the same for all participants it 
would lead to discrepancy of results as some participants would have longer resting period between 
stations that did not require as much physical activity as other testing stations.  After three weeks, data 
of the eight participants who completed the pilot study were obtained.  
 Two exercises were changed after the pilot study.  Two of the exercises posed a danger to participants 
as they had to walk around in a circle and when the music stopped they had to sit on the nearest chair.  
The chairs tended to slip on the surface of the hall and so this exercise was replaced for safety reasons.  
Another exercise involved playing netball against each other in teams as the participants had indicated 
that they enjoyed ball activities.  The two teams however became too competitive and bumped into 
each other which also posed a danger and had to be adapted.   
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8.2.7 Procedure 
 
The study conformed to the principles of the Declaration of Helsinki (643). The trial was registered as a 
clinical trial at the Pan African Clinical Trial registry (PACTR201511000689333) (Appendix 32).  Ethical 
approval was obtained from the Human Research Ethics Committee, of the Faculty of Health Sciences, at 
the University of Cape Town and the Ethics Committee of the Faculty of Health Sciences, at the 
University of the Free State.  (HREC Ref:  605/2013 and ECUFS Nr:  185/2013)  Approval was also 
obtained from the head of the Department of Health in the Free State, as well as the head of the 
community clinic before commencement of the pilot study and execution of the study.   A copy of the 
permission letter for the execution of the intervention study at the community clinic was given to the 
sister in charge of the community clinic as well as the person in charge of the community hall.  The 
person in charge of the community hall received a calendar indicating the days on which the 
intervention was to take place at the community hall.  A flow diagram of the study procedure is 
presented below in Figure 17 and Figure 18.   
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Figure 17: Flow chart of enrolment, screening and data collection process
Baseline Data 
 Questionnaires with fieldworker (EQ-5D-3L; 
WHODAS; SE-6; BPI; IPAQ) 
 Blinded research assistant – blood glucose; 
height; weight; blood pressure; Simmonds battery of 
tests; Kasch Pulse recovery test 
 Screening past medical, surgical history; allergies; 
medication
 Physical examination for oedema, cardio-
respiratory, musculoskeletal 
Telephonically contacted women form master list who indicated 
willingness to participate and met inclusion criteria 
Intervention group (n=22) 
 Provided information document 
 Completed informed consent
Allocation 
Stratified Randomisation according to BMI 
Enrolment 
Control group (n=20) 
 Provided information document
 Completed informed consent
 Screening past medical, surgical history; allergies; 
medication 
 Physical examination for oedema, cardio-
respiratory, musculoskeletal 
Intervention (see Figure 18) 
Baseline Data 
 Questionnaires with fieldworker (EQ-5D-3L; 
WHODAS; SE-6; BPI; IPAQ) 
 Blinded research assistant – blood glucose; 
height; weight; blood pressure; Simmonds battery of 
tests; Kasch Pulse recovery test 
Endpoint data collection 
Screening and baseline information 
Week 6 
 Repeat baseline data 
Week 6 
 Repeat baseline data 
Acceptability 
 Structured interview by research assistant 
Conclusion 
 Gift of “exercise is medicine” t-shirt 
Conclusion 
 Gift of “exercise is medicine” t-shirt 
Provided with workbooks and use explained 
Intervention offered to participants at MUCPP clinic 
under physiotherapy services 
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Figure 18: Flow chart of study intervention 
One week after baseline data collection 
Pedometers issued and set 
Intervention initiated
Week 1: Self-management 
Exercise session 
Educational topics: What is joint pain/high blood 
pressure/diabetes? Being overweight; self-management 
 
Week 2: Exercise 
Exercise session 
Educational topics: Exercise; steps to success 
 
Week 3: Managing common symptoms of MSC 
Exercise session 
Educational topics: symptom action charts 
(pain/stiffness/swelling/activities/tiredness); pacing 
Week 4: Stress Management 
Exercise session 
Educational topics: managing stress; communication with 
your health carer; sleep hygiene 
Week 5: Eating well 
Exercise session 
Educational topics: balanced nutrition; portions; losing 
weight 
 
Week 6: Continuing as a successful self-manager 
Exercise session 
Educational topics: action planning for the future; reflection 
on changes
Baseline information (see Figure 17) 
Endpoint data collection (see Figure 17) 
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All participants who screened positive for only joint pain or joint pain and at least one of the co-morbid 
conditions:  hypertension, diabetes mellitus type II or obesity and who indicated their willingness and 
commitment to take part in the intervention part of the study were contacted telephonically to invite 
them to enrol in the six week intervention programme.    Once their participation was confirmed 
telephonically, the eligible women were randomly divided by the researcher into a usual care control 
group and an intervention group.  After sampling, participants were contacted telephonically from the 
master list to confirm their participation in Phase II of the study.  The intervention group received a date 
and time for screening and a physical examination to exclude risk factors by a qualified medical 
practitioner.    Once all the participants had been cleared for possible risk factors they received a 
calendar indicating the time and dates for the two hour exercise sessions.  An information leaflet 
describing the study was then handed to the participants in their preferred language – English, or 
Sesotho (Appendix 33).  An informed consent form complying with the elements as required by the 
ethics committees was read by, or read to, the participants and signed before completing the 
questionnaire (Appendix 34).   
  
Reminder text messages were sent to all participants to remind them of the date for the baseline 
measures and, in the case where the participant only indicated a landline, the participants were 
contacted telephonically.   
 
Blinding was applicable to the fieldworkers responsible for assisting the participants with the completion 
of the questionnaires including the EQ-5D-3L and the International physical activity questionnaire.  The 
research assistants, who were blinded to which participants were in the control group and intervention 
group, took the venous blood glucose levels, weight, height and blood pressure of participants as 
described under instrumentation (section 8.2.3.1), performed the Simmonds battery of functional tests, 
six-minute walk test as well as the three- minute step test.  The same research assistant performed the 
same test in each instance during the baseline and after six weeks to ensure reliability of the testing 
procedure.  The research assistants were trained by the researcher to ensure that the tests were 
performed according to the procedures as described in the literature.   
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All the measurements were taken in a separate room to protect the privacy of the participants except 
for the Simmonds battery of functional tests, six-minute walk test and three-minute step test that were 
performed in the community hall.  The information was kept strictly confidential but was disclosed to 
the participants. 
At the start of the study an information session was held with participants in the intervention group to 
explain why exercise is important, and also how to use the workbook during the structured education 
classes as well as at home.  Emphasis was placed on goal setting as encouraged by the workbook.   In 
addition all participants received pedometers (model E01758) after the first intervention session, which 
would encourage activity.  The pedometers were individualised for each participant according to the 
manufacturer’s guidelines.  This procedure included entering the weight of the participant as well as the 
stride length of the participant.  The stride length was set in centimetres.  The stride length is seen as 
the distance measured heel to toe as the participant is walking.  The usual care group did not receive a 
workbook or pedometer.  Participants were requested to wear comfortable clothes, suitable for 
exercises during the intervention programme. 
A weekly educational programme, discussion group and exercise class lasting two hours were held for 
six weeks at the community hall for the intervention group, while the control group went about their 
daily lives as usual.  Both the usual care control group and the intervention group were instructed to 
adhere to their medical treatment as usual. The end-point of data collection was after six weeks of the 
intervention programme.   
During the intervention programme sandwiches with a protein filling, fruit and water to drink were 
made available to participants.  This was the first meal of the day for many of the participants.  The 
same sandwiches and water were made available to participants for the control and the intervention 
group during baseline measurements and end point of data collection.   
The control group and the intervention group received a date and time indicated on a calendar to attend 
a session at the community hall for measurements to be taken after six weeks.  All the participants were 
contacted telephonically to remind them of the date and time for the measurements to be taken and 
the day before the endpoint of data collection a text message was also sent to participants to remind 
them of the session.   
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The workbook was offered to the usual care group at the end point of data collection after the six weeks 
of the intervention.    Arrangements were made for the structured programme to continue at the 
community clinic on a weekly basis under the guidance of the community service physiotherapist 
serving the community and the physiotherapy student on the community clinical block.  The 
intervention group was encouraged to continue with the group exercise programme and to invite other 
women to join the group.  The control group was invited and encouraged to join the group and to utilise 
the workbook given to them.  The programme and the workbook were made available to the 
community physiotherapist to utilise for the purpose. 
Participants received no other remuneration other than reimbursement for their travel costs to attend 
the exercise sessions as well as the baseline measurement and endpoint measurements.    
Data were captured by the researcher on an Excel spread sheet, and a second person verified the 
captured data to ensure accuracy before statistical analyses.   
8.2.8 Statistical analysis 
Descriptive statistics were used to describe the demographic characteristics of the participants. An 
Independent t-test (parametric data) or Mann-Whitney U test (non-parametric data) was used to 
establish equivalence between the groups on admission to the study and any difference at six weeks. 
Repeated measures ANOVA were used to explore group and time interactions.  The computer software 
program Statistica (version 7) (StatSoft, Tulsa, Oklahoma, USA) was used for data analysis. 
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8.3 Results 
8.3.1 Enrolment 
Figure 19, is a flow chart which tracks the recruitment and follow-up of the participants. In total 187 
participants were eligible and invited to participate in the study, but on the day of baseline 
measurements 145 participants did not attend despite telephonic contact indicating that they would 
attend.  The remaining 42 participants were randomised into a control and intervention group.  Twenty 
participants were allocated to the control group and 22 participants into the intervention group.   Five 
participants were lost to follow-up in the control group for reasons outlined in the flow chart.  Post-hoc 
analysis indicated no difference in the baseline rank ordering of age (p=0.213), pain (0.824) or self-
reported HRQOL (p=0.081). No attrition bias could thus be detected between those who remained in the 
study and those who were lost to follow-up.   
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Figure 19: Flow diagram of recruitment and retention 
Assessed for eligibility 
(n=1376) 
Stratified randomisation 
(n=42) 
Excluded: 
Too old (n=4) 
Not meeting the inclusion criteria of 
experiencing joint pain (n=569) 
Declined to participate (n=616) 
Other reasons (n=145 did not attend despite 
telephonic contact)  
ENROLMENT 
Allocated to control group 
        (n=20) 
      (n=1 normal weight) 
      (n=2 overweight) 
      (n=17 obese) 
Lost to follow-up (n=5) 
Had to take care of their 
grandchildren (n=2) 
Were out of town (n=1) 
Analysed  
(n=15) 
Lost to follow-up 
(n=0) 
ALLOCATION 
FOLLOW-UP 
INCLUDED IN FINAL COMPARATIVE ANALYSIS 
Allocated to intervention group  
    (n=22) 
         (n=2 normal weight) 
         (n=1 overweight) 
         (n=19 obese) 
Analysed  
(n=22) 
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8.3.2 Attendance 
Table 54, indicates the attendance of participants during the six weeks of the intervention programme. 
The same participant was absent during week two and four while different participants were absent 
during the intervention period.  As can be seen in Table 54 below, one participant attended for four 
weeks, while the rest all attended for either five or six weeks of the six week intervention programme.   
There were thus 16 sessions missed out of a total of 6*22 =132 possible attendances, an attendance 
rate of 87.9% 
Table 54: Non-attendance of intervention programme over six weeks 
Week Number of non-attendance Reason for non-attendance 
1 0 N/A 
2 2 One participant had flu, and one participant 
attended an ophthalmology appointment which was 
made three months earlier. 
3 3 One participant attended her mother’s funeral, one 
was out of town for family commitments, one was 
ill, but did not disclose the nature of her illness. 
4 1 One participant took her elderly mother to the 
diabetic clinic for a follow-up visit. 
5 4 One participant was admitted to hospital after her 
blood glucose levels were too high and she 
complained of visual disturbances; two participants 
had family commitments, one participant did not 
disclose her reason for non-attendance. 
6 4 Two participants had flu, one attended a doctor’s 
appointment due to a urinary tract infection; one 
participant did not disclose her reason for non-
attendance. 
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8.3.3 Comparison of demographic information of the survey participants with joint pain  
(population) and randomised, control trial participants (sample) 
 
The ages of the participants for both the survey and the randomised, control trial (RCT) groups were not 
normally distributed (W = 0.962; p = 0.000 and W= 0.956; p = 0.013 respectively), and non-parametric 
tests were used to compare them. (Figure 20)  The median age of the participants in the survey group 
was 52 years (inter-quartile range (IQR): 46-58 years, and range of 40-65 years).  The median age of the 
participants of the randomised, control trial group was 56 years (IQR: 50-61 years and range of 40-64 
years) and was significantly higher (p = 0.014) than the median age of the survey group.  
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Histogram of age of survey participants with joint pain
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Histogram of the ages of the RCT participants
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(n=854)     (n=41,n=1 missing data) 
*Note that each category includes the upper bounds of that category.
Figure 20: Histogram of the age distribution of the survey and randomised, control trial sample 
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As can be seen  in Figure 20 above,  there were more older people in the randomised, control trial group 
but this was not statistically significant (t=-1.7, p=0.087.)  A considerably larger proportion of the survey 
population lived in houses with four or more occupants. (Table 55) and the difference in proportions 
was significant (Chi-Square=18.71, p<0.001). 
Table 55: Demographic and living conditions of the participants in the survey with joint pain and randomised, control trial 
sample 
Variable Categories Survey 
(n = 854) 
Survey  
percentage 
RCT 
(n = 42) 
RCT 
percentage 
Between Groups 
(Chi-Square test) 
Language Sesotho 586 68.22% 26 62% Chi-square=1.34* 
p = 0.512 Isixhosa 146 17.58% 8 19% 
Setswana 113 13.15% 8 19% 
English 5 0.58% 0 0% 
Afrikaans 1 0.12% 0 0% 
Zulu 3 0.35% 0 0% 
Missing 0 0% 0 0% 
Race African 852 99.77% 42 100% N/A 
Coloured 2 0.23% 0 0% 
Marital Status Married 382 44.47% 14 33% Chi-square=3.68* 
p =0.159 Never married 300 34.92% 18 36% 
Widowed/Separated/Divorced 172 20.61% 13 31% 
House ownership Own 664 77.30% 35 83% Chi-square= 0.37 * 
p = 0.543 Friend/family 186 22.24% 7 17% 
Other 2 0.23% 0 0% 
Missing 2 0.23% 0 0% 
Type of dwelling Brick 717 83.47% 34 81% Chi-square= 0.15 * 
p = 0.699 Informal 132 15.95% 8 19% 
Missing 5 0.58% 0 0% 
Number of residents  
per household 
Three or less 175 20.50% 21 50% Chi-square= 18.71* 
p <0.001 Four or more 679 79.50% 21 50% 
Missing 2 0.23% 0 0% 
Note that frequency of missing data was not included in Chi-Square analysis. 
*Calculation only included cells greater than 5.
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A comparison of the education level and employment status of the two groups (Table 56) indicated that 
the two groups were equivalent, apart from the literacy levels (as per inclusion criteria) and 
employment status. Over 90% of the randomised, control trial group were unemployed compared to 
79% the survey group (p=0.041). 
Table 56: Education level and employment status of the participants in the survey with joint pain and the randomised, 
control trial sample 
Variable Categories Survey 
(n = 854) 
Survey 
percentage 
RCT 
(n = 42) 
RCT 
percentage 
Between 
Group 
(Chi-
Square)t) 
Literacy None 114 13.27% 0 0% N/A 
Read only 19 2.21% 0 0% 
Read/write 720 84.40% 42 100% 
Missing 1 0.12% 0 0% 
Education None/Primary 392 45.90% 16 0% 
Chi-square= 
0.69 * 
p = 0.406 
Secondary/Tertiary 462 54.10% 26 62% 
Current employment status Unemployed/Housewife/Pensioner 671 78.57% 39 92.8%% Chi-square= 
4.14 * 
p = 0.041 
Worker - Full time 183 21.43% 3 7.2% 
Missing 6 0.70% 0 0% 
Reason for unemployment  
(n = 376 and n =33 ) 
Cannot find work 204 54.26% 17 52% N/A 
Health problems 149 39.63% 14 42% 
Family care 16 4.26% 2 6% 
Disabled 2 0.53% 0 0% 
Husband prevents 2 0.53% 0 0% 
Missing 3 0.80% 0 0% 
Receive grant benefits No 608 71.36% 28 67% Chi-square= 
0.21 * 
p = 0.6468 
Yes 246 28.64% 14 33% 
**Type of grant benefits  
(n = 246 and n =14) 
Disability 98 39.84% 5 35% N/A 
Pension 129 52.44% 9 64% 
Disability and pension 13 5.28% 0 0% 
Not known 6 2.44% 0 0% 
Note that frequency of missing data was not included in Chi-Square analysis.   *Calculation only included cells greater than 5. 
**Note that the type of grant is for those individuals who indicated that they do receive grant benefits. 
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In summary, the participants in the randomised, control trial group were older, fewer participants were 
employed and they lived in households with a greater number of inhabitants than the population in the 
survey.  
8.3.4 Comparison of health-related information of the survey group with joint pain and the 
randomised, control trial group 
Table 57: Health variables of the participants in the survey with joint pain and the randomised, control trial sample 
Variable Survey 
(n=854) 
RCT 
(n=41) 
Between 
Groups 
(Wilcoxon 
Two Sample 
test) 
(Z score) 
n Median IQR n Median IQR 
Weight (kg) 851 80.5 65.0 – 93.0 41 93.8 76.3-100.8 p =0.015 
(2.440) 
Height (cm) 850 158 153 – 163 41 156 153.0-159.0 p = 0.067 
(-1.829) 
BMI (kg/m2) 850 32 27.0 – 37.7 41 37.2 31.8-41.9 p = 0.002 
(3.044) 
Haemoglucose (mmol/l) 849 5.5 4.6 – 7.0 41 5.8 5.4-9.1 p = 0.045 
(2.839) 
Systolic BP (mmHg) 849 147 133 – 159 41 143 133.0-155.0 p = 0.305 
(-1.026) 
Diastolic BP (mmHg) 849 91 84 - 99 41 92 84.0-99.0 p = 0.669 
(-0.427) 
(n = 854 and n=41 n = 1 missing data) 
The median weight, BMI and haemoglucose levels of the participants in the survey group were 
significantly lower (p < 0.05) than those of the randomised, control trial group (Table 57). The median BMI 
value of the participants from both the survey and randomised, controlled trial groups fell within the 
classification of being obese, and the proportion of those with obesity in the intervention sample was 
significantly higher (p<.001) (Table 58).  
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Table 58: Health variables of the participants in the survey with joint pain and the randomised, control trial sample 
 Survey 
(n=853) 
Survey 
Percentage 
RCT 
(n=41) 
RCT 
Percentage 
Between Groups 
(Chi-Square test) 
Diabetes mellitus type II* 157 18.41% 11 27%  p = 0.177 
(Chi-square=1.819) 
 
Hypertension** (n=849)  (n=41  n=1 
missing data) 
 p = 0.734 
(Chi-square=1.279) 
Normal 270 32.21% 15 37% 
Stage I 309 36.18% 15 37% 
Stage II  158 18.50% 8 20% 
Stage III  112 13.11% 3 7% 
Obesity*** (n=851)  (n=41  n=1 
missing data) 
 p < 0.001 
(Chi-square=30.74) 
Underweight 13 1.52% 0 0% 
Normal 147 17.19% 3 7% 
Overweight 181 21.17% 3 7% 
Obese 510 60.12% 34 83% 
*Diabetes mellitus type II (non-fasting blood glucose >7.8mmol/L) 
**Normal: Systolic blood pressure 120-139mmHg, diastolic blood pressure 80-90mmHg  
 Stage I hypertension:  Systolic blood pressure 140-159mmHg, diastolic blood pressure 90-99mmHg  
 Stage 2 hypertension: Systolic blood pressure 160-179mmHg, diastolic blood pressure 100-109mmHg 
 Stage 3 hypertension: Systolic blood pressure ≥ 180mmHg, diastolic blood pressure ≥110mmHg 
***Underweight:  BMI < 18.5; Normal weight: BMI 18.5-24.9; Overweight:  BMI 25-30; Obese:  BMI > 30 = 4 
(n= 853 and n=41   n=1 missing data) 
 
 
8.3.5 Comparison of demographic information of the control and intervention groups at 
baseline 
 
The median age of the participants in the control group was 53 years (IQR: 49-58 range) and was not 
significantly different (p = 0.276) from the median age of the intervention group, which was 57 years 
(IQR: 53-61 an) as seen in Figure 21 below. 
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Histograms of the ages of the control and intervention groups
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Figure 21: Descriptive statistics regarding the age of the participants in the control and intervention group 
 (n=42) 
There was no difference in proportions between control and intervention group and any demographic 
or living condition variable, although a larger proportion of the control group spoke Sesotho (75% 
compared to 50%). (Table 59)  In the control group 40% of the participants had never been married 
while, 32% of the participants in the intervention group had never been married.  Over 75% of both 
groups lived in brick houses and owned their own homes. 
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Table 59: Demographic and living conditions of the participants in the control and intervention group 
Variable Categories Control 
(n = 20) 
Control 
percentage 
Intervention 
(n = 22) 
Intervention 
percentage 
Between 
Groups 
(Fisher’s 
Exact tests) 
Language Sesotho 15 75% 11 50% p = 0.285 
 Isixhosa 2 10% 6 27% 
Setswana 3 15% 5 23% 
Race African 20 100% 22 100% N/A 
Marital Status Married 7 35% 7 32% p = 0.671 
Never married 8 40% 7 32% 
Widowed 4 20% 6 27% 
Separated/divorced 0 0% 2 9% 
House ownership Own 17 85% 18 81% p = 1.000 
Friend/family 3 15% 4 18% 
Type of dwelling Brick 15 75% 19 86% p = 0.445 
Informal 5 25% 3 14% 
Number of residents per household 1 1 5% 2 9% p = 0.866 
2 3 15% 3 14% 
3 7 35% 5 23% 
4 2 10% 4 18% 
5 6 30% 8 36% 
6 1 5% 0 0% 
 
The participants in both the control group and the intervention group could read and write, and 60% of 
the participants in the control group and 64% in the intervention group had secondary education (Table 
60).  The unemployment rate in the control group (70%) was significantly different (p = 0.003) from that 
of the intervention group (86%).  The two reasons given by participants in both the control and 
intervention group for unemployment was the inability to find a job and health problems.  A small 
number of participants in both groups received grant benefits.  In the control group 40% received a 
benefit, while 27% in the intervention group received a benefit.  A pension was the type of grant that 
was received by most of the participants who received a benefit, with 88% of the control group and 33% 
in the intervention group receiving the benefit.   
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Table 60: Education level and employment status of the participants in the control and the intervention group 
Variable Categories Control 
(n = 20) 
Control 
percentage 
Intervention 
(n = 22) 
Intervention 
percentage 
Between 
Groups 
(Fischer’s 
Exact test) 
Literacy Read/write 20 100% 22 100% p = 1.000 
Education Primary 8 40% 8 36% p = 1.000 
Secondary 12 60% 14 64% 
Current employment status Unemployed 14 70% 19 86% p = 0.003 
Pensioner 6 30% 0 0% 
Worker - Part time 0 0% 3 14% 
Reason for unemployment 
(n = 14 and n = 19) 
Cannot find work 7 50% 10 53% p = 0.971 
Health problems 6 43% 8 42% 
Family care 1 7% 1 5% 
Receive grant benefits No 12 60% 16 73% p = 0.515 
Yes 8 40% 6 27% 
Type of grant benefits 
(n = 8 and n =6 ) 
Disability 1 13% 4 67% p  = 0.091 
Pension 7 88% 2 33% 
(n=42) 
There was therefore no significant difference between the two groups, apart from the higher 
percentage of unemployed participants and the lower percentage on pension in the intervention group. 
8.3.6 Health-related information 
8.3.6.1 Comparison at baseline 
At baseline there were no differences in the median of the health variables of the participants in the 
control and intervention groups (Table 61).     
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Table 61: Health variables at baseline of the participants in the control and intervention group 
Variable Control Intervention Between Groups 
(Mann  Whitney 
U test) 
n Median IQR n Median IQR 
Weight (kg) 15 99.3 80.1-104.8 22 88.9 76.3-96.4 p = 0.159 
(Z = 1.408) 
Height (cm) 15 157 154-162 22 155 153-158 p = 0.245 
(Z =1.163) 
BMI (kg/m2) 15 38.3 33.5-45.2 22 36.1 31.4-38.9 p = 0.246 
(Z = 1.160) 
Haemoglucose (mmol/l) 15 5.6 5.1-6.1 22 7.3 5.4-10.0 p = 0.246 
(Z =-1.161) 
Systolic BP (mmHg) 15 141 126-159 22 141.5 133-150 p = 0.828 
(Z= 0.217) 
Diastolic BP (mmHg) 15 90 84-99 22 92 83-96 p = 0.865 
(Z= 0.170) 
(n=37) 
8.3.6.2 Comparison at six weeks 
To investigate possible differences within and between groups, the Sign test was used to compare 
median values within groups and the Wilcoxon Two Sided test (also known as the Mann Whitney U Test) 
was used to compare median values between groups. There were no significant within-group 
differences from baseline to six weeks in either group.  In addition, there were no significant between-
group differences at six weeks (Table 62). 
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Table 62: Health variables of the control participants and intervention participants at baseline and after six weeks 
Variable Score Control Group 
(n=15) 
(Sign test) 
Intervention Group 
(n=22) 
(Sign test) 
Between Groups 
(Wilcoxon Two 
Sample Test) 
Baseline After 6 
weeks 
Baseline After 6 
weeks 
Baseline After 6 
weeks 
BMI 
(kg/m2) 
Median (IQR) 38.3 
(33.5-
45.2) 
38.6 
(33.4-44.8) 
36.1 
(31.4-38.9) 
35.9* 
(31.7-
39.6) 
p = 0.246 
Z= 1.160 
p = 0.259 
Z = 1.129 
Median 
difference within 
group (IQR) 
0.0 (-0.7-0.5) 
p = 0.789 
Z = -0.267 
-0.1 (-0.4-0.2) 
p = 0.264 
Z = 1.118 
p = 0.793 
Z = 0.263 
Haemoglucose 
(mmol/l) 
Median (IQR) 5.6 
(5.1-6.1) 
6.0 
(5.3-8.1) 
7.3 
(5.4-10.0) 
6.5 
(5.5-8.3) 
p = 0.246 
Z = -
1.161 
p = 0.599 
Z = -
0.526 
Median 
difference within 
group (IQR) 
-0.4 (-1.2–0.2)
p = 0.121 
Z = 1.549 
0.1 (-0.9-1.7) 
p = 0.831 
Z = -0.213 
p = 0.252 
Z = -1.145 
Systolic BP 
(mmHg) 
Median (IQR) 141 
(126-
159) 
144 
(133-152) 
141.5 
(133-150) 
146.5 
(139-155) 
p = 0.828 
Z = 0.217 
p = 0.687 
Z = -
0.403 
Median 
difference within 
group (IQR) 
-0.7 (-25.0-16.0) 
p = 1.000 
Z = -0.000 
-4.5 (-17.0-8.0) 
p = 0.286 
Z = 1.066 
p = 0.853 
Z = 0.186 
Diastolic BP 
(mmHg) 
Median (IQR) 90 
(84-99) 
90 
(83-94) 
92 
(83-96) 
90.5 
(83-104) 
p = 0.865 
Z = 0.170 
p = 0.988 
Z = -
0.016 
Median 
difference within 
group (IQR) 
1.0 (-6.0-8.0) 
p = 0.789 
Z = 0.267 
-1.0 (-9.0-5.0) 
p = 0.663 
Z = 0.436 
p = 0.556 
Z = 0.588 
Resting pulse 
rate 
(bpm) 
Median (IQR) 71 
(63-79) 
75 
(73-92) 
72 
(63-83) 
76.5 
(68-82) 
p = 
0.8284 
Z = -
0.217 
p = 
0.7806 
Z = 0.279 
Median 
difference within 
group (IQR) 
-3.0 (-13.0-0.0) 
p = 0.061 
Z = 1.870 
0.5 (-13.0-8.0) 
p = 1.000 
Z = -0.000 
p = 0.330 
Z = -0.975 
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Variable Score Control Group 
(n=15) 
(Sign test) 
Intervention Group 
(n=22) 
(Sign test) 
Between Groups 
(Wilcoxon Two 
Sample Test) 
Baseline After 6 
weeks 
Baseline After 6 
weeks 
Baseline After 6 
weeks 
Pulse rate after 
one minute 
(bpm) 
Median (IQR) 88 
(82-107) 
93 
(84-106) 
85 
(77-99) 
91.5 
(84-99) 
p = 
0.5155 
Z = 0.650 
p = 
0.6425 
Z = 0.464 
Median 
difference within 
group (IQR) 
-2.0 (-7.0-3.0) 
p = 0.789 
Z = 0.267 
-0.5 (-11.0-7.0) 
p =1.000  
Z = 0.000 
p = 0.841 
Z = -0.201 
*Note that the body weight of the participants in the intervention group increased but the BMI is reported to be lower.  
This could be due the mathematical calculation of the median in the data analysis software.    
 
To summarise, there was no significant difference between the health variables of the control group 
versus the intervention group at baseline and at six weeks.   
 
 
8.3.7 Health-related quality of life 
 
The quality of life experienced by participants within and between the control and intervention 
group is summarised in  
Table 63.  For detailed information regarding the comparison of quality of life experienced between 
and within the control and the intervention group please refer to Appendix 36. 
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BL=Baseline, 6wks = 6 weeks 
Mob=Mobility, SC=Self care, UA=Usual Activities, P/D =Pain/Discomfort, A/D=Anxiety/Depression 
n=20 at Baseline, n=15 at six weeks  
BL=Baseline, 6wks = 6 weeks 
Mob=Mobility, SC=Self care, UA=Usual Activities, P/D =Pain/Discomfort, A/D=Anxiety/Depression 
None = No problems    Some = Some problems A lot = a lot of problems 
n=22 at Baseline, n=22 at six weeks 
Figure 22: EQ-5D-3L domains in the control and intervention groups 
BL 6wks BL 6wks BL 6wks BL 6wks BL 6wks
Mob SC UA P/D A/D
None 11 12 17 14 13 14 5 5 9 9
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Table 63: Dimensions for the quality of life experienced by participants in the control and intervention group 
EQ-5D-3L 
Item 
Group Time p-value
(within-
groups) 
(Sign test) 
Mean (SD) 
(between groups) 
p-value
(between groups) 
(Wilxocon  Two Sample 
test) 
Mobility Control Baseline p = 0.134 
Z = 1.500 
21.4 (26.4) Baseline: 
p = 0.178 
Z = 1.346 
After 6 weeks: 
p = 0.034 
Z = 2.126 
After 6 weeks 21.2 (15.3) 
Intervention Baseline p = 0.074 
Z = 1.789 
17.4 (26.4) 
After 6 weeks 17.5 (15.3) 
Self-care Control Baseline p = 0.480 
Z = -0.707 
19.2 (12.7) Baseline: 
p = 0.844 
Z = 0.197 
After 6 weeks: 
p = 0.248 
Z = 1.156 
After 6 weeks 19.7 (9.1) 
Intervention Baseline No 
variance 
18.9 (12.7) 
After 6 weeks 18.5 (9.1) 
Usual Activities* Control Baseline 
p = 0.248 
Z = 1.155 
20.5 (24.1) Baseline: 
p = 0.362 
Z = 0.912 
After 6 weeks 
p = 0.248 
Z = 1.156 
After 6 weeks 19.7 (9.1) 
Intervention Baseline p = 0.134 
Z = 1.500 
17.9 (24.1) 
After 6 weeks 18.5 (9.1) 
Pain/Discomfort Control Baseline p = 0.149 
Z = 1.443 
22.1 (29.8) Baseline: 
p = 0.123 
Z = 1.156 
After 6 weeks: 
p = 0.077 
Z = 1.768 
After 6 weeks 22.3 (27.9) 
Intervention Baseline p = 0.043 
Z = 2.021 
16.9 (29.8) 
After 6 weeks 16.7 (27.9) 
Anxiety/Depression Control Baseline p = 0.505 
Z = 0.667 
18.2 (29.9) Baseline: 
p = 0.700 
Z = -0.385 
After 6 weeks: 
p = 0.171 
Z = 1.369 
After 6 weeks 21.4 (25.9) 
Intervention Baseline p = 0.010 
Z = 2.582 
19.5 (29.9) 
After 6 weeks 17.4 (25.9) 
* Usual activities include work, study, housework, family or leisure activities. Note that a positive z score indicates 
improvement and a decrease in the level of problems reported. 
 (Control n=15, Intervention n=22) 
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There was no association between group and score in any of the domains at baseline (Table 64). At 
six weeks the Intervention group reported significantly fewer problems in mobility (p = 0.034). There 
were no significant within-group differences found in the control group, but the intervention group 
improved in the pain/discomfort (p = 0.043) and anxiety/depression domains (p = 0.010). 
Table 64: Comparison of the Index and VAS scores in the control and intervention group 
Control Group 
(n=15) 
(Sign Test) 
Intervention Group 
(n=22) 
(Sign Test) 
Between Groups 
(Wilxocon Two 
Sample Test) 
Baseline After 6 
weeks 
Baseline After 6 
weeks 
Baseline After 6 
weeks 
EQ-5D-3L Index 
score 
Median 
(IQR) 
0.7 
(0.1 – 0.7) 
0.7 
(0.7 – 1.0) 
0.7 
(0.4 – 0.8) 
1.0 
(0.8 – 1.0) 
p = 0.160 
Z = 1.404 
p = 0.019 
Z = 2.344 
Median 
difference within 
group (IQR) 
p-value
-0.3 (0.0 – -0.7)
P = 0.121 
Z = 1.549 
-0.3 (0.0 – 0.-6)
p = 0.010 
Z = 2.593 
p = 0.913 
Z = 0.109 
EQ-5D-3L VAS Median 
(IQR) 
50 
(50 – 50) 
60 
(50 – 80) 
60 
(50 – 70) 
70 
(50 – 80) 
p = 0.055 
Z = 1.918 
p = 0.270 
Z = 1.102 
Median 
difference within 
group (IQR) 
p-value
10 (-10 – 30) 
p = 0.267 
Z = 1.109 
10 (-10 – 30) 
p = 0.823 
Z = -0.224 
p = 0.729 
Z = 0.346 
Note: An increase in scores indicates an improvement in HRQOL 
(Control n=15, Intervention n=22)) 
The median EQ-5D-3L Index scores in both the control and intervention group increased from 
baseline to  six weeks, but this was only significant in the participants in the intervention programme  
(p = 0.010) (Table 64). The intervention group also improved more (from 0.7 to 1.0) and there was a 
significant between-group difference at six weeks (p = 0.019).  
The correlation between the Index and the VAS scores at baseline in all participants was rho = 0.17, 
p = 0.280
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Although both groups showed  improvement in the quality of life VAS score, there was no significant 
difference in the median difference between the control and intervention groups (p = 0.913). As the 
difference in score at baseline approached significance (p = 0.055), the median difference within 
groups was compared and found to be non-significant. 
8.3.8 Self-efficacy for managing chronic diseases 
The Self-efficacy for Managing Chronic Disease six-item scale consists of six items namely fatigue, 
discomfort, emotion, symptoms, tasks and do things,   scored between 0 (not at all confident) and 10 
(totally confident).   A higher score indicates higher self-efficacy. The scale showed good internal 
consistency at baseline with Cronbach’s alpha () at baseline equal to 0.887 (control group:  = 
0.863 and intervention group:  = 0.894) and excellent internal consistency at six weeks after 
intervention with  equal to 0.904 (control group:  = 0.869 and intervention group:  = 0.933).   
The scores, which are numerical, were normally distributed (SW p < 0.05) and parametric statistics 
were used. 
At baseline, scores for all the domains were equivalent. There were significant within-group 
improvements in the intervention group in the fatigue (p = 0.024) and discomfort (p = 0.022) items 
and the difference in fatigue between the two groups approached significance after six weeks 
 (p = 0.053). (Table 65) 
248 
Table 65: Self-efficacy of managing chronic disease of participants in the control and the intervention group 
Managing 
Chronic 
Diseases 
Item 
Group Time Mean (SD) Mean difference (SD) 
and within-group comparison 
(Paired T-test) 
Comparison of mean 
values between 
groups 
(Unpaired T-test) 
Fatigue Control Before 7.0 (3.3) 1.1 (3.5) 
p = 0.262 
t Value = 1.17 
Baseline: 
p = 0.2102 
      t Value = 1.63 
After 6 weeks: 
p = 0.053 
   t Value = 4.005 
After 6 weeks 5.9 (2.5) 
Intervention Before 5.7 (2.7) -1.7 (3.3) 
p = 0.024 
t Value = -2.44 
After 6 weeks 7.5 (2.1) 
Discomfort Control Before 6.3 (3.0) 0.4 (2.3) 
p = 0.510 
t Value = 0.68 
Baseline: 
p = 0.418 
 t Value = 0.673 
After 6 weeks: 
p = 0.156 
 t value = 2.105 
After 6 weeks 5.9 (2.7) 
Intervention Before 5.6 (2.5) -1.5 (2.7) 
p = 0.022 
t Value = -2.49 
After 6 weeks 7.1 (2.2) 
Emotion Control Before 6.7 (2.9) 0.8 (2.6) 
p = 0.258 
t Value = 1.18 
Baseline: 
p = 0.375 
 t Value = 0.807 
After 6 weeks: 
p = 0.236 
 t Value = 1.454 
After 6 weeks 5.9 (2.6) 
Intervention Before 5.9 (2.7) -1.1 (3.2) 
p = 0.144 
t Value = -1.52 
After 6 weeks 7.0 (2.5) 
Symptoms Control Before 6.2 (2.8) 0 (2.5) 
p = 1.000 
t Value = 0.00 
Baseline: 
p = 0.241 
 t Value = 1.421 
After 6 weeks: 
p = 0.734 
 t Value = 0.117 
After 6 weeks 6.2 (2.6) 
Intervention Before 5.0 (3.1) -1.5 (3.8) 
p = 0.078 
 t Value = -1.86 
After 6 weeks 6.5 (2.6) 
Tasks Control Before 7.1 (2.5) -0.1 (3.3) 
p = 0.880 
t Value = -0.15 
Baseline: 
p = 0.400 
t Value = 0.728 
After 6 weeks: 
p = 0.385 
 t Value = 0.774 
After 6 weeks 7.3 (2.5) 
Intervention Before 6.4 (2.6) -0.2 (2.8) 
p = 0.760 
 t Value = -0.31 
After 6 weeks 6.6 (2.1) 
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Managing 
Chronic 
Diseases 
Item 
Group Time Mean (SD) Mean difference (SD) 
and within-group comparison 
(Paired T-test) 
Comparison of mean 
values between 
groups 
(Unpaired T-test) 
Do things Control Before 7.3 (2.3) 1.5 (3.9) 
p = 0.162 
t Value = 1.47 
Baseline: 
p = 0.097 
 t Value = 2.905 
After 6 weeks: 
p = 0.755 
 t Value = 0.099 
After 6 weeks 5.8 (2.8) 
Intervention Before 5.9 (2.6) -0.2 (3.3) 
p = 0.751 
t Value = -0.32 
After 6 weeks 6.1 (2.7) 
Note: An increase in scores indicates an improvement in self-efficacy. 
(Control n=15, Intervention n=22) 
To increase the responsiveness of the Self-efficacy scores, the total was calculated out of 60 as this is 
how the instrument was scored by the designer (426, 495).  The correlation between the EQ-5D-3L 
Index score and the total Self Efficacy scores was r = 0.27; p = 0.082 
There were no significant within- or between-group differences in the overall self-efficacy score 
(Table 66). As the intervention group had a lower mean score at baseline (although not significant, 
p=0.097) , the mean difference between the two groups from baseline to six weeks was calculated 
and found to be significantly greater in the intervention group (p = 0.040).  As can be seen from 
Figure 23 the control group got worse, while the intervention group improved.   
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Note: An increase in scores indicates an improvement in self-efficacy. The error bars indicate the standard deviation 
(Control n=15, Intervention n=22) 
Figure 23: Self-efficacy overall score between control and intervention group 
Table 66: Self-efficacy of managing chronic disease overall score of participants in the control and the intervention 
groups 
Managing 
Chronic 
Diseases 
Group Time Mean (SD) Mean difference (SD) 
and within-group 
comparison 
(Paired T-test) 
Comparison of mean 
values between groups 
(Unpaired T-test) 
Overall 
score 
Control Before 40.6(12.8) -3.6 (12.8) 
p = 0. 296
t = 1.09 
Baseline: 
p = 0.141 
 t Value = -2.27 
After 6 weeks: 
p = 0.387 
 t Value = 0.88 
After 6 weeks 37.7(12.3) 
Intervention Before 34.2(12.5) +6.5(14.8)
p = 0. 055 
 t = -2.04 
After 6 weeks 40.7(12.4) 
Change in 
score 
Control From baseline 
to six weeks 
-3.6(12.8) N/A p= 0.040 
t Value=2.13 
Intervention From baseline 
to six weeks 
6.5 (14.9) N/A 
Note: An increase in scores indicates an improvement in self-efficacy. 
(Control n =15, Intervention n =22) 
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The overall scores for the scale were also calculated as the mean of the six items. The mean overall 
scores of the control group and of the intervention group were similar at baseline (p = 0.141) and after 
six weeks (p = 0.387) as can be seen in Table 66. The mean decrease in the overall score of the control 
group was not significant (p = 0.296). The mean increase in the overall score of the intervention group 
also was not significant (p = 0.055).  
8.3.9 Brief Pain Inventory 
All of the participants in the control group and the intervention group indicated that they had 
experienced pain other than everyday kinds of pain (minor headaches, toothache and sprains). 
8.3.9.1 Sites of pain for the control and intervention group at baseline 
Most of the participants reported pain at more than one site.  At baseline, the most common site of 
pain in the control group was the knee joint (12), followed by the ankle (10) and the hip joint (6). 
Participants reported bilateral pain in 18 joints, which included all peripheral joints. In total, there 
were 52 pain sites. The most common site of pain in the intervention group was the knee joint in 
participants (23), followed by the ankle (15) and the shoulder joint (10). Participants reported 
bilateral pain in 28 joints, which included all peripheral joints. In total, there were 90 pain sites. 
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Table 67: Sites of pain for the control and intervention group at baseline 
Control (n=15) Count (n) 
(%) 
Intervention (n=22) Count (n) 
(%) 
Knee 12 (23.1%) Knee 23 (23.5%) 
Ankle 10 (19.2%) Ankle 15 (16.7%) 
Lumbar 5 (9.6%) Lumbar 6 (6.7%) 
Thoracic 4 (7.7%) Thoracic 8 (8.9%) 
Shoulder 5 (9.6%) Shoulder 10 (11.1%) 
Headache 3 (5.8%) Headache 5 (5.6%) 
Elbow 3 (5.8%) Elbow 7 (7.8%) 
Hip 6 (11.5%) Hip 7 (7.8%) 
Hand 3 (5.8%) Hand 4 (5.5%) 
Cervical 0 (0%) Cervical 3 (3.3%) 
Whole body 0 (0%) Whole body 0 (0%) 
Wrist 0 (0%) Wrist 1 (1.1%) 
Lower limb 1 (1.9%) Lower limb 1 (1.1%) 
Feet 0 (0%) Feet 0 (0%) 
SIJ 0 (0%) SIJ 0 (0%) 
Number of sites 52 (100%) Number of sites 90 (100%) 
At six weeks, the most common site of pain in the control group was the knee joint (9), followed by 
the shoulder (7) and the ankle joint (5).  Participants reported bilateral pain in 28 joints, which 
included all peripheral joints. In total, there were 35 pain sites, whereas the most common site of 
pain in the intervention group was the knee joint (7) participants, followed by the lumbar spine (6); 
the shoulder joint (5) and the wrist joint (5). Participants reported bilateral pain in eight joints, which 
included all peripheral joints. In total, there were 39 pain sites.  The number of pain sites had 
decreased from baseline to after six week for both groups.   
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Table 68: Sites of pain for the control and intervention group after six weeks 
Control (n=15) Count (n) 
(%) 
Intervention (n=22) Count (n) 
(%) 
Knee 9 (25.7%) Knee 7 (17.9%) 
Ankle 5 (14.3%) Ankle 3 (7.7%) 
Lumbar 4 (11.4%) Lumbar 6 (15.4%) 
Thoracic 2 (5.7%) Thoracic 2 (5.1%) 
Shoulder 7 (20.0%) Shoulder 5 (12.8%) 
Headache 0 (0%) Headache 3 (7.7%) 
Elbow 4 (11.4%) Elbow 3 (7.7%) 
Hip 2 (5.7%) Hip 0 (0%) 
Hand 0 (0%) Hand 1 (2.6%) 
Cervical 1 (2.9%) Cervical 2 (5.1%) 
Whole body 0 (0%) Whole body 0 (0%) 
Wrist 1 (2.9%) Wrist 5 (12.8%) 
Lower limb  0 (0%) Lower limb 0 (0%) 
Feet 0 (0%) Feet 0 (0%) 
SIJ 0 (0%) SIJ 1 (2.6%) 
Number of sites 35 (100%) Number of sites 39 (100%) 
          
 (Control n=15 and Intervention n = 22) Please note that the sites of pain are noted per area and not specifically 
for the left or the right side of the body.            
 
8.3.9.1.1 Pain descriptors of the Brief Pain Inventory 
 
Within the Brief Pain Inventory, the Pain Severity Scale was determined using the following four 
items:  pain at its worst in the last 24 hours; pain at its least in the last 24 hours; pain on the average; 
pain participants experience while completing the questionnaire. A higher score on the Pain Severity 
Scale indicates worse or more severe pain. The average pain severity experienced by the participants 
was calculated by dividing the four item scores by four.  This Pain Severity Scale showed good 
internal consistency at baseline and six weeks after intervention with Cronbach’s alpha equal to 
0.801 and 0.895 respectively.  
 
A repeated measure ANOVA, indicated that there was a significant difference between the levels of 
pain reported in both groups and that the difference lay between the worst pain and the other two 
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levels of pain.  The need to test the discriminative validity of the instrument was identified by the 
researcher, to establish if the participant understood the numerical concepts required by the 
instrument.   
F= 22.8, p<.001 n=37 
Figure 24: VAS scores for worst pain, least pain and average pain 
Pain now was not included as there was no expectation that it would be higher, lower or the same, 
whereas the other descriptors were self-evident.   There was no significant within- or between-
group difference in any item, including the mean score for pain severity either at baseline or at six 
weeks (Table 69) apart from a within-group increase in % pain relief in the intervention group  
(p = 0.003)(Figure 25) 
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Table 69: Pain descriptors in last 24 hours between control and intervention group 
Brief Pain 
Inventory 
Group Time Mean (SD) Mean difference (SD) 
and within-group comparison 
(Paired T-test) 
Comparison of 
mean values 
between groups 
(Unpaired T-test) 
Worst pain Control Before 6.5 (2.4) -1.2 (3.2) 
p = 0.170 
t Value = 1.45 
Baseline: 
p = 0.3993 
t Value = 0.85 
After 6 weeks: 
p = 0.8884 
t Value = 0.14 
After 6 weeks 5.3 (3.2) 
Intervention Before 5.9 (2.3) -0.7 (3.6) 
p = 0.387 
t Value = 0.88 
After 6 weeks 5.2 (3.2) 
Least pain Control Before 3.7 (1.7) +0.1(3.9)
p = 0.895 
t Value = -0.13 
Baseline: 
p = 0.4149 
t Value = -0.83 
After 6 weeks: 
p = 0.3470 
t Value = -0.95 
After 6 weeks 3.9 (3.2) 
Intervention Before 4.3 (2.1) +0.5 (3.4)
p= 0.485
t Value = -0.71 
After 6 weeks 4.8 (2.8) 
Average pain Control Before 4.4 (1.6) +0.2(2.5)
p = 0.760 
t Value = -0.31 
Baseline: 
p = 0.5588 
t Value = -0.59 
After 6 weeks: 
p = 0.9661 
t Value = -0.04 
After 6 weeks 4.6 (2.5) 
Intervention Before 4.7 (1.7) -0.1 (2.7) 
p = 0.876 
t Value = 0.16 
After 6 weeks 4.6 (2.6) 
Pain right now Control Before 5.1 (3.3) -1.7 (3.9) 
p = 0.123 
t Value = 1.65 
Baseline: 
p = 0.6305 
t Value = 0.49 
After 6 weeks: 
p = 0.8230 
t Value = -0.23 
After 6 weeks 3.3 (3.0) 
Intervention Before 4.7 (2.4) -1.2 (4.0) 
p = 0.184 
t Value = 1.38 
After 6 weeks 3.5 (3.2) 
Percentage 
pain relief 
with pain 
treatments or 
medication 
Control Before 58.0 (28.3) +12.9 (31.7)
P = 0.153
t value = -1.52 
Baseline: 
p = 0.4723 
t Value = 0.528 
After 6 weeks: 
p = 0.5017 
t Value = 0.461 
After 6 weeks 72.1 (22.6) 
Intervention Before 50.0 (35.2) +31.5 (40.5)
p = 0.003
t Value = -3.45 
After 6 weeks 77.6 (23.9) 
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Brief Pain 
Inventory 
Group Time Mean (SD) Mean difference (SD) 
and within-group comparison 
(Paired T-test) 
Comparison of 
mean values 
between groups 
(Unpaired T-test) 
Mean score 
for pain 
severity 
Control Before 5.0 (1.9) -0.7 (2.7) 
p = 0.328 
t Value = 1.014 
Baseline: 
p = 0.897 
t Value = 0.13 
After 6 weeks: 
p = 0.760 
t Value = -0.31 
After 6 weeks 4.3 (2.6) 
Intervention Before 4.9 (1.6) 0.4 (2.9) 
p = 0.582 
t  Value= 0.55 
After 6 weeks 4.5 (2.6) 
 (Control n=15 and Intervention n = 22) 
Figure 25: Percentage pain relief experienced by control and intervention group 
8.3.9.1.2 Pain interference 
The Pain Interference scale of the Brief Pain Inventory consists of seven items, and these are: 
general activity; mood; walking ability; normal work (both work outside the home and housework); 
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relations with other people; sleep; and enjoyment of life. This interference scale showed excellent 
internal consistency with Cronbach’s alpha () at baseline equal to 0.983 and six weeks after 
intervention with  equal to 0.957. 
 
 
Table 70: Pain interference with activities in the last 24 hours between control and intervention group 
 
Brief Pain 
Inventory 
Group Time Mean (SD) Mean difference (SD) 
and within-group  
comparison 
(Paired T-test) 
Comparison of mean values 
between groups 
(Unpaired T-test) 
General activity Control Before 3.2 (2.7) +0.2 (4.2) 
p = 0.810, 
 t Value = -0.24 
 
Baseline: 
p = 0.342,  
t Value = -0.96 
After 6 weeks: 
p = 0.946 
 t Value = -0.07 
After 6 weeks 3.5 (3.3) 
Intervention Before 4.1 (3.0) -0.6 (5.4) 
p = 0.611 
t Value = 0.52 
After 6 weeks 3.5 (3.5) 
Mood Control Before 4.5 (3.9) -1.5 (5.4) 
p = 0.294 
t Value = 1.09 
Baseline: 
p = 0.620 
t Value = -0.50 
After 6 weeks: 
p = 0.217 
t Value = -1.26 
 
 
After 6 weeks 2.9 (2.8) 
Intervention Before 5.0 (3.1) -0.9 (4.8) 
p = 0.408 
t Value = 0.85 
 
After 6 weeks 4.2 (3.1) 
Walking ability Control Before 3.7 (3.8) - 0.1 (5.9) 
p = 0.965 
t Value = -0.05 
Baseline: 
p = 0.126 
t Value = -1.57 
After 6 weeks: 
p = 0.444 
t Value = -0.77 
After 6 weeks 3.6 (3.7) 
Intervention  Before 5.7 (3.6) -1.3 (5.7) 
p = 0.315 
t Value = 1.03 
 
After 6 weeks 4.5 (3.6) 
Normal work* Control Before 3.4 (3.1) +0.4 (5.6) 
p = 0.816 
t Value = -0.24 
 
Baseline: 
p = 0.179 
t Value = -1.37 
After 6 weeks: 
p = 0.473 
t Value = -0.73 
After 6 weeks 3.5 (3.4) 
Intervention Before 5.1 (3.8) -0.7 (5.9) 
p = 0.597 
t Value = 0.54 
 
 
 
After 6 weeks 4.4 (3.7) 
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Brief Pain 
Inventory 
Group Time Mean (SD) Mean difference (SD) 
and within-group  
comparison 
(Paired T-test) 
Comparison of mean values 
between groups 
(Unpaired T-test) 
Relations with 
other people 
Control Before 3.8 (3.7) -0.7 (5.4) 
p = 0.639 
t Value = 0.48 
Baseline: 
p = 0.404 
t Value = -0.84 
After 6 weeks: 
p = 0.349 
t Value = -0.95 
After 6 weeks 3.1 (3.5) 
Intervention  Before 4.9 (3.8) -0.5 (6.5) 
p = 0722 
t Value = 0.36 
After 6 weeks 4.4 (4.1) 
Brief Pain 
Inventory 
Group Time Mean (SD) Mean difference (SD) 
and within-group  
comparison 
(Paired T-test) 
Comparison of mean values 
between groups 
(Unpaired T-test) 
Sleep Control Before 5.9 (3.4) -2.0 (4.8) 
p = 0.125 
t Value = 1.63 
Baseline: 
p = 0.360 
t Value = 0.93 
After 6 weeks: 
p = 0.613 
t Value = -0.51 
After 6 weeks 3.9 (3.5) 
Intervention  Before 4.9 (3.5) -0.4 (5.4) 
p = 0.752 
t Value = 0.32 
After 6 weeks 4.5 (3.6) 
Enjoyment of life Control Before 3.9 (4.3) -0.9 (5.6) 
p = 0.532 
t Value = 0.64 
Baseline: 
p = 0.359 
t Value = -0.93 
After 6 weeks: 
p = 0.2427 
t Value = -1.19 
After 6 weeks 3.0 (3.1) -0.9 (5.4) 
p = 0.479 
t Value = 0.72 
Intervention Before 5.1 (3.5) -0.9 (5.6) 
p = 0.532 
t Value = 0.64 
Baseline: 
p = 0.631 
t Value = 0.49 
After 6 weeks: 
p = 0.823 
t Value = -0.23 
After 6 weeks 4.4 (3.6) 0.9 (5.4) 
p = 0.479 
t Value = 0.72 
Mean score for 
pain interference 
Control Before 4.1 (2.8) -0.7 (4.7) 
p = 0.548 
t Value = 0.62 
Baseline: 
p = 0.364 
t Value = -0.92 
After 6 weeks: 
p = 0.377 
t Value = -0.90 
After 6 weeks 
3.3 (2.9) 
Intervention  
Before 5.0 (3.1) -0.7 (5.1) 
p = 0.524 
t Value = 0.65 
After 6 weeks 
4.3 (3.3) 
 (Control n=15 and Intervention n = 22) *Normal work includes both work outside the home and housework 
Similar to the pain descriptors, no significant within or between group differences were found with 
regard to the different pain interference items or the total Pain Interference Score (Table 70). 
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8.3.9.1.3 Concurrent validity of BPI 
The concurrent validity of the BPI was tested against the EQ-5D-3L pain dimension. There were no 
significant differences in the mean of the BPI,  pain now,  VAS score across the pain dimension levels 
of no pain, some pain and severe pain in the EQ-5D-3L (F = 2.34, p = 0.108). 
BPI Current Pain per EQ-5D-3L Pain Level
Vertical bars denote 0.95 confidence intervals
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Figure 26: BPI current pain per EQ-5D-3L pain level 
8.3.10 Comparison of International Physical Activity Questionnaire between and within 
the control and the intervention group 
The sample size for the International Physical Activity Questionnaire (IPAQ) data was small (n=18) as 
can be seen in Table 71 below.    In order to calculate the IPAQ categories of physical activity,  
complete data sets are needed and therefore participants were excluded from data analysis if they 
responded to questions with “Don’t know / Not sure”.   Due to the large number of missing 
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responses with regards to the number of days and time, which made it difficult to calculate the 
number of minutes of physical activity per week, analysis was consequently restricted to comparing 
the number of respondents who reported doing vigorous, moderate or low physical activity.  Due to 
missing information, only five participants in the control group and 13 participants in the 
intervention group could be compared at baseline, and after six weeks only four participants in the 
control group and 12 in the intervention group provided information. 
Table 71: Number of participants indicating level of activity between control and intervention group 
IPAQ Group Time Percentage of participants 
p-value
(Fisher’s Exact Test) 
Vigorous 
Control 
Before 60% 
Baseline: 
p = 1.000 
After 6 weeks: 
p = 0.250 
After 6 weeks 75% 
Intervention 
Before 54% 
After 6 weeks 100% 
Moderate 
Control 
Before 20% 
After 6 weeks Missing data 
Intervention 
Before 31% 
After 6 weeks Missing data 
Low 
Control 
Before 20% 
After 6 weeks 25% 
Intervention 
Before 15% 
After 6 weeks 0% 
* Vigorous- vigorous physical activities like heavy lifting, digging, aerobics, or fast bicycling
Moderate - moderate physical activities; like carrying light loads, bicycling at a regular pace, or doubles tennis
Low - walking at work and at home, walking to travel from place to place, and any other walking that you have done
 solely for recreation, sport, exercise, or leisure 
(n=12 intervention group  n=4 control group) 
As the intervention group reported spending 100% of their time on vigorous activity, the validity of 
the IPAQ in this group was questionable.  In addition, the large amount of missing responses further 
raised concerns and this measure was not used in further analysis. 
8.3.11 Pedometer readings 
The participants in the intervention programme were encouraged during the educational sessions 
each week to increase their activity levels and received pedometers to monitor their activity levels. 
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Unfortunately, this was not successful due to participants losing, breaking or resetting the 
pedometers and there was no objective measure to monitor compliance with the set goals.   
 
8.3.12 Comparison of Simmonds battery of functional tests between and within the 
control and the intervention group 
 
The results of the Simmonds Test Battery are in Table 72. There was a significant within group 
difference for all items except for the sit-to-stand in the control group and the belt-tie in both 
groups.  The intervention group performed significantly better at six weeks on the sit-to-stand  
(p = 0.013) and distance walked (p = 0.020) items. However, as the distance walked was significantly 
different at baseline, the change in score was compared and this was not found to be significant, 
with the change in the control group being greater than that seen in the intervention group 
 (t =-0.13, p = 0.890). 
 
Table 72: Simmonds battery of functional tests between control and intervention group 
Simmonds functional 
test 
Group Time Mean  (SD) Mean difference (SD) 
and within-group comparison 
(Paired T-test) 
Comparison of 
mean values 
between groups 
(Unpaired T-test) 
 
Walk normal (sec) Control Before 18.92(2.84) 2.5 (2.3) 
p = 0.001 
t Value = 4.16 
Baseline: 
p = 0.537 
t Value = 0.388 
After 6 weeks: 
p = 0.404 
t Value = 0.714 
After 6 weeks 16.42(2.19) 
Intervention Before 18.31(3.00) 2.5 (2.9) 
p = 0.001 
t Value = 4.09 
After 6 weeks 15.81(2.18) 
Walk fast (seconds) Control Before 13.41(1.27) 1.2 (2.0) 
p = 0.039 
t Value = 2.27 
Baseline: 
p = 0.013 
t Value = 6.94 
After 6 weeks: 
p = 0.120 
t Value = 2.537 
After 6 weeks 12.25(1.90) 
Intervention Before 12.25(1.34) 0.8 (1.0) 
p = 0.001 
t Value = 4.01 
After 6 weeks 11.42(1.28) 
Unloaded reach 
(centimetres) 
Control Before 28.73(7.33) -8.7 (10.0) 
p = 0.005 
t Value = -3.33 
Baseline: 
p = 0.681 
t Value = 0.172 
After 6 weeks: 
p = 0.186 
t Value = 1.8218 
After 6 weeks 37.40(6.40) 
Intervention Before 27.77(6.16) -6.9 (5.6) 
p = <0.001 
t Value = -5.76 
 
After 6 weeks 34.64(5.92) 
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Simmonds functional 
test 
Group Time Mean  (SD) Mean difference (SD) 
and within-group comparison 
(Paired T-test) 
Comparison of 
mean values 
between groups 
(Unpaired T-test) 
Sit-to-stand (seconds) Control Before 2.00(0.39) 0.2 (0.4) 
p = 0.1874 
t Value = 1.39 
Baseline: 
p = 0.064 
t Value = 3.664 
After 6 weeks: 
p = 0.013 
 t Value = 6.840 
After 6 weeks 1.85(0.53) 
Intervention Before 1.74(0.41) 0.2 (0.4) 
p = 0.010 
t Value = 2.82 
After 6 weeks 1.51(0.24) 
Put sock on (seconds) Control Before 10.91(6.56) 2.5 (4.4) 
p = 0.049 
t Value = 2.15 
Baseline: 
p = 0.277 
 t Value = 1.221 
After 6 weeks: 
p = 0.218 
 t Value = 1.574 
After 6 weeks 8.45(4.71) 
Intervention Before 8.91(4.48) 2.2 (3.9) 
p = 0.015 
t Value = 2.64 
After 6 weeks 6.70(3.76) 
Loaded reach 
(centimetres) 
Control Before 19.20(5.49) -12.5 (8.8) 
p = <0.001 
t Value = -5.54 
Baseline: 
p = 0.460 
 t Value = 0.559 
After 6 weeks: 
p = 0.609 
 t Value = 0.267 
After 6 weeks 31.73(6.90) 
Intervention Before 20.91(7.58) -9.6 (7.5) 
p = <0.000 
t Value = -6.01 
After 6 weeks 30.55(6.85) 
Reach up (seconds) Control 
Before 3.80(0.83) 1(1.1) 
- p= 0.003
t Value = 3.66 
Baseline: 
p = 0.774 
 t Value = 0.084 
After 6 weeks: 
p = 0.116 
 t Value = 2.596 
After 6 weeks 2.77(0.73) 
Intervention 
Before 3.72(0.83) 1.3 (0.9) 
p = <0.000 
t Value = 6.60 
After 6 weeks 2.46(0.44) 
Distance walk (metres) Control Before 476.47(80.69) -62.5 (71.3) 
p = 0.004
t Value = -3.40 
Baseline: 
p = 0.020 
t Value = 5.915 
After 6 weeks: 
p = 0.011 
 t Value = 7.312 
Mean difference:  
 p = 0.894 
After 6 weeks 538.93(59.76) 
Intervention Before 534.05(63.18) -59.4 (67.7) 
p = 0.001
t Value = -4.11 
After 6 weeks 593.41(60.43) 
Belt-tie (seconds) 
Control Before 10.60(1.99) -0.6 (4.3) 
p = 0.603 
t Value = -0.53 
Baseline: 
p = 0.065 
 t Value = 3.638 
After 6 weeks: 
p = 0.066 
 t Value = 3.613 
After 6 weeks 11.20(4.16) 
Intervention Before 9.03(2.72) -0.1 (2.0) 
p = 0.871 
t Value = -0.16 
After 6 weeks 9.10(2.54) 
(Control n=15, Intervention n=22) 
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8.3.13 Acceptability 
There was an attendance rate of 87.9% for the six week intervention programme.  Participants were 
asked during a group session what they liked most and least of the programme, as well as what they 
would change about the programme (Table 73; Table 74; Table 75 and Table 76) are indicated 
below.  The responses of the participants were categorised/grouped together.  In some instances if a 
participants responded in the group, other participants indicated their agreement to the statement 
and the data was presented as the total number of participants in agreement with the statement.  
As can be seen from the responses, the participants enjoyed the intervention programme. 
Table 73: What participants liked most about the programme 
Comment Frequency 
“I feel so much better”. 3 
“I do things at home easier like hanging up washing”. 3 
“I enjoyed the exercises with others”. 2 
“I liked coming to the exercises every week”. 1 
“I enjoyed it. 2 
“I made new friends”. 3 
“I don’t know”. 3 
“I am looser – move easier”. 2 
“The dancing”. 3 
Table 74: What participants liked least about the programme 
Comment Frequency 
“Liked it”. 22 
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Table 75: What participants would change in the programme 
Comment Frequency 
“More dancing”. 9 
“More playing with the balls”. 6 
“Like it”. 4 
“Why can you not always come – we want to go on with you”. 9 
“More games”. 4 
“Nothing”. 13 
Table 76: What participants thought about the workbook 
Comment Frequency 
“It helped me”. 6 
“I showed it to my friend”. 2 
“I used it”. 1 
“Don’t know”. 11 
“Too much to read”. 2 
8.3.14 Adverse outcomes 
No harm to participants was experienced during the intervention. 
8.3.15 Summary 
There were 20 participants allocated to the control group, of whom five were not available for the 
six week follow-up.   All 22 participants randomised to the intervention group remained in the study. 
The intervention sample resembled the survey population from which it was drawn, apart from 
being older, with fewer of the women in employment and living in houses with more household 
members. They had a higher haemoglucose score and a higher BMI.   
The demographic data of the control group and the intervention group were equivalent, apart from 
the larger proportion of unemployed participants in the intervention group as well as having fewer 
members on pension in the intervention group.  With regard to health status, there was no 
difference either at baseline or at six weeks between the groups. With regards to HRQOL at six 
weeks, the intervention group reported significantly fewer problems in mobility as well as in 
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pain/discomfort and showed a trend towards fewer problems with anxiety/depression. The index 
score showed significant within-group improvement in the intervention group and, after having 
been equivalent at baseline, was significantly higher in the intervention group at six weeks. The VAS 
improved in both groups, but no significant changes were found.  On the Self-efficacy scale, the 
intervention group showed within- group improvements in the fatigue and discomfort items and the 
difference in fatigue between the two groups approached significance at six weeks.  The change 
from baseline to six weeks in the overall self-efficacy score was significantly greater in the 
intervention group. 
The lower limbs were the most common sites of pain in both groups, and included the knee (most 
reported), followed by the ankle and then the hip.   The number of sites of pain decreased from 52 
sites in the control group at baseline to 35 sites after six weeks, and 90 sites in the intervention 
group at baseline to 39 sites after six weeks.  No difference was found between the groups on any of 
the subsections of the BPI, apart from a within-group increase in the percentage pain relief through 
treatment. There was a lack of concurrent validity between the BPI and the EQ-5D-3L VAS score. The 
IPAQ results were not analysed due to the large number of incomplete responses and the 
questionable validity of the findings.  Within-group improvement was found on most of the items on 
the Simmonds battery of functional tests with the intervention group performing better than the 
control group on the sit-to-stand and the distance walked items. 
The acceptability questionnaire revealed that the participants had all enjoyed the intervention and, 
apart from including more dancing and games, they would not change the programme and would 
like it to continue. The attitude towards the workbook was more ambiguous, with 13 either having 
no comment or reporting that it was too much to read. 
8.4 Discussion 
8.4.1 Introduction 
The aim of the sub-study was to explore the effectiveness of a non-pharmacological six weeks 
intervention programme for middle aged women presenting with only musculoskeletal conditions or 
musculoskeletal conditions and at least one of the following co-morbidities:  hypertension, obesity 
or diabetes mellitus type II.  The main findings of the sub-study were that in general the intervention 
had little effect on the health condition or BMI of the participants. However there was evidence that 
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mobility (including distance walked), pain/discomfort, anxiety/depression and fatigue on the EQ-5D-
3L HRQOL instrument were positively affected by attendance at the class. In addition, the high 
compliance with attendance, 88%, and the positive responses to the Acceptability Questionnaire, 
indicated that the intervention was well received and appropriate for this group of women. Another 
finding is that the numerical scales, such as the VAS of the EQ-5D-3L, the BPI and the IPAQ did not 
perform well and, despite the inclusion criterion of literacy, the participants did not appear to have 
an adequate level of numeracy to respond appropriately. 
8.4.2 Sample 
There was a somewhat disappointing response in the recruitment phase, and many of the eligible 
potential participants did not respond to the recruitment invitation. Although the sample was similar 
in most respects to the population, the larger number of unemployed and older participants in the 
intervention sample, could indicate that those who were younger and in employment were unable 
to make the time available to attend.  The larger household size might also imply that they had 
greater family responsibilities, but these hypotheses are untested.  
Another explanation for the difference between the more unemployed sample and the survey 
population is that social position in society is strongly correlated with the health outcomes of an 
individual.   Individuals from deprived backgrounds experience more disability in their lives (644) and  
a strong positive correlation is found between income, whether a person’s household or individual 
income, and their health outcomes (645). Most of the participants in the intervention group (79%) 
were unemployed.   More than half of the participants (52%) in the intervention group stated that 
not being able to find a job was the reason for their unemployment while 42% indicated that their 
health problems prevented them from being employed.  Therefore, although receiving some 
income, most of the individuals in the intervention could be classified as being in the lower range of 
socio-economic status despite living in brick houses.   
The differences discussed above do not necessarily imply that the results cannot be generalised to 
the survey population as the survey population and the intervention group were similar in most 
respects.  However, the timing of the intervention (e.g. on weekdays and during the day) might be a 
factor that could be altered in the future. If classes were offered outside of working hours, it might 
allow more participants to attend. 
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8.4.3 Health conditions and impairments 
There is ample evidence that exercise has benefits for individuals with chronic diseases of lifestyle 
(114, 332, 646-649). This study did not set out to prove that exercise is beneficial in general, but that 
the intervention programme given, resulted in these benefits.   However, participation in the 
intervention did not result in any health condition advantages, which was unexpected.  The reasons 
are not immediately obvious, but could be ascribed to insufficient exercise dosage due to a lack of 
adherence, environmental barriers and/or the lack of individualised exercise programmes.  The 
dosage of exercise, once a week for 45 to 60 minutes, is too small to bring about physiological 
improvement and the participants might not have supplemented this with increased extra-class 
activity up to the desired 150 minutes per week (650-652).  According to Shephard (1978) as cited in 
Dishman (1985) individuals who perceive their health as being poor are unlikely to adhere to an 
exercise programme and if they decide to do so, they are likely to do as little exercise as possible 
(402, 653). The participants in the intervention programme were encouraged during the educational 
sessions each week to increase their activity levels and received pedometers to monitor their activity 
levels. Unfortunately, this was not successful due to participants losing, breaking or resetting the 
pedometers and there was no objective measure to monitor compliance with the set goals.   The 
IPAQ was also intended to monitor the levels of physical activity, but this too proved to be 
unreliable.   Although the participants did give feedback in the group every week during the 
educational session regarding completion of the goal setting activities in the workbook, this does not 
necessarily imply that participants did comply with the set goals. 
The individuals’ knowledge of, attitude towards and beliefs about their health and physical activity; 
their perceived needs and abilities to perform the activity as well as their environment all influence 
their ability to adopt and maintain physical activity (654).  Although the workbook  addressed the 
educational aspects surrounding activity, environmental barriers might have outweighed the 
individuals’ intention to increase their activity levels (654).   Environmental factors can also hinder or 
facilitate exercise programmes or physical activity (655-658).  Factors such as safety, facilities, family 
and community attitudes, and appropriate equipment (e.g. good walking shoes) might have resulted 
in participants missing their activity targets.   The influence of environmental factors was not 
adequately explored in this study and should be studied further. 
A second consideration is that exercise programmes should be individualised in people with chronic 
diseases of lifestyle  taking into account the individuals’ current fitness levels, choosing the most 
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appropriate practical levels of exercise intensity, duration and frequency of the exercise sessions 
(332, 594).  Therefore,  the way forward might be to not use a  restricted standard programme  
which stipulates 20 minutes or 40 minutes of exercises typically used for improving fitness,  but to 
individualise the programme so that the goals of the individual with chronic diseases are met (332).  
This strategy should be explored in the future, with more targeted exercise programmes being 
developed for individuals.  The disadvantage of this is that developing a more targeted programme 
for each individual would require a greater level of expertise than the simply presenting a uniform 
programme. 
8.4.4 Health-related quality of life 
8.4.4.1 EQ-5D-3L Domains and index score 
As reported in many studies of community dwelling participants, the most commonly reported 
problems were in the anxiety/depression, pain/discomfort, mobility and performing usual activities 
domains (406, 659-661).  The high number of participants reporting pain was as per the inclusion 
criteria, but 11 participants in the control and 14 in the intervention group (59.5%) reported 
problems with anxiety/depression. These figures are higher than the anxiety/depression 
experienced by isiXhosa speaking individuals living with a disability in an urban population (16.9%) 
and rural (2.1%) (659), while being slightly fewer than the 63.5% in the socially and culturally diverse 
suburb of Woodstock in Cape Town (661).  The reason for the differences in reported 
anxiety/depression could be due to socio-economic circumstances of the specific community.   It is 
noteworthy that the intervention resulted in a large decrease in the numbers reporting problems 
over the course of the study.   This decrease is reflected in the significant improvement in the EQ-5D-
3L Index score. 
In contrast to the articles reviewed in Chapters 3 and 4, which did not report significant 
improvements in HRQOL, the intervention group reported a significant improvement in the EQ-5D-
3L Index score.  Whereas both groups reported a median score of 0.7 at baseline, the intervention 
group increased to 1 over the course of the study, whereas the control group remained the same. 
This is a clinically significant change as the Index score represents a Quality Adjusted Life Year 
(QALY).   An improvement of 0.3 QALY implies that the intervention group gained almost one third of 
a year of healthy life, provided that the benefit of the intervention does last for one year.   To put 
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this QALY gain into perspective, the National Institutes of Health Care and Excellence of the United 
Kingdom (NICE), which uses the EQ-5D-3L index to calculate the cost-utility of different 
interventions, suggests that £20,000-£30,000 is a reasonable amount to pay per QALY (662, 663). 
The gain of the intervention group would justify the expenditure of approximately £7,000 or  
R150 000 at current exchange rates.   Although obviously the threshold cost of a QALY gain in a high 
income country, such as the United Kingdom, would be far higher than in South Africa, the gain in 
HRQOL in the intervention group is clearly considerable.   Further cost-utility analysis is 
recommended to determine what the actual cost of the intervention offered was, but this was 
beyond the scope of this particular study. 
8.4.4.2 EQ-5D-3L VAS 
Although the median health score of the control and the intervention groups improved from 
baseline to after six weeks, the EQ-5D-3L VAS did not demonstrate greater improvement in the 
intervention group.   The median scores were low, 50 to 60, even when compared to similar groups 
in South Africa.   The mean EQ-5D-3L score for individuals living with HIV in the high-density suburb 
of Khayelitsha, in Cape Town was 60.4 (664); in  a resource-poor community in the Western Cape 
61.7 before HAART treatment (30) and 66.1 in isiXhosa-speaking individuals with disabilities in a 
rural community and 60.3 in an urban community (659).  According to Deaton (2008,) people in high 
income countries are more likely to be satisfied with their health and they become less satisfied with 
their health with age.  The rate at which health satisfaction decreases with age is greater in low and 
middle income countries like South Africa.  It seems that income provides some protection against 
the effect of aging on self-perceived health.  Individuals between the ages of 50-59 years are less 
satisfied with their health even in more affluent countries (665).   The median age of the control 
group of the present study was 56 years, and for the intervention group 52 years, which would fall 
within the boundaries of the above-mentioned age group.  The possible reason  for this age group 
experiencing less satisfaction with their health is that the group might be particularly intolerant of 
the first signs of aging (665).  As mentioned above, the median health score for the rural sample in 
the study of Jelsma et al., (2007) was 66.1 and for the urban sample slightly lower at 60.3 (659). The  
lower scores in the present study  could be attributed to the different cultures, and also the 
differences in the age groups of the two studies as well as the study conducted by Jelsma et al (2007) 
including males (659).   
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However, the validity of the VAS is somewhat questionable in this context.   Forty two percent of the 
respondents scored 50 on the scale, which may indicate a lack of understanding of what the scale 
represents. In addition, concurrent validity was poor as there was no correlation between the EQ-
5D-3L Index and the VAS scores.   The validity of the isiXhosa versions of both the WHODAS-2 and 
the VAS of the EQ-5D-3L was established in an urban, under-resourced area (406, 466), in Cape 
Town. However, both appeared to lack concurrent validity in the current group of participants and 
this is discussed further below.    
 
8.4.5 Self-efficacy  
 
The Self-efficacy scale did perform better than the EQ-5D-3L VAS but there were some aspects that 
require caution.   The internal consistency was high and there was a trend towards correlation with 
the EQ-5D-3L Index score.   However, there was some clustering around mid-scores (5 for individual 
scores and 30 for the total) and full scores (6 for individual and 60 for the total).  
 
The standard deviations of the mean scores were high and no within- or between-group difference 
was noted.   Nevertheless, the amount of change in the intervention group was found to be 
significantly greater than in the control group.   Self-efficacy plays an important role in the 
management of a chronic disease and it has been found that there is a correlation between self-
efficacy and pain in musculoskeletal conditions such as low back pain, rheumatoid arthritis and 
fibromyalgia as well as other chronic diseases including diabetes mellitus (23, 335, 426, 440, 487-
490).  According to the model of Bandura, self-efficacy is obtained by an individual through five 
sources:  information, vicarious experience, verbal encouragement and persuasion, accomplishment 
of certain goals or activities and finally the physiological state of the individual (485).   Bandura also 
states that “the more dependable the experiential sources, the greater are the changes in perceived 
self-efficacy”(485).  Therefore, the combination of the workbook based on self-efficacy theory (22, 
334, 428, 619) in addition to the intervention programme, improved the self-efficacy of the 
intervention group.   
 
There is a definite shift in responsibilities of the day-to-day management of chronic diseases away 
from the health care professional to the individual living with the chronic disease (619).  Self-
management and self-efficacy may be the mechanisms to bridge the gap between the patient’s 
needs and the capacity of the present health system services to meet the needs of the individuals 
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living with chronic diseases (619).   The emphasis on training self-efficacy as a key component of the 
intervention could be introduced into other health promotion programmes within a similar 
population. 
8.4.6 Chronic pain 
The intensity of chronic pain is linked more with emotional and psychosocial factors than with the 
pain intensity itself (666).  An important role is played by depression and anxiety in the reporting of 
pain intensity and the higher the pain intensity the bigger the role that is played by the anxiety 
experienced by the individual (667).   Therefore,  the impact of pain on the quality of life or 
participants should be considered rather than the pain intensity when treatment for pain is assessed 
clinically or in research (668).   It is suggested that the intensity of chronic pain should be interpreted 
in the light of other outcome measures such as quality of life and satisfaction with the treatment,  
which in the case of the present study is, the intervention programme (669).   As the HRQOL index 
showed improvement and the satisfaction with the intervention was high, it would be expected that 
the pain would decrease over the six weeks.   Disappointingly, the Brief Pain Inventory did not 
observe any decrease in pain severity or in pain interference with function in the intervention or the 
control group.  
It could be that the intervention did not have an influence on the pain reported, but,  as the EQ-5D-
3L pain/anxiety domain showed a significant improvement in the intervention group and the 
number of sites of pain decreased from 90 to 35, this was unlikely.  It would also be surprising that 
the percentage reporting pain relief in both groups increased from approximately 55% to 75% in 
both groups in the absence of any improvement in pain.   Another explanation for this result is that 
the participants were insufficiently numerate to respond appropriately.  This is partially supported 
by the large number of respondents who chose the mid-point of 5 (16-30%), but refuted by the 
repeated measures ANOVA which did indicate appropriate differences between the scores of the 
different levels.  
The model upon which the intervention was based,  is that individuals should decrease their 
attempts to control or avoid pain and instead focus on living life to the fullest.  They should  
participate in activities that they enjoy and pursue personal goals despite pain, which could have 
been emphasised more during the intervention programme (670).  It is possible that with education 
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the pain intensity and pain interference of the intervention group could decrease further over time 
as it was emphasised to the participants in the intervention group that they should increase their 
physical activity levels.  However, as noted in Section 8.4.3, the commitment to activity outside of 
the weekly sessions was not measured and lack of compliance with this aspect of the programme 
might have been responsible for the poor outcome with regard to pain relief.  
In summary, the effect of the intervention on pain, as measured by the BPI, is not clear, as the BPI 
failed to capture the results seen with the EQ-5D-3L VAS. 
8.4.7 Functional impact 
Of interest was the fact that the participants in both groups showed an improvement in function 
over the course of the six weeks in almost all the items of the Simmonds battery of functional tests.  
The only item in which the intervention group performed better was the sit-to-stand item.   
Although sit-to-stand was not specifically included in the intervention programme, half squats and 
lunges were included which potentially strengthened the leg muscles of the participants which could 
have led to the improvement in the sit-to-stand item.  The problem of inadequate monitoring of 
extra-sessional physical activity has been discussed previously and an inadequate increase in 
exercise dosage might be the reason that no impact was noted (652).  As previously stated, at least 
150 minutes per week of moderate-intensity physical activity or 60 minutes of vigorous intensity 
aerobic activity (651), is necessary to bring about health benefits for an individual.   
8.4.8 Behavioural changes 
Although there was improvement in certain outcomes in the individuals after the six week 
intervention programme, the changes were not significant.   A systematic review and meta-analysis 
examining the effectiveness of behavioural interventions targeting diet and physical activity in low-
income adults found that the interventions had a small positive effect on behaviour (671, 672).  
Most of the studies included in the review primarily targeted women and the interventions were 
often delivered by a healthcare professional.  The analysis of the variation in physical activity studies 
in the review, showed a trend towards studies being more effective if a single behaviour change was 
targeted, rather than two behaviours.  This substantiates the argument that human self-regulation 
draws on limited resources which might be best applied to one single behavioural change at a time 
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(671, 672).   As more than one behavioural change was targeted in the intervention programme used 
in the present study, this may have led to a reduced impact.   In future studies it is suggested that 
one behavioural change be targeted at a time.  As the workbook was used to facilitate behaviour 
changes, the researcher also explored the readability of the outcome measure questionnaires 
utilised in the study as well as the readability of the workbook to explore whether this could have an 
influence on the outcome measures (See Chapter 6, Development of the Intervention).  
The most important consideration for the present study is that the questionnaires and the workbook 
were translated into Sesotho and the participants were language proficient in Sesotho and 
consequently the Flesch Reading Ease formula which only calculates the reading difficulty in English 
is only an indicator and not a predictor of the difficulty level of the reading material of this study.  In 
the questionnaire on acceptability of the intervention, more than half of the respondents were 
ambivalent regarding the use of the workbook.  It is suggested that the contents and layout of the 
workbook be refined further to meet the requirements of participants with low levels of literacy. 
More use of pictorial material and less content should be explored in the future and subjected to 
further validation and cognitive debriefing. 
8.5 Acceptability and feasibility 
Both the attitudes of the peers in the exercise class as well as the attitude of the research assistants 
during the entire six weeks intervention programme may have contributed to the compliance of the 
participants to attend the weekly exercise programme and could have contributed to the improved 
HRQOL detected.  The physical environment may also influence the exercise programme including 
the weather, the convenience of the exercise setting and the actual geographic proximity of the 
facility to home (673).  The issues of environmental  barriers was minimised in the current study in 
that the facility utilised for the intervention programme was centrally located, within walking 
distance for most of the participants or easily accessible via taxi.  An ethical consideration taken into 
account during the study was that participants received taxi money in advance each week to ensure 
that they would be able to afford to attend the next exercise session the following week.  The time 
of year and time of day of the exercise programme was ideal as the summer months and winter 
months in the Free State are accompanied by extreme temperatures that could have influenced the 
joint pain that the participants were experiencing.   
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The feedback received regarding the sessions was consistently positive. The importance of including 
culturally acceptable and enjoyable items in the programme (634), such as dancing, was highlighted. 
Despite a lack of improvement in the impairment and functional measures, the participants 
perceived their HRQOL to have improved considerably, as measured by the EQ-5D-3L Index score. It 
is also possible that their Self-efficacy improved through the education sessions and the interactions 
with their peers. 
As discussed above, the attitude towards the workbook was not so positive and the content and 
structure might need to be revisited for future use.  On a positive note is that the feedback regarding 
the group sessions were something the participants liked and they perceived the outcome as good. 
8.6 Strengths and limitations of the study 
The major strength of the study is that it complies with the STROBE statement checklist (674) of 
items that should be addressed during randomised controlled trials. The checklist will be used to 
critique the study.  The full STROBE statement checklist is attached as Appendix 37. The major 
weaknesses, including a smaller sample size than anticipated and the questionable validity of some 
of the outcome measures, are discussed. 
8.6.1 Strengths 
The strengths of study when analysed against the STROBE statement checklist are described. The 
scientific background and the explanation of the rationale for the study are provided, with the aim of 
the study as well as the objectives of the study being listed.  The trial design is described and no 
changes to the methods were made after the trial commenced. Changes made after the pilot study 
are described and explained. The eligibility criteria for participants as well as the settings and 
locations where the data was collected are described in detail.  The intervention for each group is 
described either in the text or provided as an appendix to allow replication, including how and when 
the intervention was performed.  Information about how and when outcomes were assessed is 
provided.  Changes made to the trial outcomes after the trial commenced, with reasoning are 
identified.  Calculation of the sample size is shown and as no interim analyses and stopping 
guidelines were applicable during the study, no mention is made of this criterion.    
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The randomisation process is described in full as well as the allocation and the concealment 
mechanisms.  The implementation method as well as the blinding after assignment is also discussed.  
Statistical methods used to compare the groups as well as the intervention with the survey 
population are listed.  Baseline data as well as data after six weeks are set out in the results section.  
The numbers analysed for each group as well as number of participants are included in the results.  
No harm to participants was experienced during the intervention and therefore none is mentioned 
in the reporting of the study.  Limitations, generalisability as well as interpretation of results are 
discussed.  The registration number and name of trial registry is provided.  Sources of funding and 
role of the funders is mentioned under acknowledgements.   
 
8.6.2 Limitations 
 
A fundamental limitation to the study was the small sample size. Individuals from low-income groups 
are more difficult to recruit successfully to interventions and therefore the small sample size is not 
unique to the present study (675-677).  The sample size was calculated using data from a similar 
study in a primary health care clinic (PHCC) in Cape Town with a target of 37 women in each group.   
The calculated sample size was not reached in the study despite numerous attempts during 
enrolment to increase the number of participant willing to participate in the study. Ultimately only 
42 participants were randomised into a control and intervention group.   A further five participants 
were lost to follow-up in the control group. The study was thus underpowered and in some cases a 
Type 2 error might have occurred. 
 
A further limitation resulting from the small sample size is the validity of performing repeated 
statistical analyses on a small data set as has been done in this study.  
 
Although the participants showed commitment towards the intervention programme, and adhered 
to the workbook, there is no certainty that the participants committed themselves to their set goals 
as determined by themselves in the workbook.  The increased levels of physical activity would have 
been verifiable if the pedometers which were to be used by participants had not been lost, re-set or 
broken.  Therefore the researcher had to rely on self-reporting of the participants regarding their 
increased physical activities during the week.   The accuracy of self-reporting of physical activity is 
affected by socio-demographic characteristics of the individuals and gender, with females not 
reporting their physical activity levels accurately (678).  In addition, physical activity self-reporting is 
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not as accurate amongst obese individuals, with these individuals tending to over-report their 
physical activity (678-682).   
The amount of physical activity between sessions was not monitored as the use of pedometers was 
not feasible and the IPAQ was not a reliable measure in this group.  The lack of a measure of physical 
activity is a major weakness of the study. It is not possible to determine whether the small or 
negligible effect size for improvement in impairment, activity limitation and participation restriction 
(including HRQOL) was due to non-compliance or a lack of impact of physical activity.  The 
researcher did not enquire about exercise participation during the survey and subsequently it was 
impossible to quantify how the intervention participants performed in relation to the survey 
population.  Future studies will need to identify more appropriate outcome measures for physical 
activity. 
Another limitation was the basis of categorising people as having/not having joint pain, due to the 
specific wording of the questions in the questionnaire. Although these questions were based on the 
COPCORD questionnaire, the definitions should have been clearer and the inclusion criteria had 
been better defined.  Smaller exercise groups might also have yielded better results as the relatively 
large size of the group (n=22) might have impacted on group dynamics during the intervention.  
The lack of a longer follow-up is a further weakness of the study which should be remedied in future 
studies. 
As raised earlier in the discussion,  it appears that human self-regulation draws on limited resources 
which might be best applied to one single behavioural change at a time, for example increasing 
physical activity levels, rather than addressing more than one behavioural change as in the present 
study (683).  The analysis of the variation in physical activity studies in the systematic review, 
showed a trend towards studies being more effective if a single behaviour change was targeted, 
rather than two behaviours.   
An unexpected limitation of the study was that the outcome measures used did not perform well 
and lacked concurrent validity. The items which were less complex and relied on categorisation, such 
as the EQ-5D-3L domains performed well, but the validity of the numeric scales, such as the VAS and 
BPI was questionable.  The concept used in the questionnaires could have been foreign to a 
population that is naive to research; especially evaluative questions regarding their health and 
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physical activity levels.  Despite the fact that the questionnaires were translated into Sesotho, and 
both cognitive debriefing and  a pilot study were undertaken, the results indicate that numerical 
concepts and scales which utilise fine distinctions, such as mild, moderate, and severe,  are not well 
understood by all participants (Cf the WHODAS 2, discussed in Chapter 6).  This could have 
influenced the results of the study and therefore it is suggested that a future study should be 
conducted to determine the validity and reliability of the questionnaires in the Sesotho culture 
before these measurement tools are used in further research.   
The poor performance of the outcome measures utilising numbers, for example the EQ-5D-3L VAS 
and the Brief Pain Inventory,  suggests there might be a discrepancy between the numeracy levels of 
populations for which the questionnaire was initially developed and the population of the present 
study.  No evidence could be found regarding the numeracy skills of an older population in South 
Africa.  However, it is evident that poor numeracy and literacy skills are of grave concern in South 
Africa (684, 685).   
The data of the study is not generalisable to the general population at large but rather only to the 
clinic population, which introduced a recruitment bias to the study.  A population based survey 
would have been a better design but given funding and time constraints a convenience sample in the 
clinic was utilised and therefore introduced the potential recruitment bias to the study.   
It would have been ideal to monitor the activities external to the study which might have influenced 
the outcome.  Housework, additional physical work and other factors may have influenced the 
outcome but were not controlled. However, as this was a pragmatic trial, based in the community 
with clinic participants, it would not have been possible to prevent the participants from carrying out 
activities which might have confounded the results.  It is hoped that the randomisation process 
would have resulted in similar confounding activities in both groups but this was not monitored. 
Thus a limitation of the study was that these activities were not identified or documented. 
8.7 Conclusions and Recommendations 
This was a pragmatic study with several flaws, including a smaller sample size than planned and 
concerns about the validity of the outcome measures which relied on numerical literacy.  It may thus 
be useful to regard it as a pilot study for a larger, multi-centre intervention.  However, the following 
conclusions have been reached.  The intervention improved the HRQOL of the participants and 
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significantly increased their index score.  It may have resulted in improved Self-efficacy, particularly 
with regard to the management of fatigue, discomfort and the overall score.  It may have resulted in 
a decrease in pain as evidenced by the reduction in the EQ-5D-3L domain of pain/discomfort, the 
number of pain sites and the increased percentage pain relief in the BPI.   
In light of the above, the intervention would appear to have promise and further investigation 
appears to be warranted.  The following recommendations are thus proposed. 
8.7.1 Recommendations for clinical practice 
The positive response to the programme and the high compliance with attendance indicate that 
there is a place for group-based interventions incorporating physical activity and health education 
within the primary health care setting.   In addition, the impressive increase in QALYS suggests that 
the programme may well be cost effective.  The low recruitment rate which favoured unemployed, 
older women might require that the timing of the intervention be examined, and late afternoon or 
weekend classes might have a greater uptake.  
The clinic staff should be more involved in the management of CDL and especially MSC by screening 
patients for these conditions and by ensuring that the patients are referred to physiotherapists for 
appropriate management by means of community-based intervention programmes and workbooks.  
Physiotherapists should actively participate in the development of appropriate methods of 
intervening at community level through the medium of primary health care clinics, and by doing so, 
reduce the risk of being side-lined and confined to practice within secondary or tertiary institutions, 
as this may negatively impact on the functioning and quality of life of those individuals with MSC 
who are unable to access therapy.  Establishing a quality primary health care service will ensure a 
comprehensive response to a growing health care burden, especially in resource-poor settings and 
may have a potential economic impact.   
The lack of effect on impairment and health condition needs to be addressed and more frequent 
sessions over a longer period of time (e.g. six months) may result in an improvement in these 
parameters.  In addition, a multi-professional intervention may be the way forward, where the 
dietary sessions are managed by a dietician and the self-management skills by a psychologist.  It is 
also important to recruit local community health workers as peer trainers, who could run the 
sessions in Sesotho and who have a good understanding of the local culture. The role of the 
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Physiotherapy Department of the University of the Free State could also be expanded to give 
students exposure to community-based interventions, especially at primary health care clinics. 
8.7.2 Recommendations for policy 
The study has provided enough preliminary evidence to show that resources need to be allocated to 
the non-pharmacological management of joint pain and co-morbidities. Physiotherapists as well as 
community based staff need to be employed to further develop, test and implement similar 
programmes at different clinics. The QALYs gained are an indication that the programme may be 
cost-effective and the health authorities should be encouraged to undertake cost utility analysis of 
an intervention, modelled on the current programme, but modified in light of the limitations of this 
study. 
8.7.3 Recommendations for further research 
Despite the rigorous translation of the questionnaires from English to the target language Sesotho, it 
seems that participants in the study experienced difficulty with certain constructs used in the 
questionnaires, especially in the Brief Pain Inventory short form.   It is therefore recommended that 
cultural inferences regarding pain are explored in the Sesotho culture by means of qualitative data.  
It is also recommended that the validity and reliability of all self-reported measurement tools be 
tested within the Sesotho cultural context before the translated measurement tools are used in 
further research.  Further, the validity of self-rated health should be explored within physiotherapy 
intervention studies and specific populations groups within the South African context.  In particular 
the impact of lower levels of numeracy on validity needs to be examined. 
It is recommended that a process of questionnaire familiarisation be followed with all participants 
before commencement of baseline measurements.  This would ensure that participants are familiar 
with what is expected of them especially in populations where participants are naive to research and 
evaluative research questions.  Some of the changes reported could have been as a result of 
familiarisation with the questionnaire rather than actual change. 
Further research should be conducted on the effects of medication on exercise adaptability during 
intervention programmes designed for individuals living with chronic disease of lifestyle. This is 
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particularly relevant in the primary setting where individuals do not always receive their medication 
due to financial constraints experienced by the local governments.   The impact of activities outside 
of the intervention context which might impact on the outcomes should be monitored. 
A focus for future work should be an economic evaluation of the specific intervention programme in 
a primary health care clinic compared to other interventions for individuals living with joint pain, 
especially due to the financial constraints experienced by the local governments. 
Finally, it is recommended that a large multi-centre trial of a modified intervention based on the 
current workbook and content be undertaken. The questionnaires would need to be validated as 
discussed above. Aspects which need to be modified include the length and content of the workbook 
and the incorporation of adequate monitoring of extra-sessional physical activity to ensure sufficient 
dosage of exercise.  
8.7.4 Conclusion  
It is important that health care professionals as well as policy makers should explore and improve 
interventions, to empower groups of disadvantaged people who are often neglected by the health 
system.  These interventions should attempt to change the individuals’ health behaviours and 
reduce the existing health inequalities.  Establishing a quality primary health care service will ensure 
a comprehensive response to a growing health care burden; especially in resource-poor settings and 
in the long term may have a potential economic impact on health care in South Africa.   
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9 CONCLUSIONS AND RECOMMENDATIONS 
9.1 Introduction 
The study was undertaken to develop and ultimately test a non-pharmacological intervention which 
included exercise and health education for women with MSC attending a clinic in a poorly resourced 
area of the Free State in South Africa. In pursuit of this aim, several sub-studies were undertaken to 
inform the development of the intervention. This final chapter discusses the extent to which each of 
these sub-studies met the stated objectives and how the results influenced the decisions made with 
regard to the intervention programme. 
9.2 Preparation and development of the intervention 
The first sub-study aimed to establish the prevalence and nature of musculoskeletal conditions 
within the target population of adult middle-aged women. The prevalence of joint pain, experienced 
in either the short or long term (within the last three months) was high in the target population 
(62.1%).  It was found that for the majority of the participants the joint pain typically had been 
present for over a year and was most intense after activity or after sleeping or resting.  They had also 
experienced joint pain within the previous three months at severe to very severe levels and 
experienced joint stiffness that lasted more than 30 minutes, in the mornings.  This pain diminished 
with activity.  Most of the participants used over the counter medication to manage their joint pain.  
The results indicated that the majority of participants with joint pain (musculoskeletal conditions) 
were also living with hypertension, a small number of participants with joint pain (musculoskeletal 
conditions) were living with diabetes mellitus type II and more than 10% of the participants with 
joint pain (musculoskeletal conditions) were living with both hypertension and DM II.  There was no 
association found between DM II and joint pain (musculoskeletal conditions) in this specific 
population, while the association between joint pain (musculoskeletal conditions) and hypertension 
approached significance.  With regard to risk factors for CDL, it was found that the majority of the 
participants in the study were overweight or obese, but the majority of the participants never used 
alcohol, smoked or used snuff. 
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The second aim of the study was to determine the impact of musculoskeletal conditions on activity 
limitations and participation restrictions within the target population. It was no surprise that 
participants with joint pain (musculoskeletal conditions) reported a poorer quality of life, both with 
regard to the EQ-5D-3L Index score and the more global VAS score. The HRQOL dimensions affected 
included mobility, usual activities, pain/discomfort and anxiety/depression. Those with joint pain 
(musculoskeletal conditions) experienced a mild effect on participation such as family life, work and 
social life, and a moderate effect on their financial position.  They were currently not working or had 
altered their employment. They experienced fatigue and depression, and reported significantly more 
difficulty with concentration, walking long distances, washing and dressing, and also with interacting 
with unknown people and friends than those individuals without joint pain (musculoskeletal 
conditions).   
It was thus clear that joint pain (musculoskeletal conditions) was widely prevalent in this group, 
often in the presence of co-morbidities. In addition it had an impact on HRQOL and functioning.  The 
development of the proposed intervention was thus justified and should address the co-morbidities, 
poor HRQOL and the functional problems. 
The next aim was to modify and adapt existing non-pharmacological programmes into a non-
pharmacological intervention programme for the target population, with the programme designed 
to educate, empower, maximize functional status and improve the quality of life of the women.   
The intervention was targeted at women, aged 40 to 64 years with co-morbidities and joint pain.  
This group was targeted for the intervention as they reported worse HRQOL and more functional 
problems in the anxiety/depression and pain/discomfort domains of the EQ-5D-3L and they 
regarded their general health as fair to poor.  
The first objective of the development of the intervention component was to modify and adapt 
existing programmes into an intervention programme based on the results of the systematic reviews 
and the needs of the participants identified in the survey.  The results of the systematic reviews 
indicated that both traditional and less conventional exercises were utilised,  with different models 
of education provided resulting in moderate improvements in the quality of life of participants living 
with hypertension, DM II, obesity or MSC, but with only a small number of interventions improving 
function or reducing pain.  Most of the health education used in reviewed studies included 
information on the specific disease, advice on lifestyle modifications, coping skills training and self-
management skills.  All of the health education sessions reviewed were culturally relevant for the 
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participants.  A limited number of randomised clinical control trials had been conducted which 
included HRQOL or QOL outcome measures.  In addition, the heterogeneity of samples, lack of effect 
sizes reporting, and the lack of standardisation of intervention programmes (either exercise or 
health education) all made comparison of the studies difficult.  Therefore, based on the results of 
the systematic reviews as well as the epidemiological survey,  it was clear that a multi-component 
lifestyle modification intervention programme which included exercise, health education, goal 
setting and cognitive behavioural principles for individuals living with chronic diseases was indicated.   
 
The intervention programme was designed according to existing guidelines, but tailored to the 
environment and culture through the inclusion of the participants in the decision-making regarding 
the appropriate programme.   The result was a culturally acceptable, understandable and 
explanatory intervention programme and workbook incorporating not only education and 
behavioural change strategies, but also self-efficacy, goal setting and following the principles of adult 
learning.  The programme was designed to be held once a week for two hours (one hour education 
and one hour supervised exercises) for six weeks and delivered in group format.  A workbook titled 
“Balanced lifestyle” was adapted and modified from a workbook titled “Positive Living”  for people 
living with HIV/AIDS and “Living with Osteoarthritis: patient workbook“ which was designed for  a 
similar age group of participants living with a chronic disease.  The workbook was also translated 
into Sesotho as the population were language proficient in English and Sesotho. As part of the 
development process, participants indicated that they enjoyed dancing and ball activities, which 
resulted in dancing activities serving as aerobic exercises and as part of cooling down, as well as 
activities utilising different sized balls being incorporated into the exercise programme. 
 
9.3 Impact of the Intervention 
 
The final sub-study examined whether the intervention would result in a significant difference 
between the intervention and control groups with respect to least, worst and average pain as 
measured by the Brief Pain Inventory (Short Form);   HRQOL as measured by the EQ-5D-3L; the 
functional impact of joint pain (musculoskeletal conditions) on the individual and co-morbidities as 
measured by the Simmonds battery of functional tests and the six-minute walk test.  Unfortunately, 
the recruitment was less than anticipated, possibly due to the timing of the intervention during 
working hours as there were significantly more unemployed participants, than in the general 
population.  
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The programme was well accepted and enjoyed by the participants and on cessation they requested 
that the programme should be continued at the community clinic.  Although the Brief Pain Inventory 
did not record any decrease in pain severity or pain interference with function in the intervention or 
in the control group, the intervention group did experience an increase in the percentage pain relief 
through the intervention programme and the number of sites of pain decreased in both the control 
and the intervention groups after six weeks.  With regards to HRQOL, the intervention group 
reported significantly fewer problems in mobility as well as in pain/discomfort and showed a trend 
towards fewer problems with anxiety/depression after the intervention programme. The Index 
Score, which reflects the QALYs gained, indicated that if the experimental group maintained their 
improved health status for a year, they would have gained one third of a healthy life compared to 
those in the control group. The EQ-5D-3L VAS score did not demonstrate greater improvement in the 
intervention group after six weeks, although the median health score of both groups improved from 
baseline to after six weeks.  There was a significant improvement in the intervention group’s self-
efficacy in managing their chronic disease after six weeks, especially in managing their fatigue and 
discomfort.  The self-efficacy overall score of the intervention group improved while the overall 
score of the control group worsened.  Both groups showed an improvement in function over the 
course of the six weeks in almost all the items of the Simmonds battery of tests.  The two items in 
which the intervention group performed better were in the sit-to-stand item and the distance 
walked item.  In conclusion the intervention resulted in a large decrease in the numbers of 
participants reporting problems over the course of the study in the EQ-5D-3L domains.   
An unexpected limitation of the study was that some outcome measures, such as the WHODAS 2.0 
(which was not used in the intervention study due to poor validity in the prevalence sub-study), the 
VAS and BPI did not perform as expected and lacked concurrent validity. Appropriate outcome 
measures were chosen specifically to cover all components of the ICF.  They included measures that 
had been previously validated in similar low income contexts. A strict translation protocol was 
followed and cognitive debriefing was done with participants similar to those who would take part in 
the main study.  However, post-hoc analysis of the WHODAS 2.0 after it had been used in the 
epidemiological study indicated that it was not valid within the context of the study, particularly with 
regard to convergent and discriminate validity. This was unexpected as it had performed well in 
similar contexts within South Africa. As a result of these findings, the WHODAS 2.0 was not used as 
an outcome measure in the intervention study. The dimensions of the EQ-5D-3L appeared to give 
reliable, intuitively correct results, but the VAS less so.  
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The numerical concepts used in these questionnaires could have been foreign to a population that is 
naive to research.  Despite a rigorous translation process, cognitive debriefing and a pilot study, the 
results indicated that numerical concepts and scales which utilise fine distinctions were not well 
understood by all participants and this factor could have influenced the results of the study. 
The final objective was to determine the interrelationship between joint pain (musculoskeletal 
conditions) and co-morbidities of individuals as measured by blood pressure, body mass index, 
venous glucose readings and cardiovascular fitness using the three-minute step test.  Participation in 
the intervention did not result in any health condition advantages, which was unexpected, as there 
is ample evidence that exercise has benefits for individuals with chronic diseases of lifestyle.  It is 
suggested that the dosage of exercise might have been insufficient for physiological changes to 
occur. 
9.4 Recommendations 
Based on the experience gained in running the different sub-studies and the results obtained, 
recommendations for clinical practice, policy changes and identified areas in which further research 
might be required are put forward. 
9.4.1 Clinical recommendations 
The following clinical recommendations can be made: 
 Based on the prevalence of joint pain (musculoskeletal conditions) in this population, a
protocol should be developed for the routine screening of joint pain (musculoskeletal
conditions) in community clinics.
 Guidelines should be developed for the management of joint pain in community clinics and
especially for physiotherapy management of these musculoskeletal conditions.
 The intervention programme should be continued at the community clinic where the
patients were enrolled for the intervention phase of the study as, in addition to the overall
positive impact of the programme on HRQOL and self-efficacy, the intervention was received
enthusiastically by the participants.  The programme should be offered after working hours,
or over weekends to allow employed women to take part.
 Consideration should be given to appointing physiotherapists at community clinics or, due to
financial constraints within the Department of Health, using community service
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physiotherapists to screen individuals who are complaining of joint pain and other chronic 
diseases of lifestyle at community clinics to determine if exercises can be safely prescribed, 
followed by providing the individuals with the “Balanced Lifestyle” workbook.  
 The self-management approach utilised in the workbook should be utilised during clinical
training of students at undergraduate level to ensure that they are able to respond to the
growing health burden of South Africa.
 The biopsychosocial model approach should be central to the treatment of patients at
community clinics. Staff at community clinics should be empowered to be able to manage
patients at clinics with a patient-centred approach rather than a disease centred at approach
which seems to be followed at present.
 Health care professionals should not view different cultures as a barrier to implementing
patient-centred treatments, but should rather embrace cross-cultural differences when
addressing the health needs of the population in South Africa.
9.4.2 Policy recommendations 
The following policy recommendations can be made: 
 Policy makers should, in collaboration with health care professionals, explore and improve
interventions, to empower groups of people who are often neglected by the health system
in disadvantaged populations.
 Services at community clinics should be expanded to the include screening of individuals for
joint pain and chronic diseases of lifestyle.
 Physiotherapists should be appointed at community clinics to roll out intervention
programmes developed for the management of chronic diseases of lifestyle and MSC.
 Establishing a quality primary health care service must be a priority to ensure a
comprehensive response to a growing health care burden, especially in resource poor
settings.  This may in the long term have a potential economic impact on health care in
South Africa.
 Health education programmes and awareness campaigns, with the intent to empower the
community regarding chronic diseases including joint pain, should be rolled out by local
governments and for this purpose partnerships should be formed with universities as well as
professional bodies of health care professionals.
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 The national health insurance system proposed for South Africa needs to be implemented in
phases, with the focus of the initial phase on the burden of diseases including chronic
diseases of lifestyle.
 A new strategy should be implemented by government for incorporating non-pharmacology
intervention programmes, especially relating to chronic diseases of lifestyle, as part of
community based services through primary health care outreach programmes.  The strategy
should include advocacy on major health issues in South Africa, especially the quadruple
burden of disease but should also focus and respond to the issues identified by the
communities.
9.4.3 Research recommendations 
The primary research recommendation is that, as the sample size was smaller than anticipated and 
the study may have been under-powered.  Further research should be undertaken before the 
intervention is rolled out to other clinics in the Free State or even nationally. The outcome measures 
will need to undergo further validation, particularly those based on numerical concepts and the 
Likert scale. The dosage of exercise would also need to be investigated to determine if an 
intervention of longer duration (e.g. three months), greater dosage (twice a week for a longer period 
of time) and a better system of monitoring the extra-class exercise would result in improvement in 
the impairments and health conditions of the participants.   A large, multi-centre trial would assist in 
determining whether the results of this small study could be generalised to the larger population. 
Other related recommendations are that: 
 The constructs of all the measurement tools included in the study, but especially the BPI and
the IPAQ,  need to be validated by means of qualitative research methods in the Sesotho
population
 The reliability and validity of the Sesotho versions (including those previously translated) in
the Sesotho population, particularly in populations naive to evaluative research questions
need to established.
 The prevalence and nature of joint pain amongst rural communities should be determined,
as this sample was restricted to those attending a community clinic.
 Research should be conducted on the same population to determine the effects of
medication on exercise adaptability during an exercise intervention programme designed for
individuals living with chronic diseases of lifestyle and joint pain.
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 The effectiveness of the intervention programme delivered by a multi-professional team
including a physiotherapist, dietician and a psychologist in middle-aged women living with
joint pain and chronic diseases of lifestyle should be investigated.
 The sustainability of the intervention programme after the six weeks session should be
investigated as well as the cost-effectiveness of such an intervention programme in the
community.
 A qualitative study should be conducted to determine the meaning of living with chronic
diseases of lifestyle and the impact of the intervention programme from the perspective of
the participants.
 The study setting could be changed to investigate the participant’s way of life at home or in
their specific community and develop the workbook and exercises accordingly.
 A study should be conducted to determine the interaction of the socio-economic status and
chronic diseases of lifestyle in this specific population.
 An investigation into the culture of exercise in the specific population should be undertaken.
9.5 Conclusion 
The participants in this study were drawn from the group most disadvantaged by the apartheid 
policies that were in force for most of their lives. They bear the brunt of poor widespread education, 
unemployment and caring for families which may have been destroyed by the HIV epidemic.  They 
are a group of women who need the support of the health care system, but often do not receive the 
care they deserve.  This thesis has documented the functional needs of these women and has 
proved that a relatively low cost intervention can be not only enjoyable and culturally acceptable, 
but can also improve their health-related quality of life.  It should not be too much to expect that the 
grandmothers of the “born free” generation should eventually be given the support that they need. 
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APPENDIX 1 
Detailed description of intervention of chronic diseases 
Systematic review 
1 
The effect of the interventions for adults with diabetes mellitus type II, hypertension or obesity summarised in table format 
Author Condition Intervention Effect after intervention 
Chaveepojnkamjorn et al., 
(2009)  
Diabetes mellitus type II The programme consisted of five monthly sessions in small 
groups, lasting for two hours.  Topics included building good 
relationships, improving knowledge regarding diabetes, 
dietary control skills, physical exercise skills, improvement in 
group structure, improvement in training skills for group 
leaders, self-monitoring, motivation for self-care and sharing 
experiences. Active learning (exploring, reflecting, sharing 
and choosing personal solutions) was encouraged. 
None of the effects regarding health related 
quality of life, function and participation were 
significant.   
Deinzer et al., (2009)  Hypertension Shared decision making practice to empower patients. None of the effects regarding health related 
quality of life, function and participation were 
significant.   
Rimmer et al., (2009)  Obesity Three groups were used: (a) awareness group that received 
a recommendation to exercise by their physician, 
information brochure on physical activity, and a toolkit for 
starting a physical activity programme; (b) personalised 
exercise programme with lower level of support.  
Participants received a weekly telephone consultation with 
a health professional to plan and maintain a physical activity 
programme, a toolkit, and a monthly newsletter; (c) 
personalised exercise programme with higher level of 
support, the same intervention as the lower level support 
group as well as participation in a monthly onsite exercise 
support group designed to provide an environment for 
mutual support and encouragement. All participants 
received a toolkit containing a tracking device (pedometer), 
postcards to track daily movement and progress, safety 
precautions for physical activity, information on how to 
monitor heart rate during activity, healthy foods and water 
intake information, and contact information for the National 
Centre on Physical Activity and Disability. 
None of the effects regarding health related 
quality of life, function and participation were 
significant.   
2 
 
 
Moriyama et al., (2009)  Diabetes mellitus type II The target focus of this programme was the acquisition of 
self-management skills, the patients analysing and 
understanding their condition so that they can work with 
their physiological data to acquiring knowledge of the 
disease and self-care.  They also learned how to use family, 
peer, and professional support. By making self-supported 
decisions, the patients were able to manage their diet, 
exercise and stress. They also acquired disease-specific 
management skills. Setting goals and then monitoring the 
goals ensured the continuation of the desired behaviour 
changes and gave the patients control over their lifestyle. 
 
None of the effects regarding health related 
quality of life, function and participation were 
significant.   
Bouchard et al., (2010)  Obesity The supervised weight loss programme contained 55%, 30%, 
and 15% of energy intake from carbohydrates, fats, and 
proteins as recommended by the American Heart 
Association.  Food was self-selected with dietician 
supervision and participants were also instructed to drink 
water during the study. During the weight loss programme, 
the calorie restricted groups and the calorie restricted group 
+ resistance training groups took part in a one hour weekly 
nutritional information session to help them lose weight.  
The goal was to reduce body weight by 0.5 kg to 1.0 kg.   
Participants completed a food diary and weighed 
themselves on a daily basis. The participants were to call the 
nutritionist for a quick adjustment of caloric intake when 
reducing body weight was not adequately achieved. 
 
Participants in the resistance training group and calorie 
restriction + resistance training group trained three times 
per week on non-consecutive days under the supervision of 
a kinesiologist. One repetition maximum, defined as the 
heaviest weight that can be moved through the entire range 
of motion for no more than one repetition, was initially 
performed for each exercise and repeated at six weeks to 
change the work load. All training sessions were initiated 
None of the effects regarding health related 
quality of life, function and participation were 
significant.   
3 
with a warm-up period consisting of five minutes of low-
intensity cycling. Participants then performed the load 
phase of the resistance training which consisting of three 
series of eight repetitions for nine different exercises (leg 
press, chest press, leg extension, shoulder press, sit-up, 
seated row, triceps extension, arm curl, and calf extension) 
at 80%of their one repetition maximum. Resting periods of 
60 to 90 seconds were taken between sets as suggested by 
the Canadian Society for Exercise Physiology. Both groups 
performed the same exercises. 
Dyson et al., (2010)  Diabetes mellitus type II All subjects in the study received usual medical care from 
their primary care physician, including education about 
lifestyle management of diabetes mellitus type II from a 
practice nurse. In addition, subjects randomised to the video 
intervention received the three lifestyle videos and were 
requested to watch them in their own time.  The videos 
were developed as  three 10 to 15 minute videos entitled 
‘Food Choices’, ‘Physical Activity’ and ‘Weight Management’ 
Each video included a mixture of expert opinion intercut 
with case studies.   
None of the effects regarding health related 
quality of life, function and participation were 
significant.   
D’Eramo-Melkus et al., (2010) Diabetes mellitus type II The intervention consisted of 11 weekly group sessions. The 
first six sessions, each two hours long, provided culturally 
relevant cognitive behavioural diabetes self-management 
training.  Each of the six education sessions had specific 
learner objectives that were addressed by group leaders 
with participants actively taking part.   The group context 
was critical for support.  The first class defined diabetes, as 
well as diabetes related health risks.  Culturally specific 
materials were used for each session.  The focus was on 
cultural barriers and beliefs that support or hinder healthy 
dietary intake and ideal body weight. Included in the 
discussion was the role of social support systems or 
networks in behaviour change. Class material provided 
participants with recipes for modifying culturally preferred 
None of the effects regarding health related 
quality of life, function and participation were 
significant.   
4 
 
food. A culturally specific video and cookbook were also 
utilized.  
 
Participants discussed personal and cultural influences on 
their body images and identified ways of reaching their 
goals.  The remaining five weekly group sessions, each an 
hour long, discussed coping skills training skills. These 
sessions were led by a clinical psychologist or psychiatric 
mental health nurse practitioner.  Topics discussed included: 
understanding stress and managing stress; problem 
identification; problem-solving strategies and 
communication.   
 
Oh et al., (2010)  Metabolic syndrome A six-month therapeutic lifestyle modification programme 
with 60 sessions was provided, with sessions taking place 
three times per week during the first three months followed 
by a maintenance period twice a week during the next three 
months. Each 90 minute sessions was delivered by the 
community nurse practitioner.  The programme consisted of 
comprehensive multi-components: health monitoring, 
counselling, health education, exercise and diet.  Health 
education included defining characteristics of metabolic 
syndrome and advice on lifestyle modifications such as 
exercise, diet, and self-care. 
 
Participants attended three supervised exercise sessions per 
week for the first three months and two sessions per week 
for the next three months. The supervised group exercise 
programme consisted of yoga stretching, rhythmic aerobic 
dance (Tae-Bo), warm-up and cool down exercises for 40 
minutes per session.  To maintain a standardised exercise 
protocol, participants exercised along with a recorded video.  
The diet instructions focused on decreasing caloric intake by 
reducing high-glycaemic foods (e.g., rice, noodles). 
 
 
None of the effects regarding health related 
quality of life, function and participation were 
significant.   
5 
Young et al., (2010)  Hypertension The established intervention targeted increase in physical 
activity to at least 180 min/week, reduce daily sodium 
intake to ≤ 2,300 mg, and reduce daily total fat intake ≤ to 
30% and saturated fat to ≤ 10% of calories. The established 
plus Dietary Approaches to Stop Hypertension intervention 
targeted six behaviours:  the same physical activity and 
sodium requirements as the established intervention plus 
daily total fat and saturated fat intake goals of ≤25% and 7% 
of calories, respectively.  
Additional the participants had to increase daily fruit and 
vegetable intake to at least nine servings and to increase 
low fat dairy servings to at least two servings per day. The 
weight loss goal for both groups was 6.8 kg at six months for 
participants who were overweight or obese at baseline (BMI 
values≥25 kg/m2).Both interventions consisted of 18 face-
to-face contact sessions during the first six months of the 
intervention and 12 face-to-face sessions during the 
remaining 12 months. 
None of the effects regarding health related 
quality of life, function and participation were 
significant.   
Nicolucci et al., (2012) Diabetes mellitus type II The training programme for the exercise intervention group 
consisted of two supervised sessions of progressive mixed 
(aerobic and resistance) training for 150 minutes per week. 
A treadmill, step, elliptical, arm or cycle-ergometer was used 
for the aerobic training.   Exercise load was calculated to 
achieve the prescribed exercise intensity, expressed as a 
percentage of maximal oxygen consumption.  
Resistance training consisted of four resistance exercises: 
chest press, lateral pull-down, leg press and abdominal 
flexion, or equivalent exercises targeting the same muscles. 
Subjects also did three stretching exercises. Intensity of 
exercises was adjusted according to improvements 
inVO2max and muscle fitness.  In addition, energy 
expenditure was increased progressively by 0.4184 kJ/kg 
body weight per session every month.   
None of the effects regarding health related 
quality of life, function and participation were 
significant.   
6 
Park et al., (2011)  Hypertension The 12 week programme consists of group health education 
(once a week), individual counselling (once during the fourth 
week), and patient tailored elastic band exercise (twice a 
week). The education comprised of 12 weekly sessions 
delivered by pairs of trained nurses.  The sessions included 
an Introduction, definition and symptoms of hypertension, 
complication of hypertension, medication, checking blood 
pressure, diet, exercise, stress management, emergency 
care, smoking and alcohol,   self-management strategy, 
programme evaluation.  At the fourth week, individual 
health counselling by trained nurse was done to encourage 
the initiation and maintenance of self-management 
behaviors, and to identify any potential problems in the 
programme. It took half an hour per participant. 
Patient tailored elastic band exercise was performed for 12 
weeks (twice a week).  Exercise therapists classified the 
participants into several groups with similar fitness levels 
and two to three sets of 12 to 15 kinds of exercises (15 to 25 
repetitions per set) were performed using red Theraband.  
Exercises included warming up, light stretches and main 
exercises included shoulder presses, shrugs, front raises, 
lateral raises, biceps curls, triceps extensions, kick back’s, 
bent over row, seated row, chest presses, leg presses, 
squats, good morning, abdominal curls, pelvic lifts, crunches 
cooling down and light stretches. 
None of the effects regarding health related 
quality of life, function and participation were 
significant.   
Vadstrup (2011)] Diabetes mellitus type II The group-based rehabilitation programme consisted of an 
educational component of 90 minutes group sessions held 
weekly for a total of six weeks. Sessions were limited to 
eight participants and were taught by a nurse, a 
physiotherapist, a podiatrist, and a dietician. The 
educational curriculum included: the patho-physiology of 
diabetes, blood glucose self-monitoring, dietary instructions, 
the importance of physical activity, weight loss and smoking 
None of the effects regarding health related 
quality of life, function and participation were 
significant.   
7 
cessation, neuropathy, foot examinations, hypertension, 
complications, and medications.  
A 12 week supervised exercise component consisted of 90-
minutes sessions twice a week that included both aerobic 
and resistance exercise. The sessions were group-based, but 
a physiotherapist tailored an individual exercise programme 
for each patient. Dietary education included two three-hour 
group-based cooking classes and one two-hour session in a 
local supermarket. The education, exercise, and dietary 
interventions could overlap and their sequence could differ 
from patient to patient. 
The individual counselling programme consisted of 
individual consultations with a diabetes nurse specialist, a 
dietician, and a podiatrist over a period of six months. 
Patients participated in four one-hour sessions of individual 
counselling with a diabetes nurse specialist. Using the 
patients’ own stories patients received personalized 
information and guidance about diabetes mellitus type II, 
medications, risk factors, and late complications, blood-
glucoses self-monitoring, and increasing physical activity to 
the recommended level of 30 minutes of daily exercise. 
Over the same time period, patients participated in three 
individual counselling sessions with a dietician.   
At the initial hour-long visit, patients set personal goals and, 
in collaboration with the dietician, developed a dietary plan 
based on biochemical, anthropometrical and medical 
records and patients’ motivation and attitudes. The action 
plan, progress towards meeting it, and goals were evaluated 
at the two follow-up visits, each of which lasted 30 minutes. 
Williams et al., (2012)  Diabetes mellitus type II The intervention took place over six months during which 
they received the Australian TLC Diabetes programme. 
Its main component was the Telephone-Linked Care(TLC) 
None of the effects regarding health related 
quality of life, function and participation were 
significant.   
8 
Diabetes system, an automated interactive telephone 
System. The Australian TLC Diabetes system has been 
designed to improve diabetes management by targeting the 
following key self-management behaviours: blood glucose 
testing, nutrition, physical activity and medication-taking. 
Users were asked to call the system weekly using a landline 
or mobile phone. TLC’s responses, including feedback and 
encouragement, were tailored according to information 
entered in the TLC database at the start and the answers 
that it received from participants during all calls. 
Da Vico et al., (2013)  Diabetes mellitus type II The group education programme was structured in five 
sessions a week apart from one another, with the 
participation of eight to 10 patients at a time. The first 
session was six hours long, with the participation of a 
physician (60 min), a nurse (150 min), and a dietician (150 
min). The subsequent four sessions had were two hours 
each and were led by the dietician alone, except the last, in 
which a 30-min participation of the nurse was also planned. 
The educational curriculum included general information 
about diabetes and its complications, nutritional needs and 
functions of different nutrients, characteristics of most 
common foods, regulation of food intake, parameters for 
the assessment of nutritional status (i.e., body weight, waist 
circumference, etc.), sweeteners and ‘‘sugar-free’’ products, 
benefits and risks of physical exercise, methods for physical 
training, cardiovascular risk factors, and self-monitoring of 
blood glucose. Although the programme included some 
traditional formal sessions, most of the time was devoted to 
interactivity. 
Participants were invited to perform practical tasks, such as 
estimate of portions of different foods, choice from a 
restaurant menu, identification of the amount of different 
foods with a similar nutrient content, measurement of waist 
None of the effects regarding health related 
quality of life, function and participation were 
significant.   
9 
circumference.  Participants were encouraged to express 
their feelings toward eating and exercising, and their 
problems with body weight and shape, and to report their 
own experiences with non-pharmacological management 
of diabetes. 
One of the main features of this programme was the central 
role of self-monitoring. Patients were asked to self-monitor 
their blood glucose before and two hours after each meal 
(i.e., six times a day) at least once a week for all the duration 
of the programme, irrespective of their pharmacological 
therapy; this self-monitoring was promoted in order to help 
the patient to acquire a greater knowledge of the 
relationships between food intake and blood glucose 
control.  Patients were also asked to compile self-monitoring 
sheets, reporting their food intake and physical exercise. 
Another focus of the group programme was enhancement 
of patients’ motivation to change. Benefits determined by 
modification of dietary habits and increase of physical 
activity were discussed, with a special attention to those 
changes that can be directly monitored by patients, and 
therefore represent a positive reinforcement (e.g., increased 
physical fitness or reduced dyspnoea in common-day 
activities, reduction in measured blood glucose levels, etc.) 
Behavioural techniques for stimuli control were presented 
to reduce the risk of uncontrolled overeating, and problem-
solving techniques were used as a tool to overcome 
obstacles to lifestyle change. 
Espeland et al., (2013)  Diabetes mellitus type II The Intensive Lifestyle Intervention included diet 
modification and physical activity and was designed to 
induce at least an average 7% weight loss at the first year 
and to maintain this weight loss in subsequent years. 
Participants were assigned a calorie goal (1,200 to 1,800 
None of the effects regarding health related 
quality of life, function and participation were 
significant.   
10 
 
based on initial weight), with less than30% of total calories 
from fat (<10% from saturated fat) and a minimum of 15% 
of total calories from protein. 
 
The physical activity goal was 175 minutes or more of 
physical activity per week through activities similar in 
intensity to brisk walking. A toolbox approach that guided 
individualised problem solving for all participants who 
experienced difficulty in achieving study goals was 
incorporated in the treatment protocol that allowed 
adjustments to be made for age-related issues. 
 
Sakurai et al., (2013)  Obesity Participants did warm-up exercises for a period of 10 
minutes followed by a muscle strengthening routine (10 
different resistance training, two sets of 12 repetitions) and 
exercise using resistance bands for a period of 40 min. 
Afterwards, participants did balance and aerobic exercise 
training for a period of 20 minutes. Finally, the participants 
were instructed to cool down for a period of 5 min. During 
the exercise, the participants were asked to carry out a 
subjective intensive exercise (ratings of perceived exertion. 
Exercise classes comprised of a total of 17 lessons. 
 
Dietary modification consisted of a series of four 75 minute 
nutritional guidance classes that were carried out under the 
supervision of a nationally registered dietician. The classes 
involved a comparison of the participants’ dietary intake 
with a healthy, balanced dietary intake, and encouraged the 
participants’ to increase their awareness of a healthy diet 
through using a food model. In addition, the participants 
discussed problems of dietary habits and settled issues in a 
group setting. Nutrition guidance classes comprised a total 
of five lessons. 
 
None of the effects regarding health related 
quality of life, function and participation were 
significant.   
 
 
APPENDIX 2 
Detailed description of intervention of musculoskeletal disorders 
Systematic review 
1 
The effect of the interventions for adults with musculoskeletal disorders summarised in table format 
Author Condition Intervention Effect after intervention 
Hansson et al., 
(2010) 
Osteoarthritis During the first session the patients received education regarding human 
anatomy, physiology of pain and coping with pain.  These sessions were 
presented by a physiotherapist and occupational therapist.  They were 
also advised to use head and cold when needed.  A brainstorming session 
was included about what patients found difficult to do.  During the 
second session information was provided regarding exercise and physical 
activity. A practical demonstration of home-training exercises for the 
lower limbs, were shown by the physiotherapist while the occupational 
therapist demonstrated different orthopaedic aids.  During the third 
session an orthopaedic surgeon, a nurse and dietician gave information 
regarding OA, current research, medication and an appropriate diet.   An 
occupational therapist gave feedback of the brainstorming session to 
patients and also gave ergonomic advice and practical information 
regarding equipment and technical aids.   During the last session an 
occupational therapist gave information to patients regarding surgery of 
the hand and demonstrated applicable orthopaedic aids for the hands.  
Patients also tried hot paraffin wax treatment for the hands.  Practical 
home exercises were demonstrated for the hand as well in this session.   
There was an improvement in self-
perceived health as well as function to 
some degree but not in self-efficacy of 
patients.  
Hurley et al., (2012)  Chronic knee pain The intervention ESCAPE-knee pain participants also received whatever 
services or interventions their physician considered appropriate.  
Participants attended 12 supervised sessions twice weekly for 6 six weeks. 
For 15 to 20 minutes of each session, the supervising physiotherapist 
facilitated a discussion on a specific topic, advising and suggesting simple 
coping strategies. After the discussion for 35 to 40 minutes each 
participant performed a simple individualized exercise regimen to address 
their disabilities and progressed as they improved. The content of the 
program was similar whether delivered to individual participants or to 
small groups of eight participants. To ensure consistency in content and 
delivery, the same physiotherapist designed, supervised and made 
changes for progression to all sessions of all the participants in the study. 
After completion, participants were encouraged to perform home 
There was large initial improvement in all 
the outcome measures of the ESCAPE-knee 
pain participants, but over time there was 
no difference between the two groups, 
except for ESCAPE-knee pain participant’s 
exercise health beliefs and self-efficacy.  
The was also large improvements in 
physical function of ESCAPE-knee pain 
participants that also decreased over time, 
but were still evident 30 months after 
completing the program.   
2 
 
exercises and physical activity, especially walking. 
 
Control group received whatever services or interventions their 
physicians considered appropriate.   
Kamada et al., 
(2013)  
Middle-aged and elderly 
people 
The programme consisted of walking as an aerobic exercise, stretches of 
muscles including back muscles, adductor muscles, gluteus maximus, 
knee extensors and flexors.  These muscles groups were chosen as key 
muscle groups for treating lower back pain and knee pain and the 
exercises given did not require expensive equipment.  Marketing 
strategies including flyers, leaflets, community newsletters, banners, 
posters and local audio broadcasts were used to promote the 
programme.  Participants also received support from their local 
communities during the programme.   
 
There was no intervention effect.   
 
 
 
 
APPENDIX 3 
List of standardised instruments that are available to measure the different 
components of the ICF 
List of standardised instruments that are available to measure the different components of the ICF 
Component Function Instrument Psychometric (Clinimetric 
Information) 
Comments on feasibility for 
current study 
Included as 
outcome measure 
in current study 
Health component Self-designed questionnaire 
based on self-report. 
Designed to obtain 
demographic and medical 
information.  Used by 
trained fieldworkers. 
Only feasible method of 
obtaining the data.  
√ 
COPCORD To record joint pain and 
disability in specific 
populations rather than 
focusing on diseases 
and syndromes. 
Only feasible method of 
obtaining the data. 
√ 
Impairment Blood pressure 
maintenance 
Electronic table-model 
sphygmomanometer. 
Gold standard for 
measuring blood pressure. 
Used by trained 
fieldworkers. 
Feasible and accurate. √ 
Cardiovascular 
fitness 
Kasch Pulse Recovery (350-352) Gold standard for 
measuring cardiovascular 
fitness.  Used by trained 
research assistants. 
Feasible and accurate. √ 
6-minute walk test (353, 354) Gold standard for 
measuring cardiovascular 
fitness.   
Feasible and accurate. √ 
Random serum 
glucose levels 
Check classic blood glucose 
monitoring unit. 
Gold standard for 
measuring blood glucose 
levels.  Used by trained 
fieldworkers. 
Feasible and accurate. √ 
Maintenance of body 
weight: Weight 
Calibrated electronic digital scale 
accurate to 0.05kg. 
Gold standard for 
measuring weight.  Used 
by trained fieldworkers. 
Feasible and accurate. √
Component Function Instrument Psychometric (Clinimetric 
Information) 
Comments on feasibility for 
current study 
Included as 
outcome measure 
in current study 
 Maintenance of Body 
Weight: 
Height 
Stadiometer accurate to the 
nearest 0.1 cm. 
Gold standard for 
measuring height.  Used 
by trained fieldworkers. 
Feasible and accurate. √ 
 Pain Brief Pain Inventory (355-357) Found to be valid and 
reliable.  
 
Feasible and accurate. √ 
  Glasgow pain scale (358)  Found to be valid and 
reliable. 
Time consuming and 
detailed. 
 
  McGill pain questionnaires (359, 
360) 
Found to be valid and 
reliable. 
 
Time consuming, detailed.  
  Simmonds battery of functional 
tests (361-363) 
Found to be valid and 
reliable.  
Include upper and lower limb 
function. 
√ 
  Timed Up and Go Test (352, 364, 
365) 
Found to be valid and 
reliable for functional 
mobility. 
Included in Simmonds 
battery of functional tests. 
 
  Muscle strength (288, 366-368) Found to be valid and 
reliable.  
Included in Simmonds 
Battery of functional tests. 
 
  GaIt speeds including 
comfortable- and fast-speed 
walking (352) 
Found to be valid and 
reliable.  
Included in Simmonds 
battery of functional tests. 
 
  Functional reach test (369, 370) Found to be valid and 
reliable.  
Included in Simmonds 
battery of functional tests. 
 
Functional activities Activities of daily 
living 
Functional Independence 
measure(371-373) 
Found to be valid and 
reliable. 
Time consuming and 
expensive. 
 
  Oswestry Disability Index (374-
376) 
Found to be valid and 
reliable. 
Time consuming.   
  Roland-Morris Disability 
questionnaire (376-378) 
Found to be valid and 
reliable.  
Time consuming and only 
covers specific physical 
problems and no 
psychological or social 
problems. 
 
 
Component Function Instrument Psychometric (Clinimetric 
Information) 
Comments on feasibility for 
current study 
Included as 
outcome measure 
in current study 
WHODAS 2.0 – components Found to be valid and 
reliable in similar settings. 
Details below. 
Short, used in under-
resourced areas in South 
Africa. Compatible with ICF 
structure. 
√ 
Participation HRQOL SF36 (379-381) Found to be valid and 
reliable.  
Expensive, long, little 
experience in similar 
contexts. 
Medical Outcome Study (MOS) 
SF 12 (380) 
Found to be valid and 
reliable. 
Time consuming and very 
long. 
EQ-5D-3L (381-385) Found to be valid and 
reliable.  
Feasible and accurate, most 
often used, used in similar 
context. 
√ 
The Western Ontario and 
McMaster Universities  
Osteoarthritis Index 
(WOMAC)(386, 387) 
Found to be valid and 
reliable. 
Time consuming. 
International Physical Activity 
Questionnaire (291, 388, 389) 
Found to be valid and 
reliable. 
√ 
Baecke Questionnaire (390-392) Found to be valid and 
reliable.  
Lacks precision in estimating 
activity and bias can occur as 
the word may not mean the 
same in different 
populations. 
Personal factors Demographic Self-designed questionnaire Feasible and accurate. √ 
Self-efficacy Self-efficacy for managing 
chronic disease 6-item scale 
(393) (356, 394, 395)
Found to be valid and 
reliable.  
Feasible and accurate. √ 
Arthritis self-efficacy scale (394) 
[536] 
Found to be valid and 
reliable.  
Time consuming and very 
long. 
WHODAS 2.0 – component. As above. As above. √
Component Function Instrument Psychometric (Clinimetric 
Information) 
Comments on feasibility for 
current study 
Included as 
outcome measure 
in current study 
Environmental and 
contextual factors 
 WHODAS 2.0 – components As above. As Above. √ 
  Self-designed questionnaire  Feasible and accurate. Feasible and 
accurate. 
 
APPENDIX 4 
COPCORD 
1 
MUSCUSLOSKELETAL CONDITIONS AND CO-MORBIDITY QUESTIONNAIRE 
(Based on COPCORD Questionnaire)  
 This questionnaire is for women between the ages of 40 -64 years attending Primary Health
Care Clinics.
 This questionnaire is about joint pain, obesity, hypertension and diabetes mellitus type II.
 This questionnaire is completely voluntary.  You may choose not to participate or not to
answer any specific question.
 This questionnaire is completely anonymous.  Please make no marks of any kind on the
survey which could identify you individually.
 Composite data will be used to develop a health promotion programme
INSTRUCTIONS 
 Select only one response, unless instructed otherwise.
 Please tick the appropriate answer e.g.  □√  or circle one correct answer where indicated
Thank you very much for your co-operation 
2 
ID code _ _ _ _ _ __ _ _ 
Date: _ _ _ _ _ __ _ __ _ _ _ _ __ _ __ _ _ _ _ __ _ _ 
Clinic: _ _ _ _ _ __ _ __ _ _ _ _ __ _ __ _ _ _ _ __ _ 
PHASE I: 
THE FOLLOWING QUESTIONS ASK ABOUT YOUR PERSONAL DATA AND MEDICAL 
HISTORY (DEMOGRAPHIC CHARACTERISTICS) 
(Q1 – Q7 to be completed by the researcher or research assistant/s) 
Q1. Age:  _ _ __ _ _ _  years old  OR  Date of birth: _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ 
Q2. Weight: _ _ _ __ _ _ _  kg 
Q3. Height: _ _ _ __ _ _ _  cm 
Q4. Body Mass Index: _ _ _ _ _ _ _ _ kg/m2
Q5. Blood sugar Test (reading from folder if available): _ _ _ __ _ _ _ _ _ _ _  mmol/ℓ 
Q6. Blood Pressure:  _ _ _ __ _ _ _ _ _ _ _  mmHg 
Q7. Co-morbidities: (please indicate all applicable) 
Cancer □ Present □ Not present □ Do not know
Sugar (Diabetes Mellitus Type I) □ Present □ Not present □ Do not know
Cardio-vascular diseases (Coronary heart disease) □ Present □ Not present □ Do not know
Depression □ Present □ Not present □ Do not know
Stroke □ Present □ Not present □ Do not know
Chronic respiratory disease □ Present □ Not present □ Do not know
Q8.   Home language: 
□ Afrikaans □ English
□ Sesotho
□ Other (please specify)  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
3 
Q9. Ethnic origin / race: 
□ African/Black □ Coloured
□ White □ Indian/Asian
□ Other (please specify)  _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _
Q10. Marital status: 
□ Never married □ Married / Domestic partner (live with partner)
□ Separated / divorced □ Widowed
Q11.  Literacy: 
□ Read only □ Read and write
□ None
Q12. Highest level of education: 
□ No schooling □ Primary school
□ Secondary school □ Tertiary education
Q13. Where do you live most of the year? 
□ Your own home / flat □ Home of a friend / family member
□ Other (please specify) _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _
Q14.   Type of housing: 
□ Brick house □ Informal housing
Q15.   How many people live with you? 
□ I live alone □ 1 person
□ 2 persons □ 3 persons
□ 4 persons □ 5 or more persons
4 
Q16. Your current employment status: 
□ Working full-time (40 hours or more a week) □ Unemployed
□ Working part-time (less than 40 hours a week) □ Pensioner
□ “Piece job”
□ Other (please specify) _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ _
Q17. Your current employment (job): 
□ Housewife □ Teacher
□ Desk job □ Work at shop or business
□ Factory worker □ Domestic worker
□ Military □ Police
□ Retired □ Unemployed
□ Other (please specify) _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ _
Q18. Unemployment due to: 
□ Caring for your family □ Can’t find a job
□ Health problems □ Disabled
□ Husband does not allow me to work
□ Too old
□ Other (please specify) _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ _
Q19. Do you receive a government pension or grant: 
□ Yes □ No
Q20. If yes, is it a: 
□ Disability grant (you can’t work due to illness)
□ Pension (old age)
□ Both
5 
Q21. What best describes your history of smoking: 
□ Never smoked □ Currently smoke
□ Formerly smoked
□ If yes, how many cigarettes per day? _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ _
□ If yes, at what age did you start?  _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ __ _
Q22. What best describes your history of snuffing: 
□ Never used snuff □ Currently use snuff
□ Formerly used snuff
□ If yes, how many times per day do you snuff? _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ _
□ If yes, at what age did you start?  _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ __ __ _ _ _ _
Q23. What best describes your history of alcohol use: 
□ Never used alcohol products □ Currently use alcohol products
□ Formerly used alcohol products
□ If yes, how many times per week do you use alcohol? _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ _
□ If yes, at what age did you start?  _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ __ __ _ _ _ __ _ _ _ _
THE FOLLOWING QUESTIONS ASK ABOUT YOUR HEALTH 
Q24. How is your general health? 
□ Excellent □ Very good
□ Good □ Fair
□ Poor
Q25. Have your ever been diagnosed with? 
□ High blood (Hypertension) □ Sugar (Diabetes Mellitus Type II)
□ Obesity (overweight) □ Cholesterol (hyperlipidaemia)
□ Joint pain (Musculoskeletal conditions)
6 
Q26. What is your main reason for visiting the clinic today? 
□ To see the sister / nurse □ To see the doctor
□ To get medication □ Both sister and medication
□ Joint pain (Musculoskeletal conditions)
□ Other (please specify) _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ ___ _ _ _ _ _
Q27. Which of the following conditions did you suffer from in the last three months? 
□ High blood (Hypertension) □ Sugar (Diabetes Mellitus Type II)
□ Obesity (overweight) □ Joint or muscle pain
□ Injury or accident □ Heart problems
□ Stomach complaints □ Genitourinary problem
□ Cancer □ Infections (TB /other)
□ Paralysis
□ Other (please specify) _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ __ _ _ _ _ __ _ _ _ _ _
Q28. Has your doctor or sister / nurse ever told you to follow an exercise programme? 
□ Yes □ No
□ Not sure
Q29a. During the last 3 months have you experienced pain, aching, swelling, stiffness 
 (tightness) in or around your joints or back which is not related to an injury / accident? 
□ Yes □ No
□ Not sure
Q29b. During the last 7 days have you experienced pain, aching, swelling, stiffness 
 (tightness) in or around your joints or back which is not related to an injury / accident? 
□ Yes □ No
□ Not sure
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ID code _ _ _ _ _ __ _ _ 
Date: _ _ _ _ _ __ _ __ _ _ _ _ __ _ __ _ _ _ _ __ _ _ 
Clinic: _ _ _ _ _ __ _ __ _ _ _ _ __ _ __ _ _ _ _ __ _ 
PHASE II: 
THE FOLLOWING QUESTIONS ASK ABOUT YOUR JOINT OR MUSCLE PAIN, 
STIFFNESS / TIGHTNESS OR SWELLING AROUND YOUR JOINTS, OR LESS MOVEMENT 
IN ANY JOINTS 
Q1a.  Please indicate on the figure below, with a  all the sites where you have experienced pain in 
 the last 3 months prior to the survey and with a X all the sites where you have experienced 
 swelling. 
Front Back 
8 
Q1b. Please indicate on the figure below, with a  all the sites where you have experienced pain in 
 the last 7 days prior to the survey and with a X all the sites where you have experienced  
 swelling. 
Front Back 
Q2. When did your pain start? 
□ Less than 7 days ago □ In the last 3 months
□ 3 months – 1 year ago □ More than 1 year ago
Q3. How many days in the last 3 months have you experienced any pain? _ _ _ _ _ _ _ __ _ _ _ _ __ _ 
Q4a. Indicate on the scale the intensity of the pain you experienced during the past 7 days. 
□ No pain □ Mild □ Moderate □ Severe □ Very severe
9 
Q4b. Indicate on the scale the intensity of the pain you experienced during the past 3 months. 
□ No pain □ Mild □ Moderate □ Severe □ Very severe
Q5. If your pain is recurrent, how long does the episode last? 
□ Few days □ 4 – 6 weeks
□ 6 – 12 weeks □ More than 3 months
Q6. When is the pain most intense? 
□ In the morning when you wake up □ After an activity (doing something)
□ While resting at night
□ Other (please specify) _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ __ _ _ _ _ __ _ _ _ _ _
Q7. During the last year have you experienced tightness / stiffness in your joints in the morning 
 after getting out of bed or after a long rest without movement? 
□ Yes □ No
□ Not sure
Q8. How long did the tightness / stiffness last? 
□ 30 minutes or less □ More than 30 minutes
Q9. Did the tightness / stiffness go away after exercise or movement of the joint? 
□ Yes □ No
□ Not sure
10 
 
Q10. Have you ever been diagnosed or has anyone told you that you have arthritis or other joint    
             diseases like rheumatism? 
 
□ Yes      □ No                           
□ Not sure 
 
Q10a. What was the diagnosis given to you? _ _ _ __ _ _ _ _ _ _ _ _ _ __ _ _ _ _ __ _ _ _ _ _ 
 
 
Q10b. Where was the diagnosis made and by whom? _ _ _ __ _ _ _ _ _ _ _ _ _ __ _ _ _ _ __ _ _ _ _ _ 
 
              _ _ __ _ _ _ _ _ _ _ _ _ __ _ _ _ _ __ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ __ _ _ _ _ __ _ _ _ _ _ 
 
 
Q11. Have you been taking any medication for joint or back pain, not related to an injury, in the last 3 
            months? 
 
□ Yes      □ No                           
□ Not sure 
 
Q12. Is yes, what medication was used? 
 
□ Over the counter pain killers    □ Natural remedies, herbs, supplements                           
□ Over the counter anti-inflammatory drugs (NSAIDS’s)    
            □ Prescribed anti-inflammatory drugs (NSAID’s)   
□ Other prescribed medication                           
            □ Other (please specify) _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ __ _ _ _ _ __ _ _ _ _ _ 
 
Q13. Have you received any type of treatment, other than medication, for pain? 
 
□ Yes      □ No                           
□ Not sure 
Please specify _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ __ _ _ _ _ __ _ _ _ _ __ _ _ _ _ 
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Q14. What is the effect, if any, the pain / arthritis has had on your life as outlined below? 
None Mild Moderate Severe 
Family relations 
Social relations 
Marital relations (including 
sexual activities) 
Financial position 
Ability to work 
Hobby 
Games 
Others, please specify 
Q15. Have you stopped working due to the pain / arthritis within the last year? 
□ Yes □ No
□ Not sure
Q16. Have you changed you work / job due to the pain / arthritis within the last year? 
□ Yes □ No
□ Not sure
Q17. Are you easily depressed or get anxious because of the pain/ arhtritis? 
□ Yes □ No
□ Not sure
Q18. Do you experience abnormal sleeping patterns because of the pain / arhtritis? 
□ Yes □ No
□ Not sure
Q19. Do you feel physically tired due to the pain / arthritis (not able to manage everyday tasks)? 
□ Yes □ No
□ Not sure
THANK YOU FOR TAKING THE TIME TO COMPLETE THIS QUESTIONNAIRE. 
APPENDIX 5 (a) 
WHODAS 2.0 
Page 1 of 2 (12-item, self-administered)
12-item version, self-administered
This questionnaire asks about difficulties due to health conditions. Health conditions include diseases or 
illnesses, other health problems that may be short or long lasting, injuries, mental or emotional problems, 
and problems with alcohol or drugs.
Think back over the past 30 days and answer these questions, thinking about how much difficulty you 
had doing the following activities. For each question, please circle only one response.
Please continue to next page...
. 
In the past 30 days, how much difficulty did you have in:
S1 Standing for long periods such as 30 
minutes?
None Mild Moderate Severe Extreme 
or cannot 
do
S2 Taking care of your household 
responsibilities?
None Mild Moderate Severe Extreme 
or cannot 
do
S3 Learning a new task, for example, 
learning how to get to a new place?
None Mild Moderate Severe Extreme 
or cannot 
do
S4 How much of a problem did you have 
joining in community activities (for 
example, festivities, religious or other 
activities) in the same way as anyone 
else can?
None Mild Moderate Severe Extreme 
or cannot 
do
S5 How much have you been emotionally 
affected by your health problems?
None Mild Moderate Severe Extreme 
or cannot 
do
WHODAS-03(23Nov09).book  Page 1  Tuesday, November 24, 2009  1:30 PM
WHODAS 2.0
WORLD HEALTH ORGANIZATION 
DISABILITY ASSESSMENT SCHEDULE 2.0 
Page 2 of 2 (12-item, self-administered)
      
12   
Self
This completes the questionnaire. Thank you.
In the past 30 days, how much difficulty did you have in:
S6 Concentrating on doing something for 
ten minutes?
None Mild Moderate Severe Extreme 
or cannot 
do
S7 Walking a long distance such as a 
kilometre [or equivalent]?
None Mild Moderate Severe Extreme 
or cannot 
do
S8 Washing your whole body? None Mild Moderate Severe Extreme 
or cannot 
do
S9 Getting dressed? None Mild Moderate Severe Extreme 
or cannot 
do
S10 Dealing with people you do not know? None Mild Moderate Severe Extreme 
or cannot 
do
S11 Maintaining a friendship? None Mild Moderate Severe Extreme 
or cannot 
do
S12 Your day-to-day work? None Mild Moderate Severe Extreme 
or cannot 
do
H1 Overall, in the past 30 days, how many days were these 
difficulties present? Record number of days ____
H2 In the past 30 days, for how many days were you totally unable 
to carry out your usual activities or work because of any health 
condition?
Record number of days ____
H3 In the past 30 days, not counting the days that you were totally 
unable, for how many days did you cut back or reduce your 
usual activities or work because of any health condition?
Record number of days ____
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WHODAS 2.0
WORLD HEALTH ORGANIZATION 
DISABILITY ASSESSMENT SCHEDULE 2.0 
APPENDIX 5 (b) 
WHODAS 2.0 scoring instructions 
1 
Scoring instructions for the WHODAS 2.0 
Firstly the summary score is calculated for each participant by assigning a numerical value to the 
self-reported 5-point Likert scale where none=0, mild=1, moderate=2, severe=3 and extreme=4 for 
each of the 12 items.  The 12 scores for each participant were then added together.  
Secondly, the summary score was converted into a global score with a metric range from 0 to 100 
where 0 was no disability and 100 was full disability. This global score was interpreted as the degree 
of functional limitation.  
The full classification of the WHODAS 2.0 global scores are:  0%-4% no problems;   5%-24% mild 
problem;   25%-49% moderate problem;   50%-95% severe problem and 95%-100% extreme 
problem.   
APPENDIX 6 
EQ-5D-3L 
      
 
South Africa (English) © 1999 EuroQol Group. EQ-5D™ is a trade mark of the EuroQol Group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Health Questionnaire 
 
 
English version for South Africa 
 
South Africa (English) © 1999 EuroQol Group. EQ-5D™ is a trade mark of the EuroQol Group 
2
By placing a tick in one box in each group below, please indicate which statements 
best describe your own state of health TODAY. 
Mobility 
I have no problems in walking about  
I have some problems in walking about  
I am confined to bed  
Self-Care 
I have no problems with self-care  
I have some problems washing or dressing myself  
I am unable to wash or dress myself  
Usual Activities (e.g. work, study, housework, family or 
leisure activities) 
I have no problems with performing my usual activities  
I have some problems with performing my usual activities  
I am unable to perform my usual activities  
Pain/Discomfort 
I have no pain or discomfort  
I have moderate pain or discomfort  
I have extreme pain or discomfort  
Anxiety/Depression 
I am not anxious or depressed  
I am moderately anxious or depressed  
I am extremely anxious or depressed 
South Africa (English) © 1999 EuroQol Group. EQ-5D™ is a trade mark of the EuroQol Group 
3
To help people say how good or bad their state of 
health is, we have drawn a scale (rather like a 
thermometer) on which the best state you can imagine is 
marked 100 and the worst state you can imagine is 
marked 0. 
We would like you to indicate on this scale, in your 
opinion, how good or bad your own health is today. 
Please do this by drawing a line from the box below to 
whichever point on the scale indicates how good or bad 
your state of health is today. 
Your own 
state of health 
today 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
Worst 
imaginable 
state of health 
0 
Best 
imaginable 
state of health 
APPENDIX 7 
Self-efficacy for managing chronic disease Six item-scale 
  
Self-Efficacy for Managing Chronic Disease 6-Item Scale 
We would like to know how confident you are in doing certain activities. For each of the following questions, 
please choose the number that corresponds to your confidence that you can do the tasks regularly at the present 
time. 
 
1. How confident are you that you can keep the 
fatigue caused by your disease from interfering with 
the things you want to do? 
 
Not at all     |     |     |     |     |     |     |     |     |     |     totally 
confident    1     2    3   4    5    6    7    8    9   10  confident 
2. How confident are you that you can keep the 
physical discomfort or pain of your disease from 
interfering with the things you want to do? 
 
Not at all     |     |     |     |     |     |     |     |     |     |   totally 
confident   1     2    3   4    5    6    7    8    9   10  confident 
3. How confident are you that you can keep the 
emotional distress caused by your disease from 
interfering with the things you want to do? 
 
Not at all     |     |     |     |     |     |     |     |     |     |   totally 
confident   1     2    3   4    5    6    7    8    9   10  confident 
4. How confident are you that you can keep any other 
symptoms or health problems you have from 
interfering with the things you want to do? 
 
Not at all     |     |     |     |     |     |     |     |     |     |   totally 
confident   1     2    3   4    5    6    7    8    9   10  confident 
5. How confident are you that you can do the different 
tasks and activities needed to manage your health 
condition so as to reduce your need to see a 
doctor? 
 
Not at all     |     |     |     |     |     |     |     |     |     |   totally 
confident   1     2    3   4    5    6    7    8    9   10  confident 
6. How confident are you that you can do things other 
than just taking medication to reduce how much 
your illness affects your everyday life? 
 
Not at all     |     |     |     |     |     |     |     |     |     |   totally 
confident   1     2    3   4    5    6    7    8    9   10  confident 
APPENDIX 8 
Brief Pain Inventory Short Form 
STUDY ID #:_ _ _ _ _ _ _ _ _ _ DO NOT WRITE ABOVE THIS LINE HOSPITAL #: _ _ _ _ _ _ _ _ _ _
Brief Pain Inventory (Short Form) 
Date: _ _ _ _ / _ _ _ _ / _ _ _ _ Time: _ _ _ _ _ _ _ 
Name: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _    _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _   _ _ _ _ _ _ _ _ _ _ _ _ _ _  
Last First Middle Initial 
1. Throughout our lives, most of us have had pain from time to time (such as minor
headaches, sprains, and toothaches).  Have you had pain other than these every- 
day kinds of pain today?
1. Yes 2. No
2. On the diagram, shade in the areas where you feel pain.  Put an X on the area that
hurts the most.
Right Left Left Right 
Front Back 
3. Please rate your pain by circling the one number that best describes your pain at its
worst in the last 24 hours.
0  1  2  3  4  5  6  7  8  9 10 
No 
Pain 
Pain as bad as
you can imagine
4. Please rate your pain by circling the one number that best describes your pain at its
least in the last 24 hours.
0  1  2  3  4  5  6  7  8  9 10 
No 
Pain 
Pain as bad as
you can imagine
5. Please rate your pain by circling the one number that best describes your pain on
the average.
0  1  2  3  4  5  6  7  8  9 10 
No 
Pain 
Pain as bad as
you can imagine
6. Please rate your pain by circling the one number that tells how much pain you have
right now.
0  1  2  3  4  5  6  7  8  9 10 
No 
Pain 
Pain as bad as
you can imagine
Page 1 of 2 
  
STUDY ID #:_ _ _ _ _ _ _ _ _ _ DO NOT WRITE ABOVE THIS LINE HOSPITAL #: _ _ _ _ _ _ _ _ _ _
 
Date: _ _ _ _/ _ _ _ _ / _ _ _ _ Time: _ _ _ _ _ _ _ _ 
Name: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _    _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _   _ _ _ _ _ _ _ _ _ _ _ _ _ _  
 Last First Middle Initial  
 
7. What treatments or medications are you receiving for your pain? 
 
 
 
8. In the last 24 hours, how much relief have pain treatments or medications  
provided?  Please circle the one percentage that most shows how much relief  
you have received. 
0%    10%    20%    30%    40%    50%    60%    70%    80%    90%    100% 
No 
Relief 
Complete 
Relief 
9. Circle the one number that describes how, during the past 24 hours, pain has 
interfered with your: 
 
A. General Activity 
0  1  2  3  4  5  6  7  8  9  10 
Does not 
Interfere 
Completely 
Interferes 
 
B. Mood 
0  1  2  3  4  5  6  7  8  9  10 
Does not 
Interfere 
Completely 
Interferes 
 
C. Walking Ability 
0  1  2  3  4  5  6  7  8  9  10 
Does not 
Interfere 
Completely 
Interferes 
 
D. Normal Work (includes both work outside the home and housework) 
0  1  2  3  4  5  6  7  8  9  10 
Does not 
Interfere 
Completely 
Interferes 
 
E. Relations with other people 
0  1  2  3  4  5  6  7  8  9  10 
Does not 
Interfere 
Completely 
Interferes 
 
F. Sleep 
0  1  2  3  4  5  6  7  8  9  10 
Does not 
Interfere 
Completely 
Interferes 
 
G. Enjoyment of life 
0  1  2  3  4  5  6  7  8  9  10 
Does not 
Interfere 
Completely 
Interferes 
 
Copyright 1991 Charles S. Cleeland, PhD 
Pain Research Group 
All rights reserved 
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APPENDIX 9 
International Physical Activity Questionnaire (IPAQ) 
 SHORT LAST 7 DAYS SELF-ADMINISTERED version of the IPAQ.  Revised August 2002. 
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
 
We are interested in finding out about the kinds of physical activities that people do as 
part of their everyday lives.  The questions will ask you about the time you spent being 
physically active in the last 7 days.  Please answer each question even if you do not 
consider yourself to be an active person.  Please think about the activities you do at 
work, as part of your house and yard work, to get from place to place, and in your spare 
time for recreation, exercise or sport. 
 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous 
physical activities refer to activities that take hard physical effort and make you breathe 
much harder than normal.  Think only about those physical activities that you did for at 
least 10 minutes at a time. 
 
1. During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, digging, aerobics, or fast bicycling?  
 
_____ days per week  
 
   No vigorous physical activities  Skip to question 3 
 
 
2. How much time did you usually spend doing vigorous physical activities on one 
of those days? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
Think about all the moderate activities that you did in the last 7 days.  Moderate 
activities refer to activities that take moderate physical effort and make you breathe 
somewhat harder than normal.  Think only about those physical activities that you did 
for at least 10 minutes at a time. 
 
 
3. During the last 7 days, on how many days did you do moderate physical 
activities like carrying light loads, bicycling at a regular pace, or doubles tennis?  
Do not include walking. 
 
_____ days per week 
 
   No moderate physical activities  Skip to question 5 
 
 
 SHORT LAST 7 DAYS SELF-ADMINISTERED version of the IPAQ.  Revised August 2002.
4. How much time did you usually spend doing moderate physical activities on one
of those days?
_____ hours per day
_____ minutes per day 
Don’t know/Not sure 
Think about the time you spent walking in the last 7 days.  This includes at work and at 
home, walking to travel from place to place, and any other walking that you have done 
solely for recreation, sport, exercise, or leisure. 
5. During the last 7 days, on how many days did you walk for at least 10 minutes
at a time?
_____ days per week
No walking Skip to question 7 
6. How much time did you usually spend walking on one of those days?
_____ hours per day
_____ minutes per day
Don’t know/Not sure 
The last question is about the time you spent sitting on weekdays during the last 7 
days.  Include time spent at work, at home, while doing course work and during leisure 
time.  This may include time spent sitting at a desk, visiting friends, reading, or sitting or 
lying down to watch television. 
7. During the last 7 days, how much time did you spend sitting on a week day?
_____ hours per day
_____ minutes per day
Don’t know/Not sure 
This is the end of the questionnaire, thank you for participating. 
APPENDIX 10 
Acceptability Questionnaire 
1 
 
MUSCUSLOSKELETAL CONDITIONS AND CO-MORBIDITY QUESTIONNAIRE 
 
TO DETERMINE ACCEPTABILITY TOWARDS THE INTERVENTION 
PROGRAMME 
  
 This questionnaire is for women between the ages of 40 - 64 years attending the intervention 
programme at MUCPP community hall 
 
 This questionnaire is about how you experienced the intervention programme. 
 
 This questionnaire is completely voluntary.  You may choose not to participate or not to 
answer any specific question.  
               
 This questionnaire is completely anonymous.  Please make no marks of any kind on the 
questionnaire which could identify you individually. 
 
 
 
               
 
INSTRUCTIONS 
 
 Please give your honest opinion 
 
 
 
 
 
 
Thank you very much for your co-operation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
ID code _ _ _ _ _ __ _ _ 
Date: _ _ _ _ _ __ _ __ _ _ _ _ __ _ __ _ _ _ _ __ _ _ 
Age: _ _ _ _ _ __ _ __ _ _ _ _ __ _ __ _ _ _ _ __ _  
PHASE III: 
THE FOLLOWING QUESTIONS ASK ABOUT HOW YOU PERSONALLY FEEL ABOUT THE 
PROGRAMME YOU ATTENDED FOR 6 WEEKS 
Q1. What did you like the most about the programme? 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ 
_ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
_ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ 
_ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ _ 
Q2. What did you like the least about the programme? 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ 
_ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
_ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ 
_ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ _ 
3 
Q3. What would you change about the programme? 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ 
_ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
_ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ 
_ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ _ 
Q4. What would you add to the programme? 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ 
_ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
_ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ 
_ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ _ 
Q5. What did you think about the self-management book? 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ 
_ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
_ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ 
_ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ _ 
APPENDIX 11 
Comparison of translation:   COPCORD questionnaire 
1 
COPCORD epidemiological survey questionnaire 
English version Translated version Moderated version Comments 
LENANE LA DIPOTSO LABOKUDI BA 
MESIFA LE MASAPO A 
MMELE(MUSCULOSKELETAL) LE 
LENANE LA DIPOTSO LA MAFU A 
TSAMAELLANANG (CO-MORBIDITY) 
LENANE LA DIPOTSO LABOKUDI BA 
MESIFA LE MASAPO A 
MMELE(MUSCULOSKELETAL) LE 
LENANE LA DIPOTSO LA MAFU A 
TSAMAELLANANG (CO-MORBIDITY) 
Sentence structure corrected. 
(E theilwe hodima Lenane la Dipotso 
la COPCORD) 
(E theilwe hodima Lenane la Dipotso 
la COPCORD) 
Lenane lena la dipotso ke la basadi 
ba pakeng tsa dilemo tse 40-70 ba 
tsamayang Ditliniki tsa Tlhokomelo 
ya Motheo ya Bophelo bo Botle 
Lenane lena la dipotso ke la basadi 
ba pakeng tsa dilemo tse 40-70 ba 
tsamayang Ditliniki tsa Tlhokomelo 
ya Motheo ya Bophelo bo Botle 
Spelling correction 
Lenane lena la dipotso le mabapi le 
bohloko ba manonyeletso, monono 
o fetang tekano, kgathello e
phahameng ya madi le mofuta wa II
wa lefu la tswekere
Lenane lena la dipotso le mabapi le 
bohloko ba manonyeletso, monono 
o fetang tekano, kgathello e
phahameng ya madi le mofuta wa II
wa lefu la tswekere
Lenane lena la dipotso ke la 
boithaopo bo phethahetseng.  O ka 
nka qeto ya ho se nke karolo kapa ho 
se arabe potso efe kapa efe e itseng 
Lenane lena la dipotso ke la 
boithaopo bo phethahetseng.  O ka 
nka qeto ya ho se nke karolo kapa ho 
se arabe potso efe kapa efe e itseng 
Lenane lena la dipotso ke la 
lekunutu bo phethahetseng.  Ka 
kopo o se etse matshwao a mofuta 
ofe kapa ofe a ka o supang ka bo 
mong. 
Lenane lena la dipotso ke la 
lekunutu bo phethahetseng.  Ka 
kopo o se etse matshwao a mofuta 
ofe kapa ofe a ka o supang ka bo 
mong. 
Grammar: Wrong pronoun was used. 
Dintlha tse kopantsweng di tla 
sebediswa ho theha lenaneo la 
tsebisatso ya bophelo bo botle. 
Dintlha tse kopantsweng di tla 
sebediswa ho theha lenaneo la 
tsebisatso ya bophelo bo botle. 
Grammar: Wrong spelling format for 
term. 
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English version Translated version Moderated version Comments 
 DITAELO DITAELO  
 Kgetha karabo e le nngwe feela, ntle 
leha o laetswe ka tsela e nngwe 
Kgetha karabo e le nngwe feela, ntle 
leha o laetswe ka tsela e nngwe 
 
  Ka kopo tshwaya karabo e 
nepahetseng mohl. □√ kapa o e etse 
sedikadikwe karabong e le nngwe moo 
ho bontshitsweng. 
 
 Ka kopo tshwaya karabo e 
nepahetseng mohl. □√ kapa o e etse 
sedikadikwe karabong e le nngwe moo 
ho bontshitsweng. 
 
 
Thank you very much for your co-
operation 
 
Re lebohela tshedisanommoho ya 
hao haholo 
Re lebohela tshedisanommoho ya 
hao haholo 
 
 Khoutu ya ID Khoutu ya ID  
 Mohla: Mohla:  
 Tleliniki: Tleliniki:  
 MOKGAHLELO WA I: MOKGAHLELO WA I:  
 DIPOTSO TSE LATELANG DI BOTSA 
KA DINTLHA TSA HAO TSA BOTHO 
LE NALANE LA BOPHELO BO BOTLE 
(DINTLHA TSE FAPANENG TSA 
DITJHABA) 
DIPOTSO TSE LATELANG DI BOTSA 
KA DINTLHA TSA HAO TSA BOTHO 
LE NALANE LA BOPHELO BO BOTLE 
(DINTLHA TSE FAPANENG TSA 
DITJHABA) 
Grammar: spelling error 
Grammar: Correction by using 
conventional plural translation of the 
term “demographics”. 
 Q1 – Q7 hophethelwa ke mofuputsi 
ka ba/mothusi wa mofuputsi) 
Q1 – Q7 hophethelwa ke mofuputsi 
ka ba/mothusi wa mofuputsi) 
Wrong translation: Wrong sense of 
word used for translation. Intended 
sense of the source term “complete” 
is to “fill in”. The translation renders 
it as “finish off”.    
Correct format for showing plural 
alternative option. Without use of 
brackets for (ba) it would seem as if 
“ba/” is a word on its own, whereas 
if only indicates a plural form of the 
noun 
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English version Translated version Moderated version Comments 
Q1: Dilemo tse Dilemo tse Dilemo tse 
KAPA Letsatsi la tswalo KAPA Letsatsi la tswalo 
Q2: Boima: Boima: 
Q3: Bolelele: Bolelele: 
Q4: Indekse ya Boima ba Mmele: Indekse ya Boima ba Mmele: 
Q5: Teko ya Hemoglucose (ho bala ho 
tswa foldareng haeba e le teng): 
Teko ya Hemoglucose (ho bala ho 
tswa foldareng haeba e le teng): 
“Reading” here has been corrected 
to its true meaning as a noun and 
not a verb. 
Q6: Kgatello ya Madi: Kgatello ya Madi: 
Q 7: Mafu a tsamaellanang le a mang:(ka 
kopo bontsha tsohle tse amehang) 
Mafu a tsamaellanang le a mang:(ka 
kopo bontsha tsohle tse amehang) 
Mofetshe Kankere (Mofetshe) Both terms acceptable but 
“mofetshe” is not a generally known 
term for cancer, unlike the localized 
Afrikaans term “kankere”. Even the 
English term “cancer” is more widely 
known than the original Sesotho 
term “mofetshe”. 
Tswekere (Mofuta wa I wa Lefu la 
Tswekere) 
Tswekere (Mofuta wa I wa Lefu la 
Tswekere) 
Mafu a Methapo ya pelo (Lefu la 
pelo) 
Mafu a methapo ya madi yapelo 
(Lefu la pelo) 
“Coronary” (blood (ya madi) vessels 
of the heart) was not properly 
conveyed in the translations. 
Tshithabelo ya maikutlo Ho sithabela maikutlo The adjective form as opposed to 
the adverb (now corrected to) is not 
wrong but might be too difficult to 
understand for the average Sesotho 
speaker. 
Seterouku Seterouku 
Lefu la nako e telele la ho hema Lefu la nako e telele la ho hema 
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English version Translated version Moderated version Comments 
Q8:  Puo ya lapeng: Puo ya lapeng:  
 Afrikaans Afrikanse Now localised 
 Senyesemane Senyesemane  
 Sesotho Sesotho  
 E nngwe (hlalosa ka kopo) E nngwe (hlalosa ka kopo)  
Q9:  Morabe / Botso Morabe / Setso Wrong spelling corrected 
 MoAforika/Motsho MoAforika/Motsho  
 Mokhalate Wa mmala Better translation for “coloured” 
used 
 Mosweu E mosweu Grammatical correction. 
 
 MoIndia/MoAsia MoIndia/MoAsia  
 E nngwe (hlalosa ka kopo) E nngwe (hlalosa ka kopo)  
Q10: Boemo ba lenyalo: Boemo ba tsalenyalo: Missing conjunction added 
 
 Ha o so nyale/nyalwe Ha o so nyale/nyalwe  
 O nyetse/nyetswe / Molekane wa 
lehae (molekane ya dulang le wena) 
O nyetse/nyetswe / Molekane wa 
lapeng (molekane ya dulang le wena) 
“lehae” is a noun would be used to 
mean “local” and not “domestic”, 
particularly in this context.  
 
 Le arohane / le hlalane Le arohane / le hlalane  
 O mohlolo/mohlohadi O mohlolo/mohlolohadi  
Q11:  Tsebo ya bala: Tsebo ya hobala: Missing preposition added 
 
 Bala feela Ho bala feela Preposition added for grammatical 
correctness 
 
 Bala le ho ngola Ho bala le ho ngola  
 Ha ho letho 
 
 
Ha ho letho  
5 
English version Translated version Moderated version Comments 
Q12: Ha o wa kena sekolo Ha o a kena sekolo 
Sekolo sa mathomo Sekolo sa mathomo 
Ha o wa kena sekolo Ha o a kena sekolo 
Sekolo sa sekhondari Sekolo sa sekhondari 
Thuto ya theshari Thuto e phahameng (ya theshari) The simpler term “e phahameng” 
(higher) is more accessible to the 
reader than the localized “theshiari” 
Q13: O dula kae boholo ba selemo? O dula kae boholo ba selemo? 
Lehae / flete ya hao Lapeng / foleteng ya hao In this context, home is better 
translated as “lapeng” 
Lehaeng la motswalle / setho sa 
lelapa 
Lapeng la motswalle / setho sa 
lelapa 
In this context, home is better 
translated as “lapeng” 
E nngwe (hlalosa ka kopo) Ho sele (hlalosa ka kopo) Wrong translation of “other” 
corrected. Here “other” means 
“other place” not “other thing” as 
was translated.  
Q14: Mofuta wa ntlo: Mofuta wa ntlo: 
Ntlo ya setene Ntlo ya setene 
Ntlo e sa hlophiswang Mokhukhu There is no conventional Sesotho 
original term for the source term. 
However, “mokhukhu” is widely 
accepted as meaning “informal 
housing”. I recommend it for easy 
comprehension. Otherwise the 
translation was too literal and 
devoid of meaning. 
Q15: O dula le batho ba bakae? O dula le batho ba bakae? 
Ke dula ke le mong Ke dula ke le mong 
motho a le mong motho a le mong 
batho ba 2 atho ba 2 
6 
 
English version Translated version Moderated version Comments 
 batho ba 3 batho ba 3  
 batho ba 4 batho ba 4  
 batho ba 5 kapa ho feta batho ba 5 kapa ho feta  
Q16:  Maemo a hao a hajwale a khiro: Maemo a hao a hajwale a kgiro: Spelling corrected 
 
 O sebetsa nako yohle (dihora tse 40 
kapa ho feta ka beke) 
O sebetsa nako yohle (dihora tse 40 
kapa ho feta ka beke) 
 
 Ha o sebetse Ha o sebetse  
 O sebetsa nakwana (ka tlase ho 
dihora tse 40 ka beke) 
O sebetsa nakwana (ka tlase ho 
dihora tse 40 ka beke) 
 
 Mopenshenara Mopenshenara  
 “Mosebetsi wa nako e nyane” “Mosebetsi wa nako e nyane”  
 E nngwe (hlalosa ka kopo) E nngwe (hlalosa ka kopo)  
Q17:  Maemo a hao a hajwale a khiro 
(mosebetsi): 
Maemo a hao a hajwale a kgiro 
(mosebetsi): 
Spelling corrected 
 
 Mme wa lelapa Mme wa lelapa  
 Titjhere Titjhere  
 Mosebetsi wa tafoleng Mosebetsi wa tafoleng  
 O sebetsa lebenkeleng kapa 
kgwebong 
O sebetsa lebenkeleng kapa 
kgwebong 
 
 Mosebeletsi wa feme Mosebetsi wa femeng Spelling corrected. 
 
 Mosebeletsi wa lapeng Mosebeletsi wa lapeng I prefer to keep one term 
“mosebetsi” (worker) as opposed to 
using also “mosebeletsi” (servant) as 
domestic workers have legislated 
rights as well. “Mosebeletsi” sound a 
little inferior” and might  
 
 Sesole Sesole  
 Sepolesa Sepolesa  
7 
English version Translated version Moderated version Comments 
O beile meja fatshe O beile meja fatshe 
Ha o sebetse Ha o sebetse 
E nngwe (hlalosa ka kopo) E nngwe (hlalosa ka kopo) 
Q18: Ho hloka mosebetsi ka lebaka la: Ho hloka mosebetsi ka lebaka la: 
Ho hlokomela lelapa la hao O hlokometse lelapa la hao Better grammatical format 
Ha ke kgone ho fumana mosebetsi Ha ke kgone ho fumana mosebetsi 
Mathata a bophelo bo botle Bothata ba bophelo bo botle 
O na le bokowa O na le bokudi 
Monna ha a ntumelle ho sebetsa Monna ha a ntumelle ho sebetsa 
Ke moholo haholo Ke moholo haholo 
E nngwe (hlalosa ka kopo) Le sele (hlalosa ka kopo) Translation must be for “other 
reason” and not “other thing” (e 
nngwe) 
Q19: Na o fumana penshene kapa grante 
ya mmuso: 
Na o fumana penshene kapa 
keranteya mmuso: 
Spelling corrected 
Ee Ee 
Tjhe Tjhe 
Q20: Haeba ke ee, na ke: Haeba o re ee, na ke: Formulated for better understanding 
as “If you say yes”. English is able to 
read shorter because of its much 
more frequesnt use than Sesotho. 
Grante ya bokowa (ha o kgone ho 
sebetsa ka lebaka la bokudi) 
Keante ya bokowa (ha o kgone ho 
sebetsa ka lebaka la bokudi) 
Spelling corrected 
Penshene (o tsofetse) Penshene (ya maqheku) Incomplete translation. “tsofetse” 
just meas “old” 
Ka bobedi Ka bobedi 
Q21: Ke eng e hlalosang hantle ho fetisisa 
nalane ya hao ya ho tsuba: 
Ke eng e hlalosang hantle kaho 
fetisisa nalane ya hao ya ho tsuba: 
Conjunction added 
Ha o so tsube ho hang Ha o so tsube ho hang 
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O tsuba hona jwale O a tsuba hona jwale 
O ne o tsuba nakong e fetileng O ne o tsuba nakong e fetileng 
Haebake ee, ke dikwae tse kae ka 
letsatsi? 
Haebao re ee, ke kwae e kae ka 
letsatsi? 
See previous 
dikwae” (cigarettes) is not 
grammatically correct. It is noun that 
is incapable of pluralizing for 
Sesotho. Rather “disikarete” could 
be used as in this case; I left the term 
in singular, which by implication 
means also plural, and this will be 
found in the ”how many” part.    
Haeba ke ee, o qadile o le dilemo tse 
kae? 
Haeba o re ee, o qadile o le dilemo 
tse kae? 
See previous 
Q22: Ke eng e hlalosang hantle ho fetisisa 
nalane ya hao ya ho tsuba senifi 
Ke efe e hlalosang hantle ho fetisisa 
nalane ya hao ya ho tsuba seneifi 
Spelling corrected 
Ha ke so sebedise senifi ho hang Ha ke so sebedise seneifi ho hang 
O tsuba senifi hona jwale O tsuba seneifi hona jwale 
Ke ne ke sebedisa senifi nakong e 
fetileng 
Ke ne ke sebedisa seneifi nakong e 
fetileng 
Spelling corrected 
Haeba ke ee, o tsuba senifi makgetlo 
a makae ka letsatsi? 
Haeba o re ee, o tsuba seneifi 
makgetlo a makae ka letsatsi? 
See previous 
Haeba ke ee, o qadile o le dilemo tse 
kae? 
Haeba o re ee, o qadile o le dilemo 
tse kae? 
See previous 
Q23: Ke eng e hlalosang hantle ho fetisisa 
nalane ya hao ya tshebediso ya 
jwala: 
Ke efe e hlalosang hantle ka ho 
fetisisa nalane ya hao ya tshebediso 
ya jwala: 
See previous 
Ha ke so sebedise dihlahiswa tsa 
jwala ho hang 
Ha ke so sebedise dihlahiswa tsa 
jwala ho hang 
Ke sebedisa dihlahiswa tsa jwala a 
jwale 
Ke sebedisa dihlahiswa tsa jwala a 
jwale 
Ke ne ke sebedisa dihlahiswa tsa 
jwala nakong e fetileng 
Ke ne ke sebedisa dihlahiswa tsa 
jwala nakong e fetileng 
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 Haeba ke ee, o sebedisa jwala ka 
makgetlo a makae ka beke? 
Haeba o re ee, o sebedisa jwala ka 
makgetlo a makae ka beke? 
See previous 
 
 Haeba ke ee, o qadile o le dilemo tse 
kae? 
Haeba o re ee, o qadile o le dilemo 
tse kae? 
See previous 
 
 DIPOTSO TSE LATELANG DI MABAPI 
LE BOPHELO BA HAO BO BOTLE 
DIPOTSO TSE LATELANG DI MABAPI 
LE BOPHELO BA HAO BO BOTLE 
 
Q24:  Bophelo ba hao bo botle ka 
kakaretso bo  
Bophelo ba hao bo botle ka 
kakaretso bo  
 
 Bo tswa pele Bo tswile matsoho Correct form of the Sesotho saying. 
 
 Bo botle haholo Bo botle haholo  
 Bo botle Bo botle  
 Bo mahareng Bo mahareng  
 Bo a fokola Bo a fokola  
 Na o kile wa bolellwa ke ngaka hore 
o na le? 
Na o kile wa bolellwa ke ngaka hore 
o na le? 
 
 Kgatello e phahameng ya madi 
(Hypertension) 
Kgatello e phahameng ya madi 
(Hypertension) 
 
 Tswekere (Mofuta wa II wa Lefu la 
Tswekere) 
Tswekere (Mofuta wa II wa Lefu la 
Tswekere) 
 
 Botenya bo fetang tekano Botenya bo fetang tekano  
 Kholesterole (hyperlipidaemia) Kholesterole (hyperlipidaemia)  
 Bohloko ba manonyeletso (Bokudi 
ba mesifa le masapo a mmele) 
Bohloko ba manonyeletso (Bokudi 
ba mesifa le masapo a mmele) 
 
 Lebaka la hao la sehlooho la ho 
etela tleliniki kajeno ke lefe? 
Lebaka la hao la sehlooho la ho 
etela tleliniki kajeno ke lefe? 
 
 Ho tla bona sista / mooki Ho tla bona sista / mooki  
 Ho tla bona ngaka Ho tla bona ngaka  
 Ho fumana meriana Ho fumana meriana  
 Bobedi sista le meriana Bobedi sista le meriana 
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Bohloko ba manonyeletso (Bokudi 
ba mesifa le masapo a mmele) 
Bohloko ba manonyeletso (Bokudi 
ba mesifa le masapo a mmele) 
E nngwe (hlalosa ka kopo)  E nngwe (hlalosa ka kopo) 
Ke efe ya mafu a latelang ao o 
bileng le ona dikgweding tse tharo 
tse fetileng? 
Ke afe a mafu a latelang ao o bileng 
le oona dikgweding tse tharo tse 
fetileng? 
Grammatical correction: The context 
is plural, “conditions”. Translation 
was singular and asking as if only 
one could apply. 
Kgatello e phahameng ya madi 
(Hypertension) 
Kgatello e phahameng ya madi 
(Hypertension) 
Tswekere (Mofuta wa II wa Lefu la 
Tswekere) 
Tswekere (Mofuta wa II wa Lefu la 
Tswekere) 
Botenya bo fetang tekano Botenya bo fetang tekano 
Bohloko ba manonyeletso kapa 
mesifa 
Bohloko ba manonyeletso kapa 
mesifa 
Ho lemala kapa kotsi Ho lemala kapa kotsi 
Mathata a pelo Mathata a pelo 
Ditletlebo mabapi le mpa Ditletlebo mabapi le mpa 
Mathata a amanang lebong kapa 
ditho tsa mosese 
Mathata a amanang leditho tsa bong 
kapa tsa mosese 
Previous translation was saying 
“bong” which means “sex/gender” 
as opposed to the correction offered 
now “ditho tsa bong” (genito…”) 
Mofetshe Seso se sa foleng A simpler translation as already 
mentioned above offered.  
Ditshwaetso (TB/e nngwe Ditshwaetso (TB/e sele See previous 
Kgolofalo Kgolofalo 
E nngwe (hlalosa ka kopo) Le sele (hlalosa ka kopo) See previous 
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 Na ngaka ya hao kapa sista / mooki 
o kile a o jweta hore o hloka ho 
latela lenaneo la boikwetliso? 
Na ngaka ya hao kapa sista / mooki 
o kile a o jwetsa hore o hloka ho 
latela lenaneo la boikwetliso? 
Spelling corrected. 
 
 Ee Ee  
 Tjhe Tjhe  
 Ha ke na bonnete Ha ke na bonnete  
 Nakong ya dikgwedi tse 3 tse 
fetileng na o bile le bohloko, ho 
opelwa, ho ruruha, ho satalla (ho 
tiya) kahare kapa ho potoloha 
manonyeletso a hao kapa 
mokokotlo bo sa amananeng le ho 
lemala / kotsi? 
Nakong ya dikgwedi tse 3 tse 
fetileng na o bile le bohloko, ho 
opelwa, ho ruruha, ho satalla (ho 
tiya) kahare kapa ho potoloha 
manonyeletso a hao kapa 
mokokotlo bo sa amananeng le ho 
lemala / kotsi? 
 
 Ee Ee  
 Tjhe Tjhe  
 Ha ke na bonnete Ha ke na bonnete  
 Nakong ya matsatsi a 7 a fetileng na 
o bile le bohloko, ho opelwa, ho 
ruruha, ho satalla (ho tiya) kahare 
kapa ho potoloha manonyeletso a 
hao kapa mokokotlo bo sa 
amananeng le ho lemana / kotsi? 
Nakong ya matsatsi a 7 a fetileng na 
o bile le bohloko, ho opelwa, ho 
ruruha, ho satalla (ho tiya) kahare 
kapa ho potoloha manonyeletso a 
hao kapa mokokotlo bo sa 
amananeng le ho lemana / kotsi? 
 
 Ee Ee  
 Tjhe Tjhe  
 Ha ke na bonnete Ha ke na bonnete  
 Khoutu ya ID Khoutu ya ID  
 Mohla: Mohla:  
 Tleliniki: Tleliniki:  
 MOKGAHLELO WA II: 
 
 
MOKGAHLELO WA II:  
12 
English version Translated version Moderated version Comments 
DIPOTSO TSE LATELANG DI BOTSA 
KA BOHLOKO KA MANONYELETSO 
KAPA MESIFA, HO SATALLA / HO 
TIYA KAPA HO RURUHA HO 
POTOLOHA MANONYELETSO A 
HAO, KAPA MOTSAMAO O 
FOKOTSEHILENG 
MANONYELETSONG AFE KAPA AFE 
DIPOTSO TSE LATELANG DI BOTSA 
KA BOHLOKO BA MANONYELETSO 
KAPA MESIFA, HO SATALLA / HO 
TIYA KAPA HO RURUHA HO 
POTOLOHA MANONYELETSO A 
HAO, KAPA MOTSAMAO O 
FOKOTSEHILENG 
MANONYELETSONG AFE KAPA AFE 
Spelling corrected 
Ka kopo bontsha sebopehong se ka 
tlase, ka dibaka tsohle tseo o 
utlwileng bohloko ho tsona 
dikgweding tse 3 tse fetileng pele 
ho patlisiso mmele ka X dibakeng 
tsohle moo o bileng le ho ruruha 
Ka kopo bontsha setshwanshong se 
ka tlasemona, ka dibaka tsohle 
tseo o utlwileng bohloko ho tsona 
dikgweding tse 3 tse fetileng pele 
ho patlisiso le ka X dibakeng tsohle 
moo o bileng le ho ruruha 
Wrong translation of “figure” 
corrected. 
Missing word added 
Unnecessary additional word 
deleted.  
Ka pele Ka pele 
Ka morao Ka morao 
Ka kopo bontsha sebopehong se ka 
tlase, ka dibaka tsohle tseo o 
utlwileng bohloko ho tsona 
matsatsing a 7 a fetileng pele ho 
patlisiso mme le ka X dibakeng 
tsohle moo o bileng le ho ruruha 
Ka kopo bontsha setshwantshong se 
ka tlasemona, ka dibaka tsohle 
tseo o utlwileng bohloko ho tsona 
matsatsing a 7 a fetileng pele ho 
patlisiso le ka X dibakeng tsohle 
moo o bileng le ho ruruha 
Wrong translation of “figure” 
corrected. 
Missing word added 
Unnecessary additional word 
deleted.  
Ka pele Ka pele 
Ka morao Ka morao 
Bohloko bo qadile neng? Bohloko bo qadile neng? 
Ka tlase ho matsatsi a 7 a fetileng Ka tlase ho matsatsi a 7 a fetileng 
Dikgweding tse 3 tse fetileng Dikgweding tse 3 tse fetileng 
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 Dikgwedi tse 3 – selemo se 1 se 
fetileng 
Dikgwedi tse 3 ho isa selemong se 1 
se fetileng 
Not advisable to use hyphen if there 
is a mixture of a number and words. 
Preferable only when numerals a 
used. 
Spelling corrected 
 
 Ho feta selemo se 1 se fetileng Ho feta selemo se 1 se fetileng  
 Ke matsatsi a makae dikgweding tse 
3 tse fetileng na o bile le bohloko 
bofe kapa bofe? 
Ke matsatsi a makae dikgweding tse 
3 tse fetileng o bileng le bohloko 
bofe kapa bofe? 
Correct language format for a 
question used.   
 Bontsha sekaleng matla a bohloko 
boo o bileng le bona nakong ya 
matsatsi a 7 a fetileng. 
Bontsha sekaleng matla a bohloko 
boo o bileng le bona nakong ya 
matsatsi a 7 a fetileng. 
 
 Ha ho bohloko         Ha ho bohloko          
 Bo bobebe Bo bobebe  
 Bo bobebe Bo bobebe  
 Totile Bo totileng Preposition used and correct 
phrasing used. These terms are 
incapable of standing on their own 
without a preposition.  
 
 Totile haholo Bototileng haholo Preposition used and correct 
phrasing used. These terms are 
incapable of standing on their own 
without a preposition. 
 
 Totile haholo Bototileng haholo Preposition used and correct 
phrasing used. These terms are 
incapable of standing on their own 
without a preposition. 
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Bontsha sekaleng matla a bohloko 
boo o bileng le bona nakong ya 
dikgwedi tse 3 tse fetileng. 
Bontsha sekaleng matla a bohloko 
boo o bileng le bona nakong ya 
dikgwedi tse 3 tse fetileng. 
Ha ho bohloko Ha ho bohloko 
Bo bobebe Bo bobebe 
Bo bobebe Bo bobebe 
Bo totileng Bo totileng Preposition used and correct 
phrasing used. These terms are 
incapable of standing on their own 
without a preposition.  
Bototileng haholo Bototileng haholo Preposition used and correct 
phrasing used. These terms are 
incapable of standing on their own 
without a preposition. 
Bototileng haholo Bototileng haholo Preposition used and correct 
phrasing used. These terms are 
incapable of standing on their own 
without a preposition. 
Ha ho bohloko Ha ho bohloko 
Bo bobebe Bo bobebe 
Haeba bohloko bo hlaha hape le 
hape, ketsahalo eo e nka nako e 
kae? 
Haeba bohloko bo hlaha 
kgafetsakgafetsa, ketsahalo eo e 
nka nako e kae? 
Proper translation term now used. 
Matsatsi a mmalwa Matsatsi a mmalwa 
dibeke tse 4 - 6 dibeke tse 4 - 6 
dibeke tse 6 - 12 dibeke tse 6 - 12 
Ho feta dikgwedi tse 3 Ho feta dikgwedi tse 3 
Bohloko to matla haholo neng? Bohloko bo matla haholo neng? Spelling corrected 
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 Hoseng ha o tsoha Hoseng ha o tsoha  
 Kamora tshebetso (ho etsa ho hong) Kamora tshebetso (ho etsa ho hong)  
 Ha o phomotse bosiu Ha o phomotse bosiu  
 E nngwe (hlalosa ka kopo) E nngwe (hlalosa ka kopo)  
 Nakong ya selemo se fetileng na o 
bile le ho tiya / ho satalla 
manonyeletsong a hao hoseng 
kamora ho tswa dikobong kapa 
kamora phomolo e telele ntle le 
motsamao? 
Nakong ya selemo se fetileng na o 
bile le ho tiya / ho satalla 
manonyeletsong a hao hoseng 
kamora ho tswa dikobong kapa 
kamora phomolo e telele ntle le ho 
tsamaya? 
Grammatical correction: Adverb 
used instead of an adjective. 
 
 Ee Ee  
 Tjhe Tjhe  
 Ha ke na bonnete Ha ke na bonnete  
 Ho tiya /  ho satalla ho bile teng 
nako e kae? 
Ho tiya /  ho satalla ho bile teng 
nako e kae? 
 
 metsotso e 30 kapa ka tlase  metsotso e 30 kapa ka tlase   
 Ho feta metsotso e 30  Ho feta metsotso e 30   
 Na ho tiya /  ho satalla ho ile ha 
tsamaya kamora ho ikwetlisa kapa 
ho itsamaisa manonyeletso? 
Na ho tiya /  ho satalla ho ile ha fela 
kamora ho ikwetlisa kapa ho 
itsamaisa manonyeletso? 
Literal translation corrected. “go 
away” here means “end” or “stop” 
 
 Ee Ee  
 Tjhe Tjhe  
 Ha ke na bonnete Ha ke na bonnete  
 Na o kile wa fumanwa kapa na 
motho o kile a o jwetsa hore o na le 
lefu la masapo kapa mafu a mang a 
manonyeletso jwalo ka ramatiki? 
Na o kile wa fumanwa kapa na 
motho o kile a o jwetsa hore o na le 
lefu la masapo kapa mafu a mang a 
manonyeletso jwalo ka ramatiki? 
 
 Phumano ya lefu eo o e fuweng ke 
efe? 
Phumano ya lefu eo o e fuweng ke 
efe? 
 
 Phumano ya lefu e entswe kae mme 
ke mang? 
Phumano ya lefu e entswe kae?  
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Na o ntse o nwa moriana bakeng sa 
bohloko ba manonyeletso kapa 
mokokotlo, o sa amananeng le 
temalo, nakong ya dikgwedi tse 3? 
Na o ntse o nwa moriana bakeng sa 
bohloko ba manonyeletso kapa 
mokokotlo, o sa amananeng le 
temalo, nakong ya dikgwedi tse 3? 
“Addiction” needs further clarity in 
the English. Otherwise, wrongly 
translated in Sesotho 
Ee Ee 
Tjhe Tjhe 
Ha ke na bonnete Ha ke na bonnete 
Haeba ke ee, ho sebedisitswe 
meriana efe? 
Haeba o re ee, o sebedisitse 
meriana efe? 
See previous 
Dibolaya bohloko tse ithekelwang 
Meriana ya tlhaho, dimela, 
ditlatsetso 
Meriana ya tlhaho, dimela, 
ditlatsetsotsa phepo 
Incomplete translation made 
complete 
Meriana e ithekelwang e kgahlano le 
tlerefalo (NSAIDS’s) 
Meriana e ithekelwang e alafang 
tlerefalo (di-NSAIDS) 
Literal wrong translation for “anti” 
(against) here. The purposive 
meaning here is “something that 
treats/works against”  
Meriana e laetsweng ke ngaka e 
kgahlano le tlerefalo (NSAIDS’s) 
Meriana e laetsweng ke ngaka e 
alafang tlerefalo (di-NSAIDS) 
Literal wrong translation for “anti” 
(against) here. The purposive 
meaning here is “something that 
treats/works against”  
Meriana e meng e laetsweng ke 
ngaka 
Meriana e meng e laetsweng ke 
ngaka 
E nngwe (hlalosa ka kopo) E meng (hlalosa ka kopo) Spelling corrected 
Na o fumane mofuta ofe kapa ofe o 
mong wa kalafo, ntle le moriana wa 
bohloko? 
Na o fumane mofuta ofe kapa ofe o 
mong wa kalafo, ntle le moriana wa 
bohloko? 
Ee Ee 
Tjhe Tjhe 
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Ha ke na bonnete Ha ke na bonnete 
Hlalosa ka kopo Hlalosa ka kopo 
Kameho ke efe, haeba e le teng, eo 
bohloko / lefu la masapo le bileng le 
yona bophelong ba hao jwalo ka ha 
ho bontshitswe ka tlase? 
Kameho ke efe, haeba e le teng, eo 
bohloko / lefu la masapo le bileng le 
yona bophelong ba hao jwalo ka ha 
ho bontshitswe ka tlasemoo? 
Left out word added. 
Ha ho letho Ha ho letho 
Bobebe Bobebe 
Mahareng Mahareng 
Totile Totile 
Dikamano tsa lelapa Dikamano tsa lelapa 
Dikamano tsa setjhaba Dikamano tsa setjhaba 
Dikamano tsa lenyalo (ho 
kenyeletswa mesebetsi yathobalano 
Dikamano tsa lenyalo (ho 
kenyeletswa diketso tsathobalano 
In Sesotho “thobalano” incorporates 
“activities” by implication. “Acts 
of/activities” (mesebetsi ya) is not 
necessary to translate.   
Maemo a ditjhelete Maemo a ditjhelete 
Bokgoni ba ho sebetsa Bokgoni ba ho sebetsa 
Mosebetsi wa boithabiso Mosebetsi wa boithabiso 
Dipapadi Dipapadi 
Tse ding, hlalosa ka kopo Tse ding, hlalosa ka kopo 
Na o emisitse ho sebetsa ka lebaka 
la bohloko / lefu la masapo nakong 
ya selemo se fetileng? 
Na o emisitse ho sebetsa ka lebaka 
la bohloko / lefu la masapo nakong 
ya selemo se fetileng? 
Ee Ee 
Tjhe Tjhe 
Ha ke na bonnete Ha ke na bonnete 
Na o fetotse mosebitsi wa hao ka 
lebaka la bohloko / lefu la masapo 
nakong ya selemo se fetileng? 
Na o fetotse mosebetsi wa hao ka 
lebaka la bohloko / lefu la masapo 
nakong ya selemo se fetileng? 
Spelling corrected 
Ee Ee 
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Tjhe Tjhe 
Ha ke na bonnete Ha ke na bonnete 
Na o nyahama ha bonolo kapa o 
ngongorehe ka lebaka la bohloko / 
lefu la masapo? 
Na o nyahama ha bonolo kapa o 
ngongorehe ka lebaka la bohloko / 
lefu la masapo? 
a boroko ba hao bo etsahala ka 
tsela e sa tlwaelehang ka lebaka la 
bohloko / lefu la masapo? 
a boroko ba hao bo etsahala ka 
tsela e sa tlwaelehang ka lebaka la 
bohloko / lefu la masapo? 
Ee Ee 
Tjhe Tjhe 
Ha ke na bonnete Ha ke na bonnete 
Na o ikutlwa o khathetse mmeleng 
ka lebaka la bohloko / lefu la 
masapo (o sa kgone ho etsa 
mesebetsi ya letsatsi le letsatsi)? 
Na o ikutlwa o kgathetse mmeleng 
ka lebaka la bohloko / lefu la 
masapo (o sa kgone ho etsa 
mesebetsi ya letsatsi le letsatsi)? 
Spelling corrected 
RE A LEBOHA HA O NKILE NAKO YA 
HO PHETHELA LENANE LENA LA 
DIPOTSO 
RE A LEBOHA HA O NKILE NAKO YA 
HO PHETHA LENANE LENA LA 
DIPOTSO 
“phethela” means to finish off 
something that was left off. 
“Phetha” means complete. 
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Comparison of translation:   WHODAS 2.0 
1 
WHODAS 2.0 self-administered 12-item questionnaire 
English version Translated version Moderated version Comments 
Kgatiso ya  dintho tse 12, tse 
tsamaiswang ke wena 
Kgatiso ya  dintho tse 12, tse 
tsamaiswang ke wena 
Wrong translation. Translation of 
“version” is “kgatiso” and not 
“mofuta”, which means “type of” 
Lenane lena la dipotso le botsa ka 
mathata a bakwang ke maemo a 
amangbophelo bo botle. Maemo a 
amangbophelo bo botle a kenyeletsa 
mafu kapa bokudi, mathata a mang a 
bophelo bo botle a ka bang 
makgutshwane kapa a nka nako e 
telele, ditemalo, mathata a kelello 
kapa maikutlo, le mathata ka jwala 
kapa dithethefatsi. 
Lenane lena la dipotso le botsa ka 
mathata a bakwang ke maemo a 
amangbophelo bo botle. Maemo a 
amangbophelo bo botle a kenyeletsa 
mafu kapa bokudi, mathata a mang a 
bophelo bo botle a ka bang 
makgutshwane kapa a nka nako e 
telele, ditemalo, mathata a kelello 
kapa maikutlo, le mathata ka jwala 
kapa dithethefatsi. 
Omission of conjunction corrected. 
Nahana ka matsatsi a 30 a fetileng 
mme o arabe dipotso tsena, o 
nahana ka boholo ba bothata bo o 
bileng le bona ho etsa mesebetsi e 
latelang Bakeng sa potso ka nngwe, 
ka kopo etsa sedikadikwe ho karabo 
e le nngwe feela. 
Nahana ka matsatsi a 30 a fetileng 
mme o arabe dipotso tsena, o 
nahana ka boholo ba bothata bo o 
bileng le bona ho etsa mesebetsi e 
latelang Bakeng sa potso ka nngwe, 
ka kopo etsa sedikadikwe ho karabo 
e le nngwe feela. 
In the past 30 days, how much 
difficulty did you have in: 
Nakong ya matsatsi a fetileng a 30, o 
bile le bothata bo bokae ba ho 
Nakong ya matsatsi a fetileng a 30, o 
bile le bothata bo bokae ba ho 
None Letho Letho 
Mild Bobebe Bobebe 
Moderate Mahareng Mahareng 
Severe Totileng Totileng Grammatical correction (participle 
form) 
Extreme of cannot do Totileng haholo kapa ha o kgone ho 
etsa 
Totileng haholo kapa ha o kgone ho 
etsa 
Grammatical correction (participle 
form) 
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S1: Standing for long periods such as 
30 minutes? 
Ho hlokomela boikarabello ba hao ba 
lapeng? 
Ho hlokomela boikarabello ba hao ba 
lapeng? 
S2: Taking care of your household 
responsibilities? 
Ho ithuta mosebetsi o motjha, 
mohlala, ho ithuta ho fihla sebakeng 
se sejtha? 
Ho ithuta mosebetsi o motjha, 
mohlala, ho ithuta ho fihla sebakeng 
se sejtha? 
S3: Learning a new task, for 
example, learning how to get to a 
new place? 
O bile le bothata bo bokae ka ho nka 
karolo mesebetsing ya 
setjhaba(mohlala, mesebetsi ya 
mekete, bodumedi kapa e meng) ka 
tsela e tshwanang le batho ba bang? 
O bile le bothata bo bokae ka ho nka 
karolo mesebetsing ya 
setjhaba(mohlala, mesebetsi ya 
mekete, bodumedi kapa e meng) ka 
tsela e tshwanang le batho ba bang? 
S4: How much of a problem did you 
have joining in community activities 
(for example, festivities, religious or 
other activities) in the same way as 
anyone else can? 
O amehile hakae maikutlong ke 
mathata a hao a bophelo bo botle? 
O amehile hakae maikutlong ke 
mathata a hao a bophelo bo botle? 
S5: How much have you been 
emotionally affected by your health 
problems? 
Matsatsing a 30 a fetileng,a bileng le 
bothata bo bokae ka: 
Matsatsing a 30 a fetileng,a bileng le 
bothata bo bokae ka: 
Translation was too verbose for a 
questionnaire question. I excised the 
redundant words “matsatsing a 
makae” 
S6: Concentrating on doing 
something for ten minutes? 
Ho tsepamisa maikutlo ho etseng 
ntho bakeng sa metsotso e 10 
Ho tsepamisa maikutlo ho etseng 
ntho bakeng sa metsotso e 10 
S7: Walking a long distance such as a 
kilometre [or equivalent]? 
Ho tsamaya sebaka se se lelele 
bakhilomitara[kapa ho lekana]? 
Ho tsamaya sebaka se se lelele 
bakhilomitara[kapa ho lekana]? 
Not part of source and unnecessary. 
S8: Washing your whole body? Ho hlapa mmele wa hao kaofela? Ho hlapa mmele wa hao kaofela? Spelling corrected 
S9: Getting dressed? Hoapara? Hoapara? 
S10: Dealing with people you do not 
know? 
Ho sebetsana  le bathobao o sa ba 
tsebeng? 
Ho sebetsana  le bathobao o sa ba 
tsebeng? 
S11: Maintaining a friendship? Ho boloka setswalle? Ho boloka setswalle? 
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English version Translated version Moderated version Comments 
S12: Your day-to-day work? Mosebetsi / sekolo  sa hao sa letsatsi le 
letsatsi?  
Mosebetsi / sekolo  sa hao sa letsatsi le 
letsatsi?  
 
H1: Overall, in the past 30 days, how 
many days were these difficulties 
present? 
Ka kakaretso, matsatsing a 30 a 
fetileng, ke ka matsatsi a makae 
mathata ao a bileng teng? 
Ka kakaretso, matsatsing a 30 a 
fetileng, ke ka matsatsi a makae 
mathata ao a bileng teng? 
 
H2: In the past 30 days, for how 
many days were you totally unable 
to carry out your usual activities or 
work because of any health 
condition? 
Matsatsing a 30 a fetileng, ke ka 
matsatsi a makae o neng o sa kgone 
ho hang ho etsa mesebetsi ya hao 
ya tlwaelo kapa ho sebetsa ka 
lebaka la boemo bofe kapa bofe 
bo amang bophelo bo botle? 
Matsatsing a 30 a fetileng, ke ka 
matsatsi a makae o neng o sa kgone 
ho hang ho etsa mesebetsi ya hao 
ya tlwaelo kapa ho sebetsa ka 
lebaka la boemo bofe kapa bofe 
bo amang bophelo bo botle? 
Necessary conjunction added 
 
H3: In the past 30 days, not counting 
the days that you were totally 
unable, for how many days did you 
cut back or reduce your usual 
activities or work because of any 
health condition 
Matsatsing a 30 a fetileng, ho sa 
balwe matsatsi ao oneng o sa 
kgone kahohlehohle, ke ka 
matsatsi a makae o ileng wa 
fokotsakapa wa theola mesebetsi ya 
hao ya tlwaelo kapa mosebetsi ka 
lebaka la maemo a hao a 
amangbophelo bo botle? 
Matsatsing a 30 a fetileng, ho sa 
balwe matsatsi ao oneng o sa 
kgone kahohlehohle, ke ka 
matsatsi a makae o ileng wa 
fokotsakapa wa theola mesebetsi ya 
hao ya tlwaelo kapa mosebetsi ka 
lebaka la maemo a hao a 
amangbophelo bo botle? 
Omission corrected. 
Typing error corrected. 
Necessary conjunction added 
 
This completes the questionnaire. 
Thank you. 
 
Sena se phethela puisano ya rona Ke 
a lebohaha o nkile karolo 
Sena se phethela puisano ya rona Ke 
a lebohaha o nkile karolo 
Omitted words added.  
 
 
APPENDIX 13 
Comparison of translation: Self-efficacy for managing chronic disease Six-item scale 
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Self-efficacy for Managing Chronic Disease Six-Item Scale 
English version Translated version Moderated version Comments 
Self-efficacy for Managing Chronic 
Disease six-Item 
Bonna boikemetseng ka ho 
bookamedi ba Chronic Disease ka 
dintlha tse tseletseng 
Bonna boikemetseng ka ho 
bookamedi ba mafu a sa foleng ka 
dintlha tse tseletseng 
Chronic disease was not translated 
We would like to know how 
confident you are in doing certain 
activities. For each of the following 
questions, please choose the 
number that corresponds to your 
confidence that you can do the tasks 
regularly at the present time. 
Re ka thabela ho tseba ka botshepo 
ba hao ka ho nka karolo ho 
dithebetso tsena.  Ho tswa potsong 
engwe le engwe ho dipotsi tsena tse 
latelang. Ka kopa kgetha nomoro ka 
ho araba ka boitshepo ba hao ka ho 
ka etsa karolo motsotsong ona. 
Re ka thabela ho tseba ka boitshepo 
ba hao ka ho nka karolo ho 
ditshebetso tsena.  Ho tswa potsong 
engwe le engwe ho dipotsi tsena tse 
latelang. Ka kopa kgetha nomoro ka 
ho araba ka boitshepo ba hao ka ho 
ka etsa karolo motsotsong ona. 
Typing error corrected 
1. How confident are you that you
can keep the fatigue caused by your
disease from interfering with the
things you want to do?
1. O ka hole hokae ka ho
tshwarella mokgathala o
etswang ke ho kula ha hao ka ho
setiswa ke dintho tseo o batlang
ho di etsa?
1. O ka itshepa hole hokae ka ho
tshwarella mokgathala o
etswang ke ho kula ha hao ka ho
setiswa ke dintho tseo o batlang
ho di etsa?
Word omitted 
2. How confident are you that you
can keep the physical discomfort or
pain of your disease from interfering
with the things you want to do?
2. O ka itshepa hole hokae ka ho
tshwarela ha mmele osa tsitsang
kapa bokloko ba ho kula ha hao
ka ho setiswa ke dintho tseo o
batlang ho di etsa?
2. O ka itshepa hole hokae ka ho
tshwarella ha mmele osa tsitsang
kapa bokloko ba ho kula ha hao
ka ho setiswa ke dintho tseo o
batlang ho di etsa?
Typing error corrected 
3. How confident are you that you
can keep the emotional distress
caused by your disease from
interfering with the things you want
to do?
3. O ka itshepa hole hokae ka ho
tshwarella bohloko ba maikutlo bo
etswng ke ho kula ha hao ka ho
setiswa ke dintho tseo o batlang
ho di etsa?
3. O ka itshepa hole hokae ka ho
tshwarella bohloko ba maikutlo bo
etswng ke ho kula ha hao ka ho
setiswa ke dintho tseo o batlang
ho di etsa?
2 
English version Translated version Moderated version Comments 
4. How confident are you that you
can keep any other symptoms or
health problems you have from
interfering with the things you want
to do?
4. O ka itshepa hole ho kae ka ho
tshwarella ke matshwao kappa
bothata ba bophelo boo onang le
bona bo setisehang ke dintho tseo
o batlang ho di etsa?
5. How confident are you that you
can do the different tasks and
activities needed to manage your
health condition so as to reduce your
need to see a doctor?
5. O ka itshepa hole ho kae ka hore
o etse dikarolo tse fapaneng le
ditshebetso tse hlokahlang ho
hlkomela bophelo ba ha obo tlasa
dipehelo ka ho theoloa dihloko tsa
hao ka hore o bone ngaka?
6. How confident are you that you
can do things other than just taking
medication to reduce how much
your illness affects your everyday
life?
6. O itshepa hole ho kae ka ho ka
etsa dintho ho feta ka ho nka
moriana hore o theole bongata ba
ho kula ha hao boo bo etswang ka
ho phela letsatsi le letsatsi?
6. O itshepa hole ho kae ka ho ka
etsa dintho ho feta ka ho nka
meriana hore o theole bongata ba
ho kula ha hao boo bo etswang ka
ho phela letsatsi le letsatsi?
Typing error corrected 
Not at all confident Ha ho bonnete haholo 
Totally confident Bonnete bo boholo 
APPENDIX 14 
Comparison of translation:  International Physical Activity Questionnaire 
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International Physical Activity Questionnaire 
English version Translated version Moderated version Comments 
LENANE LA DIPOTSO LA MATJHABA 
LA DIKETSO TSA TSHEBEDISO YA 
MMELE 
LENANE LA DIPOTSO LA MATJHABA 
LA DIKETSO TSA TSHEBEDISO YA 
MMELE 
Lenaneo” means “programme”. This 
is a list of questions, therefore the 
correct term is “lenane”  
I feel the use of “diketso” 
(acts/actions/activities) in the 
opening here will help provide better 
clarity on the broad meaning of 
“activity” which unfortunately in 
Sesotho has no unique translation 
equivalent. We use the generic term 
“work”. Thankfully the context here 
is enough to clarify that activity can 
also mean sport or just about 
anything a person does.  
“Tshebetso” would be wrong as it 
means things that the body does, 
whether on its own or through a 
person’s acts..  
Re lakatsa ho tseba mefuta ya 
mesebetsi ya mmele eo batho ba e 
etsang jwalo ka karolo ya maphelo a 
bona a letsatsi le letsatsi 
Re lakatsa ho tseba mefuta ya 
mesebetsi ya mmele eo batho ba e 
etsang jwalo ka karolo ya maphelo a 
bona a letsatsi le letsatsi 
“Re na le kgahleho” is not simply put 
(too verbose) as it should compare 
to “re lakatsa” (we want to …).  
Dipotso di tla o botsa ka nako eo o e 
qetileng o sebedisa mmele nakong 
ya matsatsi a 7 a fetileng 
Dipotso di tla o botsa ka nako eo o e 
qetileng o sebedisa mmele nakong 
ya matsatsi a 7 a fetileng 
2 
English version Translated version Moderated version Comments 
Ka kopo araba potso ka nngwe le 
haeba o sa ipone jwalo ka motho ya 
sebedisang mmele 
Ka kopo araba potso ka nngwe le 
haeba o sa ipone jwalo ka motho ya 
sebedisang mmele 
Ka kopo nahana ka mesebetsi eo o e 
etsang mosebetsing, jwalo ka karolo 
ya mosebetsi wa hao wa ka tlung le 
jareteng, ho tloha sebakeng se seng 
ho ya ho se seng, le ka nako ya hao 
ya boithapollo, boikwetliso kapa 
dipapadi 
Ka kopo nahana ka mesebetsi eo o e 
etsang mosebetsing, jwalo ka karolo 
ya mosebetsi wa hao wa ka tlung le 
jareteng, ho tloha sebakeng se seng 
ho ya ho se seng, le ka nako ya hao 
ya boithapollo, boikwetliso kapa 
dipapadi 
Typing error corrected 
Nahana ka mesebetsi yohle e matla 
eo o e entseng matsatsing a 7 a 
fetileng. 
Nahana ka mesebetsi yohle e matla 
eo o e entseng matsatsing a 7 a 
fetileng. 
Mesebetsi e matla ya mmele e bua 
ka mesebetsi e hlokang matla a 
mangata a mmele mme e etsa hore 
o heme kamatla haholo ho feta
tlwaelo.
Mesebetsi e matla ya mmele e bua 
ka mesebetsi e hlokang matla a 
mangata a mmele mme e etsa hore 
o heme kamatla haholo ho feta
tlwaelo.
Typing error corrected. 
Nahana feela ka mesebetsi ya mmele 
eo o eentseng bakeng sa bonyane 
metsotso e 10 ka nako 
Nahana feela ka mesebetsi ya mmele 
eo o eentseng bakeng sa bonyane 
metsotso e 10 ka nako 
Omitted word added. 
1. Nakong ya matsatsi a 7 a fetileng, ke 
ka matsatsi a makae o entseng 
mesebetsi e matla ya mmele jwalo 
ka ho phahamisa dintho tse boima, 
ho tjheka, diaerobiki, kapa hopalama 
le ho potlakisabaesekele? 
Nakong ya matsatsi a 7 a fetileng, ke 
ka matsatsi a makae o entseng 
mesebetsi e matla ya mmele jwalo 
ka ho phahamisa dintho tse boima, 
ho tjheka, diaerobiki, kapa hopalama 
le ho potlakisabaesekele? 
Spelling corrected. 
“tsamaya” means “walk”. In oral 
language it would go un noticed, 
however, in written language it is 
nonsensical. The appropriate term is 
“ride” (palama). 
matsatsi a ka beke matsatsi a ka beke Omitted conjunction added. 
Ha ho mesebetsi e matla ya mmele Ha ho mesebetsi e matla ya mmele 
Tlolela ho potso ya 3 Tlolela ho potso ya 3 
3 
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2. O ne o qeta nako e kae ka tlwaelo o 
etsa mesebetsi e matla ya mmele ka 
le le leng la matsatsi ao? 
O ne o qeta nako e kae ka tlwaelo o 
etsa mesebetsi e matla ya mmele ka 
le le leng la matsatsi ao? 
dihora tse ka letsatsi dihora tse ka letsatsi Omitted conjunction added. 
metsotso e ka letsatsi metsotso e ka letsatsi Omitted conjunction added. 
Ha ke tsebe/Ha ke na bonnete Ha ke tsebe/Ha ke na bonnete 
Nahana ka mesebetsi yohle e 
mahareng eo o e entseng 
matsatsing a 7 a fetileng 
Nahana ka mesebetsi yohle e 
mahareng eo o e entseng 
matsatsing a 7 a fetileng 
Mesebetsi e mahareng e bua ka 
mesebetsi e hlokang matla 
amahareng a mmele mme e etsa 
hore o heme haholwanyane ho feta 
tlwaelo. 
Mesebetsi e mahareng e bua ka 
mesebetsi e hlokang matla 
amahareng a mmele mme e etsa 
hore o heme haholwanyane ho feta 
tlwaelo. 
The term “physical effort” was not in 
the translation. Now added.  
Typo corrected. 
Harder” means “more 
faster/rapidly” and does not imply 
“pain” or “distress” as translated 
here. 
Nahana feela ka mesebetsi ya 
mmele eo o e entseng bakeng sa 
bonyane metsotso e 10 ka nako 
Nahana feela ka mesebetsi ya mmele 
eo o e entseng bakeng sa bonyane 
metsotso e 10 ka nako 
3. Nakong ya matsatsi a 7 a fetileng, ke 
ka matsatsi a makae o entseng 
mesebetsi e mahareng ya mmele 
jwalo ka ho phahamisa dintho tse 
bobebe, ho tsamaya ka baesekele ka 
sekgahla se tlwaelehileng, kapa ho 
bapala tenese ya batho ba bane? 
Nakong ya matsatsi a 7 a fetileng, ke 
ka matsatsi a makae o entseng 
mesebetsi e mahareng ya mmele 
jwalo ka ho phahamisa dintho tse 
bobebe, ho tsamaya ka baesekele ka 
sekgahla se tlwaelehileng, kapa ho 
bapala tenese ya batho ba bane? 
O se ke wa kenyeletsa ho tsamaya. O se ke wa kenyeletsa ho tsamaya. 
matsatsi a ka beke matsatsi a ka beke Omitted conjunction added. 
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Ha ho mesebetsi e mahareng ya 
mmele 
Ha ho mesebetsi e mahareng ya 
mmele 
Tlolela ho potso ya 5 Tlolela ho potso ya 5 
4. O ne o qeta nako e kae ka tlwaelo o 
etsa mesebetsi e mahareng ya 
mmele ka le le leng la matsatsi ao? 
O ne o qeta nako e kae ka tlwaelo o 
etsa mesebetsi e mahareng ya 
mmele ka le le leng la matsatsi ao? 
dihora tse ka letsatsi dihora tse ka letsatsi Omitted conjunction added. 
metsotso e ka letsatsi metsotso e ka letsatsi Omitted conjunction added. 
Nahana ka nako eo o eqetileng o 
tsamaya matsatsing a 7 a fetileng 
Nahana ka nako eo o eqetileng o 
tsamaya matsatsing a 7 a fetileng 
Typing omission corrected. 
Sena se kenyelletsa mosebetsing le 
hae, ho tsamaya ho tloha sebakeng 
ho ya ho se seng, le ho tsamaya hofe 
kapa hofe hoo o ho entseng bakeng 
sa boithapollo, dipapadi, 
boikwetliso, kapa phomolo feela 
Sena se kenyelletsa mosebetsing le 
hae, ho tsamaya ho tloha sebakeng 
ho ya ho se seng, le ho tsamaya hofe 
kapa hofe hoo o ho entseng bakeng 
sa boithapollo, dipapadi, 
boikwetliso, kapa phomolo feela 
This is too cluttered and ends up 
rendering the translation absurd. 
Now corrected.   
5. Nakong ya matsatsi a 7 a fetileng, ke 
ka matsatsi a makae o tsamaileng 
bakeng sa bonyane metsotso e 10 ka 
nako? 
Nakong ya matsatsi a 7 a fetileng, ke 
ka matsatsi a makae o tsamaileng 
bakeng sa bonyane metsotso e 10 ka 
nako? 
matsatsi a ka beke matsatsi a ka beke Omitted conjunction added. 
Ha ke a tsamaya Ha ke a tsamaya 
Tlolela ho potso ya 7 Tlolela ho potso ya 7 
6. O ne o qeta nako e kae ka tlwaelo o 
tsamaya ka le le leng la matsatsi ao? 
O ne o qeta nako e kae ka tlwaelo o 
tsamaya ka le le leng la matsatsi ao? 
Unnecessary word deleted. 
Dihoratse ka letsatsi Dihoratse ka letsatsi Omitted conjunction added. 
metsotso e ka letsatsi metsotso e ka letsatsi Omitted conjunction added. 
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Ha ke tsebe/Ha ke na bonnete Ha ke tsebe/Ha ke na bonnete 
Potso ya ho qetela e mabapi le nako 
eo o e qetilengo dutse hara beke 
nakong ya matsatsi a 7 a fetileng 
Potso ya ho qetela e mabapi le nako 
eo o e qetilengo dutse hara beke 
nakong ya matsatsi a 7 a fetileng 
This is corrected to past participle 
tense as it should 
Kenya nako eo o e qetang 
mosebetsing, hae, ha o etsa 
mosebetsi wa sekolo le ka nako ya 
boiketlo. 
Kenya nako eo o e qetang 
mosebetsing, hae, ha o etsa 
mosebetsi wa sekolo le ka nako ya 
boiketlo. 
phomolo” means “rest” but the term 
is “leisure” which does not mean 
doing nothing. It means doing things 
that are not work/study related and 
could even be inclusive of resting.  
Wrong pronoun here and now 
corrected.  
Ena e ka kenyeletsa nako eo o e 
qetang o dutse tafoleng, o etetse 
metswalle, o bala, kapa o dutse kapa 
o paqame fatshe ho shebella
thelevishene
Ena e ka kenyeletsa nako eo o e 
qetang o dutse tafoleng, o etetse 
metswalle, o bala, kapa o dutse kapa 
o paqame fatshe ho shebella
thelevishene
7. Nakong ya matsatsi a 7 a fetileng, o 
qetile nako e kae o dutseletsatsingla 
hara beke? 
Nakong ya matsatsi a 7 a fetileng, o 
qetile nako e kae o dutseletsatsingla 
hara beke? 
This is supposed to be past perfect 
tense, as is now corrected here. The 
corrected translation was present 
continuous tense.   
Dihoratse ka letsatsi Dihoratse ka letsatsi Omitted conjunction added. 
metsotso e ka letsatsi metsotso e ka letsatsi Omitted conjunction added. 
Ha ke tsebe/Ha ke na bonnete Ha ke tsebe/Ha ke na bonnete 
Ena ke pheletso ya lenane la 
dipotso, re a leboha ha o nkile 
karolo. 
Ena ke pheletso ya lenane la 
dipotso, re a leboha ha o nkile 
karolo. 
  
 
 
 
 
 
 
 
APPENDIX 15 
 
Comparison of translation:  Acceptability Questionnaire 
1 
Acceptability Questionnaire 
English version Translated version Moderated version Comments 
LENANE LA DIPOTSO LA BOKUDI BA 
MESIFA LE SEKELETHONE 
(MUSCULOSKELETAL) LE MAFU A 
TSAMAELLANANG (CO-MORBIDITY 
LENANE LA DIPOTSO LA BOKUDI BA 
MESIFA LE SEKELETHONE 
(MUSCULOSKELETAL) LE MAFU A 
TSAMAELLANANG (CO-MORBIDITY 
The term “lenane la dipotso” 
(questionnaire) must be at the 
beginning of the title because it 
applies to both the conditions. 
HO FUMANA KAMOHELEHO 
MABAPI LE LENANEO LA KENO-
DIPAKENG 
HO FUMANA KAMOHELEHO 
MABAPI LE LENANEO LA KENO-
DIPAKENG 
Mistranslation: “kamohelo” means 
“acceptance.”It  must be 
“kamoheleho”  
Lenane lena la dipotso ke la basadi 
ba pakeng tsa dilemo tse 40-64 ba 
tsamayang lenaneo la keno-dipakeng 
holong ya setjhaba ya MUCPP 
Lenane lena la dipotso ke la basadi 
ba pakeng tsa dilemo tse 40-64 ba 
tsamayang lenaneo la keno-dipakeng 
holong ya setjhaba ya MUCPP 
Lenane lena la dipotso le mabapi le 
hore na o fumane lenaneo la keno-
dipakeng le le jwang. 
Lenane lena la dipotso le mabapi le 
hore na o fumane lenaneo la keno-
dipakeng le le jwang. 
Lenane lena la dipotso ke la 
boithaopo bo phethahetseng 
Lenane lena la dipotso ke la 
boithaopo bo phethahetseng 
O ka nka qeto ya ho se nke karolo 
kapa ho se arabe potso efe kapa efe 
e itseng. 
O ka nka qeto ya ho se nke karolo 
kapa ho se arabe potso efe kapa efe 
e itseng. 
Lenane lena la dipotso ke la 
sephirise phethahetseng(ha le 
hlahise lebitso la motho) 
Lenane lena la dipotso ke la 
sephirise phethahetseng(ha le 
hlahise lebitso la motho) 
lekunutu”means “secret” as opposed 
to “confidentiality 
This is a further addition to clarify 
the actual result – does not reveal 
person’s name 
2 
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Ka kopo o se etse matshwao a 
mofuta ofe kapa ofe lenaneng la 
dipotso a ka o tsebahatsang. 
Ka kopo o se etse matshwao a 
mofuta ofe kapa ofe lenaneng la 
dipotso a ka o tsebahatsang. 
Grammatical correction. This term 
must be in participle form.  
Mistranslation of “individually”. It 
has been translated in a literal sense 
here, whereas the purposive 
meaning is about revealing a person 
him/herself, and not “separate 
DITAELO DITAELO 
Ka kopo fana ka maikutlo a hao a 
nnete 
Ka kopo fana ka maikutlo a hao a 
nnete 
Ke leboha tshebedisanommoho ya 
hao haholo 
Ke leboha tshebedisanommoho ya 
hao haholo 
Khoutu ya ID Khoutu ya ID 
Mohla: Mohla: 
Dilemo: Dilemo: 
MOKGAHLELO WA III MOKGAHLELO WA III 
DIPOTSO TSE LATELANG DI BOTSA 
KA HORE NA O IKUTLWA JWANG KA 
LENANEO LEO O LE KENETSENG 
BAKENG SA DIBEKE TSE 6 
DIPOTSO TSE LATELANG DI BOTSA 
KA HORE NA O IKUTLWA JWANG KA 
LENANEO LEO O LE KENETSENG 
BAKENG SA DIBEKE TSE 6 
Q1: O ratile eng kaho fetisisa ka 
lenaneo? 
O ratile eng kaho fetisisa ka 
lenaneo? 
Omitted conjunction added. 
Q2: Ke eng eo o e ratilenghanyane kaho 
fetisisa ka lenaneo? 
Ke eng eo o e ratilenghanyane kaho 
fetisisa ka lenaneo? 
Mistranslation: This question must 
complement the previous one (Q1) 
as opposites. The previous 
translation was saying “what did you 
dislike most about the program?” It 
must be about “like” and not 
“dislike”. It might sound academic 
but the effect is clearly different.   
3 
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Q3: O ka fetola eng lenaneong? O ka fetola eng lenaneong? Correct to participle form. 
Q4: O ka eketsa eng lenaneong? O ka eketsa eng lenaneong? Mistranslation: the source term is 
“add” and not “introduce” or “put 
in”. The effect must be that it adds 
to something there already. 
Q5: O ile wanahana eng ka buka ya 
boitsamaiso? 
O ile wanahana eng ka buka ya 
boitsamaiso? 
Must be past tense, as corrected 
here. 
APPENDIX 16 
Qualifications of translators 
1 
Translators utilised in the translation project 
Translator Sex Occupation 
A Female Free-lance translator 
B Male Lecturer in Interpreting at a university as well as a freelance translator 
and interpreter 
C Female Professional translator at a provincial government department 
D Male Free-lance translator and the only translator that was accredited 
Moderator Sex Occupation and qualifications 
Male Associate Professor in Department of Linguistics and Language Practice 
in the Faculty  of the Humanities, teaching translation studies at under- 
and post-graduate level at the University of the Free State as well as 
editing at under-graduate level.   MA in Translation Studies from the 
University of the Free State (cum laude). An Accredited Professional 
Translator with the South African Translators’ Institute (SATI) with 13 
years of experience as a professional translator.  Since then has 
translated 23 full-length books.  A member of the Linguistics Society of 
Southern Africa, the International Association for Translation and 
Intercultural Studies, the European Association of Translation Studies 
and the Association of Translation Studies in Africa.  Have extensive 
experience in translating in various fields such as psychology, theology, 
education, development studies. Also have 15 years of experience as 
an editor. Edited hundreds of research reports (even for the 
International Labour Organisation) and academic articles in 
development studies, theology, education, psychology, literary studies, 
business managements, etc.  
APPENDIX 17 
Cognitive debriefing results – COPCORD questionnaire 
1 
COPCORD epidemiological survey questionnaire 
English version Moderated version Changes after cognitive debriefing Comments 
LENANE LA DIPOTSO LABOKUDI BA 
MESIFA LE MASAPO A 
MMELE(MUSCULOSKELETAL) LE 
LENANE LA DIPOTSO LA MAFU A 
TSAMAELLANANG (CO-MORBIDITY) 
(E theilwe hodima Lenane la Dipotso 
la COPCORD) 
Lenane lena la dipotso ke la basadi 
ba pakeng tsa dilemo tse 40-70 ba 
tsamayang Ditliniki tsa Tlhokomelo 
ya Motheo ya Bophelo bo Botle 
Lenane lena la dipotso le mabapi le 
bohloko ba manonyeletso, monono 
o fetang tekano, kgathello e
phahameng ya madi le mofuta wa II
wa lefu la tswekere
Lenane lena la dipotso ke la 
boithaopo bo phethahetseng.  O ka 
nka qeto ya ho se nke karolo kapa ho 
se arabe potso efe kapa efe e itseng 
Lenane lena la dipotso ke la 
lekunutu bo phethahetseng.  Ka 
kopo o se etse matshwao a mofuta 
ofe kapa ofe a ka o supang ka bo 
mong. 
Dintlha tse kopantsweng di tla 
sebediswa ho theha lenaneo la 
tsebisatso ya bophelo bo botle. 
DITAELO 
2 
English version Moderated version Changes after cognitive debriefing Comments 
Kgetha karabo e le nngwe feela, ntle 
leha o laetswe ka tsela e nngwe 
Ka kopo tshwaya karabo e nepahetseng
mohl. □√ kapa o e etse sedikadikwe 
karabong e le nngwe moo ho 
bontshitsweng. 
 
Thank you very much for your co-
operation 
Re lebohela tshedisanommoho ya 
hao haholo 
Khoutu ya ID 
Mohla: 
Tleliniki: 
MOKGAHLELO WA I: 
DIPOTSO TSE LATELANG DI BOTSA 
KA DINTLHA TSA HAO TSA BOTHO 
LE NALANE LA BOPHELO BO BOTLE 
(DINTLHA TSE FAPANENG TSA 
DITJHABA) 
Q1 – Q7 hophethelwa ke mofuputsi 
ka ba/mothusi wa mofuputsi) 
Q1: Dilemo tse 
KAPA Letsatsi la tswalo 
Q2: Boima: 
Q3: Bolelele: 
Q4: Indekse ya Boima ba Mmele: 
Q5: Teko ya Hemoglucose (ho bala ho 
tswa foldareng haeba e le teng): 
Q6: Kgatello ya Madi: 
Q 7: Mafu a tsamaellanang le a mang:(ka 
kopo bontsha tsohle tse amehang) 
3 
English version Moderated version Changes after cognitive debriefing Comments 
Kankere (Mofetshe) 
Tswekere (Mofuta wa I wa Lefu la 
Tswekere) 
Mafu a methapo ya madi yapelo 
(Lefu la pelo) 
Ho sithabela maikutlo 
Seterouku 
Lefu la nako e telele la ho hema Lefu la nako e telele “la ho hema” was omitted 
Q8: Puo ya lapeng: 
Afrikanse 
Senyesemane 
Sesotho 
E nngwe (hlalosa ka kopo) 
Q9: Morabe / Setso Morabe “Setso” was omitted 
MoAforika/Motsho MoAforika “Motsho” was omitted 
Wa mmala 
E mosweu 
MoIndia/MoAsia 
E nngwe (hlalosa ka kopo) 
Q10: Boemo ba tsalenyalo: 
Ha o so nyale/nyalwe 
O nyetse/nyetswe / Molekane wa 
lapeng (molekane ya dulang le wena) 
Le arohane / le hlalane Le hlalane “arohane” was ommitted 
O mohlolo/mohlolohadi mohlolohadi “O mohlolo” was ommitted 
Q11: Tsebo ya hobala: 
Ho bala feela 
Ho bala le ho ngola 
Ha ho letho Ha ke tsebe hoh bala le hongola Wording was changed 
Q12: 
Ha o a kena sekolo 
4 
English version Moderated version Changes after cognitive debriefing Comments 
Sekolo sa mathomo Sekolo sa  pele “mathomo” was changed to “sa 
pele” 
Sekolo sa sekhondari 
Thuto e phahameng (ya theshari) 
Q13: O dula kae boholo ba selemo? 
Lapeng / foleteng ya hao 
Lapeng la motswalle / setho sa 
lelapa 
Ho sele (hlalosa ka kopo) 
Q14: Mofuta wa ntlo: 
Ntlo ya setene 
Mokhukhu 
Q15: O dula le batho ba bakae? O dula le batho ba bakae? Wording and sentence construction 
was changed 
Ke dula ke le mong 
motho a le mong 
atho ba 2 bedi Numbers changed to words 
batho ba 3 bararo Numbers changed to words 
batho ba 4 bane Numbers changed to words 
batho ba 5 kapa ho feta bahlano Numbers changed to words 
Q16: Maemo a hao a hajwale a kgiro: Maemo a hao a hajwale a khiro: Spelling corrected 
O sebetsa nako yohle (dihora tse 40 
kapa ho feta ka beke) 
O sebetsa nako yohle (dihora tse  
mashome a mane kapa ho feta ka 
beke) 
Wording changed 
Ha o sebetse 
O sebetsa nakwana (ka tlase ho 
dihora tse 40 ka beke) 
Mopenshenara 
“Mosebetsi wa nako e nyane” “Mosebetsi wa nako nakwana” Wording changed 
E nngwe (hlalosa ka kopo) 
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English version Moderated version Changes after cognitive debriefing Comments 
Q17:  Maemo a hao a hajwale a kgiro 
(mosebetsi): 
Maemo a hao a hajwale a khiro 
(mosebetsi): 
Spelling corrected 
 
 Mme wa lelapa   
 Titjhere Titjhere/marutabana “morulatane” omitted 
 Mosebetsi wa tafoleng   
 O sebetsa lebenkeleng kapa 
kgwebong 
  
 Mosebetsi wa femeng   
 Mosebeletsi wa lapeng   
 Sesole   
 Sepolesa   
 O beile meja fatshe   
 Ha o sebetse   
 E nngwe (hlalosa ka kopo)    
Q18:  Ho hloka mosebetsi ka lebaka la:   
 O hlokometse lelapa la hao   
 Ha ke kgone ho fumana mosebetsi   
 Bothata ba bophelo bo botle   
 O na le bokudi   
 Monna ha a ntumelle ho sebetsa   
 Ke moholo haholo   
 Le sele (hlalosa ka kopo)    
Q19:  Na o fumana penshene kapa 
keranteya mmuso: 
  
 Ee   
 Tjhe   
Q20:  Haeba o re ee, na ke:   
 Keante ya bokowa (ha o kgone ho 
sebetsa ka lebaka la bokudi) 
  
 Penshene (ya maqheku)   
 Ka bobedi   
6 
English version Moderated version Changes after cognitive debriefing Comments 
Q21: Ke eng e hlalosang hantle kaho 
fetisisa nalane ya hao ya ho tsuba: 
Ha o so tsube ho hang 
O a tsuba hona jwale 
O ne o tsuba nakong e fetileng 
Haebao re ee, ke kwae e kae ka 
letsatsi? 
Haeba o re ee, ke kwae tse kae ka 
letsatsi? 
Wording changed 
Haeba o re ee, o qadile o le dilemo 
tse kae? 
Q22: Ke efe e hlalosang hantle ho fetisisa 
nalane ya hao ya ho tsuba seneifi 
Ha ke so sebedise seneifi ho hang 
O tsuba seneifi hona jwale 
Ke ne ke sebedisa seneifi nakong e 
fetileng 
Haeba o re ee, o tsuba seneifi 
makgetlo a makae ka letsatsi? 
Haeba o re ee, o qadile o le dilemo 
tse kae? 
Q23: Ke efe e hlalosang hantle ka ho 
fetisisa nalane ya hao ya tshebediso 
ya jwala: 
Ha ke so sebedise dihlahiswa tsa 
jwala ho hang 
Ha ke so sebedise dihlahiswa tsa 
nnotahi ho hang tsa jwala 
Wording changed 
Ke sebedisa dihlahiswa tsa jwala a 
jwale 
Ke ne ke sebedisa dihlahiswa tsa 
jwala nakong e fetileng 
Haeba o re ee, o sebedisa jwala ka 
makgetlo a makae ka beke? 
7 
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Haeba o re ee, o qadile o le dilemo 
tse kae? 
DIPOTSO TSE LATELANG DI MABAPI 
LE BOPHELO BA HAO BO BOTLE 
Q24: Bophelo ba hao bo botle ka 
kakaretso bo  
Bo tswile matsoho 
Bo botle haholo 
Bo botle 
Bo mahareng 
Bo a fokola 
Na o kile wa bolellwa ke ngaka hore 
o na le?
Kgatello e phahameng ya madi 
(Hypertension) 
Tswekere (Mofuta wa II wa Lefu la 
Tswekere) 
Botenya bo fetang tekano 
Kholesterole (hyperlipidaemia) 
Bohloko ba manonyeletso (Bokudi 
ba mesifa le masapo a mmele) 
Lebaka la hao la sehlooho la ho 
etela tleliniki kajeno ke lefe? 
Ho tla bona sista / mooki Ho tla bona mooki Wording changed “sista” not used 
commonly rather “mooki” 
Ho tla bona ngaka 
Ho fumana meriana 
Bobedi sista le meriana Bobedi mooki le meriana Wording changed “sista” not used 
commonly rather “mooki” 
Bohloko ba manonyeletso (Bokudi 
ba mesifa le masapo a mmele) 
8 
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 E nngwe (hlalosa ka kopo) 
Ke afe a mafu a latelang ao o bileng 
le oona dikgweding tse tharo tse 
fetileng? 
Kgatello e phahameng ya madi 
(Hypertension) 
Tswekere (Mofuta wa II wa Lefu la 
Tswekere) 
Botenya bo fetang tekano 
Bohloko ba manonyeletso kapa 
mesifa 
Ho lemala kapa kotsi 
Mathata a pelo 
Ditletlebo mabapi le mpa 
Mathata a amanang leditho tsa bong 
kapa tsa mosese 
Seso se sa foleng Mofetshe Wording changed 
Ditshwaetso (TB/e sele 
Kgolofalo Holofala Wording changed 
Le sele (hlalosa ka kopo) 
Na ngaka ya hao kapa sista / mooki 
o kile a o jwetsa hore o hloka ho
latela lenaneo la boikwetliso?
Na ngaka ya hao kapa mooki o kile a o 
jwetsa hore o hloka ho latela lenaneo la
boikwetliso? 
Wording changed “sista” not used 
commonly rather “mooki” 
Ee 
Tjhe 
Ha ke na bonnete 
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English version Moderated version 
 
Changes after cognitive debriefing Comments 
 Nakong ya dikgwedi tse 3 tse 
fetileng na o bile le bohloko, ho 
opelwa, ho ruruha, ho satalla (ho 
tiya) kahare kapa ho potoloha 
manonyeletso a hao kapa 
mokokotlo bo sa amananeng le ho 
lemala / kotsi? 
 
Nakong ya dikgwedi tse  tharo tse  
fetileng na o bile le bohloko, ho opelwa, 
ho ruruha, ho satalla  (ho tiya) kahare  
kapa ho potoloha manonyeletso a hao 
 kapa mokokotlo bo sa amananeng le 
 ho lemala / kotsi? 
 
Wording changed 
 Ee 
 
  
 Tjhe 
 
  
 Ha ke na bonnete 
 
  
 Nakong ya matsatsi a 7 a fetileng na 
o bile le bohloko, ho opelwa, ho 
ruruha, ho satalla (ho tiya) kahare 
kapa ho potoloha manonyeletso a 
hao kapa mokokotlo bo sa 
amananeng le ho lemana / kotsi? 
Nakong ya matsatsi a  supilenga fetileng 
na o bile le bohloko, ho opelwa, ho 
ruruha, 
 ho satalla (ho tiya) kahare kapa ho 
potoloha manonyeletso a hao kapa 
mokokotlo bo sa amananeng le ho  
lemaa / kotsi? 
 
Wording changed 
 Ee 
 
  
 Tjhe 
 
  
 Ha ke na bonnete   
 Khoutu ya ID   
 Mohla:   
 Tleliniki: 
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 MOKGAHLELO WA II:   
 DIPOTSO TSE LATELANG DI BOTSA 
KA BOHLOKO BA MANONYELETSO 
KAPA MESIFA, HO SATALLA / HO 
TIYA KAPA HO RURUHA HO 
POTOLOHA MANONYELETSO A 
HAO, KAPA MOTSAMAO O 
FOKOTSEHILENG 
MANONYELETSONG AFE KAPA AFE 
  
 Ka kopo bontsha setshwanshong se 
ka tlasemona, ka dibaka tsohle 
tseo o utlwileng bohloko ho tsona 
dikgweding tse 3 tse fetileng pele 
ho patlisiso le ka X dibakeng tsohle 
moo o bileng le ho ruruha 
Ka kopo bontsha setshwanshong se ka 
tlase mona, ka dibaka tsohle tseo o 
utlwileng bohloko  ho tsonadikgweding
tse tharo tse fetileng pele ho patlisiso le 
ka X dibakeng tsohle moo o bileng  
le ho ruruha.  
 
 
 Ka pele   
 Ka morao   
 Ka kopo bontsha setshwantshong se 
ka tlasemona, ka dibaka tsohle 
tseo o utlwileng bohloko ho tsona 
matsatsing a 7 a fetileng pele ho 
patlisiso le ka X dibakeng tsohle 
moo o bileng le ho ruruha 
  
 Ka pele   
 Ka morao   
 Bohloko bo qadile neng?   
 Ka tlase ho matsatsi a 7 a fetileng Ka tlase ho matsatsi a supileng a 
fetileng 
Wording instead of numbers 
 Dikgweding tse 3 tse fetileng Dikgweding tse tharo tse fetileng Wording instead of numbers 
 Dikgwedi tse 3 ho isa selemong se 1 
se fetileng 
Dikgwedi tse tharo ho isa selemong se 
le seng se fetileng  
Wording instead of numbers 
11 
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Ho feta selemo se 1 se fetileng Ho feta selemo se le seng se fetileng Wording instead of numbers 
Ke matsatsi a makae dikgweding tse 
3 tse fetileng o bileng le bohloko 
bofe kapa bofe? 
Bontsha sekaleng matla a bohloko 
boo o bileng le bona nakong ya 
matsatsi a 7 a fetileng. 
Bontsha sekaleng matla a bohloko boo 
o bileng le bona nakong ya matsatsi a
supileng a fetileng.
Wording instead of numbers 
Ha ho bohloko 
Bo bobebe 
Bo bobebe 
Bo totileng 
Bototileng haholo 
Bototileng haholo 
Bontsha sekaleng matla a bohloko 
boo o bileng le bona nakong ya 
dikgwedi tse 3 tse fetileng. 
Bontsha sekaleng matla a bohloko boo 
o bileng le bona nakong ya dikgwedi tse
tharo tse fetileng.
Wording instead of numbers 
Ha ho bohloko 
Bo bobebe 
Bo bobebe 
Bo totileng 
Bototileng haholo 
Bototileng haholo 
Ha ho bohloko 
Bo bobebe 
Haeba bohloko bo hlaha 
kgafetsakgafetsa, ketsahalo eo e 
nka nako e kae? 
12 
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Matsatsi a mmalwa 
dibeke tse 4 - 6 nne ho isa hotse tsheletsheng Wording changed 
dibeke tse 6 - 12 tsheletsheng ho isa ho tse leshone le 
metso e mmedi 
Wording changed 
Ho feta dikgwedi tse 3 Ho feta dikgwedi tse tharo Wording instead of numbers 
Bohloko bo matla haholo neng? 
Hoseng ha o tsoha 
Kamora tshebetso (ho etsa ho hong) 
Ha o phomotse bosiu 
E nngwe (hlalosa ka kopo) 
Nakong ya selemo se fetileng na o 
bile le ho tiya / ho satalla 
manonyeletsong a hao hoseng 
kamora ho tswa dikobong kapa 
kamora phomolo e telele ntle le ho 
tsamaya? 
Ee 
Tjhe 
Ha ke na bonnete 
Ho tiya /  ho satalla ho bile teng 
nako e kae? 
metsotso e 30 kapa ka tlase metsotso e  mashome a mararo  kapa 
ka tlase 
Wording changed 
Ho feta metsotso e 30 Ho feta metsotso e mashome a mararo Wording changed 
Na ho tiya /  ho satalla ho ile ha fela 
kamora ho ikwetlisa kapa ho 
itsamaisa manonyeletso? 
Ee 
Tjhe 
13 
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Ha ke na bonnete 
Na o kile wa fumanwa kapa na 
motho o kile a o jwetsa hore o na le 
lefu la masapo kapa mafu a mang a 
manonyeletso jwalo ka ramatiki? 
Phumano ya lefu eo o e fuweng ke 
efe? 
Phumano ya lefu e entswe kae? 
Na o ntse o nwa moriana bakeng sa 
bohloko ba manonyeletso kapa 
mokokotlo, o sa amananeng le 
temalo, nakong ya dikgwedi tse 3? 
Na o ntse o nwa moriana bakeng sa 
bohloko ba manonyeletso kapa  
mokokotlo, o sa amananeng le temalo, 
nakong ya  
dikgwedi tsetharo? 
Wording instead of numbers 
Ee 
Tjhe 
Ha ke na bonnete 
Haeba o re ee, o sebedisitse 
meriana efe? 
bohloko tse ithekelwang 
Meriana ya tlhaho, dimela, 
ditlatsetsotsa phepo 
Meriana e ithekelwang e alafang 
tlerefalo (di-NSAIDS) 
Meriana e laetsweng ke ngaka e 
alafang tlerefalo (di-NSAIDS) 
Meriana e meng e laetsweng ke 
ngaka 
E meng (hlalosa ka kopo) 
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Na o fumane mofuta ofe kapa ofe o 
mong wa kalafo, ntle le moriana wa 
bohloko? 
Ee 
Tjhe 
Ha ke na bonnete 
Hlalosa ka kopo 
Kameho ke efe, haeba e le teng, eo 
bohloko / lefu la masapo le bileng le 
yona bophelong ba hao jwalo ka ha 
ho bontshitswe ka tlasemoo? 
Ha ho letho 
Bobebe 
Mahareng 
Totile 
Dikamano tsa lelapa 
Dikamano tsa setjhaba 
Dikamano tsa lenyalo (ho 
kenyeletswa diketso tsathobalano 
Maemo a ditjhelete 
Bokgoni ba ho sebetsa 
Mosebetsi wa boithabiso Mosebetsi wa boithabiso Wording changed 
Dipapadi 
Tse ding, hlalosa ka kopo 
Na o emisitse ho sebetsa ka lebaka 
la bohloko / lefu la masapo nakong 
ya selemo se fetileng? 
Ee 
Tjhe 
Ha ke na bonnete 
15 
English version Moderated version Changes after cognitive debriefing Comments 
Na o fetotse mosebetsi wa hao ka 
lebaka la bohloko / lefu la masapo 
nakong ya selemo se fetileng? 
Ee 
Tjhe 
Ha ke na bonnete 
Na o nyahama ha bonolo kapa o 
ngongorehe ka lebaka la bohloko / 
lefu la masapo? 
a boroko ba hao bo etsahala ka 
tsela e sa tlwaelehang ka lebaka la 
bohloko / lefu la masapo? 
Ee 
Tjhe 
Ha ke na bonnete 
Na o ikutlwa o kgathetse mmeleng 
ka lebaka la bohloko / lefu la 
masapo (o sa kgone ho etsa 
mesebetsi ya letsatsi le letsatsi)? 
RE A LEBOHA HA O NKILE NAKO YA 
HO PHETHA LENANE LENA LA 
DIPOTSO 
APPENDIX 18 
Time to complete questionnaires 
1 
Demographic information regarding cognitive debriefing per questionnaire 
1 Epidemiological survey 
Language:  Sesotho 
Age of each 
participants: 
Gender: Profession: Specify time taken by each 
participants to complete the 
survey, in minutes: 
R1: 46 Female Supervisor for cleaning 
company 
R1: 20 
R2: 52 Female General worker R2: 25 
R3: 42 Female Unemployed R3: 22 
R4: 54 Female Cleaning lady R4: 20 
R5: 60 Female Retired R5: 27 
Mean age:  50.8 years Mean time:  16.8 minutes 
Median age:  52 years Median time:  17 minutes 
2 WHODAS 2.0 (Self-administered) 
Language:  Sesotho 
Age of each 
participants: 
Gender: Profession: Specify time taken by each 
participants to complete the 
survey, in minutes: 
R1: 46 Female Supervisor for cleaning 
company 
R1: 5 
R2: 52 Female General worker R2: 7 
R3: 42 Female Self-employed R3: 5 
R4: 54 Female Cleaning lady R4: 8 
R5: 60 Female Manager R5: 8 
Mean age:  50.8 years Mean time:  6.6 minutes 
Median age:  52 years Median time:  7 minutes 
The median time for the participants to complete the WHODAS 2.0 is in accordance to Ustun et al’s 
(2010) findings that the 12-item version can be completed in five to 10 minutes when self- 
administered.(1) 
2 
1. Ustun TB, Chatterji S, Kostanjsek N, Rehm  J, Kennedy C, Epping-Jordan J, et al. Developing
the World Health Organization Disability Assessment Schedule 2.0. Bulletin of the World
Health Organization. 2010;88(11):815-23.
APPENDIX 19 
Results of cognitive debriefing 
1 
Results of the cognitive debriefing session of the translation project 
Only the questions that participants experienced difficulty with will be mentioned in the results. 
Only slight difficulty was experienced with the questions. 
Phase I:  Questions ask about your personal data and medical history (demographic 
characteristics) 
Question 7:  Co-morbidities (please indicate all applicable).  Participants had to indicate present, 
not present or do not know. 
Chronic respiratory disease:  Two of the participants did not understand what was meant by chronic 
respiratory disease and thought it meant that you go shortness of breath when walking.  The other 
three participants did understand that it is a specific disease and mentioned that it is something like 
asthma.   
Question 12:  Highest level of education:  Participants were given the options of no schooling, 
primary school, secondary school and tertiary education. 
Two of the participants wanted to change the word tertiary education to university – while the other 
three did understand that it included other institutions for example a university of technology or the 
word the participants used “technicon”. 
Phase II:     The following questions ask about your joint or muscle pain, stiffness / tightness or 
swelling around your joints, or less movement in any joints. 
Question 5:  If your pain is recurrent, how long does the episode last?  Participants had the option 
to choose few days, four to six weeks, six to 12 weeks and more than 3 months. 
All the participants preferred that the 12 weeks were to be put into three months as they did not 
understand that the 12 weeks were the same time frame as three months.   
Question 9:  Did the tightness / stiffness go away after exercise or movement of the joint? 
Participants were given the options of yes, no and not sure. 
One of the participants did not understand what was meant by movement of the joint.  The other 
four participants could explain exactly what was meant by the wording.  A note was made that the 
fieldworkers need to explain the concept to participants when asking the question during the survey 
to ensure that there is no misunderstanding of the concept.   
2 
Question 10:  Have you ever been diagnosed or has anyone told you that you have arthritis or 
other joint diseases like rheumatism?  Once again participants were given the options of yes, no or 
not sure. 
Three of the participants did not understand what was meant by rheumatism.  They understood that 
“rumatiki” meant older joints but they were not familiar with rheumatoid arthritis.  When the 
facilitator explained the difference between the two diseases to them they acknowledge that they 
had seen people with the disease and understood the difference between the two diseases.  A note 
was made that during the training of the fieldworkers they had to be made aware of the difference 
between the two diseases and that they must explain the two concepts to participants when 
completing the question during the survey.   
Question 10a:  What was the diagnosis given to you? 
All the participants struggled with the concept of diagnosis given to you.  Once the facilitator 
explained to them that the doctor after examination informs you what is wrong with you, therefore 
giving you a diagnosis, they laughed and said that the doctor normally just gives them medicine and 
does not tell them what is wrong with them.  If they do tell them it is normally that they have “high 
blood” or “high sugar”.  They never say anything about their joint pain.   
Question 14:  What is the effect, if any, the pain / arthritis has had on your life as outlined below?  
A table was given indicating that participants should indicate if there was no effect, a mild, moderate 
or severe effect. The aspects of life that was included in the table was family, social, marital 
relations, financial position, ability to work, hobby, games and other.   
All five the participants did not understand the word hobby in Sesotho.  Once the facilitator 
explained the concept to them, they acknowledge that they were familiar with the concept, but then 
realized that there was a spelling error in the questionnaire and that is why they did not recognise 
the word.  
Further minor changes were made to wording, typing errors or grammatical errors that participants 
felt would enhance the questionnaire.   
APPENDIX 20 
Results of cognitive debriefing of fieldworkers 
1 
Feedback from fieldworkers during translation project 
The fieldworkers mentioned that older participants did not feel comfortable answering questions 
regarding difficulties experienced during their sexual activities and the researcher made it clear to 
the fieldworkers that participants had the right to refuse to answer questions that made them 
uncomfortable and that this would be noted as missing data.  Please refer to Question 14 below.   
Other questions that posed problems for the participants were: 
Question 29a:  During the last 3 months have you experienced pain, aching, swelling, stiffness 
(tightness) in or around your joints or back which is not related to an injury / accident?  
Participants had to indicate yes, no or not sure.  There was uncertainty what to indicate when the 
joint pain was present a year ago or if they experienced joint pain for longer than three months.  The 
fieldworkers were instructed after the pilot study to note the answer next to the question.   
Question 12:  If yes, what medication was used? Participants were given the options over the 
counter pain killers; natural remedies, herbs, supplements; over the counter anti-inflammatory 
drugs (NSAIDS’s); prescribed anti-inflammatory drugs (NSAID’s); other prescribed medication and 
other.  The fieldworkers replaced the word “over the counter” with “which you can buy in a shop or 
pharmacy without a doctor’s note” which the participants understood better.   
Question 14:  What is the effect, if any, the pain / arthritis has had on your life as outlined below? 
Participants could indicate none, mild, moderate and severe.  Participant’s especially older women 
did not feel comfortable to answer the question regarding their marital relations (including sexual 
activities).   
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MS RY BARNES 
DEPARTMENT OF PHYSIOTHERAPY 
FACULTY OF HEALTH SCIENCES 
CR DE WET BUILDING 
UFS 
Dear Ms Barnes 
ECUFS NR 185/2013 
E-mail address: StraussHS@ufs.ac.za 
2014-06-26 
REC Reference nr 230408-011 
IRB nr 00006240 
PROJECT TITLE: AN INVESTIGATION INTO THE PREVALENCE AND NATURE OF 
MUSCULOSKELETAL CONDITIONS AMONGST WOMEN ATTENDING MUCPP AND THE 
EFFECTIVENESS OF AN INTERVENTION PROGRAM FOR THESE PATIENTS. 
• You are hereby kindly informed that the Ethics Committee approved the above study after all 
conditions have been met when the following signed permission letters were submitted. It will be 
condoned at the meeting scheduled for 22 July 2014: 
• Head of the Dept of Health, Free State Province 
• Head of MUCCP 
• The Ethics Committee also approved the following: 
• Project title of the study changed from "An investigation into the prevalence and nature of 
musculoskeletal conditions amongst women attending Primary Health Care Clinics, and 
the effectiveness of an intervention program for these patients to "An investigation into 
the prevalence and nature of musculoskeletal conditions amongst women attending 
MUCPP and the effectiveness of an intervention program for these patients". 
• Amendments to the protocol 
• Committee guidance documents: Declaration of Helsinki, ICH, GCP and MRC Guidelines on Bio 
Medical Research . Clinical Trial Guidelines 2000 Department of Health RSA; Ethics in Health 
Research: Principles Structure and Processes Department of Health RSA 2004; Guidelines for Good 
Practice in the Conduct of Clinical Trials with Human Participants in South Africa, Second Edition 
(2006); the Constitution of the Ethics Committee of the Faculty of Health Sciences and the Guidelines 
of the SA Medicines Control Council as well as Laws and Regulations with regard to the Control of 
Medicines. 
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• Kindly refer to the ECUFS reference number in correspondence to the Ethics Committee secretariat.
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CHAIR: ETHICS COMMITTEE 
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Community clinic permission letter 
20 May2014 
Dear Sister 
Re: Permission for research study in women between the ages of 40 64 vears attending 
Primarv Health Care Clinics in the Bloemfontein area and MUCPP. 
Research title: An investigation in the prevalence and nature of musculoskeletal conditions amongst 
women attending Primary Health Care Clinics, and the effectiveness of an intervention program for 
these patients. 
I am a PhD student in physiotherapy at the University of Cape Town and a lecturer in physiotherapy 
at the University of the Free State (UFS). My field of interest is neuromusculoskeletal conditions and 
co-morbidities, therefore I would like to examine the nature and prevalence of non-traumatic joint 
pain and the relationship between joint pain and other co-morbid conditions in women attending 
Primary Health Care Clinics in Bloemfontein. I have randomly selected9 clinics for the study and 
MUCPP of which your clinic is one. I will need 135 women from this clinic to meet my sample size 
of 1 353. 
My hypothesis is that there will be a high incidence of co-morbidities and musculoskeletal conditions 
amongst women between the ages of 40 - 64 years attending Primary Health Care Clinics. 
Participants will be recruited while waiting in the queue at the clinic. Participation iu the survey will 
take approximately 20 minutes. Participants will not forfeit their place in the queue at the clinic and 
completing the questionnaire will not affect their scheduled visit to the clinic. The rest of their 
treatment at the clinic will stay the same, thus there will be no impact on the service delivery of the 
clinic during the survey. Taking part in the survey is voluntary and participants may decide to stop 
taking part in the survey at any time without being penalised in any way. There is no risk involved in 
taking part in the survey as participants will only be answering questions or completing the 
questionnaires by themselves. 
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Blood pressure measurements and glucose readings of the participants will be required and a finger 
prick test will be perfonned to detennine the glucose readings of each participant after informed 
consent has been obtained. Participants will also be weighed and their height will be measured to 
determine their body max index. The researcher will provide electronic scales that will be available at 
each clinic. The researcher will also provide blood pressure monitors as well as Accu check monitors 
for the finger prick test. This will ensure that there is no impact on the service delivery and no extra 
costs will be incurred by the clinic. 
The information of the participants will be strictly confidential. Each participant will receive a unique, 
arbitrary code and any written documents will be labelled with that number to keep the nature and 
quality of the participants' information strictly confidential. The result of the study may be published 
in an accredited journal and presented at a congress. 
This letter is to ask permission to perform the survey at the Clinic. No responsibilities are expected 
of you or your staff. 
Ethical approval has been obtained from the Human Research Ethics Committee, Faculty of Health 
Sciences, University of Cape Town and the Ethical committee at the Medical Faculty of the 
University of the Free State. Numbers: HREC Ref 605/2013 and ECUFS nr 185/2013. 
For any questions regarding the study, you can contact me at 082 740 1069 or e-mail me at 
BarnesRY@ufs.ac.7-3 or contact the secretariat of the ethics committee of the University of Free 
State's Faculty of Health Science at 051-4052812 or the Human Research Ethics Cornmiitee, Faculty 
of Health Sciences, University of Cape Town (contact number: 021 - 406 6411). 
I have also received permission from the Head of the Department of Health from the Free State. 
Please see attached signed letter. 
If permission is granted fot the study, please sign the attached slip. 
Yours faithfully 
Roline Barnes 
(Researcher)(Physiotherapist 
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To: Roline Barnes 
M po I' ..i c.,. sister in charge at _,_1'1---'\.A--'--'C,'--'-..._L __ ...,v=---n-'---------------
have read the information document and.understand the nature of the study'as well as the benefits and 
risks involved. I give my permission for the survey into musculoskeletal conditions and co-morbidity, 
amongst women attending Primary Health Care Clinics and MUCPP to take place at the clinic. I 
wish to be kept informed of any changes to the survey if deemed necessary. 
.-l • "I 
�� 
" 
Date: �14-' ···OS· d] 
08c) z, g \3,6 Cf 
DE:'{ y,,'356<..v� 
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Epidemiological study  
Participant information leaflet 
1 
University of Cape Town:  An investigation into musculoskeletal conditions and co-morbidity amongst 
women attending Primary Health Care Clinics and the effectiveness of an intervention programme  for 
patients with these conditions. 
Dear Participant 
Introduction 
I, Roline Barnes, am currently a student in Physiotherapy at the University of Cape Town and a lecturer at 
the University of the Free State.   I need to do a research project in order to get my degree. Research is 
simply the process to learn the answer to a question. 
Title of the research project 
The title of the survey is “An investigation into musculoskeletal conditions and co-morbidity amongst 
women attending Primary Health Care Clinics and the effectiveness of an intervention programme for 
patients with these conditions.” 
Purpose of the survey 
I am interested in knowing how many women attending the clinics have pain in their joints and also have 
other illnesses, for example sugar; high blood and are overweight.  I am also interested in finding out how 
these illnesses and joint pain affect their lifestyle and how the pain in their joint and illnesses prevent 
them from doing things in their lives (e.g. climbing stairs, walking to the shop).  Telling me this can help 
me to inform people in the Local Government and the Department of Health to help people in the 
community to cope better with the joint pain and other illnesses.  The government can also place people at 
the clinics that are trained to give patients at the clinics exercises and information to handle the pain and 
illnesses better. 
INFORMATION LEAFLET 
EPIDEMIOLOGICAL STUDY 
2 
Selection of participants 
All women at the clinic on the day of the research, between the ages of 40 – 64 years will be asked to take 
part in the survey (answering questions).  
Description of research 
They will be answering a few questions regarding their age, weight, where they live, their general health 
and when they experience pain in their joints (if any).  It will take more or less 20 minutes to answer all 
the questions.  They will not lose their place in the queue (line) and answering the questions will not 
affect their visit to the clinic.  The rest of their treatment at the clinic will stay the same.  They are taking 
part in the survey as a volunteer / of their own free will and they may decide to stop taking part in the 
survey (answering the questions) at any time without being punished in any way.  There is no danger 
involved in taking part in the survey as they will only be answering questions that will be completed on 
paper.  Their weight and height will be measured and their finger will be pricked to get a drop of blood to 
test their sugar levels.  This will not be painful.  They will see that there is a number in the top corner of 
the questionnaire and their name and telephone number will be put on a separate paper with the special 
number that only I will have.  It will be secret to everybody else.  Nobody will be able to know which 
form is the information they have given - this will protect who they are (their identity). They will receive 
no money to take part in the survey. 
There are no direct benefits for them taking part in the survey, but the results of the survey will help me, 
the researcher, to use the information to develop a programme that might help women with high blood, 
high sugar and being overweight to live healthier.  The women taking part in the study will not receive 
any money for taking part and the study will also not cost them any money to take part. 
The results of the survey might be put in a magazine for doctors, nurses and other people working with 
health, so that they can know how many people like themselves, have problems with joint pain and other 
illnesses in the community. 
The person in charge of the clinics and the sister told me that I may do the study at the clinic and that I 
may give women the form to fill in, if they want to help me.   
If they want to ask anything before we start with the questions, or later on, they can phone me, Roline 
Barnes, at 082 740 1069, or the person supervising me, Prof Jelsma, at 021 – 406 6595.  They may also 
contact the University of Cape Town, Faculty of Health Sciences Human Research Ethics Committee 
(contact number: 021 – 406 6411) or the University of the Free State Ethics Committee (contact number: 
3 
051 – 405 2812) if they have any queries/questions or concerns regarding their rights or welfare as 
research participant.  
Thank you 
Roline Barnes 
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Epidemiological study 
Participant informed consent document 
1 
University of Cape Town:  An investigation into musculoskeletal conditions and co-morbidity amongst 
women attending Primary Health Care Clinics. 
I ____________________________________________________ have read (or had read to me by) 
 _____________________________________ the information sheet. 
I understand what is required of me and I have had all my questions answered.  I do not feel that I am 
forced to take part in this study and I am doing so of my own free will.  I know that I can withdraw at any 
time if I so wish and that it will have no consequences for me. 
Signed: 
__________________________________ _____________________________ 
Participant  Date and place 
__________________________________ _____________________________ 
Researcher  Date and place 
__________________________________ _____________________________ 
Witness (if necessary)   Date and place 
CONSENT TO PARTICIPATE IN RESEARCH 
EPIDEMIOLOGICAL STUDY 
APPENDIX 27 
Epidemiological Study 
STROBE checklist 
1 
STROBE guidelines for observational studies in epidemiology and indication of section where items were addressed 
Section/Topic Item 
No 
Checklist item Reported in 
Title and abstract 1 (a) 
1 (b) 
Identification of the study design 
Abstract 
Section 6.2.1 
Abstract 
Introduction 
Background/objectives 2 (a) 
2 (b) 
Scientific background and rationale 
Specific objectives 
Section 1.1.1 -
1.1.2 and 1.3  
and 6.1      
Section 1.2 and 
6.1.1        
Methods 
Study design 
Setting 
4 
5 
Study design 
Setting, locations and relevant dates, including periods of recruitment and data collection 
Section 6.2.1 
Section 1.4 and 
6.7 
Participants 
Cross-sectional study 6 Eligibility criteria, source and methods of selection of participants Section 6.2.2 - 
6.2.3   and 
6.2.3.1 
Variables 
7 Define outcomes, exposures, predictors, potential confounders and effect modifiers Section 5.2.1 – 
5.2.3 and 6.3  
2 
Section/Topic Item 
No 
Checklist item Reported in 
Data sources/ 
measurement 8 Details of methods of measurement Section 5.2.1 – 
5.2.3 and 6.3 
and 6.7 
Bias 9 Efforts to address potential sources of bias 
Study size 
10 Study size arrived at Section 6.2.3.2 
Quantitative variables 
11 Quantitative variables handled in analysis Section 6.9 
Statistical methods 
12 
(b) 
(c) 
(d) 
(e) 
Describe all statistical methods 
Methods used to examine subgroups and interactions 
Missing data 
Cross-sectionals study – analytical methods of sampling strategy 
Sensitivity analyses 
Section 6.8 and 
6.9 
Sections 6.8 and 
6.9 
Section 6.9 
Section 6.8 and 
6.9 
Section 6.9 
Results 
13 Numbers of individuals at each stage of study Section 6.9 and 
Figure 7 
3 
Section/Topic Item 
No 
Checklist item Reported in 
(b) 
(c) 
Reasons for non-participation 
Flow diagram 
Section 6.9.1 
and Figure 7 
Figure 7 
Descriptive data 
14 
(b) 
Characteristics of study participants 
Number of participants with missing data 
Section 6.9.1 
and 6.9.2 
Section 6.9.1 
and Figure 7 
Outcome data 
15 Numbers of outcome events (Objectives) or summary measures Section 6.9 
Main results 
16 
(b) 
(c) 
Unadjusted estimates and if applicable confounder-adjusted estimates and precision (95% 
confidence interval) 
Category boundaries when continuous variables were categorized 
Consider translating estimates of relative risk into absolute risk for a meaningful time period 
Section 6.9 
Section 6.9.3 – 
6.9.9 
Section 6.9.6 
Other analyses 
17 
Other analyses done 
N/A 
4 
Section/Topic Item 
No 
Checklist item Reported in 
Discussion 
 Key results 
 Limitations 
  Interpretation 
 Generalisability 
18 
19 
20 
21 
Summary of key results 
Discussion of limitations of the study 
Cautious overall interpretation of results 
Discussion of generalisability (external validity) 
Section 6.9.10 
and Section 6.10 
Section 6.10.7 
Section 6.10.8 
Section 6.10.7 
and 6.10.8 
Other information 
Funding 22 Sources of funding and role of the funders N/A 
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Balanced Lifestyle workbook 
Balanced lifestyle 
Name: 
1 
Balanced Lifestyle 
This a workbook designed to be used over 6 weeks which aims to help people develop self-management skills 
for living with musculoskeletal pain, diabetes mellitus type II, hypertension and being overweight. Using this 
workbook is not about sitting and reading or listening to your group leader. In order to get the most out of this 
workbook and group you will be asked to share your experiences, set goals and share these goals with other 
members in the group and you will need to take part in exercises and activities. This workbook is NOT a 
substitute for any other medical care that has been recommended for the treatment of your condition(s). 
Throughout the workbook and group session we will refer to musculoskeletal pain (joint pain), diabetes (sugar); 
hypertension (high blood pressure) and being overweight.  You may suffer from one, two or even more than two 
of the conditions mentioned at the same time.  Please only use the information in the workbook and group 
sessions that is applicable to your condition(s).  
You will benefit most from this workbook if you commit yourself to completing all the sessions within the 6 week 
period of time. Research tells us that these group sessions are of great benefit to people living with chronic 
diseases such as diabetes, high blood pressure and arthritis.  But to benefit from the group session, it is essential 
to use the workbook regularly over 6 weeks and to participate in the exercises and group activities.   The 
workbook is divided into six sections: 
1. Week 1:  What is Hypertension, Diabetes Mellitus Type II and being overweight
 Self-management 
2. Week 2: Exercise
3. Week 3: Stress Management
4. Week 4: Pain (Musculoskeletal pain – joint pain)
5. Week 5: Eating Well
6. Week 6: Continuing as a successful self-manager
Your group leader is……………………………………………. . She has been trained to give you all the exercises 
as well as the information you need to manage your chronic disease. She has been trained by a physiotherapist 
lecturer who specializes in musculoskeletal conditions/diabetes, high blood pressure and being overweight.  
2 
Week 1: High Blood Pressure (Hypertension)  
Blood pressure is a measurement of the amount of pressure in a type of blood vessel called an artery. The 
measurement is given as two numbers.  A normal blood pressure is 120/80 mmHg.  Both numbers are important 
because a high reading for either type of pressure can cause damage.  Most people who have high blood 
pressure have no symptoms and cannot tell if their blood pressure is high and the cause is unknown.  People, 
whose blood pressure is high, can feel well.  Over years untreated high blood pressure can damage blood 
vessels and in some people this damage can cause strokes, heart attack or damage to the eyes or kidneys. That 
is why it is important to control your blood pressure.  Blood pressure can be lowered by a combination of a low 
salt diet, exercise, maintaining a healthy weight, limiting alcohol and using your medication properly (if you have 
any).   
 
 
 
 
 
 
 
 
 
Get help immediately if: 
Heart attack warning signs: 
♥If you feel a severe, crushing or squeezing chest pain
♥Pain or discomfort in one or both arms, the back, neck, jaw or stomach
♥Chest pain lasting longer than 5 minutes when there is no apparent cause and it is not
relieved by rest.
♥Chest pain and any of the following at the same time:  irregular heartbeat, sweating, nausea or
vomiting, shortness of breath, light-headedness, or unusual weakness.  For women chest pain
may not be present with these symptoms
♥Stop immediately what you are doing
♥Sit down
♥Call 051 – 405 8911 or 051 - 407 6000
♥If you are not allergic to aspirin, take one tablet of 325 mg. (Disprin)
Stroke warning signs: 
 Sudden numbness or weakness of the face, arms or leg especially on one side of the body
 Sudden confusion, trouble speaking or trouble understanding
 Sudden trouble seeing in one or both eyes that does not clear with blinking
 Sudden trouble walking, dizziness, loss of balance or coordination
 Sudden severe headache with no known cause
 Don’t wait more than 5 minutes to call for help
3 
Diabetes Mellitus Type II (Sugar) 
Diabetes is a disease that makes it difficult for the body to use the sugar in the blood.  The body normally 
produces a hormone called insulin. People with diabetes either don’t have enough insulin in their body or the 
insulin in their body is not working properly.   This means that the body cannot move the sugar out of the blood 
so the sugar levels remain high.  The extra sugar in the blood causes problems for the body’s functions.  Type II 
diabetes may start as a result of being overweight, lack of exercise, eating and other lifestyle habits.  It is more 
common among people who are overweight. Increased fat makes it hard for the body to use the insulin in the 
correct way.  Diabetes does not happen overnight, it happens slowly over time.  There are many people whose 
blood sugar levels are higher than normal but not high enough to be diagnosed with diabetes.  Most people with 
type II diabetes can manage their blood glucose (that is the amount of sugar in the blood) with medication, 
controlling their exercise, diet and weight, sometimes by losing between 4-6 kg.  The general rule is that if you 
can lose 7% of your body weight you can bring blood glucose into a healthy range.  So if you weigh 80kg, if you 
lose 6kg and get down to 74kg you have a good chance of getting your blood glucose under control. 
Early symptoms of diabetes mellitus type II may include: 
 Fatigue (very tired all the time)
 Hunger
 Increased thirst
 Going to the toilet more often (urinating)
 Blurred vision
 Pain or numbness in the feet or hands
 Skin or other infections that heal slowly or occur often
4 
Being overweight 
Being overweight is a disease in itself and is also a risk for other chronic diseases.  Being overweight makes your 
life shorter; increases the risk of heart disease, and stroke; increases the risk for type II diabetes and 
hypertension.  It is also associated with problems with breathing when you are asleep (this is called obstructive 
sleep apnea) and being overweight reduces the quality of life. Losing weight can lower your blood pressure, 
cholesterol and decrease the risk of dying earlier.  Weight loss may improve your quality of life and your self-
esteem.  Losing weight is not easy but it can be done and has many benefits for your health. 
Get help immediately if: 
 If you feel chest pain or pressure
 If you have fainted or find someone unconscious
 If you have a seizure
 If you feel that you can’t breathe and are short of breath
 Call 051 – 405 8911 or 051 - 407 6000
Go to the clinic if you have: 
 Numbness, tingling, or pain in your feet or legs
 Problems with your eyesight
 Sores or infections on your feet
 Symptoms of high blood sugar (being very thirsty, having blurry vision, having dry skin,
feeling weak or tired, needing to urinate a lot)
 Symptoms of low blood sugar (feeling weak or tired, trembling, sweating, feeling irritable,
having trouble thinking clearly, fast heartbeat, double or blurry vision, feeling uneasy)
5 
Musculoskeletal conditions (Joint pain) 
Musculoskeletal conditions are a large group of conditions that affect the joints and muscles over a long period of 
time.  This happens when the joint is worker harder or stretching further than what it is prepared for.  How serious 
the condition is may vary from person to person.  Pain and discomfort may interfere with everyday tasks such as 
walking.  Go to the clinic if you feel recurrent pain, if your joints are stiff and painful and there is swelling around 
your joints. 
Self-Management 
What is self-management? Self-management does not mean that you are expected to look after your health on 
your own.  Someone who is a successful self-manager takes responsibility for their own well-being and health. 
They choose to work with the health team, with their medicine (if applicable) and with themselves to live a 
healthy, balanced life (just like a manager in a business – who doesn’t have to do everything themselves, they 
work with a team to reach a specific goal).  
There are lots of things you can learn to do which will help you to become a successful self-manager. The first 
thing is to understand your conditions which might be joint pain; diabetes mellitus type II, hypertension and being 
overweight.  You need to understand about the condition(s), how they can affect your life and, if you have been 
given any, about the medication(s) given to you to treat the condition(s).  
The second thing about being a self-manager is being able to think about the information and how it affects you 
and your life. The last thing is to think what you would like to be able to do, decide how you are going to do it and 
then to learn and practice the skills you need to be able to do it. Some of the things you will read and learn about 
and practice every day during the group sessions and when using the workbook include exercising, relaxation 
techniques and healthy eating. 
During the group sessions and using this workbook you will learn about exercises and its benefits, in the second 
week you will learn about the common symptoms of joint pain, diabetes, high blood pressure and being 
overweight; and how to manage these. The third week will focus on stress management, and the final weeks will 
focus on managing pain, and eating well. Some of you may already know a lot about these topics, while others 
may not know much. It is important to share information in the group sessions and make sure that everyone has 
the knowledge they need to become a self-manager, even if you think you know a lot about these topics it is still 
worthwhile going through the workbook and attending the group session to make sure you have not missed out 
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on any information. Research tells us that people, who are well informed and understand about their health, 
manage their condition(s) better and have a better quality of life. Using this workbook, you will also learn and 
discuss the steps that you need to become a good self-manager.  The steps are discussed below.  
Self-management steps 
Step 1: 
To be a good self-manager you need to learn about and practice several skills during the group sessions and use 
the workbook. The first step is to decide what it is you would like to be able to do. This can be the hardest step. 
For example you might feel that you are overweight. First you need to think why you are overweight. Perhaps 
one of the reasons you are overweight is that you have not been eating the right types of food. Your first step 
might be to decide that you would start eating the right types of food. This will help you to feel better.  
Write down three things that you would like to be able to do: 
1) 
2) 
3) 
Step 2: 
But deciding that you are going to lose weight doesn’t mean it will happen. You will have to make it happen. The 
second step in being a self-manager is to decide how you are going to do it. Sometimes the thought of doing 
something new can seem too much and we don’t even try. If you want to lose weight you need to think about the 
different options you have. For example you could eat smaller portions of food, or you could decide you would 
decide you would make better choices about the types of food you are going to eat or by joining an exercise 
group. Never think that what you would like to be able to do is impossible. Always look at every available option 
and look at it from every angle.  
Write down three different ways that you could try to achieve what you would like to do: 
1) 
2) 
3) 
Now that you have decided on how you are going to do things you need to compile an action plan. It is important 
that this plan is realistic otherwise it is likely that you will not succeed.  
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 First decide what you are going to do this week
 Now make a specific plan
Saying that this week I’m going to try to meet some new people or you are going to eat healthier food is NOT a 
specific plan. To be specific, the plan must have different parts. It is useful to ask yourself some questions to 
make ea specific plan. Questions like: 
 What?
Exactly what are you going to do? For example you could decide that in order to lose weight you are going
to eat smaller portions of food.
 How much?
Then you must decide how much you are going to do. For example are you going to dish up your food on a
smaller plate and change the way you are cooking food all at once.  Changing two things at once is going to
be more challenging than only changing one thing at a time. So you have to decide how much you will be
able to do.
 When will you do it?
Then you must decide on exactly on which day you are going to start changing the portion size of your food
and what meal. Maybe it is better to start off with your main meal of the day because that is when you eat
the biggest plate of food.   Or you can start by changing the portions size of your breakfast to ease you into a
new routine.
 How often?
This is always the hardest part. We would all like to be able to do more things every day. But we are human
and this is not always possible. When people want to start exercising, we often say we are going to do it
every day.  But this is often not possible and if we then miss a day we feel that we have failed and we give
up. How often will you exercise? Not every day, but maybe three times a week. You know that you won’t
become fit immediately and that it will take time.
 Is it a good plan?
To test whether you have come up with a good plan you need to ask yourself a question:
“If I give myself a score from 0 -10 for how confident I am that I will achieve my plan this
week, where 0 is not at all confident, and 10 is totally confident. What score will I give myself
to show how confident I am that I can complete this plan?”
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If your answer is 7 or more out of 10 then this is probably a very good plan. If your score is less than 7 you 
need to think about why you are not confident. What are the problems?  Can you change the plan or solve 
the problems to make you feel more confident? 
Step 3: 
Now, write down your plan and put it somewhere you will see it every day. There is an action planning form at the 
end of this section and 5 more at the back of this workbook book. Use one for every week you are goingtotake 
part in the group sessions. You are welcome to draw up more of the action planning forms and keep on working 
on your plans in the future. 
Now you need to start carrying out your action plan. If it is a good plan then doing it is usually fairly easy. It helps 
to tell family or friends what your plan is and to report back to them on how you are doing. During the group 
sessions you are going to make a plan every week and record how you are doing. It helps to report back to the 
group because then you can have an idea on how well you are doing. If you haven’t been able to keep to the 
plan you can discuss the problems with the group which might give you ideas about how to change or make 
plans to cope better. 
Step 4: 
Always check if you have achieved your plan and give yourself a reward. Also think about how achieving 
your plan makes you feel. Is the plan helping you to achieve what you want? What about problems? 
What if your plan doesn’t work? Are you going to give up and decide you had a bad plan? There are seven 
steps to solving problems with plans. The steps are the following: 
1. Deciding what the problem is (you might need friends and family to help you here)
2. List ideas to solve the problem
3. Select one idea to try and solve the problem
4. How did it go?
A good action plan is: 
 Something I want to do
 Something I can expect to do this week
 Specific
 Answers the questions: What? How much? When? How often?
 One I am confident that I can achieve this with a score of at least 7 out of 10.
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5. If it didn’t work, try another idea
6. If your ideas don’t work, ask friends, family, counsellors, professionals for ideas
7. Finally you might have to accept that you can’t solve the problem.
At the end of each section and at the end of the workbook there are “Action Planning Forms”.  Please use these 
forms to plan what you would like to do and how you are going to do it.  Exercise is one of the most important 
aspects of the group sessions and workbook for all the conditions this workbook is used for.  Please use the 
“Action Planning Form” at the end of this section to plan what exercise you are going to do this week. 
A successful self-manager is someone who: 
 Sets goals
 Makes a list of ways to achieve the goals
 Makes action plans to achieve the goals
 Carries out the action plans
 Checks progress every week
 Is able to change the action plan if there are problems
 Gives themselves a reward for achieving their goals
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Week 2: Exercise 
Exercise is an important way to keep healthy. Scientific research tells us that exercise has a lot of good effects 
on our bodies like helping our digestive system absorb and process food; it trains our heart to be stronger and 
healthier and keeps our lungs working. Exercise makes our muscles and bones strong and our joints flexible so 
that we can keep moving. Exercise also helps us feel happy, improves our memory, helps us sleep better and 
lessens the effects of high blood pressure and diabetes.  Exercise might also help us lose weight. 
In the past, when people became ill with a chronic disease like high blood pressure or diabetes, medical care 
focused on helping them when their symptoms became worse. Treatment focused on using drugs and people 
were often advised to rest or decrease their activity. Today we know that if we teach people who develop chronic 
diseases about their disease and encourage them to do exercise we can prevent a lot of the problems which 
used to be treated with medicines. We also know that exercise can help to treat a lot of the symptoms which 
people with chronic diseases develop. Symptoms which may be caused by the disease or by the drugs used to 
treat the disease.  
One of the biggest benefits of exercise is that exercising regularly makes you feel more in control of 
your life.  
Although exercise is good for you and safe for you to do, sometimes your body will give you clues that you must 
not exercise today.  
Exercise is good for: 
 Improving mood
 Strength
 Improving sleep
 Concentration and memory
 Heart and lung health
 Decreasing body fat
 Digestion
 Increasing confidence to self-manage chronic diseases.
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What kind of exercise should you do? 
You do not have to join a gym or a club to exercise. There are lots of ways of exercising from formal sports like 
running, playing netball or swimming.  But, walking is a very good way to exercise for all ages. Any activity which 
makes your heart beat faster and makes you breathe a little harder is exercise. Dancing is exercise, walking up 
the stairs is exercise and even cleaning the house is exercise. There are lots of ways that you can exercise every 
day without having to go to a class or join a club. You could walk a little further before catching the bus or the taxi 
or you could play with your children/grandchildren!  
There are three general kinds of exercises: 
1. Endurance exercises like walking or dancing. Endurance exercise is sometimes called
aerobic exercise which means that you will be breathing faster and your heart will be
beating faster. We know that this kind of exercise is very important to keep healthy and we need to do
30 minutes of this kind of exercise three times a week to keep healthy or we can do 150 minutes of
exercise over the weekend. If we need to lose weight we have to do 45 – 60 minutes of exercises. You
don’t have to start with this amount straight away, start of slowly, set goals and build up the amount of
time.
2. The second kind of exercise is strengthening exercises. This kind of exercise focuses on making us
stronger. To make muscles stronger we have to do exercises which make the muscles work harder
against a resistance, like weight training but you can also strengthen your muscles by working with
heavy bags of shopping!
3. The last kind of exercise is stretching exercise. Stretching exercises focus on keeping us mobile and
flexible.
Do not exercise if: 
 You have a fever
 You are dizzy
 You have been vomiting
 You have diarrhoea
 Your joints have suddenly become swollen
 You have a new pain which you don’t know the cause of
Miss one exercise session if you have one of these problems until you can speak to a nurse or 
doctor.  
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Endurance Strengthening Flexibility 
We know one of the hardest things about exercise is not doing it once, but to keep on doing it. There are several 
steps we can follow to make sure that when we start to exercise we stick to it. We usually have lots of excuses 
why we can’t exercise. Here are some of the excuses: 
“I don’t have time” 
It doesn’t take a lot of time to start exercising. Five minutes a day is a good start. Exercise is as 
important as medicine to help us remain healthy (remember it doesn’t mean you should stop using 
your medicine). If we know that it is that important we can make time for it. 
“I’m too tired” 
When people feel tired they become less active. As you become less active, your body loses fitness 
and you become weaker, you may feel stiffer and you will become tired more easily. This means that 
exercising might feel harder and so you exercise less. This often results in a downward spiral and 
people often get to the point where even walking down the street to the taxi rank can feel like too much. 
Being active or doing exercise, when you are feeling tired will give you more energy and you will feel less tired. 
Types of exercise: 
 Endurance exercise which makes you breathe harder (sometimes called aerobic)
 Strengthening exercise which makes you stronger
 Stretching or flexibility exercise which makes you more mobile and supple
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“I’m too sick” 
You may be too sick to undertake vigorous exercise but you can still try and be more active. You can even 
break your exercise into one minute sessions which you repeat several times through your day. The fitter 
you get, the better you will be able to cope.  . 
“I get enough exercise already” 
You may be getting a lot of exercise already in your job or simply walking around doing your daily chores. But for 
most people if we add up this time, it still isn’t enough exercise to keep us healthy and fit. This kind of exercise 
also doesn’t include one of the most important components that make exercise good for us – fun!  
“Exercise is boring” 
You don’t have to do the exercises that everyone else does if you find them boring. Choose something 
that is fun, exercise with a friend or with your favourite music or listen to the radio. You can also keep 
your exercises fun by changing them regularly. 
“Exercise is painful” 
Exercise may be uncomfortable but it shouldn’t be painful. If you have pain before you start to exercise, it should 
not get worse while you are exercising. If you do not have pain before you start to exercise and you start to feel 
pain while you exercise you need to stop exercising and evaluate your pain using the guidelines in Week 4: Pain. 
If you have muscle or joint pain for more than two hours after you exercise then you have probably done too 
much. Next time do a little less, either exercise for less time or less vigorously. 
“It’s too dangerous, it’s too hot, or I’m too old” 
We can always find reasons not to exercise. Remember that exercise can be done anywhere, anytime. You can 
put on music and dance, if it’s too dangerous find a group of people to exercise with which will not only make it 
safer but also more fun! 
“I know I won’t stick to it so there is no point in starting” 
First review the steps we discussed on how to be a successful self-manager. If you set your exercise goals using 
these steps you have more chance of sticking to your exercises. Remember it is important to reward yourself for 
achieving your goals; this makes it easier to move on to your next goal. We will now look at the important steps 
to be successful at putting your exercise plan into action. 
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Your exercise program: 
An exercise program should include the three different types of exercise:  endurance, flexibility and strength 
exercises. Following the steps in the box “Steps to success with exercise”, you need to decide on what you 
would like to be able to do and what exercise you would like to do. Now that you know what exercise you are 
going to do, you need to decide how much to do. The amount of exercise you are going to begin with will depend 
on different things. If you have not done any exercise for a long time, have not been feeling well, if you have had 
stiffness or pain that interferes with your daily activities then you need to start your exercise slowly. You can 
begin slowly by starting with some flexibility and strengthening exercises. Do these exercises every other day for 
5 minutes. Once you can do this comfortably and without feeling stiff or sore the next day, increase it to 10 
minutes. Once you can do 10 minutes comfortably, you can start doing the exercises every day (when we say 
exercise every day, we usually mean exercise for 5 days of the week; it can be very hard to keep a routine to 
exercise on weekends when activities are different). Once you can do at least 10 minutes every day then you are 
ready to begin endurance exercises. Choose your exercises from the ones set out in the sections below. Follow 
the instructions in the box to make sure you get the most out of the exercises and do them safely. 
Steps to success with exercise: 
 Set a clear goal using the steps outlined in “How to be a successful self-manager”
 Choose exercises or activities that you want to do and that are fun
 Set a specific time and place to do your exercises
 Decide how long you are going to stick to the plan before you think about changing it (6 to 8
weeks is a good time)
 Keep an exercise diary to keep track of how you are doing (there is one at the back of this
workbook, so please make use of it)
 Start now – don’t wait. Begin gradually and progress slowly
 Revise your program At the end of the 6 – 8 weeks make a new plan for the next 6 weeks
 Reward yourself. It is already a reward to feel better and healthier but also give yourself a
reward for achieving your goal, like eating a favourite meal or going to visit a friend.
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Flexibility Exercises: 
Remember, these exercises are aimed at improving your ability to move. There is a long list of 
exercises that could be included here and you might not be able to do them all every time you 
exercise. Try to include flexibility exercises at least once a week.  
Strengthening Exercises: 
You do not need to go to a gym to do strengthening exercises; most exercises can be done at home. 
To make muscles stronger you must make them work against a resistance or a force – the muscles 
have to push or pull. You should not do strengthening exercises every day, they should be done every 
second day. Your muscles need a day of rest to adapt and get stronger. To make a muscle stronger you 
need to start off doing each exercise 5 times. Once you can do an exercise 10 times you will not get stronger by 
doing more exercises. Now you will need to add more resistance to the exercise (heavier shopping bags for 
example) to get stronger.  
Getting the most out of your flexibility and strength exercises: 
 Move slowly and gently. Do not use jerking or bouncing movements as this will make your
muscles shorter and tighter.
 Stretch to the point of tension in a muscle and hold for 30 seconds to a minute before you
relax.
 Don’t push until it hurts, stretch to tension not pain.
 Start off with 5 repetitions of each exercise. After 1 week increase it to 7, after another week
increase to 10.
 Always do the same number of exercises on both sides of your body.
 Keep breathing; do not hold your breath when you exercise. Think about breathing out as you
move to make sure you do not hold your breath.
 Use the two hour rule. If you have increased symptoms for more than two hours after you
exercise you have probably done too much. Don’t stop doing the exercises but decrease the
number of how much you do next time.
 If you find an exercise difficult this does not mean you should not do it at all. You should adapt
and try and do it as completely as you can.
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Endurance Exercises: 
The difficult thing is deciding how much exercise to start with. The easiest starting point is to ask: “how much do I 
think I can do without suffering for it tomorrow?” If you feel you can do 5 minutes; then do 5 minutes. Remember 
that any exercise is better than none. You don’t have to do 30 minutes from the first day. It is important to start 
slowly and increase gradually. It is better to start off by doing less than you think you can and increase from 
there.  
There are three things you need to think about when you do endurance exercises. The three things are 
frequency (how often am I going to do this exercise); duration (how long am I going to do this exercise) 
and intensity (how hard am I going to work when I exercise).  
1. Frequency:
Endurance exercise must be done 3 or 4 times a week. By doing this you can rest every second day and allow
your body to recover. All athletes have at least one day a week when they rest. Rest does not mean that that you
have to lie in bed all day, it means that you do not do exercise.
2.Duration:
How much can I do without suffering for it tomorrow? That is your starting point. If you start with a few minutes
you can gradually increase it over time until you can do 30 minutes at a time. The easiest way to increase the
time is to use intervals of exercise. For example to walk fast for 3 minutes, then walk slowly for 2 minutes; then
walk fast again for another 3 minutes. Slowly over time cut down the slow walking and increase the fast walking.
You could also break your exercise into separate sessions. You could walk for 10 or 15 minutes in the morning
and do it again in the evening. This would still count as 30 minutes of exercise. You can also walk the total of 150
minutes in one day over the weekend.  The effect on your body will be the same, but you will find it difficult and
will have to be fit to be able to do this.
3. Intensity:
How will you know that you are exercising hard enough? How will you know if you are exercising too hard? When
doing endurance exercises the easiest way to check the intensity is to use the “Talk Test”. When you are doing
moderate intensity exercise you should be able to talk comfortably but if you try to sing it would be difficult and
you would have to stop singing to take deeper breaths. Moderate intensity means you should feel that you are
breathing a little faster and a little deeper but you can still talk. It may take you a while to find the right intensity
for you during your exercise session. This is normal; take your time to get to know how your body responds.  You
can also increase your walking exercise by increasing your arm work.  Bend your elbow a bit and swing your
arms more vigorously, or you can hold a tin of food in each hand, or put sand, or dried beans in two small plastic
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bottles or socks.  The extra work you do with your arms increases your intensity of exercise without forcing you to 
walk faster than you find comfortable. 
How will you know that you are improving in your exercises? For the flexibility and strength exercises it is easy to 
feel the improvement as you will be able to move easier and you will feel stronger and be able to lift heavier 
items. For some people it is harder to know if they are improving with the endurance exercises. One way to see 
improvement is to do a test. One of the easiest tests is a timed test. Decide on a route that you can walk near 
your home. Walk this route at a moderate intensity and time how long it takes. After several weeks of exercise 
walk the route again and time it again. You may see that you can walk the same route a little faster within 4 
weeks, but it may take 8 to 12 weeks before you see that you can do the route in a faster time. The goal is to 
complete the same route faster or in the same time but at a lower intensity (breathing easier).  
Please use the exercise diary at the end of each section to record your goals and your 
progress in achieving them. 
Exercise Routine
This is a 20 minute exercise routine which is safe for people with musculoskeletal conditions, diabetes type II, 
hypertension and being overweight. This routine includes exercises which make you stronger (strength 
exercises), more flexible (stretching exercises) and fitter (endurance exercises). 
1. Start by standing up straight and tall, feel your weight across your feet, relax your
shoulders and open your chest, hold your head straight. Take a deep breath in and
breathe out.
2. March on the spot for 2 minutes. March at a steady pace – that is a pace which you can
maintain for 2 minutes. Do not start fast and get slower or start slowly and get faster.
Pace yourself, start and finish at the same speed. You should be marching so that you
can feel you are breathing a little bit harder than normal, you should be able to talk but
not be able to sing.
You can also dance for 2 minutes. 
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3. Stretch your neck – keep your shoulders relaxed and turn to look over your right shoulder, hold
for 30 seconds. Bring your head back to the middle, then turn to look over your left shoulder –
hold for 30 seconds and then bring your head back to the middle. Now put your left ear on your
left shoulder - hold for 30 seconds and then bring your head back to the middle. Repeat to the
right. Now put your chin on your chest - hold for 30 seconds and then bring your head back to
the middle. Roll shoulders forwards 5 times, then roll your shoulders backwards 5 times.
4. March on the spot for 2 minutes – 30 steps normal, 30 steps lift your knees up as high as you can. Keep
changing every 30 steps.
5. Stretch your quadriceps muscles by bending your right leg backwards and holding your
foot if possible below your buttock. You will feel the stretch down the front of your thigh.
Hold it for 30 seconds and then do the same on the left.
6. Stretch your hamstring muscle by putting your right heel on the ground and pulling your toes
upward, put your hands above your knee and lean forward to feel the stretch behind your knee.
Repeat on the left for 30 seconds.
7. Sit on a chair – make both your knees straight and then bend again. Do this
30 times. This works the front thigh muscles.
8. Sit on a chair – now stand up, keep sitting down and standing up for 2 minutes. Stand
up and sit down at a steady pace – that is a pace which you can maintain for 2 minutes.
Do not start fast and get slower or start slowly and get faster. Pace yourself, start and
finish at the same speed.
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9. Then with your arms folded on your chest, stand up from the chair and sit down again.
Keep sitting down and standing up for 2 minutes. Do this at a steady pace – that is
a pace which you can maintain for 2 minutes.
10. March on the spot for 2 minutes – 30 steps normal, 30 steps lift your feet up as high as you can (try to
kick your buttocks). Keep changing every 30 steps.
11. Stand up straight. Take one big step forward with your right foot and bend your knees
So that your left knee almost touches the ground (lunge) or as far as you can go. Push
Back with your right leg to bring your feet back together again. Repeat on the left.
Do 10 lunges on each leg.
12. March on the spot for 2 minutes – 30 steps normal, 30 steps lift your knees up as high as you can. Keep
changing every 30 steps.
13. Stretch your body – with your feet shoulder width apart, slide your right hand down your
right leg so that you bend sideways. Bend as far as you can - hold for 30 seconds and
then stand up straight again. Repeat this to the left. Put your hands on your bottom; bend
your body backwards as far as you can. Now bend forward and try to touch your toes.
14. Finish by standing up straight and tall, feel your weight across your feet, relax your
shoulders and open your chest, hold your head straight. Take a deep breath in and
breathe out.
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Action Planning Form - Exercise 
Use this form to develop an action plan for exercise. What exercise would you like to do? 
Be sure your action plan includes: 
What you would like to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
(what) 
(how much) 
(when) 
(how many?) 
How confident are you that you can complete this action plan? 
Keep a record of how you did: 
I Plan to….. I did….. 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
Saturday 
Sunday 
____________________________ 
Not at all     |    |     |     |     |     |     |     |     |     | Totally 
Confident    1    2   3    4   5    6    7    8    9   10confident 
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Week 3: Managing Common Symptoms of 
Musculoskeletal Disorders 
Musculoskeletal conditions may and can affect a person’s quality of life, with pain being the most common 
reason for seeing a doctor, clinic sister or physiotherapist. Other symptoms may be: 
 joint stiffness (especially following a period of rest or early morning stiffness for less than two hours),
 swelling and problems moving the joint through the whole range of motion
 difficulty in performing daily tasks
 Fatigue
 Frustration, isolation, depression
What is pain? 
It is important for you to understand what pain is and what type of pain you may experience with 
musculoskeletal conditions (MSC) in order to manage your symptoms.  Acute pain comes on 
suddenly (e.g. after banging your finger in a door), and lasts for a few days or even weeks (usually less than six 
weeks) while the body heals itself. This pain protects the part of the body while it heals. Once the body is healed, 
there is no more pain. Musculoskeletal conditions usually begin as acute pain, which means that pain starts 
suddenly and lasts for a short time. The pain usually comes on when the joint is moved or used and then the pain 
subsides.   
MSC don’t always remain as acute pain but sometimes changes to what we call chronic pain. This can cause 
pain when you aren’t moving or even at night or during movements/activities that don’t usually cause pain. 
Chronic pain is described as pain that is experienced on most days for at least three months. The reason why 
this happens is not yet known. Chronic pain occurs after the body has healed itself and this means that there 
shouldn’t be a reason why we need to protect that area anymore. But often we listen to the pain and don’t use 
that joint or do certain things in case we cause damage. This is not possible with MSC as the joint pain is not 
something new, so we can’t damage it anymore by moving and exercise.   
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Flare ups of pain: 
Although a person with MSC may have chronic pain, pain is not necessarily present at all times and you can 
experience periods of less or worse pain. When pain becomes worse this is called a flare up. This means you will 
have acute pain at this time and there are ways to deal with this. It is important to note what causes such a flare 
up so you know what and how those activities can be changed to reduce the flare up of pain again.  If your pain 
is being caused by tense muscles then heat can help to decrease the pain. You can warm up the muscles by 
having a warm bath or shower. If you cannot have a hot bath or shower, then keeping the muscles warm with 
clothes or a blanket can also help. If you touch the painful area and it is already hot, this means it is inflamed and 
you should not make it hotter by applying heat to it. 
Signs of a flare up are: 
 a sudden increase in pain
 redness
 a warm or hot joint
 swelling
What can I do about pain in a flare up? 
A flare up can be managed by taking a short time to rest from whatever has caused the flare up. Don’t 
rest TOO much as your joints can get stiff. It is helpful to take painkillers as prescribed by your doctor if 
your pain gets worse. Putting ice onto the joint for not more than 10-20 minutes at a time on the painful 
area can also help. You can use a small bag of ice wrapped in a towel or wrap a towel around a bag of frozen 
vegetables. Don’t put ice directly onto bare skin. If you do not have a freezer then putting a damp cloth on your 
skin (if you have a fridge then use water from the fridge) will also work.  
Take home message about pain: 
 Hurt does not always mean harm. There can be pain without injury or something being
wrong due to the changes that take place in the nervous system.
 There are physiological reasons why there is pain without injury.
 Your pain is NOT imaginary or in your head or psychological.
 Chronic pain is NOT the same as acute pain.
 Chronic pain is NOT a sign of on-going damage
 Chronic pain cannot be “switched off.”
 An increase in your pain (with or without exercise) does not mean a new injury.
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Medicine 
If you have medicine to help your pain it is important that you take it regularly. Do not wait for the pain to start 
before you take the medicine, if you wait it will not work as well. If the doctor or nurse has 
told you to take the medicine several times a day then it is important that you do this, even if 
you are not feeling any pain at the time; not feeling pain means that the medicine is working. 
Do not wait for the pain to come back again before taking another pill, it won’t work as well. 
If your medicines are not helping the pain then you must go back to the nurse or doctor. You 
might need stronger medicine or you might need to take two different kinds of medicine at the same time.  
Common medicines used to treat pain are: 
 Paracetomol (panado, dolorol, painamol, painstop) is a very good, very effective and safe medicine for pain.
It is important not to take more than 10 tablets per day.
 Aspirin (disprin) is also very good but some people need to be careful with this medicine. If you use it for a
long time you need to be careful of side-effects like ulcers, asthma or kidney problems.
 Anti-inflammatories like indomethacin (indocid), dicolfenac (voltaren or panamor) or ibuprofen (brufen or
inza) are good if your pain is being caused by inflamed muscles or joints. These must be taken with food.
These can also cause side-effects like ulcers.
 Paracetomol and Codeine is stronger than paracetomol on its own. If you have been using paracetomol on
its own and taking it as the nurse or doctor told you but your pain is not getting better they may give you
paracetomol with codeine.
Remember that the most important thing about the pain medicines is to take them before the pain starts or as 
soon as the pain starts. Don’t wait for the pain to become severe before you take the pain medicine. It won’t work 
nearly as well. 
What is stiffness? 
Stiffness is when your joints feel like they aren’t able to move easily or they feel stuck. This is common in the 
morning just after waking up as your joints have not been moving much while you sleep. The joints get used to 
being in the one position and then when you try to get up and start moving it feels difficult to move (stiff).  
What can I do about stiffness? 
After a period of rest/sleep or limited movement the joints need to slowly get moving in order to get used to 
moving again. So before getting out of bed in the morning move your feet up and down 20 times. Then bend 
each knee up and down 20 times and open and close your legs 20 times to get the joints warmed up.  
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What is swelling? 
Swelling is a common symptom of a flare up or may be a regular symptom experienced during MSC. Swelling is 
caused by a build-up of fluid in the tissues in and around the joint. This causes the area to feel bigger than usual, 
hard; painful and it’s difficult to move the swollen area.  
What to do about swelling? 
Decreased 
swelling
Movement 
(bending knees, 
moving feet up 
and down)
Elevate (putting 
your leg on two 
pillows or chair 
while sitting 
down)
Ice for no more 
than 10-20 
minutes 
Decreased 
swelling
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Difficulties doing certain activities? 
Sometimes you may feel that you are unable to do a specific task at home or outside of the house. You may feel 
too stiff, weak or sore to do a certain activity. You may just need to “warm up” in the morning before trying 
something or you may be having a flare up and then you should follow the management tips as given above.. 
What to do when you are struggling when doing an activity? 
First try and think WHY you are struggling with a certain activity and then how you might be able to 
deal with this.  There are some ways to help yourself when you feel like there are certain activities 
you are struggling with. 
Joint protection, assistive devices 
To reduce the weight and stresses going through a joint, an assistive device such as a walking stick, crutch or 
walker can be very helpful to protect your joints. This allows your arms to take some of the weight of your body 
when stepping on the affected leg. Using one stick or crutch gives you a little support and allows one of your 
arms to take the full weight of your body off your leg but also allows your other arm to be free to use during 
activities such as preparing food. Two crutches or a walking frame uses both arms and gives more support but 
often take up more space while walking and both hands are being used on the device instead of being able to 
use them for daily activities. Try and start with the least supportive if you need to use something like this. 
Activity modifications: 
 Can change the way you do activities to protect joints. 
 Avoiding certain activities that put a lot of strain on the joint, like kneeling or climbing steps.
 Use a padded pillow under your knee if you must kneel.
 Sit on a chair instead of kneeling.
 If you struggle to stand up after sitting for some time then try sitting on a harder chair so you
are not deep in the chair.
 Using a chair with armrests makes it easier to stand up.
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 Avoid sitting on a low chair as it is more difficult to stand up from a lower chair than from a higher one.
 Walking up a ramp is better than struggling to climb steps if this is available.
Pacing and activity/resting cycles: 
During exercise and daily life, you need to learn to pace yourself. When you finish an activity/exercise you need 
energy at the end of it for your body to recover easily to enable you to carry on for the rest of the day. When you 
start an activity you need to pace yourself at a speed at which you can maintain throughout the activity without 
getting faster or slower. At the end you should still have energy left to be able to do more.  
How to pace? 
 Pace your activities during the day so that they are spread out with enough rest periods in between so
you don’t tire yourself out in one session of too many activities.
 Find a balance between completing a task and resting. You should not do an activity for too long that
you feel exhausted afterwards and you should also not rest too long so that you feel too stiff to get
moving again.
For instance if you have washing and cleaning and ironing to do in a week, instead of doing all three on one day, 
spread them out over three days or if needed, with a day in between. Start exercising or walking at a pace that 
you know you can keep the same until the end, without stopping or slowing down. If you find you are too tired 
then you must start slower or do less at one time and find the balance. 
Tiredness 
If you do too many activities at one time or in a short time without break periods of rest, your body 
will feel extremely tired and you will be tired.  It is important to slowly start small activities and short 
times of exercise to allow your body to adjust. If you are tired it is wise to stop the activity and rest 
for a short while (1-2 days) until you feel better. This does not mean you need to lie in bed; you can 
continue with your daily tasks but take a break from the exercise and then once you begin again, listen to your 
body and look for signs of doing too much in one go. This could be getting short of breath or your muscles feeling 
weak, your legs shaky. 
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Action Planning Form – Managing Symptoms 
Think about a common symptom which you experience. Use this form to draw up an action plan of how you plan 
to manage this symptom the next time it occurs. 
Be sure your action plan includes: 
What you would like to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
(what) 
(how much) 
(when) 
(how many?) 
How confident are you that you can complete this action plan? 
Keep a record of how you did: 
I Plan to….. I did….. 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
Saturday 
Sunday 
____________________________ 
Not at all     |    |     |     |     |     |     |     |     |     |   Totally 
Confident   1    2   3     4   5    6    7    8    9   10  confident 
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Exercise Diary 
Use this exercise diary to keep track of the exercise goals and plan you drew up in week one. 
Start by writing down your goal.  
Write down here what you would like to be able to do:  
Now, what would you like to be able to do this week which will help you to reach your goal? 
Remember from your action plan to include:  
What you would like to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
(what) 
(how much) 
(when) 
(how many?) 
Exercise Planned Exercise I did... How did I feel? Do you need to change 
anything? 
e.g. 20 minutes in the 
morning after breakfast 
and in the evening after 
supper 
Very tired by the second session, I’m 
going to cut down to morning only for this 
week. 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
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Week 4: Stress Management 
We talk about stress a lot. We might say that it is stressful to live in South Africa. That it is stressful 
to worry about our families, about money or worrying about getting a job or coping with my job. 
Stress is a feeling; it is a combination of feeling tense and worried. When we feel stressed we 
may be irritable, and find it difficult to concentrate or remember things, stress can affect our 
sleep, our appetite and our relationships. 
The most common reason why we feel stressed is a lack of control. We tend to feel that things are stressful if we 
don’t have any control over them. We feel stressed if we are going to be late for work because the trains are late 
– this is out of our control. We feel stressed about where we live if we don’t feel safe there – those who commit
crimes against us are also out of our control. In the same way, we may feel stressed when we have a chronic
illness like diabetes or high blood pressure. If you feel that your illness is out of your control and there is nothing
you can do to affect it, this makes you feel stressed.
Stress is not always bad. Stress can be useful too. For many people if we feel some stress, we might feel under 
pressure to perform better. You might feel stressed because your family is coming to visit, but this stress makes 
you tidy up your home – a good effect of the stress.  
Sometimes we wish for a “stress-free” life. But, we know that if there was no stress in our lives, if we did not have 
to do anything all day long, this would not be good for us either. If I lay in bed all day and did not do anything, my 
muscles would get weak, my joints would get stiff and I would become ill. We need some stress in our lives to 
keep us healthy. The important thing is to keep the amount of stress at a level that we feel we can manage. This 
is why we talk about stress management, not stress removal! 
There are many different things we can do in our lives to manage stress. The first step is to understand why we 
are feeling stressed. There are usually three things which affect how stressed we feel. 
1. The stressful situation:
Usually the less you expect the situation and the less familiar you are with a situation, the more stressful it will 
be. If you needed to take the taxi to work but you knew the day before that taxi would be late, this would be less 
stressful than finding out after you have got onto the taxi that it is going to be late. If you think about having pain, 
if you know the cause of the pain is it more or less stressful? If you don’t know what is causing your pain and you 
are worrying that there is something seriously wrong, is this more or less stressful? 
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2. How you see the situation and how you cope with it:
If the situation you are in is not important, you are likely to feel less stressed about it. If you are on a taxi which is
going to be late, but you are going shopping on your own, then you are likely not to get so stressed about it. If
you are on a taxi which is going to be late and you are going to work this might be more stressful, but if you have
a cell phone with you and you have airtime on the cell phone and you telephone your boss to explain why you
will be late, then this might be less stressful. Your ability to cope with the situation, affects the amount of stress
you feel. While it is stressful to live with a chronic disease like diabetes or high blood pressure, if you thought you
could cope with it and it would not interfere with your job and your life would it be more or less stressful? Having
knowledge about your condition allows you to think about it in a different way and will change the way that you
cope.
3. Support from family and friends:
Friends and family who understand and support you will affect your levels of stress. Feeling alone and feeling
like you have no support will probably make you feel more stressed. But, we need to be careful about support
from family and friends. If they take over doing everything for us (because they care about us and are trying
to help), we might feel useless and like we don’t have a purpose. Support does not mean doing everything
for you.
Stress is not just the things that happen to us. There are many different things we can do to manage stress every 
day. 
Managing Stress: 
1.Dealing with the cause of the stress
The first step in dealing with stress is to identify why you are feeling this way. Use the self-management steps to
help you identify the problem. Once you know why you are feeling this way then you need to decide what you
can do about it. Sometimes dealing with the things that stress us is easy, if you are friends with your neighbours
and the noise from their television is irritating you it might be easy to ask them to turn down the volume. If you
are not friends with your neighbours, or you are very shy it might be quite difficult to ask them to turn down the
volume. Sometimes we can identify the things that stress us and do something about it. But, often we either
cannot deal with it or it is out of our control. If you cannot deal with it or it is out of your control, the next step is to
change the way you are looking at the problem.
The second step is to look at the problem in a different way. Think about how you are feeling. Are your thoughts 
and feelings about the problem inaccurate? Maybe you are very worried about your health, this is stressing you. 
Are you worried that you will be unable to work? Are these thoughts and feelings accurate? On what information 
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are you basing these thoughts and feelings? Have you spoken to experts about your health or are you basing 
your thoughts and feelings and stress on poor information? 
Step three is - plan your life. Do you get stressed by the same things over and over again? Or do you find 
yourself getting stressed because there are times when your life is very busy? If you are doing 
the same things over and over and getting stressed, you might want to look at how you are 
dealing with it and see if you can try a different plan. What about a busy life? This is also 
about planning, being very busy and having no time for ourselves, can be very stressful. Plan 
things carefully, make sure you have time to at least do some relaxation or exercise even when you are very 
busy. Do not leave things for the last minute.  
The last step to deal with stress is to get help. Family and friends and support groups are a great way to 
decrease stress. If we want support from people though, we have to tell them clearly what the problem is and 
what we would like from them. Often we do not communicate clearly and this might make the stress worse! If you 
find your family or friends are not very helpful or supportive, it might be worth sitting down with them when you 
are not feeling stressed to talk about these things. It might be that they see things differently to you, this does not 
mean they are right and you are wrong, or that you are right and they are wrong. It just means that you see 
things differently and you can discuss how to handle things better. If having a discussion like this is difficult, it 
might be useful to ask a counsellor to help with the conversation. You can ask for assistance at a clinic or you 
can go to FAMSA who specialise in family and relationship counselling. 
1. Relaxation
When we feel relaxed, we feel calm. Sometimes if we are relaxed and we are tired, we might feel sleepy. At other 
times we might feel relaxed and alert and be able to concentrate calmly on tasks. Relaxation can help us 
to concentrate and it can help us to unwind and go to sleep. Relaxation is a very useful way to 
manage stress and some of the symptoms of chronic diseases such as pain. 
If we are stressed, this can make our muscles tense, our hearts beat faster and we breathe faster, if we are also 
feeling unwell and have pain we will feel worse. Relaxation can decrease the tension in muscles and slow down 
our hearts and breathing and help to make us feel better. If we are stressed we often become irritable and 
moody, relaxation helps to calm you and make you feel more in control of your life. When we are stressed 
sometimes it is difficult to fall asleep as we are worrying about things out of our control, if you are also unwell, not 
sleeping will make you feel worse. Relaxation will help you get to sleep, this will help manage your stress and 
improve your health.  
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Just like learning to play a new sport or doing exercise, relaxation takes practice. The specific way that you relax 
doesn’t matter; we are all different and might relax in different ways. The important thing is to practice it regularly. 
You can do these at home in a quiet and comfortable safe place to begin with. But, once you get good at 
relaxation, you can relax in a crowded waiting room, on a train or a taxi. You can do relaxation anywhere! 
2. Sleep
People with chronic illnesses often struggle to sleep because they are stressed and worried about their condition, 
they worry about what this means for them, for their family, for their future. People also often struggle to sleep 
because of the illness itself, perhaps you have pain, you feel sick or you may even be so tired you can’t sleep. 
Some people find it difficult to get to sleep and only fall asleep very late at night, others find that they fall asleep 
but then wake up during the night and can’t get back to sleep. Some people find it difficult to sleep at all at night 
and sleep during the day.  
Sleep is very important to keep healthy. We all need different amounts of sleep. Some 
people need 8 hours of sleep a night, some may need 10 hours and some people only 
need 5 hours of sleep. We are all different. We have been learning how to fall asleep 
and sleep well since we were babies. If you do not sleep well, following these steps will 
help you to learn how to fall asleep and sleep well. Remember that like learning anything new, this will take time. 
It might take up to 3 months to learn to sleep well if you have been struggling with sleep for a while. 
Suggestions for Improving Sleep 
1. Have a bedtime routine: try to go to bed at around the same time every night and always do the same things
before getting into bed. A bedtime routine could be to lock the house, get undressed, wash your face, clean
your teeth, get into bed and do a relaxation session.
2. Your bed and bedroom are for sleeping: try not to use your bedroom during the day. Do not watch TV in bed.
If you are not asleep within 30 minutes of going to bed, get up and do something else. Do not lie in bed and
Good times to practice relaxing are when: 
 You feel you are getting tense or irritable or you are worried
 You feel you are in pain
 You want to go to sleep
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worry that you have not fallen asleep. This will only make you feel stressed and lessen the chance of falling 
asleep. 
3. Have a morning routine: get up at the same time every day, even if you don’t feel like it. Our bodies like to
work on regular patterns to fall asleep and get up at the same time every day.
3. Exercise
Exercise is a very effective way of managing stress. People who exercise regularly doing at least 20 to 30 
minutes of exercise, 3 times a week have less risk of suffering from stress related illnesses. Go back to the 
section on exercise for more on how to exercise safely and effectively. 
5. Communicating with your health carer
Anyone living with a long term health problem, whether it a MSC, high blood pressure or diabetes will have to 
visit the clinic regularly. Visiting the clinic regularly can be stressful because it takes time, you have to plan 
ahead, and you might not be sure how long you are going to have to wait. One of the most important ways of 
Good sleep habits: 
 Go to sleep at the same time every day
 Have a bedtime routine
 Do relaxation before going to sleep
 Use your bed only for sleeping or relaxing
 Have a morning routine
Exercise: 
 Decreases stress
 Helps us sleep better
 Decreases pain
 Makes us healthy and decreases our chances of developing other illnesses
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managing the stress associated with visiting clinics and seeing health carers is to think about and plan how to 
communicate with them.  
 When visiting the clinic to see a health care practitioner it is important that you feel comfortable 
asking questions (any questions, even if you feel they are “silly” or “stupid” questions) and 
comfortable expressing how you feel. It is also important that you feel you can negotiate your 
treatment with your health care provider so that both you and the carer feel that you are 
receiving the best care for you. It is important that you not feel that your health care provider is 
ignoring you. We know that doctors and nurses have a lot of patients to see and they have little time to spend 
with each person. One helpful way to make sure that you get the most out of your appointments with the doctor 
or nurse is for you to take PART – Prepare, Ask, Repeat, Take action. 
Take PART: 
Prepare: 
Before your appointment at a clinic it is important to prepare. Think about the reason for your appointment and 
whether there are any issues in particular that are worrying you. Write down your questions or the things that are 
worrying you. There will probably only be time to answer one or two of the things on your list. Make sure the most 
important problems are at the top of the list. Take your list with you to your clinic appointment, and when the 
doctor or nurse asks if there is anything you want to ask, you can use your list.  
If there are particular symptoms you want to discuss, write down the specific information the doctor or nurse will 
want to know. Helpful things are: when did it start, how long do the symptoms last, what makes you feel better or 
worse, have you changed anything like your diet, exercise, medicines. If you have already received treatment for 
a problem, be ready to report back on how well it has worked, or on whether it has not worked at all.  
Be open about how you are feeling and about the things that are worrying you. The more open you are, the more 
the health care provider can help you. Finally, give feedback. If you don’t like the way you have been treated you 
can tell the doctor or nurse. If you do not want to tell them directly then you can speak to someone else in the 
clinic or to someone in a support group. Remember too that doctors and nurses and other health care providers 
also appreciate being complimented. If you feel that you have been treated well and are happy with your 
treatment, it is acceptable to compliment the health carer. 
Ask: 
Another important step in having good communication and decreasing stress is to ask questions. Having good 
information is essential to you being successful in self-managing your health. Ask questions about your diagnosis 
such as what is wrong, what has caused it? Then ask questions if you have had tests, what is the test for; what if 
I don’t have the test and what will the test involve? Remember to ask questions about your treatment options, 
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what are the benefits of treatment and what are the risks and side effects? Finally ask questions about follow-up, 
when should you return to the clinic, what should you watch out for and what should you do next? 
If you find you have difficulty remembering information it is a good idea to write things down during 
your visit. Or you could ask someone you trust to come to the appointment with you to help with 
remembering.  
Repeat: 
One of the important things to do to help with remembering things is to repeat it. So if the nurse or doctor 
explains something to you, repeat back to them in your own words what you have understood. This is very useful 
to make sure there are no misunderstandings.  
Take Action: 
At the end of your appointment, it is important that you know exactly what you will need to do next. It might be 
that you need to make another appointment, or that you need to go home and change something or get new 
medicine from the pharmacy. Make sure that you are clear about what you need to do next, and then do it! 
Relaxation 
Deep breathing not only helps to cure anxiety and stress, it also triggers relaxation. 
Here's how to breathe deeply 
 Breathe in slowly to the count of four (count slowly; to the pace of one-one-
thousand, two-one-    thousand....). Pause to the count of three. 
 Breathe out slowly to the count of five.
 The breathing process goes like this:
 Inhale... two, three, four...pause...two, three....exhale...two, three, four five.... 
 Inhale... two, three, four...pause...two, three....exhale...two, three, four five.... 
Repeat for a minute or two 
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Action Planning Form – Stress Management 
Think about one thing that is causing you stress. Use this action plan form to come up with a plan of how to 
manage your stress this week. 
Be sure your action plan includes: 
What you would like to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
(what) 
(how much) 
(when) 
(how many?) 
How confident are you that you can complete this action plan? 
Keep a record of how you did: 
I Plan to….. I did….. 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
Saturday 
Sunday 
____________________________ 
Not at all     |    |     |     |     |     |     |     |     |     |  Totally 
Confident   1    2    3   4    5    6    7    8   9   10  confident 
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Exercise Diary 
Use this exercise diary to keep track of your exercise goals and activities. 
Start by writing down your goal.  
Write down here what you would like to be able to do:  
Now, what would you like to be able to do this week which will help you to reach your goal? 
Remember from your action plan to include:  
What you would like to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
(what) 
(how much) 
(when) 
(how many?) 
Exercise Planned Exercise I did... How did I feel? Do you need to change 
anything? 
e.g. 20 minutes in the 
morning after breakfast 
and in the evening after 
supper 
Very tired by the second session, I’m 
going to cut down to morning only for this 
week. 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
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Week 5: Eating Well
In our current daily life, healthy and freshly prepared food is often replaced by foods high in fat and energy, 
containing insufficient vitamins and minerals.  Healthy eating is necessary to get a healthy body weight and to 
have enough energy for daily activities.  A healthy, nutritious diet can help you look and feel your best. 
It is also important to control your cholesterol levels.  Cholesterol is a waxy substance produced by the liver and 
found in certain foods.  A high cholesterol level may speed up the hardening of your arteries and increase the 
risk of a heart attack.  A healthy low-fat diet with plenty of high-fibre starch helps to control cholesterol levels.   
1. Enjoy a variety of foods
Different foods provide different nutrients. Eating different types of food gives your body all the nutrients it needs.
It is important to remember that there is not one food that provides all the nutrients that our body needs. To make
sure that your diet is balanced, try to eat one food from each of the following three food groups at every meal.
Protective foods 
Foods in this group have enough vitamins and minerals that can help protect you against diseases. 
Protective foods are: 
* All fruits
* All vegetables
Building foods 
Foods in the building group are rich in protein, which is necessary to build muscle and new body tissues. Building 
foods are: 
* Meat, fish and poultry (chicken, duck, turkey) You may have one or two portions of protein per day.
* Eggs
* Milk/maas/yoghurt
* Dried beans/lentils
* Nuts
39 
 
 
 
 
 
Energy foods 
Energy foods give the body the energy to do every day activities like going to work. 
Energy foods are: 
* Bread
* Rice
* Porridge
* Potatoes
* Samp
* Mealies
* Butter / margarine
* Oil
Be active 
Both exercise and healthy eating must be part of a healthy lifestyle. Many people spend a lot of time sitting in 
chairs. Remember…your body has been built to be active! 
Balanced DietExercise  Healthy Lifestyle 
Drink lots of clean, safe water 
Often when we feel hungry, it is our body telling us we are in fact thirsty. So we need to drink enough fluids and 
our main source of good fluid is of course water. We have some of the cleanest tap water in the world, here in 
Portion size: 
FOODS  UNIT 
Fish, white  1 large piece 
Fish, high fat flesh  1 small piece 
Chicken, no skin  1 medium breast 
Meat, lean   palm size, sliced 10mm 
Eggs, hens 2 
Liver, chicken  3 
Cheese, yellow cube 30mm 3 
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South Africa – and it is free!  Water makes up 50-55% of your body weight and water and oxygen are the most 
needed elements for life. Water carries nutrients to, and waste away from cells; cools the body and is important 
for the body and organs to work properly.  Water comes from the fluid you drink; the food you eat and chemical 
reactions inside your body. 
Adults should drink 6 to 8 glasses of water a day but this water includes the water in the food we eat so you don’t 
have to drink a whole 8 glasses. If it is very hot or you are doing exercise you need to drink more than 8 glasses.  
Hints: 
* Drink when you are thirsty and in between.
* Drink at least one glass of water/juice every morning with breakfast.
* Drink 2 glasses one hour before exercise and another after exercise.
* Caffeine (coffee, tea & Coke) and Alcohol make you lose water.
* In general, juices from supermarkets have a lot of sugar in even when labels say 100% fruit juice. If you
have juice, one glass a day is more than enough – and when possible, rather have a piece of fruit and then a
glass of water.
Make starchy foods part of most meals 
Starch is the fuel for your body that gives most of the energy in food for your organs to function. It is important to 
eat 5-8portions of bread, porridge, rice, pasta and potatoes every day.  These foods are usually the staple food 
in the diet. 
Starchy foods are: 
* rich in carbohydrates (main source of energy for the body)
* low in fat
* contains important vitamins such as B-complex
* vitamins, fibre and minerals
Portion size: 
FOODS  UNIT 
Bread, brown / white  1 slice 
Porridge, soft  ½ cup 
Maize meal, dry powder   3 heaped tablespoons 
Potato   1 medium 
Rice/ pasta/ whole grains, cooked ½ cup 
Breakfast cereal Varies 
Cut corn, mealie  ½ cup 
Popcorn, popped, no salt or fat 2 cups 
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* unrefined / whole grain starch lets us feel fuller for longer
* starchy vegetables like sweet potatoes provide useful amounts of vitamin A
and C
There are two kinds of carbohydrates – refined and unrefined. They both provide the body with energy. The 
refined carbohydrates give you a lot of energy very quickly, but also a high rise in blood sugar, followed by a 
quick drop which makes you feel tired and hungry again quickly. The unrefined carbohydrates raise your blood 
sugar slowly, so you have energy for longer. We need more of the unrefined carbohydrates than the refined 
carbohydrates.  
Unrefined carbohydrates are also called whole grains. Examples are whole grain breakfast cereal, mealies on 
the cob and cut corn, popcorn, rolled oats, barley, brown rice, cracked wheat, and sorghum.  
Examples of unrefined carbohydrates Examples of refined carbohydrates 
Eat plenty of vegetables and fruit every day 
Vegetables give the body small amounts of carbohydrates, sugars, and lots of fibre if we  
eat the skins. Pure fruit juices also belong to this group, but have less fibre and a lot more sugar than 
fresh fruit.   
Vegetables and fruit contain lots of vitamins and minerals and form part of the protective food group.  Eat 3 -5 
portions of vegetables and fruit every day.Eat vegetables and fruit from the different colour groups (red, green, 
yellow and orange). Fruit and vegetables can be eaten as part of a snack and/or main meal. 
Eat dry beans, peas, lentils and soya often 
Portion size: 
FOODS  UNIT 
Fresh / frozen vegetables   ½ cup cooked 
Raw leafy vegetables 1 cup raw 
All fresh fruits e.g. apple, banana. 1 piece medium sized 
Small fruit e.g. apricots, plums 2 pieces  
Large fruit e.g. grapefruit  ½ piece 
Chopped fruit   ½ cup 
Fruit juice ½ cup 
Raisins  2 tablespoons 
42 
Dry beans, peas, lentils and soya gives energy and are a good source of protein, high in fibre and low in fat.We 
can eat these foods in the place of meat in some meals.  These foods can help you to lose weight because they 
help you feel full for longer and can also help you to maintain healthy blood glucose levels. 
Eat one portion from this group at least 2 -3 times per week. 
Fish, chicken, lean meat, or eggs could be eaten daily 
Small portions of one of these foods may be eaten every day. These foods come from animals, gives protein and 
important minerals, but they also have fat which is not healthy when you have high blood pressure.Choose lean 
or lower fat options with less bad (saturated) fats.Some types of fish contain good fat. Try to eat tinned or fresh 
fish at least twice a week. 
Drink milk, maas or yoghurt every day 
Dairy products are a good source of calciumwhich helps to protect bones and prevent high blood 
pressure and diabetes.  Low-fat or fat-free dairy products are good options.Have one portion of 
low-fat milk, maas or low-fat sugar free yoghurt per day.  
Using coffee or tea whitener (e. g. Cremora) instead of milk is not good. It does not have the nutrients that milk 
has, and is high in fat. 
Don’t use fat too much and choose vegetable oils rather than hard fats 
Choose vegetable oils rather than hard fats. Some fat is necessary, and is important for your body. Use only 
small amounts of food that has the right types of fat. Nuts, seeds, peanut butter (sugar free) and avocados are all 
good fats. It is better to eat/use fats and oils from plants sources, and not fats and oils from animal sources. Try 
not to eat food that is cooked by deep frying. You may use four portions of fat or oils per day. 
Portion size: 
FOODS  UNIT 
Dry beans, cooked ½ cup 
Lentils, split peas, cooked ½ cup 
Soya mince, dry   30g (½ cup) 
Raisins       2 tablespoons 
Portion size: 
FOODS  UNIT 
Milk, low fat or skim 1 cup 
Maas, low fat  1 cup 
Yoghurt, low fat or fat free 1 tub, 100ml 
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 * Avoid hard fats such as butter, margarine and animal fats.  
* Use plant oils, nuts and seeds. 
* Don’t fry or roast food, rather, steam or microwave the food or eat it raw.  
* Rather grill or roast meat, than fry it. 
* Use non-stick pans instead of oil. 
 
 
 
 
 
 
Don’t use salt and foods high in salt  
Food high in salt or eating too much salt can raise your blood pressure. Instead of using 
salt use herbs and spices like garlic, ginger or curry, and use plenty of vegetables when you make stews and 
bean dishes. Don’t use too much salt when cooking.  Foods with lots of salt in are stock cubes, soup powders, 
and salty snacks like chips and meats like polony. Do not use more than 1 teaspoon of salt a day from all 
sources. 
 
Don’t use too much sugar 
Too much sugar can make you gain weight.Sugar gives energy, but doesn’t have any other nutrients.  
 
You can eat sugar, food and drinks that have sugar in as part of a healthy eating plan, but only two portions per 
day. There is lots of sugar in cakes, biscuits, doughnuts, sweets, chocolates and sweetened cold drinks (a can of 
fizzy drink has 3 tablespoons of sugar in it). You can use alittle bit of sugar with foods and drinks like soft 
porridge or tea. Foods made with sugar, like jam, can be used to make a mixed meal or a snack. It is better to 
eat foods that have sugar in with a meal, than to eat it in between meals, especially if you have high sugar 
(diabetes). Sweets and cold drinks may be eaten sometimes but should not be eaten in the place of a balanced 
meal.  
 
 
 
 
 
Portion size: 
FOODS          UNIT 
Oil; sunflower, canola, olive or other plant oil      1 teaspoon 
Tub margarine         1 teaspoon 
Peanut butter         1 heaped teaspoon 
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Information about the use of alcohol 
Alcohol has a lot of energy and no other nutrients. Alcohol can make you gain weight. Women can have one 
drink per day.One drink is the same as ½ a glass of wine or one dumpie of beer or one tot of spirits. 
Alcohol used with medications can be very dangerous to a persons’ health. 
Losing weight 
When you first came to the clinic we measured your height and weight and we made a sum to determine your 
BMI (Body Mass Index). If you have a BMI of more than 25 this is not healthy, you should focus on what you are 
eating and how much you are exercising. 
BMI Class Range 
Underweight <18 
Normal 18-25
Overweight 25-30
Obese 1 31-35
Obese 2 35-40
Obese 3 >40
From research we know that joint pain, high blood pressure and blood sugar are closely linked to being 
overweight. What this means, is that when you weigh a lot more than you should, there are added stresses and 
strains on your body’s joints, especially the big joints like the hips and knees. This means that when doing daily 
activities or exercise your symptoms of pain increase and the natural reaction is to stop being active. If you are 
overweight losing weight will improve your health by decreasing the loading on your joints and it will feel a lot 
easier for you to move around,  do exercise and daily activities.  
Portion size: 
FOODS  UNIT 
Sugar, brown or white 1 teaspoon 
Jam   1 heaped teaspoon 
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Action Planning Form- Nutrition 
Think about your eating habits. Use this form to come up with a plan to improve one thing about your nutrition. 
Be sure your action plan includes: 
What you would like to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
(what) 
(how much) 
(when) 
(how many?) 
How confident are you that you can complete this action plan? 
Keep a record of how you did: 
I Plan to….. I did….. 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
Saturday 
Sunday 
____________________________ 
Not at all     |    |     |     |     |     |     |     |     |     |   Totally 
Confident   1    2   3    4    5    6    7    8    9   10  confident 
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Exercise Diary 
Keep using the exercise diary to keep track of your exercise goals from week one. You may want to start 
increasing your exercise plan. 
Start by writing down your goal.  
Write down here what you would like to be able to do:  
Now, what would you like to be able to do this week which will help you to reach your goal? 
Remember from your action plan to include:  
What you would like to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
(what) 
(how much) 
(when) 
(how many?) 
Exercise Planned Exercise I did... How did I feel? Do you need to change 
anything? 
e.g. 20 minutes in the 
morning after breakfast 
and in the evening after 
supper 
Very tired by the second session, I’m 
going to cut down to mornings only for this 
week. 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
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Week 6: Continuing as a Successful Self-Manager 
Over the last six weeks you have learnt many skills which will help you to live a balanced lifestyle with your 
condition. Research tells us that people living with any chronic disease who follow these steps have better a 
quality of life. This is true for people living with high blood pressure, diabetes or MSC. You have learnt how to be 
a positive self-manager by being able to solve problems and set goals for yourself so that you can move forward 
with your life. You have learnt about the importance of exercise. How exercise can make you feel better, and 
what exercises you should do! You have learnt about the common symptoms that trouble people living with MSC, 
high blood pressure and diabetes and you have learnt how to manage these symptoms. You have learnt about 
pain, what might be causing pain and how to treat and manage any pain you may have. You have learnt about 
food and eating well. With all of these you have also had the chance to practice doing things differently and to 
think about how this has made you feel.  
Action Planning for the Future 
Now it is time to think about the future. People with chronic conditions often worry about how they will manage 
their lives; how they will look after their families. Worrying about these things can also make people feel sad, 
angry or depressed. By working through this book you have already started to deal with these emotions. You 
have increased your knowledge and this is one of the main ways that we manage fear. If we are afraid of 
something, knowing more about it helps us to tackle the fear. If you know more about it, you can make a plan 
around it and making a plan helps us to get a sense of control over the very thing that we are afraid of.  
Planning for the future means thinking about the things that might happen to you in the future and planning for 
them. You may never ever need to use the plan as the things that you worry about may not happen, but, having 
a plan will help you to worry less about these things and stay in control should they happen. You can use the 
action planning forms you have been using in this workbook to think about the things which worry you about the 
future. You can then start making a plan about what you want to do if these things happen. If you are not sure 
about making a plan, you may want to talk to different people who might be able to help you with this. 
Step 1: 
To be able to plan for the future, you need to decide what it is that you are worried about happening. This can be 
the hardest step to think about. For example you might be feeling very sad and depressed. First you need to 
think about why you are feeling that way. It might be that you are worried about not being able to look after your 
family. Once you have identified what it is that worries you and makes you feel sad, depressed or afraid then you 
can start to make a plan to deal with it.  This will help you to feel less sad, depressed or afraid.  
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Write down here some of the things that might happen in the future that you worry about: 
1) 
2) 
3) 
Step 2: 
Now that you have identified some of the things which worry you, start to think about different ways to manage 
these things. If you were worried about not being able to look after your family, make a list of things that you 
would need help with. Then write down who you could ask to help you with those things. The people who can 
help might be friends, social workers and counsellors. If you are not sure who could help you, you may want to 
talk to someone you trust to help you identify who could help.  
Write down here three different things you could do to help plan for the things in the future that you worry about: 
1) 
2) 
3) 
Action Plan Form for Future Worries 
I am worried that in the future I will not be able to: 
My plan to manage this if it happens is to: 
(what, who, how, when?) 
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Changes I have made in my life: 
How confident are you that you can complete this action plan? (remember you are aiming for 7 out of 10 on the 
confidence line) 
Moving forward: 
Over the last 6 weeks you have learnt many things about how to live with a chronic illness like high blood 
pressure and diabetes. You have learnt about the disease and how to be a successful self-manager. This does 
not mean that you should be managing your health on your own. What it does mean is that you now have the 
ability to manage your health and your life as part of the health team. Remember you are not alone but are part 
of a team of people whose aim is to help you get the most out of life. We encourage you to keep using the skills 
you have learnt in this workbook to live a balanced life. There are extra “Action Plan Forms” and “Exercise 
Diaries” in the back of the workbook for you to use. Try to keep using these forms to help you remain active and 
give you a sense of purpose and accomplishment in your life. Being active and involved, using the skills you 
have learnt in this workbook are important steps in helping you achieve the best quality of life you can. In the box 
write down some of the important changes you have made in your life over the past few weeks. 
   ____________________________ 
Not at all     |     |     |     |     |     |     |     |     |      |       Totally 
confident  1  2  3  4  5  6  7  8  9  10  confident 
50 
Things that are still missing in my life: 
Now, your final task is to think about changes you still want to make in your life. Remember, this is about getting 
the most out of life, increasing your quality of life. Are there still some things missing in your life, things that you 
would still like to be able to do? In the box below, write down some of the things that are still missing. You can 
use this list to keep working on your goals from now on.  
You have now completed this workbook. By working through this workbook you made an important commitment 
to yourself. You have chosen to spend time looking after yourself. Do not put this workbook away; keep it 
somewhere safe where you will be able to review it from time to time. We all forget things at times and it is useful 
to be able to look back and remind ourselves of things we may have forgotten. We can also look back and see 
how far we have come. We hope that the knowledge and the skills you have learnt by using this workbook will 
continue to have a positive effect on your life. 
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Useful Organisations: 
MUCPP (Mangaung-University of the Free State Community Partnership Program) 
119057 Singozo Street 
Heidedal, Bloemfontein 
Tel:  051 – 435 6430 
Family and Marriage Society of South Africa (FAMSA) (http://www.famsa.org.za) 
10 Strauss Street 
Universitas, Bloemfontein 
Tel:  051 – 525 2395 
Pelonomi Regional Hosiptal 
Dr Belcher Road 
Heidedal, Bloemfontein 
Tel:  051 – 405 1911 
National District Hospital 
Roth Avenue 
Willows, Bloemfontein 
Tel:  051 – 403 9600 
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Additional Reading 
The information is this workbook is based on several sources of information. If you would like to read more on 
any of these topics we suggest you explore these: 
Living Well with HIV & AIDS; Gifford A.L.;  Lorig K; Laurent D; Gonzalez V (3rd edition) Bull Publishing Company, 
Boulder Colorado2005 
Self-management of Long-term Health Conditions: A handbook for people with chronic disease. Expert Patients 
Programme Community Interest Company.  Bull Publishing Company, Boulder Colorado 2007 
Manage your pain. Nicholas M, Molloy A, Tonkin L, Beeston L ABC Books, Sydney 2000 
Department of Health. 2012. Guidelines for Healthy Eating Information for Nutrition Educators. Department of 
Health. Directorate: Nutrition: Pretoria. 
ACSM’s Exercise Management for Persons with Chronic Diseases and Disabilities.  Durstine JL; Moore GE; 
Painter PL; Roberts SD. Third Edition.  ACSM Group Publishing. United States of America.   
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Action Planning Form
Be sure your action plan includes: 
What you would like to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
(what) 
(how much) 
(when) 
(how many?) 
How confident are you that you can complete this action plan? 
Keep a record of how you did: 
I Plan to….. I did….. 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
Saturday 
Sunday 
____________________________ 
Not at all     |    |     |     |     |     |     |     |     |     |   Totally 
Confident    1    2   3    4    5    6   7    8    9   10  confident 
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Action Planning Form 
Be sure your action plan includes: 
What you would like to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
(what) 
(how much) 
(when) 
(how many?) 
How confident are you that you can complete this action plan? 
Keep a record of how you did: 
I Plan to….. I did….. 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
Saturday 
Sunday 
____________________________ 
Not at all     |    |     |     |     |     |     |     |     |     |   Totally 
Confident   1    2   3    4    5    6    7    8    9   10  confident 
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Action Planning Form 
Be sure your action plan includes: 
What you would like to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
(what) 
(how much) 
(when) 
(how many?) 
How confident are you that you can complete this action plan? 
Keep a record of how you did: 
I Plan to….. I did….. 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
Saturday 
Sunday 
____________________________ 
Not at all     |    |     |     |     |     |     |     |     |     |   Totally 
Confident   1    2   3    4    5    6    7    8    9   10  confident 
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Action Planning Form 
 
Be sure your action plan includes: 
What you would like to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
How confident are you that you can complete this action plan? 
 
 
 
 
 
Keep a record of how you did: 
 I Plan to….. I did….. 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
  
 ____________________________ 
Not at all     |    |     |     |     |     |     |     |     |     |   Totally 
Confident   1    2   3     4   5    6    7    8    9   10  confident 
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Exercise Diary 
Start by writing down your goal.  
Write down what you would like to be able to do: 
Now, what would you like to be able to do this week which will help you reach your goal? 
Remember from your action plan to include:  
What you would like to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
(what) 
(how much) 
(when) 
(how many?) 
Exercise Planned Exercise I did... How did I feel? Do you need to change 
anything? 
e.g. 20 minutes in the 
morning after breakfast 
and in the evening after 
supper 
Very tired by the second session, I’m 
going to cut down to morning only for this 
week. 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
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Exercise Diary 
Start by writing down your goal.  
Write down what you would like to be able to do: 
Now, what would you like to be able to do this week which will help you reach your goal? 
Remember from your action plan to include:  
What you would like to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
(what) 
(how much) 
(when) 
(how many?) 
Exercise Planned Exercise I did... How did I feel? Do you need to change 
anything? 
e.g. 20 minutes in the 
morning after breakfast 
and in the evening after 
supper 
Very tired by the second session, I’m 
going to cut down to morning only for this 
week. 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
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Exercise Diary 
Start by writing down your goal.  
Write down here what you would like to be able to do: 
Now, what would you like to be able to do this week which will help you reach your goal? 
Remember from your action plan to include:  
What you would like to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
(what) 
(how much) 
(when) 
(how many?) 
Exercise Planned Exercise I did... How did I feel? Do you need to change 
anything? 
e.g. 20 minutes in the 
morning after breakfast 
and in the evening after 
supper 
Very tired by the second session, I’m 
going to cut down to morning only for this 
week. 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
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Exercise Diary 
Start by writing down your goal.  
Write down here what you would like to be able to do: 
Now, what would you like to be able to do this week which will help you reach your goal? 
Remember from your action plan to include:  
What you would like to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
(what) 
(how much) 
(when) 
(how many?) 
Exercise Planned Exercise I did... How did I feel? Do you need to change 
anything? 
e.g. 20 minutes in the 
morning after breakfast 
and in the evening after 
supper 
Very tired by the second session, I’m 
going to cut down to morning only for this 
week. 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
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Exercise Diary 
Start by writing down your goal.  
Write down here what you would like to be able to do: 
Now, what would you like to be able to do this week which will help you reach your goal? 
Remember from your action plan to include:  
What you would like to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three times (how 
many). 
This week I will: 
(what) 
(how much) 
(when) 
(how many?) 
Exercise Planned Exercise I did... How did I feel? Do you need to change 
anything? 
e.g. 20 minutes in the 
morning after breakfast 
and in the evening after 
supper 
Very tired by the second session, I’m 
going to cut down to morning only for this 
week. 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
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APPENDIX 29 
Non-pharmacological six weeks intervention programme 
1 
EXERCISE PRESCRIPTION – Week 1 
Motivational Factor of Exercise Programme: 
To lower blood pressure 
To lower blood glucose levels 
To lose weight 
To increase physical activity levels 
Client (group) specifications/risks/precautions: 
Vital signs of each participant- recently measured and available 
Correct use of medication  
Use of beta-blockers 
Participants may use assistive devices 
Additional pathologies/lifestyle diseases 
Attention to safety of the environment  
Participant should be able to take own heart rate/pulse (teach participants) 
Research assistant available during exercise class to monitor heart rate 
Calculate the target heart rate for each participant 
Beginning of programme: 
Organise area: Sufficient chairs and water available.  
Obstacles in hall removed.  
Music available. 
All equipment available and ready for use:  balls, bags etc. 
Sphygmomanometer available. 
Information to participants: Should not feel out of breath, light headed, nauseas. 
Each participant should take their resting heart rate or research assistants should take heart rates of each participant. 
Para-medic available in hall for emergencies.    
2 
Exercises: 
Functional outcome 
Purpose of exercise 
(muscles and joints) 
(Type of exercise) 
Description of exercise 
Frequency, Intensity & 
Time 
Biomechanical 
safety/risks 
Objective measure of progress 
Warm-up 
Dynamic warm-up 
Dance: 
 5 minutes
 Participants may
rest as they feel
necessary.  Not applicable
 3 x steps left &
clap
 3 x steps right &
clap
 3 x steps forward
& clap
 3 x steps in place
(alternating trunk
flexion/extension
& clap with each
step)
 Turn 90˚ left
Repeat 
Improve quality of life 
General mobility and 
increase flexibility 
Stretching and warming 
up of muscles 
 Neck rotation to Left
and hold
 3 x 10 second hold  Participants may
rest as they feel
necessary.
 Participants are
instructed that
they should only
feel a slight stretch
and no pain.
 If participant’s
heart rate or blood
pressure is
 Participant should maintain
normal neck range of motion.
 Participants should maintain
normal gleno-humeral range
of motion.
 Participant should maintain
normal trunk range of
movement.
 Participants should maintain
functional hip and trunk
 Neck rotation to
Right and hold
 3 x 10 second hold
 Neck flexion and
hold
 3 x 10 second hold
 Lateral neck flexion
to Left and hold
 3 x 10 second hold
 Lateral neck flexion
to Right and hold
 3 x 10 second hold
 Shoulder elevation
and roll shoulder
anterior
 3 x 10 repetitions
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 Shoulder elevation
and roll shoulder
posterior
 3 x 10 repetitions unstable they 
should not perform 
bilateral shoulder 
flexion activities. 
 Participants are
allowed to sit and
perform activities if
they feel unstable.
 Research assistants
should correct
performing of
stretches and
should ensure that
participants do not
over stretch the
muscles.
movements. 
 Arm circles of
increasing
circumference (with
bilateral upper limbs
in 90˚Abduction)
 3 x 10 repetitions
 Make circles in the
air with
outstretched arms,
make the circles
bigger as time goes
on/on command.
 Posterior Deltoid
stretch bilaterally
 3 x 10 second hold
 Pull arm across
body, provide
overpressure with
opposite arm.
Should feel stretch
in back of the
shoulder.
 Triceps stretch
bilaterally
 3 x 10 second hold
 Try to touch hand
to back of shoulder
on same side,
provide
overpressure with
opposite arm in a
posterior direction.
Should feel stretch
in back of the arm.
 Trunk Rotations to
Left & Right
 Rotate as far as
possible to left and
right, while keeping
hips still.
 3 x 10 repetitions
 Standing bilateral
hamstring stretch –
 Rounding of the
lower back is not
4 
keep legs straight 
whilst flexing at the 
hips to try and touch 
the toes 
allowed. 
 3 x 10 second hold
1 minute water break 
Improve quality of life 
Improved cardio-vascular 
function (endurance and 
fitness) 
Improved functionality 
Muscle Strengthening 
and Cardiovascular 
training 
 Walking on the spot  2 minutes
 Participants are
allowed to hold
onto chair for
balance/assistance.
 Participants may
rest as they feel
necessary.
 Participant should be able to
individually train at their own
target heart rate or decrease
the number of resting periods
that they chose to take.
 Participants should maintain
their muscle strength in the
upper and lower limbs.
 Half Squats  Perform a squat
without moving
into pain or
extreme
stiffness/approxima
tely half of active
range of
movement.
 4 x 10 repetitions
 Walking on the spot  Increase speed
every minute.
 2 minutes
 Half squat with
isometric hold
 Perform a squat
without moving
into pain or
extreme
stiffness/approxim
ately half of active
range of
movement.
 5 x 10 second holds
 Marching  2 x steps
forward,2 steps
backward, Total 4
5 
min 
 Step and punch(Left
& Right)
 Step forward with
one leg and punch
the air with the
arm on the same
side.
 Total 5 minutes
 Lateral stepping(Left
& Right)*
 20 x repetitions
each
 Alternating High
knees to elbow*
 Flex the hip and
knee in standing,
then raise the knee
until it can be
touched by the
elbow on the same
side of the body
without bending
over.
 3 x 10 repetitions
 Walking on the spot  2 minutes
1 minute water break 
Improve quality of life 
Improved cardio-vascular 
function (endurance and 
fitness) 
Improved functionality 
Functional strengthening 
and cardiovascular 
training 
 Ball transfer over
obstacle course
 Challenge ends
when each
participant has
completed the
course.
 Participants are
divided into 3
equal teams.  One
by one,
participants have
to fill a material
shopping bag with
 Participants are
warned that they
must not fall over
the cones, but
must rather do the
activity slower to
prevent any
injuries.
 Material shopping
bags are used in
the place of plastic
shopping bags as
 The first team to have every
member complete the course
wins the challenge.
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10 hockey balls and 
transfer the balls 
into a crate 10 m 
away whilst 
walking around 
and over various 
cones acting as 
obstacles along the 
way.  Participants 
should then race 
back to their team 
at the starting 
position.   
plastic shopping 
bags may tear and 
the material 
shopping bags are 
also more 
environmental 
friendly.   
Ending off for programme: 
 Educational session - participants were briefed regarding the definition of hypertension; diabetes mellitus type II, joint pain being obese and what self management 
means. The steps of self management were discussed in detail with the participants.  Workbook pages 2-9. 
Provide home advice:   
Need to complete their goals as set out in the workbook and must try and achieve their goals. 
Drink plenty of water.   
Reduce daily salt and fat intake. 
Increase physical activity levels. 
Wear the pedometer all the time. 
Variety of exercises included: 
Target heart rate, mobility, muscle strengthening, muscle stretches, balance 
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EXERCISE PRESCRIPTION – Week 2 
Motivational Factor of Exercise Programme: 
To lower blood pressure 
To lower blood glucose levels 
To lose weight 
To increase physical activity levels 
Client (group) specifications/risks/precautions: 
Vital signs of each participant- recently measured and available 
Correct use of medication  
Use of beta-blockers 
Participants may use assistive devices 
Additional pathologies/lifestyle diseases 
Attention to safety of the environment  
Participant should be able to take own heart rate/pulse (teach participants) 
Research assistant available during exercise class to monitor heart rate 
Calculate the target heart rate for each participant 
Beginning of programme: 
Organise area: Sufficient chairs and water available.  
Obstacles in hall removed.  
Music available. 
All equipment available and ready for use:  balls, bags etc. 
Sphygmomanometer available. 
Information to participants: Should not feel out of breath, light headed, nauseas. 
Each participant should take their resting heart rate or research assistants should take heart rates of each participant. 
Para-medic available in hall for emergencies.    
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Exercises: 
Functional outcome 
Purpose of exercise 
(muscles and joints) 
(Type of exercise) 
Description of exercise 
Frequency, Intensity & 
Time 
Biomechanical 
safety/risks 
Objective measure of progress 
Warm-up 
Dynamic warm-up 
Dance: 
 5 minutes
 Participants may
rest as they feel
necessary.  Not applicable
 3 x steps left &
clap
 3 x steps right &
clap
 3 x steps forward
& clap
 3 x steps in place
(alternating trunk
flexion/extension
& clap with each
step)
 Turn 90˚ left
Repeat 
Improve quality of life 
General mobility and 
increase flexibility 
Stretching and warming 
up of muscles 
 Neck rotation to Left
and hold
 3 x 10 second hold  Participants may
rest as they feel
necessary.
 Participants are
instructed that
they should only
feel a slight stretch
and no pain.
 If participant’s
heart rate or blood
pressure is
 Participant should maintain
normal neck range of motion.
 Participants should maintain
normal gleno-humeral range
of motion.
 Participant should maintain
normal trunk range of
movement.
 Participants should maintain
functional hip and trunk
 Neck rotation to
Right and hold
 3 x 10 second hold
 Neck flexion and
hold
 3 x 10 second hold
 Lateral neck flexion
to Left and hold
 3 x 10 second hold
 Lateral neck flexion
to Right and hold
 3 x 10 second hold
 Shoulder elevation
and roll shoulder
anterior
 3 x 10 repetitions
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 Shoulder elevation
and roll shoulder
posterior
 3 x 10 repetitions unstable they 
should not perform 
bilateral shoulder 
flexion activities. 
 Participants are
allowed to sit and
perform activities if
they feel unstable.
 Research assistants
should correct
performing of
stretches and
should ensure that
participants do not
over stretch the
muscles.
movements 
 Arm circles of
increasing
circumference (with
bilateral upper limbs
in 90˚Abduction)
 3 x 10 repetitions
 Make circles in the
air with
outstretched arms,
make the circles
bigger as time goes
on/on command.
 Posterior Deltoid
stretch bilaterally
 3 x 10 second hold
 Pull arm across
body, provide
overpressure with
opposite arm.
Should feel stretch
in back of the
shoulder.
 Triceps stretch
bilaterally
 3 x 10 second hold
 Try to touch hand
to back of shoulder
on same side,
provide
overpressure with
opposite arm in a
posterior direction.
Should feel stretch
in back of the arm.
 Trunk Rotations to
Left & Right
 Rotate as far as
possible to left and
right, while keeping
hips still.
 3 x 10 repetitions
 Standing bilateral
hamstring stretch –
 Rounding of the
lower back is not
10 
keep legs straight 
whilst flexing at the 
hips to try and touch 
the toes. 
allowed. 
 3 x 10 second hold
1 minute water break 
Improve quality of life 
Improved cardio-vascular 
function (endurance and 
fitness) 
Improved functionality 
Muscle Strengthening 
and Cardiovascular 
training 
 Walking on the spot  2 minutes
 Participants are
allowed to hold
onto chair for
balance/assistance.
 Participants may
rest as they feel
necessary.
 Participant should be able to
individually train at their own
target heart rate or decrease
the number of resting periods
that they chose to take.
 Participants should maintain
their muscle strength in the
upper and lower limbs.
 Half Squats  Perform a squat
without moving
into pain or
extreme
stiffness/approxima
tely half of active
range of
movement.
 4 x 10 repetitions
 Walking on the spot  Increase speed
every minute.
 2 minutes
 Half squat with
isometric hold
 Perform a squat
without moving
into pain or
extreme
stiffness/approxim
ately half of active
range of
movement.
 5 x 10 second holds
 Marching  2 x steps
forward,2 steps
backward, Total 4
11 
min 
 Step and punch(Left
& Right)
 Step forward with
one leg and punch
the air with the
arm on the same
side.
 Total 5 minutes
 Lateral stepping(Left
& Right)*
 20 x repetitions
each
 Alternating High
knees to elbow*
 Flex the hip and
knee in standing,
then raise the knee
until it can be
touched by the
elbow on the same
side of the body
without bending
over.
 3 x 10 repetitions
 Walking on the spot  2 minutes
1 minute water break 
Improve quality of life 
Improved cardio-vascular 
function (endurance and 
fitness) 
Improved functionality 
Functional strengthening 
and cardiovascular 
training 
 Ball transfer over
obstacle course
 Challenge ends
when each
participant has
completed the
course.
 Participants are
divided into 3
equal teams.  One
by one,
participants have
to fill a material
shopping bag with
 Participants are
warned that they
must not fall over
the cones, but
must rather do the
activity slower to
prevent any
injuries.
 Material shopping
bags are used in
the place of plastic
shopping bags as
 The first team to have every
member complete the course
wins the challenge.
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10 hockey balls and 
transfer the balls 
into a crate 10 m 
away whilst 
walking around 
and over various 
cones acting as 
obstacles along the 
way.  Participants 
should then race 
back to their team 
at the starting 
position.   
plastic shopping 
bags may tear and 
the material 
shopping bags are 
also more 
environmental 
friendly.   
Ending off for programme: 
 Educational session – The importance of exercise and the type of exercises were discussed.  Examples of exercises performed correctly were given to participants by the 
group leader.  Workbook pages 10 – 20. 
Provide home advice:   
Need to complete their goals as set out in the workbook and must try and achieve their goals. 
Drink plenty of water.   
Reduce daily salt and fat intake. 
Increase physical activity levels. 
Variety of exercises included: 
Target heart rate, mobility, muscle strengthening, muscle stretches, balance 
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EXERCISE PRESCRIPTION – Week 3 
Motivational Factor of Exercise Programme: 
To lower blood pressure 
To lower blood glucose levels 
To lose weight 
To increase physical activity levels 
Client (group) specifications/risks/precautions: 
Vital signs of each participant- recently measured and available 
Correct use of medication  
Use of beta-blockers 
Participants may use assistive devices 
Additional pathologies/lifestyle diseases 
Attention to safety of the environment  
Participant should be able to take own heart rate/pulse (teach participants) 
Research assistant available during exercise class to monitor heart rate 
Calculate the target heart rate for each participant 
Beginning of programme: 
Organise area: Sufficient chairs and water available.  
Obstacles in hall removed.  
Music available. 
All equipment available and ready for use:  balls, bags etc. 
Sphygmomanometer available. 
Information to participants: Should not feel out of breath, light headed, nauseas. 
Each participant should take their resting heart rate or research assistants should take heart rates of each participant. 
Para-medic available in hall for emergencies.    
Note: 
One participant who fell at home and had an ulcer on her right lower leg were encouraged to sit while performing stretches and walk on the spot while in the sitting position to relieve some of the 
discomfort she experienced.   
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Exercises: 
 
Functional outcome 
Purpose of exercise 
(muscles and joints) 
(Type of exercise) 
Description of exercise 
Frequency, Intensity & 
Time 
Biomechanical 
safety/risks 
Objective measure of progress 
 
 
 
 
 
 
 
Warm-up 
 
 
 
 
 
 
 
 
Dynamic warm-up 
Dance: 
 5 minutes 
 Participants may 
rest as they feel 
necessary. 
 
 
 Not applicable 
 3 x steps left & 
clap 
 3 x steps right & 
clap 
 3 x steps forward 
& clap 
 3 x steps in place 
(alternating trunk 
flexion/extension 
& clap with each 
step) 
 Turn 90˚ left  
Repeat 
Improve quality of life 
 
General mobility and 
increase flexibility 
 
Stretching and warming 
up of muscles 
 Neck rotation to Left 
and hold 
 3 x 10 second hold  Participants may 
rest as they feel 
necessary. 
 
 Participants are 
instructed that 
they should only 
feel a slight stretch 
and no pain. 
 
 If participant’s 
heart rate or blood 
pressure is 
 Participant should maintain 
normal neck range of motion. 
 
 Participants should maintain 
normal gleno-humeral range 
of motion. 
 
 Participant should maintain 
normal trunk range of 
movement. 
 
 Participants should maintain 
functional hip and trunk 
 Neck rotation to 
Right and hold 
 3 x 10 second hold 
 Neck flexion and 
hold 
 3 x 10 second hold 
 Lateral neck flexion 
to Left and hold 
 3 x 10 second hold 
 Lateral neck flexion 
to Right and hold 
 3 x 10 second hold 
 Shoulder elevation 
and roll shoulder 
anterior 
 3 x 10 repetitions 
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 Shoulder elevation
and roll shoulder
posterior
 3 x 10 repetitions unstable they 
should not perform 
bilateral shoulder 
flexion activities. 
 Participants are
allowed to sit and
perform activities if
they feel unstable.
 Research assistants
should correct
performing of
stretches and
should ensure that
participants do not
over stretch the
muscles.
movements. 
 Arm circles of
increasing
circumference (with
bilateral upper limbs
in 90˚Abduction)
 3 x 10 repetitions
 Make circles in the
air with
outstretched arms,
make the circles
bigger as time goes
on/on command.
 Posterior Deltoid
stretch bilaterally
 3 x 10 second hold
 Pull arm across
body, provide
overpressure with
opposite arm.
Should feel stretch
in back of the
shoulder.
 Triceps stretch
bilaterally
 3 x 10 second hold
 Try to touch hand
to back of shoulder
on same side,
provide
overpressure with
opposite arm in a
posterior direction.
Should feel stretch
in back of the arm.
 Trunk Rotations to
Left & Right
 Rotate as far as
possible to left and
right, while keeping
hips still.
 3 x 10 repetitions
 Standing bilateral  Rounding of the
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hamstring stretch – 
keep legs straight 
whilst flexing at the 
hips to try and touch 
the toes 
lower back is not 
allowed. 
 3 x 10 second hold 
 
 
1 minute water break 
 
 
 
Improve quality of life 
 
Improved cardio-vascular 
function (endurance and 
fitness) 
 
Improved functionality 
 
Muscle Strengthening 
and Cardiovascular 
training 
 
 Walking on the spot  2 minutes 
 
 Participants are 
allowed to hold 
onto chair for    
balance/assistance. 
 
 Participants may 
rest as they feel 
necessary. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Participant should be able to 
individually train at their own 
target heart rate or decrease 
the number of resting periods 
that they chose to take.   
 
 Participants should maintain 
their muscle strength in the 
upper and lower limbs.  
 Half Squats 
 
 Perform a squat 
without moving 
into pain or 
extreme 
stiffness/approxima
tely half of active 
range of 
movement. 
 4 x 10 repetitions 
 Walking on the spot  Increase speed 
every minute. 
 2 minutes 
 Half squat with 
isometric hold 
 Perform a squat 
without moving 
into pain or 
extreme 
stiffness/approxim
ately half of active 
range of 
movement. 
 5 x 10 second holds  
 Marching   2 x steps  
forward,2 steps 
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backward, Total 4 
min 
 Step and punch(Left
& Right)
 Step forward with
one leg and punch
the air with the
arm on the same
side.
 Total 5 minutes
 Lateral stepping(Left
& Right)*
 20 x repetitions
each
 Alternating High
knees to elbow*
 Flex the hip and
knee in standing,
then raise the knee
until it can be
touched by the
elbow on the same
side of the body
without bending
over.
 3 x 10 repetitions
 Walking on the spot  2 minutes
1 minute water break 
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Improve quality of life 
Improved cardio-vascular 
function (endurance and 
fitness) 
Improved functionality 
Functional strengthening 
and cardiovascular 
training 
 Ball throwing and
catching
“Over and under” ball 
game 
 1 x 10 rounds
 Each participant
should stand facing
their partner.  They
should then throw
a netball ball to
each other, taking
1 step backward
every time the ball
is returned to the
initial participant.
This was repeated
until both
participants
retreated for at
least 20 m.
 10 x 20 m
 Groups of 5
participants were
formed, with
participants
standing behind
one another.  The
first participant
then passes the
ball down the line
either going above
their head or
sideways.  The
second participant
passes the ball on
to the next
participant through
their legs and
move to the back
 Participants with
uncontrolled
hypertension were
to pass the ball
sideways and not
over their head
during the ball
activity.
 The first team to have every
member complete the course
wins the challenge.
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of the line.  This 
sequence is 
repeated until the 
line moves back a 
total of 20 m.  The 
first team to have 
every member 
across the 20 m 
mark wins the 
challenge. 
Ending off for programme:  
Educational session – Managing the common symptoms of musculoskeletal disorders were discussed.   Joint pain, swelling and stiffness were discussed as well as 
management of the condition.  The management included the use of medication for pain, elevation of limbs for decreasing possible swelling.  Exercises were explained to 
increase flexibility and mobility and to decrease joint pain and stiffness.  Participants were briefed how to manage their pain as well as swelling in their joints.  Examples of 
assistive devices were shown to patients.  Workbook pages 21-28. 
Provide home advice:  
Need to complete their goals as set out in the workbook and must try and achieve their goals. 
Drink plenty of water.   
Reduce daily salt and fat intake. 
Increase physical activity levels. 
Variety of exercises included: 
Target heart rate, mobility, muscle strengthening, muscle stretches, balance 
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EXERCISE PRESCRIPTION – Week 4 
Motivational Factor of Exercise Programme: 
To lower blood pressure 
To lower blood glucose levels 
To lose weight 
To increase physical activity levels 
Client (group) specifications/risks/precautions: 
Vital signs of each patient- recently measured and available 
Correct use of medication  
Use of beta-blockers 
Patients may use assistive devices 
Additional pathologies/lifestyle diseases 
Attention to safety of the environment  
Patient should be able to take own heart rate/pulse (teach patients)  
Research assistant available during exercise class to monitor heart rate 
Calculate the target heart rate for each patient 
Beginning of programme: 
Organise area: Sufficient chairs and water available.  
Obstacles in hall removed.  
Music available. 
All equipment available and ready for use:  balls, bags etc. 
Sphygmomanometer available. 
Information to patients: Should not feel out of breath, light headed, nauseas. 
Each participant should take their resting heart rate or research assistants should take heart rates of each participant. 
Para-medic available in hall for emergencies.    
Note: 
One participant complained of feeling dizzy and experiencing blurred vision – the researcher took her to the nearby clinic for assessment. 
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Exercises: 
Functional outcome 
Purpose of exercise 
(muscles and joints) 
(Type of exercise) 
Description of exercise 
Frequency, Intensity & 
Time 
Biomechanical 
safety/risks 
Objective measure of progress 
Warm-up 
Dynamic warm-up 
Dance: 
 5 minutes
 Participants may
rest as they feel
necessary.
 Not applicable
 3 x steps left &
clap
 3 x steps right &
clap
 3 x steps forward
& clap
 3 x steps in place
(alternating trunk
flexion/extension
& clap with each
step)
 Turn 90˚ left
Repeat 
Improve quality of life 
General mobility and 
increase flexibility 
Stretching and warming 
up of muscles 
 Neck rotation to Left
and hold
 3 x 10 second hold  Participants may
rest as they feel
necessary.
 Participants are
instructed that
they should only
feel a slight stretch
and no pain.
 Participant should maintain
normal neck range of motion.
 Participants should maintain
normal gleno-humeral range
of motion.
 Patient should maintain
normal trunk range of
movement.
 Participants should maintain
functional hip and trunk
movements.
 Neck rotation to
Right and hold
 3 x 10 second hold
 Neck flexion and
hold
 3 x 10 second hold
 Lateral neck flexion
to Left and hold
 3 x 10 second hold
 Lateral neck flexion
to Right and hold
 3 x 10 second hold
 Shoulder elevation
and roll shoulder
anterior
 3 x 10 repetitions
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 Shoulder elevation
and roll shoulder
posterior
 3 x 10 repetitions
 If participant’s
heart rate or blood
pressure is
unstable they
should not perform
bilateral shoulder
flexion activities.
 Participants are
allowed to sit and
perform activities if
they feel unstable.
 Research assistants
should correct
performing of
stretches and
should ensure that
participants do not
over stretch the
muscles.
 Arm circles of
increasing
circumference (with
bilateral upper limbs
in 90˚Abduction)
 3 x 10 repetitions
 Make circles in the
air with
outstretched arms,
make the circles
bigger as time goes
on/on command.
 Posterior Deltoid
stretch bilaterally
 3 x 10 second hold
 Pull arm across
body, provide
overpressure with
opposite arm.
Should feel stretch
in back of the
shoulder.
 Triceps stretch
bilaterally
 3 x 10 second hold
 Try to touch hand
to back of shoulder
on same side,
provide
overpressure with
opposite arm in a
posterior direction.
Should feel stretch
in back of the arm.
 Trunk Rotations to
Left & Right
 Rotate as far as
possible to left and
right, while keeping
hips still.
 3 x 10 repetitions
 Standing bilateral
hamstring stretch –
 Rounding of the
lower back is not
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keep legs straight 
whilst flexing at the 
hips to try and touch 
the toes 
allowed. 
 3 x 10 second hold
1 minute water break 
Improve quality of life 
Improved cardio-vascular 
function (endurance and 
fitness) 
Improved functionality 
Muscle Strengthening 
and Cardiovascular 
training 
 Walking on the spot  2 minutes
 Participants are
allowed to hold
onto chair for
balance/assistance.
 Participants may
rest as they feel
necessary.
 Participant should be able to
individually train at their own
target heart rate or decrease
the number of resting periods
that they chose to take.
 Participants should maintain
their muscle strength in the
upper and lower limbs.
 Half Squats  Perform a squat
without moving
into pain or
extreme
stiffness/approxima
tely half of active
range of
movement.
 4 x 10 repetitions
 Walking on the spot  Increase speed
every minute.
 2 minutes
 Half squat with
isometric hold
 Perform a squat
without moving
into pain or
extreme
stiffness/approxim
ately half of active
range of
movement.
 5 x 10 second holds
 Marching  2 x steps
forward,2 steps
backward, Total 4
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min 
 Step and punch(Left
& Right)
 Step forward with
one leg and punch
the air with the
arm on the same
side.
 Total 5 minutes
 Lateral stepping(Left
& Right)*
 20 x repetitions
each
 Alternating High
knees to elbow*
 Flex the hip and
knee in standing,
then raise the knee
until it can be
touched by the
elbow on the same
side of the body
without bending
over.
 3 x 10 repetitions
 Walking on the spot  2 minutes
1 minute water break 
Improve quality of life 
Improved cardio-vascular 
function (endurance and 
fitness) 
Improved functionality 
Functional strengthening 
and cardiovascular 
training 
 Ball throwing and
catching
 1 x 10 rounds
 Each participant
should stand facing
their partner.  They
should then throw
a netball ball to
each other, taking
1 step backward
every time the ball
is returned to the
initial participant.
This was repeated
 The first team to have every
member complete the course
wins the challenge.
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 “Over and under”
ball game
until both 
participants 
retreated for at 
least 20 m.   
 10 x 20 m
Groups of 5
participants were
formed, with
participants standing
behind one another.
The first participant
then passes the ball
down the line either
going above their head
or sideways.  The
second participant
passes the ball on to
the next participant
through their legs and
move to the back of the
line.  This sequence is
repeated until the line
moves back a total of
20 m.  The first team to
have every member
across the 20 m mark
wins the challenge.
 Participants with
uncontrolled
hypertension were
to pass the ball
sideways and not
over their head
during the ball
activity.
Ending off for programme: 
 Educational session – Stress and stress full situations was discussed as it was found that stress was a contributing factor to majority of the participants health conditions. 
How to deal with stress effectively was also discussed in the group.  A relaxation technique was taught to participants.  Workbook pages 29 – 37. 
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Provide home advice:  
Need to complete their goals as set out in the workbook and must try and achieve their goals. 
Drink plenty of water.   
Reduce daily salt and fat intake. 
Increase physical activity levels. 
Variety of exercises included: 
Target heart rate, mobility, muscle strengthening, muscle stretches, balance 
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EXERCISE PRESCRIPTION – Week 5 
Motivational Factor of Exercise Programme: 
To lower blood pressure 
To lower blood glucose levels 
To lose weight 
To increase physical activity levels 
Client (group) specifications/risks/precautions: 
Vital signs of each patient- recently measured and available 
Correct use of medication  
Use of beta-blockers 
Patients may use assistive devices 
Additional pathologies/lifestyle diseases 
Attention to safety of the environment  
Patient should be able to take own heart rate/pulse (teach patients)  
Research assistant available during exercise class to monitor heart rate 
Calculate the target heart rate for each patient 
Beginning of programme: 
Organise area: Sufficient chairs and water available.  
Obstacles in hall removed.  
Music available. 
All equipment available and ready for use:  balls, bags etc. 
Sphygmomanometer available. 
Information to patients: Should not feel out of breath, light headed, nauseas. 
Each participant should take their resting heart rate or research assistants should take heart rates of each participant. 
Para-medic available in hall for emergencies.    
Note: 
The participants who did not feel well the previous week returned and informed the researcher that she was admitted to hospital for two days for tests.  She received different medication for her blood 
pressure and is doing well. 
One participant fell on her knee while walking to the shop and complained that her knee was painful (3/10).  Both the researcher and the paramedic assessed the knee.  There was no swelling, all ranges 
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and muscle strength were normal.  Upon assessment it was found that her patella was removed during previous knee surgery.  She was given a support bandage, did not engage in activities of the lower 
limb and was referred to physiotherapy services for treatment. 
Exercises: 
Functional outcome 
Purpose of exercise 
(muscles and joints) 
(Type of exercise) 
Description of exercise 
Frequency, Intensity & 
Time 
Biomechanical 
safety/risks 
Objective measure of progress 
Warm-up 
Dynamic warm-up 
Dance:  5 minutes  Participants may
rest as they feel
necessary.
 Alternate squats
and lunges each
round
 Alternate one
repetition of
overhead reaches
with one repetition
of knee touches.
 Participants with
unstable
hypertension must
not do the
overhead activities.
 Not applicable
 3 x steps left &
clap
 3 x steps right &
clap
 3 x steps forward
& clap
 3 x steps in place
(alternating trunk
flexion/extension
& clap with each
step)
 Squats/lunges to
the Left side and
the Right side.
 1 x 10 repetitions
 Bilateral
overhead reach
with arms
 1 x 5 repetitions
 Bilateral knee
touch with arms
 1 x 5 repetitions
 Turn 90˚ left
Repeat 
Improve quality of life 
General mobility and 
increase flexibility 
Stretching and warming 
up of muscles 
 Neck rotation to Left
and hold
 3 x 20 second hold  Participants may
rest as they feel
necessary.
 Participants are
instructed that
 Participant should maintain
normal neck range of motion.
 Participants should maintain
normal gleno-humeral range
of motion.
 Neck rotation to
Right and hold
 3 x 20 second hold
 Neck flexion and hold  3 x 20 second hold
 Lateral neck flexion  3 x 20 second hold
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to Left and hold they should only 
feel a slight stretch 
and no pain. 
 If participant’s
heart rate or blood
pressure is
unstable they
should not perform
bilateral shoulder
flexion activities.
 Participants are
allowed to sit and
perform activities if
they feel unstable.
 Research assistants
should correct
performing of
stretches and
should ensure that
participants do not
over stretch the
muscles.
 Patient should maintain
normal trunk range of
movement.
 Participants should maintain
functional hip and trunk
movements.
 Lateral neck flexion
to Right and hold
 3 x 20 second hold
 Shoulder elevation
and roll shoulder
anterior
 3 x 20 repetitions
 Shoulder elevation
and roll shoulder
posterior
 3 x 20 repetitions
 Arm circles of
increasing
circumference (with
bilateral upper limbs
in 90˚Abduction)
 3 x 20 repetitions
 Make circles in the
air with
outstretched arms,
make the circles
bigger as time goes
on/on command.
 Posterior Deltoid
stretch bilaterally
 3 x 20 second hold
 Pull arm across
body, provide
overpressure with
opposite arm.
Should feel stretch
in back of the
shoulder.
 Triceps stretch
bilaterally
 3 x 20 second hold
 Try to touch hand
to back of shoulder
on same side,
provide
overpressure with
opposite arm in a
posterior direction.
Should feel stretch
in back of the arm.
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 Trunk Rotations to
Left & Right
 Rotate as far as
possible to left and
right, while keeping
hips still.
 3 x 20 repetitions
 Standing bilateral
hamstring stretch –
keep legs straight
whilst flexing at the
hips to try and touch
the toes
 Rounding of the
lower back is not
allowed.
 3 x 20 second hold
1 minute water break 
Improve quality of life 
Improved cardio-
vascular function 
(endurance and fitness) 
Improved functionality 
Muscle Strengthening 
and Cardiovascular 
training 
 Walking on the spot  5 minutes
 Participants are
allowed to hold
onto chair for
balance/assistance.
 Participants may
rest as they feel
necessary.  Participant should be able to
individually train at their own
target heart rate or decrease
the number of resting periods
that they chose to take.
 Participants should maintain
their muscle strength in the
 Half Squats  Perform a squat
without moving
into pain or
extreme
stiffness/approxima
tely half of active
range of
movement.
 5 x 10 repetitions
 Walking on the spot  Increase speed
every minute.
 5 minutes
 Half squat with
isometric hold
 Perform a squat
without moving
into pain or
extreme
stiffness/approxim
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ately half of active 
range of 
movement. 
 7 x 10 second holds  
upper and lower limbs.  
 Marching   2 x steps  
forward,2 steps 
backward, Total 8 
min 
 Step and punch(Left 
& Right) 
 Step forward with 
one leg and punch 
the air with the 
arm on the same 
side. 
 Total 8 minutes 
 Lateral stepping(Left 
& Right)* 
 20 x repetitions 
each  
 Alternating High 
knees to elbow* 
 Flex the hip and 
knee in standing, 
then raise the knee 
until it can be 
touched by the 
elbow on the same 
side of the body 
without bending 
over. 
 5 x 10 repetitions 
 Walking on the spot  5 minutes 
1 minute water break 
 
32 
 
Improve quality of life 
 
Improved cardio-
vascular function 
(endurance and fitness) 
 
Improved functionality 
 
Functional strengthening 
and cardiovascular 
training 
 Ball throwing and 
catching 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 “Over and under” ball 
game 
 1 x 10 rounds 
 Each participant 
should stand facing 
their partner.  They 
should then throw 
a netball ball to 
each other, taking 
1 step backward 
every time the ball 
is returned to the 
initial participant.  
This was repeated 
until both 
participants 
retreated for at 
least 20 m.   
 
 10 x 20 m 
Groups of 5 
participants were 
formed, with 
participants standing 
behind one another.  
The first participant 
then passes the ball 
down the line either 
going above their head 
or sideways.  The 
second participant 
passes the ball on to 
the next participant 
through their legs and 
move to the back of the 
line.  This sequence is 
repeated until the line 
moves back a total of 
 
 
 
 
 
 
 
 
 
 
 
 
 Participants with 
uncontrolled 
hypertension were 
to pass the ball 
sideways and not 
over their head 
during the ball 
activity. 
 
 The first team to have every 
member complete the course 
wins the challenge. 
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20 m.  The first team to 
have every member 
across the 20 m mark 
wins the challenge.   
Ending off for programme: 
 Educational session – The importance of a healthy diet and the roles of different types of food in the body.  The protective mechanism of certain foods was discussed, as 
well as the energy provided by certain foods.  Food that builds up in the body was also discussed.  Participants were also educated on portion size as well as the 
recommended daily allowance of carbohydrates, protein and fat.  Workbook pages 38 – 46. 
Provide home advice:  
Need to complete their goals as set out in the workbook and must try and achieve their goals. 
Drink plenty of water.   
Reduce daily salt and fat intake. 
Increase the physical activity levels. 
Variety of exercises included: 
Target heart rate, mobility, muscle strengthening, muscle stretches, balance 
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EXERCISE PRESCRIPTION – Week 6 
Motivational Factor of Exercise Programme: 
To lower blood pressure 
To lower blood glucose levels 
To lose weight 
To increase physical activity levels 
Client (group) specifications/risks/precautions: 
Vital signs of each patient- recently measured and available 
Correct use of medication  
Use of beta-blockers 
Patients may use assistive devices 
Additional pathologies/lifestyle diseases 
Attention to safety of the environment  
Patient should be able to take own heart rate/pulse (teach patients)  
Research assistant available during exercise class to monitor heart rate 
Calculate the target heart rate for each patient 
Beginning of programme: 
Organise area: Sufficient chairs and water available.  
Obstacles in hall removed.  
Music available. 
All equipment available and ready for use:  balls, bags etc. 
Sphygmomanometer available. 
Information to patients: Should not feel out of breath, light headed, nauseas. 
Each participant should take their resting heart rate or research assistants should take heart rates of each participant. 
Para-medic available in hall for emergencies.    
Note: 
The patient with the knee injury returned without the support bandage, informed the researcher that she received treatment from physiotherapy and was not experiencing any pain or discomfort.  She 
continued with the exercise programme after being instructed to exercise within limits and inform the researcher immediately if she experienced any discomfort or pain.   
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Exercises: 
Functional outcome 
Purpose of exercise 
(muscles and joints) 
(Type of exercise) 
Description of exercise 
Frequency, Intensity & 
Time 
Biomechanical 
safety/risks 
Objective measure of progress 
Warm-up 
Dynamic warm-up 
Dance:  5 minutes  Participants may
rest as they feel
necessary.
 Alternate squats
and lunges each
round
 Alternate one
repetition of
overhead reaches
with one repetition
of knee touches.
 Participants with
unstable
hypertension must
not do the
overhead activities.
 Not applicable
 3 x steps left &
clap 
 3 x steps right &
clap
 3 x steps forward
& clap
 3 x steps in place
(alternating trunk
flexion/extension
& clap with each
step)
 Squats/lunges to
the Left side and
the Right side.
 1 x 10 repetitions
 Bilateral
overhead reach
with arms
 1 x 5 repetitions
 Bilateral knee
touch with arms
 1 x 5 repetitions
 Turn 90˚ left
Repeat 
Improve quality of life 
General mobility and 
increase flexibility 
Stretching and warming 
up of muscles 
 Neck rotation to Left
and hold
 3 x 20 second hold  Participants may
rest as they feel
necessary.
 Participants are
 Participant should maintain
normal neck range of motion.
 Participants should maintain
normal gleno-humeral range
 Neck rotation to
Right and hold
 3 x 20 second hold
 Neck flexion and hold  3 x 20 second hold
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 Lateral neck flexion
to Left and hold
 3 x 20 second hold instructed that 
they should only 
feel a slight stretch 
and no pain. 
 If participant’s
heart rate or blood
pressure is
unstable they
should not perform
bilateral shoulder
flexion activities.
 Participants are
allowed to sit and
perform activities if
they feel unstable.
 Research assistants
should correct
performing of
stretches and
should ensure that
participants do not
over stretch the
muscles.
of motion. 
 Patient should maintain
normal trunk range of
movement.
 Participants should maintain
functional hip and trunk
movements.
 Lateral neck flexion
to Right and hold
 3 x 20 second hold
 Shoulder elevation
and roll shoulder
anterior
 3 x 20 repetitions
 Shoulder elevation
and roll shoulder
posterior
 3 x 20 repetitions
 Arm circles of
increasing
circumference (with
bilateral upper limbs
in 90˚Abduction)
 3 x 20 repetitions
 Make circles in the
air with
outstretched arms,
make the circles
bigger as time goes
on/on command.
 Posterior Deltoid
stretch bilaterally
 3 x 20 second hold
 Pull arm across
body, provide
overpressure with
opposite arm.
Should feel stretch
in back of the
shoulder.
 Triceps stretch
bilaterally
 3 x 20 second hold
 Try to touch hand
to back of shoulder
on same side,
provide
overpressure with
opposite arm in a
posterior direction.
Should feel stretch
in back of the arm.
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 Trunk Rotations to
Left & Right
 Rotate as far as
possible to left and
right, while keeping
hips still.
 3 x 20 repetitions
 Standing bilateral
hamstring stretch –
keep legs straight
whilst flexing at the
hips to try and touch
the toes
 Rounding of the
lower back is not
allowed.
 3 x 20 second hold
1 minute water break 
Improve quality of life 
Improved cardio-
vascular function 
(endurance and fitness) 
Improved functionality 
Muscle Strengthening 
and Cardiovascular 
training 
 Walking on the spot  5 minutes
 Participants are
allowed to hold
onto chair for
balance/assistance.
 Participants may
rest as they feel
necessary.  Participant should be able to
individually train at their own
target heart rate or decrease
the number of resting periods
that they chose to take.
 Participants should maintain
their muscle strength in the
 Half Squats  Perform a squat
without moving
into pain or
extreme
stiffness/approxima
tely half of active
range of
movement.
 5 x 10 repetitions
 Walking on the spot  Increase speed
every minute.
 5 minutes
 Half squat with
isometric hold
 Perform a squat
without moving
into pain or
extreme
stiffness/approxim
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ately half of active 
range of 
movement. 
 7 x 10 second holds
upper and lower limbs. 
 Marching  2 x steps
forward,2 steps
backward, Total 8
min
 Step and punch(Left
& Right)
 Step forward with
one leg and punch
the air with the
arm on the same
side.
 Total 8 minutes
 Lateral stepping(Left
& Right)*
 20 x repetitions
each
 Alternating High
knees to elbow*
 Flex the hip and
knee in standing,
then raise the knee
until it can be
touched by the
elbow on the same
side of the body
without bending
over.
 5 x 10 repetitions
 Walking on the spot  5 minutes
1 minute water break 
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Improve quality of life 
Improved cardio-
vascular function 
(endurance and fitness) 
Improved functionality 
Functional strengthening 
and cardiovascular 
training 
 Ball throwing and
catching
 “Over and under” ball
game
 1 x 10 rounds
 Each participant
should stand facing
their partner.  They
should then throw
a netball ball to
each other, taking
1 step backward
every time the ball
is returned to the
initial participant.
This was repeated
until both
participants
retreated for at
least 20 m.
 10 x 20 m
 Groups of 5
participants were
formed, with
participants
standing behind
one another.  The
first participant
then passes the
ball down the line
either going above
their head or
sideways.  The
second participant
passes the ball on
to the next
participant through
their legs and
 Participants with
uncontrolled
hypertension were
to pass the ball
sideways and not
over their head
during the ball
activity.
 The first team to have every
member complete the course
wins the challenge.
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move to the back 
of the line.  
 This sequence is
repeated until the
line moves back a
total of 20 m.  The
first team to have
every member
across the 20 m
mark wins the
challenge.
Ending off for programme: 
 Educational session – Time was spent on planning the way forward.  Participant received information on how to continue to be a successful self manager of their 
conditions and of their life.  Workbook pages 47 – 50.   
Provide home advice:  
Need to complete their goals as set out in the workbook and must try and achieve their goals. 
Drink plenty of water.   
Reduce daily salt and fat intake. 
Increase the physical activity levels. 
Variety of exercises included: 
Target heart rate, mobility, muscle strengthening, muscle stretches, balance 
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Borg Scale 
01
2
3
4
5
6
7
8
9
10
 •
Nothing at all
Weak
Moderate
Strong
Very Strong
Extremely Strong
All-out effort
How you feel sitting or 
simply standing
Exercise goal: How 
you feel when you  
walk or exercise
How you feel when 
you really push 
yourself
You’re unable to go on
Our trusted brands
Burdick® • HeartCentrix® • Powerheart® • Quinton®
www.cardiacscience.com
Rating of Perceived Exertion 
Borg CR10 Scale
Borg-CR-10 Scale™  © Gunnar Borg 
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8
9
10
11
12
13
14
15
16
17
18
19
20
No activity at all
Light activity
Moderate activity
Hard
Very hard
Very, very hard
All-out effort
How you feel sitting or
simply standing
Exercise goal: How 
you feel when you 
walk or exercise
How you feel when 
you really push 
yourself
You’re unable to go on
Our trusted brands
Burdick® • HeartCentrix® • Powerheart® • Quinton®
www.cardiacscience.com
Borg Scale of 
Perceived Exertion
Borg-RPE Scale®  © Gunnar Borg 
70-00437-01 Rev A
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Intervention study 
Participant data form 
1 
SIMMONDS BATTERY OF FUNCTIONAL TESTS 
Date: _ _ _ _ _ __ _ __ _ _ _ _ __ _ __ _ _ _ _ _            Age: _ _ _ _ _ __ _  ID code _ _ _ _ _ __ _ 
Activity Description Baseline reading After 6 weeks 
15 m walking at preferred speed Walk 7.5 m turn around and walk back to the starting position at preferred 
walking speed. 
15 m walking at fastest speed Walk 8 m turn around and walk back to the start as fast as you can. 
Unloaded forward reach 
(cm) 
Stand adjacent to a wall on which a tape measure is positioned 
horizontally at shoulder height.  Reach forward as far as you can. 
Timed, repeated sit-to-stand Sit in a standard chair – stand up and then sit back down.  Repeat after a 
brief rest. 
1st 2nd AVG 1st 2nd AVG 
Sock test Sit in a standard chair. Put on one loose-fitting sock. 
Loaded forward reach 
(cm) 
Stand adjacent to a wall on which a tape measure is positioned 
horizontally at shoulder height.  Hold a weighted 4.46 kg bar with both 
hands close to your body and at shoulder height.  Reach forward as far as 
you can with the bar in a horizontal position, maintaining hands at shoulder 
height. 
Timed, repeated reach-up Stand facing a wall and reach up as high as you can with both hands.  A 
mark is placed on the wall at the reached distance.  You must reach up 
and return your hands to your side 3 times as fast as you can. 
Distance walked in 6 minutes Walk as far and as fast as you can for 6 minutes.  You are allowed to rest 
if necessary during the 6 minutes. 
Timed belt tie Sit in a standard chair and wrap a standard wrap bandage (approximately 
1 m) around your waist and tie it in from of you. 
2 
BASELINE INFORMATION 
Date: _ _ _ _ _ __ _ __ _ _ _ _ __ _ __ _ _ _ _ __ _ _ 
 ID code _ _ _ _ _ __ _ 
Description Baseline reading After 6 weeks 
Height  (cm) – to nearest 0.1 cm 
Weight  (kg) – accurate to 0.05 kg 
Body Mass Index (weight in kg ÷ height in cm 2)
Blood pressure reading (mmHg) 
Venous plasma glucose concentration (mmol/L) 
Kasch Pulse Recovery test:  pulse rate per minute 
(3 minute step test) 
Resting pulse rate 
Pulse rate 1 min after 
step test 
Resting pulse rate 
Pulse rate 1 min 
after step test 
Cholesterol (lipid metabolism) (mmol/L or mg/dL) 
Medication used Name Dosage 
3 
PEDOMETER READINGS 
Date: _ _ _ _ _ __ _ __ _ _ _ _ __ _ __ _ _ _ _ __ _ _ 
 ID code _ _ _ _ _ __ _ 
Description Baseline reading After 6 weeks 
Step length in cm 
Weight  (kg) – accurate to 0.05 kg 
Pedometer reading 
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Pan African Clinical Trial Registry letter 
THE SOUTH AFRICAN MEDICAL RESEARCH COUNCIL 
Cochrane South Africa  |  PO Box 19070, Tygerberg, 7505  
Tel: +27 (0)21 938 0438  |  Email: cochrane@mrc.co.za  |  Web: www.southafrica.cochrane.org  
19 November 2015 
To Whom It May Concern: 
RE: An investigation into the prevalence and nature of musculoskeletal 
conditions amongst women attending Primary Health Care Clinics, and the 
effectiveness of an intervention program for these patients. 
As project manager for the Pan African Clinical Trial Registry (www.pactr.org) database, it is my 
pleasure to inform you that your application to our registry has been accepted. Your unique 
identification number for the registry is PACTR201511000689333 
Please be advised that you are responsible for updating your trial, or for informing us of changes 
to your trial.  
Additionally, please provide us with copies of your ethical clearance letters as we must have 
these on file (via email, post or fax) at your earliest convenience if you have not already done so. 
Please do not hesitate to contact us at +27 21 938 0835 or email epienaar@mrc.ac.za should 
you have any questions.  
Yours faithfully, 
Elizabeth D Pienaar 
www.pactr.org Project Manager 
+27 021 938 0835
THE SOUTH AFRICAN MEDICAL RESEARCH COUNCIL 
Cochrane South Africa  |  PO Box 19070, Tygerberg, 7505  
Tel: +27 (0)21 938 0438  |  Email: cochrane@mrc.co.za  |  Web: www.southafrica.cochrane.org  
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Intervention study 
Participant information leaflet 
1 
University of Cape Town:  An investigation into musculoskeletal conditions and co-morbidity amongst 
women attending a community clinic and the effectiveness of an intervention programme for patients with 
these conditions. 
Dear Participant 
Introduction 
I, Roline Barnes, am currently a student in Physiotherapy at the University of Cape Town and a lecturer at 
the University of the Free State.   I need to do a research project in order to get my degree. Research is 
simply the process to learn the answer to a question. 
 Title of the research project 
The title of the survey is “An investigation into musculoskeletal conditions and co-morbidity amongst 
women attending a community clinic and the effectiveness of an intervention programme for patients with 
these conditions”. 
Purpose of the survey 
I am interested in knowing what the changes would be in women between the ages of 40 – 64 years with 
joint pain and illnesses (high blood, sugar or overweight), if they receive a workbook with information 
and exercise for six weeks or go about what they normally do.  This can help women to change their 
lifestyles by doing more exercises and looking at what they eat.  It is possible that they may lose weight, 
that their sugar and high blood will be lower, that they will have less pain in their joints and that they may 
move easier. They will help me to tell people in the community that they should exercise more often. 
They will also help me to inform the local government and Department of Health about the exercises and 
how it helped them.  The local government and Department of Health may then place people at the clinics 
that are trained to give patients at the clinics exercises and information when they have joint pain and 
other illnesses.   
INFORMATION LEAFLET 
INTERVENTION STUDY 
2 
Selection of participants 
All women between the ages of 40 – 64 years, who showed with the first questionnaire that they have 
joint pain, sugar, high blood and being overweight and who are willing to come once a week to MUCPP 
for two hours to exercise and receive information for the next six weeks. 
Description of research 
All the women who tell me that they want to take part in the study and have joint pain, sugar, high blood 
and are overweight will be put into two groups.  I will choose 121 women and they will help me to 
choose exercises that they would like and that they think they will enjoy doing.  After the exercises have 
been chosen I will make a workbook that will be used for six weeks.   
The 121 women will then be put into three groups of 37 in each group.  But ten will only be used for the 
test study (pilot study).  This means that five will exercise with me for only three weeks and five will not 
exercise but fill in the forms and have the tests done as explained.  The test study is very important as this 
will show me how I must change things to make them better, before I start with the big study that the 111 
other women will be in.   
Unfortunately I cannot tell them at this stage in which group they will be.  This will only be done after the 
book has been completed and I use a computer to divide the names for myself.  I will then phone them to 
tell them in what group they are and when we will start with the tests in the MUCPP hall.  Please 
remember that they must have a cell phone number and that they must fill their number in on the form 
that I give them to ask if they want to be part of the study. 
The 111 women will also be put into three groups.  Two groups will receive the exercise and information 
workbook.  One group will have 37 participants and they will do exercises and receive information given 
by a physiotherapist or a physiotherapy student in the hall of MUCPP once a week for two hours. This 
they will have to do for six weeks.   The other group, which will also have 37 participants, will go about 
their lives as usual.   All three groups’ sugar readings and cholesterol readings (pricking their finger for a 
drop of blood and getting a reading of a portable machine), blood pressure readings (the same way the 
sister and the clinic always takes the blood pressure reading), weight (standing on a scale) and height 
(standing against a wall, and looking how tall they are) will be taken at the beginning of the programme, 
and at the end of the six weeks.  They will complete forms that will ask them certain questions about 
things that they do during the day, about their health and about their pain.   
3 
Both the workbook and the exercise groups will receive a monitor that they will have to wear all the time 
during the day.  This will measure how much they move each day.  The monitor is the property of the 
researcher and must be given back to me after the six weeks.  They must please take care of the monitor 
and make sure that it does not get lost or damaged. 
If a participant is chosen to be in the exercise group a doctor will ask them certain questions, about the 
medication that they are taking, listen to their heart and lungs, take their blood pressure and see how fit 
they are,  to make sure that they are healthy enough to exercise in the group.  During the exercise session 
a paramedic will also be in the hall to help me if someone does not feel well or gets ill.  
There is little chance for the participants to hurt themselves while doing the exercises, but a little bit of 
pain or the muscles feeling tight after the exercises is normal and should go away after a day or two.  The 
more they exercise, the less pain and muscle tightness they will feel.  I will do everything I can to make 
sure that they do not hurt themselves, but in the unfortunate case this does happen, the physiotherapist or 
physiotherapy student will refer them to National district hospital’s physiotherapy department for 
treatment free of charge.  They are taking part in the exercises as a volunteer / of their own free will and 
they may decide to stop taking part at any time without being punished in any way. 
They will see that there is a number in the top corner of the paper that I will use to write their readings 
(blood sugar, weight and blood pressure) on.  Their name and telephone number will be put on a separate 
paper with the number that only I will have.  Nobody will know their readings (blood sugar, weight, and 
blood pressure readings) - this will protect who the participant is. They will receive no money to do the 
exercises.  All 111 women will receive R20 to come to the allocated times for the test and the filling in of 
the forms, so that the study does not cost the participants any money.  The women taking part in the study 
will not receive any money for taking part and the study will also not cost them any money to take part. 
The women doing the exercises will be given R20 for taxi/bus fees to make sure that they can come to the 
exercise classes once a week for the six weeks.  There might not be direct benefit for the women in the 
group that does not exercise with the physiotherapist for six weeks, or receive the workbook, but the 
information that they will give me is very important so that I can see if the exercises work if I compare 
the information from the three groups.  The women in the group that exercises with the physiotherapist or 
get the workbook might lose some weight, their sugar and high blood can become lower and the pain in 
the joints can also be less.  But this is not for sure.  That is why we are doing the study to see if this will 
make a difference.   
4 
The results of the study might be put in a magazine for doctors, nurses and other people working with 
health, so that they can know that exercises help people with similar pain in the joint and other diseases 
just like the participants.  
If they want to ask anything before we start with the questions, or later on, they can phone me, Roline 
Barnes, at 082 740 1069, or the person supervising me, Prof Jelsma, at 021 – 406 6595.They may also 
contact the University of Cape Town, Faculty of Health Sciences Human Research Ethics Committee 
(contact number: 021 – 406 6411) or the University of the Free State Ethics Committee (contact number: 
051 – 405 2812) if they have any queries/questions or concerns regarding their rights or welfare as 
research participant.  
Thank you 
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Participant informed consent document 
1 
University of Cape Town:  An investigation into the effectiveness of an intervention programme for 
patients with co-morbidities attending community clinics. 
I ____________________________________________________ have read (or had read to me by) 
_____________________________________ the information sheet. 
I understand what is required of me and I have had all my questions answered.  I do not feel that I am 
force to take part in this study and I am doing so of my own free will.  I know that I can withdraw at 
any time if I so wish and that it will not have consequences for me. 
Signed: 
__________________________________ _____________________________ 
Participant  Date and place 
__________________________________ _____________________________ 
Researcher  Date and place 
__________________________________ _____________________________ 
Witness (if necessary)   Date and place 
CONSENT TO PARTICIPATE IN RESEARCH 
INTERVENTION STUDY 
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Comparison of demographic information and health variables survey group  
(with and with out joint pain) compared to the randomised, control trial 
group at baseline 
1 
1.1 Comparison of demographic information of survey participants and 
randomised, control trial participants at baseline 
According to the Shapiro-Wilk test of normality the distribution of the age of the participants for both 
the survey and the randomised, control trial groups did not follow a normal distribution (W = 0.956; p < 
0.0001 and W= 0.956; p = 0.013 respectively).  Figure 1  Histogram of the age distribution of the survey 
and randomised, control trial groupbelow shows the age distribution of the survey and randomised, 
control trial groups. 
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Figure 1  Histogram of the age distribution of the survey and randomised, control trial groups 
The median age of the participants in the survey group was 52 years (inter-quartile range (IQR): 46-58 
years, and range of 40-65 years).  The median age of the participants of the randomised, control trial 
group was 56 years (IQR: 50-61 years and range of 40-64 years) and was significantly higher (p = 0.014) 
than the median age of the survey group as seen in Figure 1  Histogram of the age distribution of the 
survey and randomised, control trial groups 
below. 
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Figure 2  Descriptive statistics regarding the age of the participants in the survey and randomised, control trial groups 
In the survey group 68% of the participants and in the randomised, control trial group 62% of the 
participants were Sesotho speaking, while Isixhosa was the next most spoken language with 18% of 
participants speaking Isixhosa in the survey group and 19% in the randomised, control trial group (Table 
1  Demographic and living conditions of the participants in the survey and randomised, control trial  
group  The marital status of the survey group was slightly different compared to the randomised, control 
trial group with 36% of the participants in the survey group never being married and  46% being 
married, while in the randomised, control trial group the majority of the participants (36%) were never 
married and 33% being married.  The majority of the participants in both the groups owned their own 
brick homes.  The median number of residents per household in the survey was 5 people (IQR: 4-6 
people) which was significantly different (p < 0.000) from the median number of four people (IQR: 3-5 
people) in the randomised, control trial group.   
3 
Table 1  Demographic and living conditions of the participants in the survey and randomised, control trial  group 
Variable Categories 
Survey 
(n = 1376) 
Survey 
percentage 
RCT 
(n = 42) 
RCT 
percentage 
Between Groups 
(Chi-Square test) 
Language 
Sesotho 935 67.95% 26 62% 
Chi-
square=1.45* 
p = 0.484 
Isixhosa 246 17.87% 8 19% 
Setswana 176 12.79% 8 19% 
English 11 0.8% 0 0% 
Afrikaans 2 0.15% 0 0% 
Zulu 4 0.29% 0 0% 
Missing 2 0.15% 0 0% 
Race 
African 1371 99.64% 42 100% 
- 
Coloured 3 0.22% 0 0% 
White 1 0.07% 0 0% 
Missing 1 0.07% 0 0% 
Marital Status 
Married 638 46.37% 14 33% 
Chi-square=5.55 
p =0.062 
Never married 494 35.89% 15 36% 
Widowed/Separated/Divorced 242 17.59% 13 31% 
Missing 2 0.15% 0 0% 
House ownership 
Own 1024 74.42% 35 83% Chi-
square=1.08* 
p = 0.299 
Friend/family 340 24.71% 7 17% 
Other 7 0.51% 0 0% 
Missing 5 0.36% 0 0% 
Type of dwelling 
Brick 1145 83.21% 34 81% Chi-
square=0.06* 
p = 0.807 
Informal 225 16.35% 8 19% 
Missing 6 0.44% 0 0% 
Number of residents 
per household 
Three or less 283 20.56% 21 50% Chi-
square=19.16 
p <.001 
Four or more 1090 79.22% 21 50% 
Missing 3 0.22% 0 0% 
Note that frequency of missing data was not included in Chi-Square analysis. 
*Calculation only included cells greater than 5.
5 
Almost 15% of the participants in the survey were either illiterate or could only read in their home 
language, while all the participants in the randomised, control trial group could read and write as this 
was an inclusion criterion for participation in the randomised, control trial. (Table 2  Education level and 
employment status of the participants in the survey and the randomised, control trial  group)  In the 
survey group 90% of the participants had some level of education, which included primary, secondary or 
tertiary education while 62% of the participants in the randomised, control trial had secondary 
education.  Only 14% of the participants in the survey had full time employment and 18% of the 
participants in the survey were pensioners.  In contrast most of the participants in the randomised, 
control trial group (79%) were unemployed and were pensioners.  Sixty three percent of the participants 
in the survey indicated the reason for unemployment as not being able to find a job, followed by health 
problems 31%.  In the randomised, control trial group 52% of the participants indicated that not being 
able to find a job was the reason for their unemployment while 42% indicated that their health 
problems prevented them from being employed.  Twenty five percent of the participants in the survey 
group received a grant while 33% in the randomised, control trial group received a grant.  The results 
indicate that 58% of the survey group’s participants and 64% of the randomised, control trial group’s 
participants received pension.   
6 
Table 2  Education level and employment status of the participants in the survey and the randomised, control trial  group  
Variable Categories 
Survey 
(n = 1376) 
Survey 
percentage 
RCT 
(n = 42) 
RCT 
percentage 
Between Group 
(Chi-Square test) 
Literacy 
None 164 11.92% 0 0% 
- 
Read only 38 2.76% 0 0% 
Read/write 1171 85.10% 42 100% 
Missing 3 0.22% 0 0% 
Education 
None/Primary 634 46.08% 16 0% 
Chi-square=0.76* 
p = 0.383 
Secondary/Tertiary 741 53.85% 26 62% 
Missing 1 0.07% 0 0% 
Current employment status 
Unemployed/Housewife/Pensioner 1070 77.77% 39 79% 
Chi-square =4.31* 
p = 0.060 
Worker - Full time 296 21.51% 3 0% 
Missing 10 0.72% 0 0% 
Reason for unemployment 
(n = 675 and n =33 ) 
Cannot find work 425 62.96% 17 52% 
- 
Health problems 209 30.96% 14 42% 
Family care 22 3.26% 2 6% 
Disabled 6 0.89% 0 0% 
Husband prevents 4 0.59% 0 0% 
Missing 9 1.34% 0 0% 
Receive grant benefits 
No 1025 74.49% 28 67% 
Chi-square=0.96* 
p = 0.327 
Yes 349 25.36% 14 33% 
Missing 2 0.15% 0 0% 
*Type of grant benefits
(n = 349 and n =14)
Disability 123 35.24% 5 35% 
- 
Pension 202 57.88% 9 64% 
Disability and pension 17 4.87% 0 0% 
Not known 7 2.01% 0 0% 
*Note that the type of grant is for those individuals who indicated that they do receive grant benefits 
Note that frequency of missing data was not included in Chi-Square analysis. 
*Calculation only included cells greater than 5.
8 
In summary, the randomised, control trial group were older, fewer participants were employed and they 
lived in households with a greater number of inhabitants.  
1.2 Comparison of health related information of the survey group and the 
randomised, control trial group 
The median weight, height, BMI and haemoglucose level of the participants in the survey group were 
significantly different (p < 0.05) than from the median values of the participants in the randomised, 
control trial group (Table 3  Health variables of the participants in the survey and the randomised, 
control trial group). The median height of the participants in the survey group was two cm taller than 
the survey participants.  The median BMI value of the participants from both the survey and 
randomised, control trial groups fell within the classification of being obese. 
Table 3  Health variables of the participants in the survey and the randomised, control trial group 
Variable 
Survey RCT Between 
Groups 
(Wilcoxon 
Two-Sample 
test) 
(Z score) 
n Median IQR n Median IQR 
Weight (kg) 1372 80.0 65.0 – 92.7 41 93.8 76.3-100.8 
p =0.007 
(2.72) 
Height (cm) 1370 158 154 – 163 41 156 153.0-159.0 
p = 0.037 
(-2.091) 
BMI (kg/m2) 1370 31.6 26.8 – 37.0 41 37.2 31.8-41.9 
p = 0.0001 
(3.449) 
Haemoglucose (mmol/l) 1366 5.5 4.6 – 7.2 41 5.8 5.4-9.1 
p = 0.006 
(2.735) 
Systolic BP (mmHg) 1369 147 132 – 159 41 143 133.0-155.0 
p = 0.427 
(-0.794) 
Diastolic BP (mmHg) 1369 91 84 - 99 41 92 84.0-99.0 
p = 0.66 
(-0.429) 
(n=41) 
In the survey (20%) of the participants had diabetes mellitus type II compared to 27% in the randomised, 
control trial group.  Most of the participants in the survey (33%) and in the randomised, control trial 
(37%) had stage I hypertension.  Sixty percent of the participants in the survey and 83% in the 
randomised, control trial were obese (Table 4 Health variables of the participants in the survey and the 
randomised, control trial group).  
Table 4 Health variables of the participants in the survey and the randomised, control trial group 
Survey 
(n=1366) 
Survey 
Percentage 
RCT 
(n=41) 
RCT 
Percentage 
Between Groups 
(Chi-Square test) 
Diabetes mellitus type II* 275 
20% 
11 27% 
p = 0.294 
(Chi-square=1.1025) 
Hypertension** (n=1369) (n=41) 
p = 0.726 
(Chi-square=1.313) 
Normal 458 34% 15 37% 
Stage I 499 37% 15 37% 
Stage II 232 17% 8 20% 
Stage III 180 13% 3 7% 
Obesity*** (n=1370) (n=41) 
p < 0.001 
(Chi-square=43.372) 
Underweight 23 2% 0 0% 
Normal 228 17% 3 7% 
Overweight 294 22% 3 7% 
Obese 825 60% 34 83% 
*Diabetes mellitus type II (non-fasting blood glucose >7.8mmol/L)
**Normal: Systolic blood pressure<120-139 Diastolic blood pressure < 80-90 
Stage I hypertension:  Systolic blood pressure 140-159 Diastolic blood pressure 90-99 
Stage 2 hypertension: Systolic blood pressure ≥160-179 Diastolic blood pressure ≥ 100-109 
Stage 3 hypertension: Systolic blood pressure ≥ 180 Diastolic blood pressure ≥110 
***Underweight:  BMI < 18.5; Normal weight: BMI 18.5-24.9; Overweight:  BMI 25-30; Obese:  BMI > 30 = 4 
(n=41) 
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Comparison of health related quality of life experienced between and within 
control and intervention group 
1 
Dimensions for the quality of life experienced by participants in the control and intervention group 
EQ-5D 
Item 
Group Time No problems Some problems Unable 
p-value 
(within-groups) 
(Sign test) 
p-value 
(between groups) 
(Wilxocon Two-
Sample test) 
Mobility 
Control (n=15) 
Baseline 8 7 0 
p = 0.134 
z = 1.500 
Baseline: 
p = 0.178 
Z = 1.346 
After 6 weeks: 
p = 0.034 
z = 2.126 
After 6 weeks 12 3 0 
Intervention (n=22) 
Baseline 17 4 1 
p = 0.074 
z = 1.789 After 6 weeks 22 0 0 
Self-care 
Control 
Baseline 14 1 0 
p = 0.480 
z = -0.707 
Baseline: 
p = 0.844 
z = 0.197 
After 6 weeks: 
p = 0.248 
z = 1.156 
After 6 weeks 14 1 0 
Intervention 
Baseline 21 0 1 
- 
After 6 weeks 22 0 0 
Usual Activities* 
Control 
Baseline 10 5 0 
p = 0.248 
z = 1.155 
Baseline: 
p = 0.362 
Z = 0.912 
After 6 weeks 
p = 0.248 
z= 1.156 
After 6 weeks 14 1 0 
Intervention 
Baseline 18 3 1 
p = 0.134 
z = 1.500 After 6 weeks 22 0 0 
Pain/Discomfort 
Control 
Baseline 3 6 6 
p = 0.149 
z = 1.443 
Baseline: 
p = 0.123 
z= 1.156 
After 6 weeks: 
p = 0.077 
z = 1.768 
After 6 weeks 5 10 0 
Intervention 
Baseline 7 12 3 
p = 0.043 
z = 2.021 
After 6 weeks 14 8 0 
2 
EQ-5D 
Item 
Group Time No problems Some problems Unable 
p-value 
(within-groups) 
(Sign test) 
p-value 
(between groups) 
(Wilxocon Two-
Sample test) 
Anxiety/Depression 
Control 
Baseline 7 4 4 
p = 0.505 
z = 0.667 
Baseline: 
p = 0.700 
z = -0.385 
After 6 weeks: 
p = 0.171 
z = 1.369 
After 6 weeks 9 3 3 
Intervention 
Baseline 6 13 3 
p = 0.010 
z = 2.582 After 6 weeks 17 5 0 
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STROBE checklist 
1 
STROBE guidelines for randomised controlled trials and indication of section where items were addressed 
Section/Topic Item 
No 
Checklist item Reported in 
Title and abstract 1b Identification as a randomised trial in the title 
Structured summary of trial design, methods, results, and conclusions 
Abstract 
Will be specified 
for publication 
Introduction 
 Background/objective 
2a 
2b 
Scientific background and explanation of rationale 
Specific objectives or hypotheses 
Section 1.3 and 
8.1 
Section 1.2 and 
8.1.1 
Trial design 3a 
3b 
Description of trial design (such as parallel, factorial) including allocation ratio 
Important changes to methods after trial commencement (such as eligibility criteria), with reasons 
Section 8.2.1 
N/A 
Participants 4a 
4b 
Eligibility criteria for participants 
Settings and locations where the data were collected 
Section 8.2.2.1 
Section 8.2.4 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when they 
were actually administered 
Section 7.2 
Appendix 27 and 
28 
Outcomes 6a 
6b 
Completely defined pre-specified primary and secondary outcome measures, including how and when they 
were assessed 
Any changes to trial outcomes after the trial commenced, with reasons 
Section 5.2 and 
8.2.3 
Section 8.2.3 and 
8.4.3 
2 
Section/Topic Item 
No 
Checklist item Reported in 
Sample size 7a 
7b 
How sample size was determined 
When applicable, explanation of any interim analyses and stopping guidelines 
Section 8.2.2.3 
N/A 
 Randomisation: 
Sequence 
generation 
8a 
8b 
Method used to generate the random allocation sequence 
Type of randomisation; details of any restriction (such as blocking and block size) 
Section 8.2.2.2 
Section 8.2.2.2 
 Allocation concealment 
 mechanism 
9 Mechanism used to implement the random allocation sequence (such as sequentially numbered containers), 
describing any steps taken to conceal the sequence until interventions were assigned 
Section 8.2.2.2 
Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants 
to interventions 
Section 8.2.2.2 
Blinding 11a 
11b 
If done, who was blinded after assignment to interventions (for example, participants, care providers, those 
assessing outcomes) and how 
If relevant, description of the similarity of interventions 
Section 8.2.7  
N/A 
Statistical methods 12a 
12b 
Statistical methods used to compare groups for primary and secondary outcomes 
Methods for additional analyses, such as subgroup analyses and adjusted analyses 
Section 8.2.8 
Results 
      Participant flow 
 (a diagram is strongly 
recommended) 
13a 
13b 
For each group, the numbers of participants who were randomly assigned, received intended treatment, and 
were analysed for the primary outcome 
For each group, losses and exclusions after randomisation, together with reasons 
Figure 17 and 
8.3.1 
Section 8.3.1 and 
8.3.2 
3 
Section/Topic Item 
No 
Checklist item Reported in 
Recruitment 14a 
14b 
Dates defining the periods of recruitment and follow-up 
Why the trial ended or was stopped 
Section 8.2.2.2  
and 8.2.4 and 
8.2.7  and  Figure 
17 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group Section 8.3 
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the analysis 
was by original assigned groups 
Section 8.3 
Outcomes and 
estimation 
17a 
17b 
For each primary and secondary outcome, results for each group, and the estimated effect size and its 
precision (such as 95% confidence interval) 
For binary outcomes, presentation of both absolute and relative effect sizes is recommended 
Section 8.3 
N/A 
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing 
pre-specified from exploratory 
Section 8.3 
Harms 19 All important harms or unintended effects in each group N/A 
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses Section 8.6 and 
8.7 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings Section 8.6 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant 
evidence 
Section 8.4 – 8.7 
Other information 
Registration 23 Registration number and name of trial registry Section 8.2.7 
4 
Section/Topic Item 
No 
Checklist item Reported in 
Protocol 24 Where the full trial protocol can be accessed, if available N/A 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders Acknowledge 
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